International	PMC5005937	0	13	O	-1	-1	0
Journal	PMC5005937	14	21	O	-1	-1	0
of	PMC5005937	22	24	O	-1	-1	0
Epidemiology	PMC5005937	25	37	O	-1	-1	0
,	PMC5005937	37	38	O	-1	-1	0
2016	PMC5005937	39	43	O	-1	-1	0
,	PMC5005937	43	44	O	-1	-1	0
683–692	PMC5005937	45	52	O	-1	-1	0

doi	PMC5005937	53	56	O	-1	-1	0
:	PMC5005937	56	57	O	-1	-1	0

10.1093	PMC5005937	58	65	O	-1	-1	0
/	PMC5005937	65	66	O	-1	-1	0
ije	PMC5005937	66	69	O	-1	-1	0
/	PMC5005937	69	70	O	-1	-1	0
dyv118	PMC5005937	70	76	O	-1	-1	0
Advance	PMC5005937	77	84	O	-1	-1	0
Access	PMC5005937	85	91	O	-1	-1	0
Publication	PMC5005937	92	103	O	-1	-1	0
Date	PMC5005937	104	108	O	-1	-1	0
:	PMC5005937	108	109	O	-1	-1	0

13	PMC5005937	110	112	O	-1	-1	0
July	PMC5005937	113	117	O	-1	-1	0
2015	PMC5005937	118	122	O	-1	-1	0

Cohort	PMC5005937	123	129	O	-1	-1	0
Profile	PMC5005937	130	137	O	-1	-1	0


	PMC5005937	137	139	O	-1	-1	0

Cohort	PMC5005937	139	145	O	-1	-1	0
Profile	PMC5005937	146	153	O	-1	-1	0


	PMC5005937	153	155	O	-1	-1	0

Cohort	PMC5005937	155	161	O	-1	-1	0
Profile	PMC5005937	162	169	O	-1	-1	0
:	PMC5005937	169	170	O	-1	-1	0

The	PMC5005937	171	174	O	-1	-1	0
Breast	PMC5005937	175	181	O	-1	-1	0
Cancer	PMC5005937	182	188	O	-1	-1	0
Prospective	PMC5005937	189	200	O	-1	-1	0
Family	PMC5005937	201	207	O	-1	-1	0
Study	PMC5005937	208	213	O	-1	-1	0
Cohort	PMC5005937	214	220	O	-1	-1	0
(	PMC5005937	221	222	O	-1	-1	0
ProF	PMC5005937	222	226	O	-1	-1	0
-	PMC5005937	226	227	O	-1	-1	0
SC	PMC5005937	227	229	O	-1	-1	0
)	PMC5005937	229	230	O	-1	-1	0

Mary	PMC5005937	231	235	O	-1	-1	0
Beth	PMC5005937	236	240	O	-1	-1	0
Terry,1,2	PMC5005937	241	250	O	-1	-1	0

*	PMC5005937	250	251	O	-1	-1	0
Kelly	PMC5005937	252	257	O	-1	-1	0
-	PMC5005937	257	258	O	-1	-1	0
Anne	PMC5005937	258	262	O	-1	-1	0
Phillips,3,4,5	PMC5005937	263	277	O	-1	-1	0
Mary	PMC5005937	278	282	O	-1	-1	0
B	PMC5005937	283	284	O	-1	-1	0
Daly,6	PMC5005937	285	291	O	-1	-1	0

Esther	PMC5005937	292	298	O	-1	-1	0
M	PMC5005937	299	300	O	-1	-1	0
John,7,8	PMC5005937	301	309	O	-1	-1	0

Irene	PMC5005937	310	315	O	-1	-1	0
L	PMC5005937	316	317	O	-1	-1	0
Andrulis,9	PMC5005937	318	328	O	-1	-1	0
Saundra	PMC5005937	329	336	O	-1	-1	0
S	PMC5005937	337	338	O	-1	-1	0

Buys,10	PMC5005937	339	346	O	-1	-1	0

David	PMC5005937	347	352	O	-1	-1	0
E	PMC5005937	353	354	O	-1	-1	0
Goldgar,11	PMC5005937	355	365	O	-1	-1	0
Julia	PMC5005937	366	371	O	-1	-1	0

A	PMC5005937	372	373	O	-1	-1	0
Knight,12,13	PMC5005937	374	386	O	-1	-1	0

Alice	PMC5005937	387	392	O	-1	-1	0
S	PMC5005937	393	394	O	-1	-1	0

Whittemore,8	PMC5005937	395	407	O	-1	-1	0

Wendy	PMC5005937	408	413	O	-1	-1	0
K	PMC5005937	414	415	O	-1	-1	0
Chung,14	PMC5005937	416	424	O	-1	-1	0
Carmel	PMC5005937	425	431	O	-1	-1	0
Apicella4	PMC5005937	432	441	O	-1	-1	0
and	PMC5005937	442	445	O	-1	-1	0
John	PMC5005937	446	450	O	-1	-1	0
L	PMC5005937	451	452	O	-1	-1	0
Hopper4	PMC5005937	453	460	O	-1	-1	0

*	PMC5005937	460	461	O	-1	-1	0

1	PMC5005937	462	463	O	-1	-1	0


	PMC5005937	463	465	O	-1	-1	0
Department	PMC5005937	465	475	O	-1	-1	0
of	PMC5005937	476	478	O	-1	-1	0
Epidemiology	PMC5005937	479	491	O	-1	-1	0
,	PMC5005937	491	492	O	-1	-1	0
Columbia	PMC5005937	493	501	O	-1	-1	0
University	PMC5005937	502	512	O	-1	-1	0
Mailman	PMC5005937	513	520	O	-1	-1	0
School	PMC5005937	521	527	O	-1	-1	0
of	PMC5005937	528	530	O	-1	-1	0
Public	PMC5005937	531	537	O	-1	-1	0
Health	PMC5005937	538	544	O	-1	-1	0
,	PMC5005937	544	545	O	-1	-1	0
New	PMC5005937	546	549	O	-1	-1	0
York	PMC5005937	550	554	O	-1	-1	0
,	PMC5005937	554	555	O	-1	-1	0

NY	PMC5005937	556	558	O	-1	-1	0
,	PMC5005937	558	559	O	-1	-1	0

USA	PMC5005937	560	563	O	-1	-1	0
,	PMC5005937	563	564	O	-1	-1	0
2Herbert	PMC5005937	565	573	O	-1	-1	0
Irving	PMC5005937	574	580	O	-1	-1	0
Comprehensive	PMC5005937	581	594	O	-1	-1	0
Cancer	PMC5005937	595	601	O	-1	-1	0
Center	PMC5005937	602	608	O	-1	-1	0
,	PMC5005937	608	609	O	-1	-1	0
Columbia	PMC5005937	610	618	O	-1	-1	0
University	PMC5005937	619	629	O	-1	-1	0
Medical	PMC5005937	630	637	O	-1	-1	0
Center	PMC5005937	638	644	O	-1	-1	0
,	PMC5005937	644	645	O	-1	-1	0
New	PMC5005937	646	649	O	-1	-1	0
York	PMC5005937	650	654	O	-1	-1	0
,	PMC5005937	654	655	O	-1	-1	0

NY	PMC5005937	656	658	O	-1	-1	0
,	PMC5005937	658	659	O	-1	-1	0
USA	PMC5005937	660	663	O	-1	-1	0
,	PMC5005937	663	664	O	-1	-1	0
3Peter	PMC5005937	665	671	O	-1	-1	0
MacCallum	PMC5005937	672	681	O	-1	-1	0
Cancer	PMC5005937	682	688	O	-1	-1	0
Centre	PMC5005937	689	695	O	-1	-1	0
and	PMC5005937	696	699	O	-1	-1	0
Sir	PMC5005937	700	703	O	-1	-1	0
Peter	PMC5005937	704	709	O	-1	-1	0
MacCallum	PMC5005937	710	719	O	-1	-1	0
Department	PMC5005937	720	730	O	-1	-1	0
of	PMC5005937	731	733	O	-1	-1	0
Oncology	PMC5005937	734	742	O	-1	-1	0
,	PMC5005937	742	743	O	-1	-1	0
4School	PMC5005937	744	751	O	-1	-1	0
of	PMC5005937	752	754	O	-1	-1	0
Population	PMC5005937	755	765	O	-1	-1	0
and	PMC5005937	766	769	O	-1	-1	0
Global	PMC5005937	770	776	O	-1	-1	0
Health	PMC5005937	777	783	O	-1	-1	0
,	PMC5005937	783	784	O	-1	-1	0
5St	PMC5005937	785	788	O	-1	-1	0
Vincent	PMC5005937	789	796	O	-1	-1	0
’s	PMC5005937	796	798	O	-1	-1	0
Hospital	PMC5005937	799	807	O	-1	-1	0
,	PMC5005937	807	808	O	-1	-1	0
University	PMC5005937	809	819	O	-1	-1	0
of	PMC5005937	820	822	O	-1	-1	0
Melbourne	PMC5005937	823	832	O	-1	-1	0
,	PMC5005937	832	833	O	-1	-1	0
Melbourne	PMC5005937	834	843	O	-1	-1	0
,	PMC5005937	843	844	O	-1	-1	0
VIC	PMC5005937	845	848	O	-1	-1	0
,	PMC5005937	848	849	O	-1	-1	0

Australia	PMC5005937	850	859	O	-1	-1	0
,	PMC5005937	859	860	O	-1	-1	0
6Department	PMC5005937	861	872	O	-1	-1	0
of	PMC5005937	873	875	O	-1	-1	0
Clinical	PMC5005937	876	884	O	-1	-1	0
Genetics	PMC5005937	885	893	O	-1	-1	0
,	PMC5005937	893	894	O	-1	-1	0
Fox	PMC5005937	895	898	O	-1	-1	0
Chase	PMC5005937	899	904	O	-1	-1	0
Cancer	PMC5005937	905	911	O	-1	-1	0
Center	PMC5005937	912	918	O	-1	-1	0
,	PMC5005937	918	919	O	-1	-1	0
Philadelphia	PMC5005937	920	932	O	-1	-1	0
,	PMC5005937	932	933	O	-1	-1	0
PA	PMC5005937	934	936	O	-1	-1	0
,	PMC5005937	936	937	O	-1	-1	0
USA	PMC5005937	938	941	O	-1	-1	0
,	PMC5005937	941	942	O	-1	-1	0

7Cancer	PMC5005937	943	950	O	-1	-1	0

Prevention	PMC5005937	951	961	O	-1	-1	0
Institute	PMC5005937	962	971	O	-1	-1	0
of	PMC5005937	972	974	O	-1	-1	0
California	PMC5005937	975	985	O	-1	-1	0
,	PMC5005937	985	986	O	-1	-1	0
Fremont	PMC5005937	987	994	O	-1	-1	0
,	PMC5005937	994	995	O	-1	-1	0
CA	PMC5005937	996	998	O	-1	-1	0
,	PMC5005937	998	999	O	-1	-1	0
USA	PMC5005937	1000	1003	O	-1	-1	0
,	PMC5005937	1003	1004	O	-1	-1	0
8Department	PMC5005937	1005	1016	O	-1	-1	0
of	PMC5005937	1017	1019	O	-1	-1	0
Health	PMC5005937	1020	1026	O	-1	-1	0
Research	PMC5005937	1027	1035	O	-1	-1	0
&	PMC5005937	1036	1037	O	-1	-1	0
Policy	PMC5005937	1038	1044	O	-1	-1	0
,	PMC5005937	1044	1045	O	-1	-1	0
Stanford	PMC5005937	1046	1054	O	-1	-1	0
University	PMC5005937	1055	1065	O	-1	-1	0
School	PMC5005937	1066	1072	O	-1	-1	0
of	PMC5005937	1073	1075	O	-1	-1	0
Medicine	PMC5005937	1076	1084	O	-1	-1	0
,	PMC5005937	1084	1085	O	-1	-1	0
Stanford	PMC5005937	1086	1094	O	-1	-1	0
,	PMC5005937	1094	1095	O	-1	-1	0
CA	PMC5005937	1096	1098	O	-1	-1	0
,	PMC5005937	1098	1099	O	-1	-1	0
USA	PMC5005937	1100	1103	O	-1	-1	0
,	PMC5005937	1103	1104	O	-1	-1	0
9Lunenfeld	PMC5005937	1105	1115	O	-1	-1	0
-	PMC5005937	1115	1116	O	-1	-1	0
Tanenbaum	PMC5005937	1116	1125	O	-1	-1	0
Research	PMC5005937	1126	1134	O	-1	-1	0
Institute	PMC5005937	1135	1144	O	-1	-1	0
,	PMC5005937	1144	1145	O	-1	-1	0

University	PMC5005937	1146	1156	O	-1	-1	0
of	PMC5005937	1157	1159	O	-1	-1	0
Toronto	PMC5005937	1160	1167	O	-1	-1	0
,	PMC5005937	1167	1168	O	-1	-1	0
Toronto	PMC5005937	1169	1176	O	-1	-1	0
,	PMC5005937	1176	1177	O	-1	-1	0
ON	PMC5005937	1178	1180	O	-1	-1	0
,	PMC5005937	1180	1181	O	-1	-1	0
Canada	PMC5005937	1182	1188	O	-1	-1	0
,	PMC5005937	1188	1189	O	-1	-1	0
10Department	PMC5005937	1190	1202	O	-1	-1	0
of	PMC5005937	1203	1205	O	-1	-1	0
Medicine	PMC5005937	1206	1214	O	-1	-1	0
,	PMC5005937	1214	1215	O	-1	-1	0
11Department	PMC5005937	1216	1228	O	-1	-1	0
of	PMC5005937	1229	1231	O	-1	-1	0
Dermatology	PMC5005937	1232	1243	O	-1	-1	0
,	PMC5005937	1243	1244	O	-1	-1	0

Huntsman	PMC5005937	1245	1253	O	-1	-1	0
Cancer	PMC5005937	1254	1260	O	-1	-1	0
Institute	PMC5005937	1261	1270	O	-1	-1	0
,	PMC5005937	1270	1271	O	-1	-1	0
University	PMC5005937	1272	1282	O	-1	-1	0
of	PMC5005937	1283	1285	O	-1	-1	0
Utah	PMC5005937	1286	1290	O	-1	-1	0
School	PMC5005937	1291	1297	O	-1	-1	0
of	PMC5005937	1298	1300	O	-1	-1	0
Medicine	PMC5005937	1301	1309	O	-1	-1	0
,	PMC5005937	1309	1310	O	-1	-1	0
Salt	PMC5005937	1311	1315	O	-1	-1	0
Lake	PMC5005937	1316	1320	O	-1	-1	0
City	PMC5005937	1321	1325	O	-1	-1	0
,	PMC5005937	1325	1326	O	-1	-1	0
UT	PMC5005937	1327	1329	O	-1	-1	0
,	PMC5005937	1329	1330	O	-1	-1	0
USA	PMC5005937	1331	1334	O	-1	-1	0
,	PMC5005937	1334	1335	O	-1	-1	0

12	PMC5005937	1336	1338	O	-1	-1	0

Lunenfeld	PMC5005937	1339	1348	O	-1	-1	0
-	PMC5005937	1348	1349	O	-1	-1	0
Tanenbaum	PMC5005937	1349	1358	O	-1	-1	0
Research	PMC5005937	1359	1367	O	-1	-1	0
Institute	PMC5005937	1368	1377	O	-1	-1	0
,	PMC5005937	1377	1378	O	-1	-1	0
Mount	PMC5005937	1379	1384	O	-1	-1	0
Sinai	PMC5005937	1385	1390	O	-1	-1	0
Hospital	PMC5005937	1391	1399	O	-1	-1	0
,	PMC5005937	1399	1400	O	-1	-1	0
Toronto	PMC5005937	1401	1408	O	-1	-1	0
,	PMC5005937	1408	1409	O	-1	-1	0
ON	PMC5005937	1410	1412	O	-1	-1	0
,	PMC5005937	1412	1413	O	-1	-1	0
Canada	PMC5005937	1414	1420	O	-1	-1	0
,	PMC5005937	1420	1421	O	-1	-1	0

13Dalla	PMC5005937	1422	1429	O	-1	-1	0
Lana	PMC5005937	1430	1434	O	-1	-1	0
School	PMC5005937	1435	1441	O	-1	-1	0
of	PMC5005937	1442	1444	O	-1	-1	0
Public	PMC5005937	1445	1451	O	-1	-1	0
Health	PMC5005937	1452	1458	O	-1	-1	0
,	PMC5005937	1458	1459	O	-1	-1	0
University	PMC5005937	1460	1470	O	-1	-1	0
of	PMC5005937	1471	1473	O	-1	-1	0
Toronto	PMC5005937	1474	1481	O	-1	-1	0
,	PMC5005937	1481	1482	O	-1	-1	0
Toronto	PMC5005937	1483	1490	O	-1	-1	0
,	PMC5005937	1490	1491	O	-1	-1	0
ON	PMC5005937	1492	1494	O	-1	-1	0
,	PMC5005937	1494	1495	O	-1	-1	0
Canada	PMC5005937	1496	1502	O	-1	-1	0
and	PMC5005937	1503	1506	O	-1	-1	0
14Departments	PMC5005937	1507	1520	O	-1	-1	0
of	PMC5005937	1521	1523	O	-1	-1	0
Pediatrics	PMC5005937	1524	1534	O	-1	-1	0
and	PMC5005937	1535	1538	O	-1	-1	0
Medicine	PMC5005937	1539	1547	O	-1	-1	0
,	PMC5005937	1547	1548	O	-1	-1	0
Columbia	PMC5005937	1549	1557	O	-1	-1	0
University	PMC5005937	1558	1568	O	-1	-1	0
,	PMC5005937	1568	1569	O	-1	-1	0
New	PMC5005937	1570	1573	O	-1	-1	0
York	PMC5005937	1574	1578	O	-1	-1	0
,	PMC5005937	1578	1579	O	-1	-1	0
NY	PMC5005937	1580	1582	O	-1	-1	0
,	PMC5005937	1582	1583	O	-1	-1	0
USA	PMC5005937	1584	1587	O	-1	-1	0

*	PMC5005937	1588	1589	O	-1	-1	0

Corresponding	PMC5005937	1589	1602	O	-1	-1	0
authors	PMC5005937	1603	1610	O	-1	-1	0
.	PMC5005937	1610	1611	O	-1	-1	0

Mary	PMC5005937	1612	1616	O	-1	-1	0
Beth	PMC5005937	1617	1621	O	-1	-1	0
Terry	PMC5005937	1622	1627	O	-1	-1	0
,	PMC5005937	1627	1628	O	-1	-1	0
Columbia	PMC5005937	1629	1637	O	-1	-1	0
University	PMC5005937	1638	1648	O	-1	-1	0
Mailman	PMC5005937	1649	1656	O	-1	-1	0
School	PMC5005937	1657	1663	O	-1	-1	0
of	PMC5005937	1664	1666	O	-1	-1	0
Public	PMC5005937	1667	1673	O	-1	-1	0
Health	PMC5005937	1674	1680	O	-1	-1	0
,	PMC5005937	1680	1681	O	-1	-1	0
Department	PMC5005937	1682	1692	O	-1	-1	0
of	PMC5005937	1693	1695	O	-1	-1	0
Epidemiology	PMC5005937	1696	1708	O	-1	-1	0
,	PMC5005937	1708	1709	O	-1	-1	0
722	PMC5005937	1710	1713	O	-1	-1	0
West	PMC5005937	1714	1718	O	-1	-1	0
168th	PMC5005937	1719	1724	O	-1	-1	0
St	PMC5005937	1725	1727	O	-1	-1	0
,	PMC5005937	1727	1728	O	-1	-1	0
New	PMC5005937	1729	1732	O	-1	-1	0
York	PMC5005937	1733	1737	O	-1	-1	0
,	PMC5005937	1737	1738	O	-1	-1	0
NY	PMC5005937	1739	1741	O	-1	-1	0
10032	PMC5005937	1742	1747	O	-1	-1	0
,	PMC5005937	1747	1748	O	-1	-1	0
USA	PMC5005937	1749	1752	O	-1	-1	0
.	PMC5005937	1752	1753	O	-1	-1	0

E	PMC5005937	1754	1755	O	-1	-1	0
-	PMC5005937	1755	1756	O	-1	-1	0
mail	PMC5005937	1756	1760	O	-1	-1	0
:	PMC5005937	1760	1761	O	-1	-1	0
mt146@columbia.edu	PMC5005937	1762	1780	O	-1	-1	0
;	PMC5005937	1780	1781	O	-1	-1	0
John	PMC5005937	1782	1786	O	-1	-1	0
L	PMC5005937	1787	1788	O	-1	-1	0
Hopper	PMC5005937	1789	1795	O	-1	-1	0
,	PMC5005937	1795	1796	O	-1	-1	0
The	PMC5005937	1797	1800	O	-1	-1	0
University	PMC5005937	1801	1811	O	-1	-1	0
of	PMC5005937	1812	1814	O	-1	-1	0
Melbourne	PMC5005937	1815	1824	O	-1	-1	0
,	PMC5005937	1824	1825	O	-1	-1	0
School	PMC5005937	1826	1832	O	-1	-1	0
of	PMC5005937	1833	1835	O	-1	-1	0
Population	PMC5005937	1836	1846	O	-1	-1	0
Health	PMC5005937	1847	1853	O	-1	-1	0
,	PMC5005937	1853	1854	O	-1	-1	0
Centre	PMC5005937	1855	1861	O	-1	-1	0
for	PMC5005937	1862	1865	O	-1	-1	0
Molecular	PMC5005937	1866	1875	O	-1	-1	0
,	PMC5005937	1875	1876	O	-1	-1	0
Environmental	PMC5005937	1877	1890	O	-1	-1	0
,	PMC5005937	1890	1891	O	-1	-1	0
Genetic	PMC5005937	1892	1899	O	-1	-1	0
and	PMC5005937	1900	1903	O	-1	-1	0
Analytic	PMC5005937	1904	1912	O	-1	-1	0
Epidemiology	PMC5005937	1913	1925	O	-1	-1	0
,	PMC5005937	1925	1926	O	-1	-1	0
Level	PMC5005937	1927	1932	O	-1	-1	0
3	PMC5005937	1933	1934	O	-1	-1	0
,	PMC5005937	1934	1935	O	-1	-1	0
207	PMC5005937	1936	1939	O	-1	-1	0
Bouverie	PMC5005937	1940	1948	O	-1	-1	0
Street	PMC5005937	1949	1955	O	-1	-1	0
,	PMC5005937	1955	1956	O	-1	-1	0
Carlton	PMC5005937	1957	1964	O	-1	-1	0
,	PMC5005937	1964	1965	O	-1	-1	0

Vic	PMC5005937	1966	1969	O	-1	-1	0
3053	PMC5005937	1970	1974	O	-1	-1	0
,	PMC5005937	1974	1975	O	-1	-1	0
Australia	PMC5005937	1976	1985	O	-1	-1	0
.	PMC5005937	1985	1986	O	-1	-1	0

E	PMC5005937	1987	1988	O	-1	-1	0
-	PMC5005937	1988	1989	O	-1	-1	0
mail	PMC5005937	1989	1993	O	-1	-1	0
:	PMC5005937	1993	1994	O	-1	-1	0

j.hopper@unimelb.edu.au	PMC5005937	1995	2018	O	-1	-1	0


	PMC5005937	2018	2020	O	-1	-1	0

Why	PMC5005937	2020	2023	O	-1	-1	0
was	PMC5005937	2024	2027	O	-1	-1	0
the	PMC5005937	2028	2031	O	-1	-1	0
cohort	PMC5005937	2032	2038	O	-1	-1	0
established	PMC5005937	2039	2050	O	-1	-1	0
?	PMC5005937	2050	2051	O	-1	-1	0

For	PMC5005937	2052	2055	O	-1	-1	0
breast	PMC5005937	2056	2062	O	-1	-1	0
cancer	PMC5005937	2063	2069	O	-1	-1	0
,	PMC5005937	2069	2070	O	-1	-1	0
like	PMC5005937	2071	2075	O	-1	-1	0
most	PMC5005937	2076	2080	O	-1	-1	0
other	PMC5005937	2081	2086	O	-1	-1	0
common	PMC5005937	2087	2093	O	-1	-1	0
diseases	PMC5005937	2094	2102	O	-1	-1	0
,	PMC5005937	2102	2103	O	-1	-1	0
having	PMC5005937	2104	2110	O	-1	-1	0
a	PMC5005937	2111	2112	O	-1	-1	0
family	PMC5005937	2113	2119	O	-1	-1	0
history	PMC5005937	2120	2127	O	-1	-1	0
of	PMC5005937	2128	2130	O	-1	-1	0
the	PMC5005937	2131	2134	O	-1	-1	0
disease	PMC5005937	2135	2142	O	-1	-1	0
is	PMC5005937	2143	2145	O	-1	-1	0
associated	PMC5005937	2146	2156	O	-1	-1	0
with	PMC5005937	2157	2161	O	-1	-1	0
an	PMC5005937	2162	2164	O	-1	-1	0
increased	PMC5005937	2165	2174	O	-1	-1	0
risk	PMC5005937	2175	2179	O	-1	-1	0
.	PMC5005937	2179	2180	O	-1	-1	0

There	PMC5005937	2181	2186	O	-1	-1	0
is	PMC5005937	2187	2189	O	-1	-1	0
large	PMC5005937	2190	2195	O	-1	-1	0
heterogeneity	PMC5005937	2196	2209	O	-1	-1	0
in	PMC5005937	2210	2212	O	-1	-1	0
absolute	PMC5005937	2213	2221	O	-1	-1	0
and	PMC5005937	2222	2225	O	-1	-1	0
relative	PMC5005937	2226	2234	O	-1	-1	0
breast	PMC5005937	2235	2241	O	-1	-1	0
cancer	PMC5005937	2242	2248	O	-1	-1	0
risks	PMC5005937	2249	2254	O	-1	-1	0
associated	PMC5005937	2255	2265	O	-1	-1	0
with	PMC5005937	2266	2270	O	-1	-1	0
family	PMC5005937	2271	2277	O	-1	-1	0
history	PMC5005937	2278	2285	O	-1	-1	0
,	PMC5005937	2285	2286	O	-1	-1	0
depending	PMC5005937	2287	2296	O	-1	-1	0
on	PMC5005937	2297	2299	O	-1	-1	0
the	PMC5005937	2300	2303	O	-1	-1	0
age	PMC5005937	2304	2307	O	-1	-1	0
of	PMC5005937	2308	2310	O	-1	-1	0
the	PMC5005937	2311	2314	O	-1	-1	0
woman	PMC5005937	2315	2320	O	-1	-1	0
,	PMC5005937	2320	2321	O	-1	-1	0
the	PMC5005937	2322	2325	O	-1	-1	0
age(s	PMC5005937	2326	2331	O	-1	-1	0
)	PMC5005937	2331	2332	O	-1	-1	0
at	PMC5005937	2333	2335	O	-1	-1	0
diagnosis	PMC5005937	2336	2345	O	-1	-1	0
of	PMC5005937	2346	2348	O	-1	-1	0
her	PMC5005937	2349	2352	O	-1	-1	0
affected	PMC5005937	2353	2361	O	-1	-1	0
relative(s	PMC5005937	2362	2372	O	-1	-1	0
)	PMC5005937	2372	2373	O	-1	-1	0
and	PMC5005937	2374	2377	O	-1	-1	0
the	PMC5005937	2378	2381	O	-1	-1	0
genetic	PMC5005937	2382	2389	O	-1	-1	0
relationship(s	PMC5005937	2390	2404	O	-1	-1	0
)	PMC5005937	2404	2405	O	-1	-1	0
.	PMC5005937	2405	2406	O	-1	-1	0

Women	PMC5005937	2407	2412	O	-1	-1	0
with	PMC5005937	2413	2417	O	-1	-1	0
one	PMC5005937	2418	2421	O	-1	-1	0
affected	PMC5005937	2422	2430	O	-1	-1	0
first	PMC5005937	2431	2436	O	-1	-1	0
-	PMC5005937	2436	2437	O	-1	-1	0
degree	PMC5005937	2437	2443	O	-1	-1	0
relative	PMC5005937	2444	2452	O	-1	-1	0
are	PMC5005937	2453	2456	O	-1	-1	0
on	PMC5005937	2457	2459	O	-1	-1	0
average	PMC5005937	2460	2467	O	-1	-1	0
at	PMC5005937	2468	2470	O	-1	-1	0
2-fold	PMC5005937	2471	2477	O	-1	-1	0
increased	PMC5005937	2478	2487	O	-1	-1	0
risk	PMC5005937	2488	2492	O	-1	-1	0
of	PMC5005937	2493	2495	O	-1	-1	0
breast	PMC5005937	2496	2502	O	-1	-1	0
cancer	PMC5005937	2503	2509	O	-1	-1	0
relative	PMC5005937	2510	2518	O	-1	-1	0
to	PMC5005937	2519	2521	O	-1	-1	0
women	PMC5005937	2522	2527	O	-1	-1	0
with	PMC5005937	2528	2532	O	-1	-1	0
no	PMC5005937	2533	2535	O	-1	-1	0
first	PMC5005937	2536	2541	O	-1	-1	0
-	PMC5005937	2541	2542	O	-1	-1	0
degree	PMC5005937	2542	2548	O	-1	-1	0
family	PMC5005937	2549	2555	O	-1	-1	0
history	PMC5005937	2556	2563	O	-1	-1	0
,	PMC5005937	2563	2564	O	-1	-1	0
and	PMC5005937	2565	2568	O	-1	-1	0
this	PMC5005937	2569	2573	O	-1	-1	0
increases	PMC5005937	2574	2583	O	-1	-1	0
to	PMC5005937	2584	2586	O	-1	-1	0
4-fold	PMC5005937	2587	2593	O	-1	-1	0
for	PMC5005937	2594	2597	O	-1	-1	0
women	PMC5005937	2598	2603	O	-1	-1	0
with	PMC5005937	2604	2608	O	-1	-1	0
three	PMC5005937	2609	2614	O	-1	-1	0
or	PMC5005937	2615	2617	O	-1	-1	0
more	PMC5005937	2618	2622	O	-1	-1	0
affected	PMC5005937	2623	2631	O	-1	-1	0
first	PMC5005937	2632	2637	O	-1	-1	0
-	PMC5005937	2637	2638	O	-1	-1	0
degree	PMC5005937	2638	2644	O	-1	-1	0
relatives1	PMC5005937	2645	2655	O	-1	-1	0
.	PMC5005937	2655	2656	O	-1	-1	0

Under	PMC5005937	2657	2662	O	-1	-1	0
a	PMC5005937	2663	2664	O	-1	-1	0
multiplicative	PMC5005937	2665	2679	O	-1	-1	0
risk	PMC5005937	2680	2684	O	-1	-1	0
model	PMC5005937	2685	2690	O	-1	-1	0
,	PMC5005937	2690	2691	O	-1	-1	0
the	PMC5005937	2692	2695	O	-1	-1	0
underlying	PMC5005937	2696	2706	O	-1	-1	0
risk	PMC5005937	2707	2711	O	-1	-1	0
distribution	PMC5005937	2712	2724	O	-1	-1	0
must	PMC5005937	2725	2729	O	-1	-1	0
be	PMC5005937	2730	2732	O	-1	-1	0
highly	PMC5005937	2733	2739	O	-1	-1	0
skewed	PMC5005937	2740	2746	O	-1	-1	0
,	PMC5005937	2746	2747	O	-1	-1	0
and	PMC5005937	2748	2751	O	-1	-1	0
most	PMC5005937	2752	2756	O	-1	-1	0
women	PMC5005937	2757	2762	O	-1	-1	0
in	PMC5005937	2763	2765	O	-1	-1	0

the	PMC5005937	2766	2769	O	-1	-1	0
population	PMC5005937	2770	2780	O	-1	-1	0
are	PMC5005937	2781	2784	O	-1	-1	0
well	PMC5005937	2785	2789	O	-1	-1	0
below	PMC5005937	2790	2795	O	-1	-1	0
average	PMC5005937	2796	2803	O	-1	-1	0
risk	PMC5005937	2804	2808	O	-1	-1	0
;	PMC5005937	2808	2809	O	-1	-1	0
see	PMC5005937	2810	2813	O	-1	-1	0
Figure	PMC5005937	2814	2820	O	-1	-1	0
1	PMC5005937	2821	2822	O	-1	-1	0
,	PMC5005937	2822	2823	O	-1	-1	0


	PMC5005937	2823	2825	O	-1	-1	0
which	PMC5005937	2825	2830	O	-1	-1	0
illustrates	PMC5005937	2831	2842	O	-1	-1	0
the	PMC5005937	2843	2846	O	-1	-1	0
difference	PMC5005937	2847	2857	O	-1	-1	0
between	PMC5005937	2858	2865	O	-1	-1	0
women	PMC5005937	2866	2871	O	-1	-1	0
unselected	PMC5005937	2872	2882	O	-1	-1	0
for	PMC5005937	2883	2886	O	-1	-1	0
familial	PMC5005937	2887	2895	O	-1	-1	0
or	PMC5005937	2896	2898	O	-1	-1	0
genetic	PMC5005937	2899	2906	O	-1	-1	0
risk	PMC5005937	2907	2911	O	-1	-1	0
(	PMC5005937	2912	2913	O	-1	-1	0
blue	PMC5005937	2913	2917	O	-1	-1	0
line	PMC5005937	2918	2922	O	-1	-1	0
)	PMC5005937	2922	2923	O	-1	-1	0
and	PMC5005937	2924	2927	O	-1	-1	0
women	PMC5005937	2928	2933	O	-1	-1	0
enriched	PMC5005937	2934	2942	O	-1	-1	0
for	PMC5005937	2943	2946	O	-1	-1	0
familial	PMC5005937	2947	2955	O	-1	-1	0
/	PMC5005937	2955	2956	O	-1	-1	0
genetic	PMC5005937	2956	2963	O	-1	-1	0
risk	PMC5005937	2964	2968	O	-1	-1	0
(	PMC5005937	2969	2970	O	-1	-1	0
dotted	PMC5005937	2970	2976	O	-1	-1	0
red	PMC5005937	2977	2980	O	-1	-1	0
line	PMC5005937	2981	2985	O	-1	-1	0
)	PMC5005937	2985	2986	O	-1	-1	0
.	PMC5005937	2986	2987	O	-1	-1	0

Given	PMC5005937	2988	2993	O	-1	-1	0
that	PMC5005937	2994	2998	O	-1	-1	0
epidemiological	PMC5005937	2999	3014	O	-1	-1	0
studies	PMC5005937	3015	3022	O	-1	-1	0
make	PMC5005937	3023	3027	O	-1	-1	0
inference	PMC5005937	3028	3037	O	-1	-1	0
about	PMC5005937	3038	3043	O	-1	-1	0
risk	PMC5005937	3044	3048	O	-1	-1	0
for	PMC5005937	3049	3052	O	-1	-1	0
the	PMC5005937	3053	3056	O	-1	-1	0
controls	PMC5005937	3057	3065	O	-1	-1	0
,	PMC5005937	3065	3066	O	-1	-1	0
almost	PMC5005937	3067	3073	O	-1	-1	0
all	PMC5005937	3074	3077	O	-1	-1	0
existing	PMC5005937	3078	3086	O	-1	-1	0
knowledge	PMC5005937	3087	3096	O	-1	-1	0
about	PMC5005937	3097	3102	O	-1	-1	0
risk	PMC5005937	3103	3107	O	-1	-1	0
factors	PMC5005937	3108	3115	O	-1	-1	0
is	PMC5005937	3116	3118	O	-1	-1	0
not	PMC5005937	3119	3122	O	-1	-1	0
relevant	PMC5005937	3123	3131	O	-1	-1	0
to	PMC5005937	3132	3134	O	-1	-1	0
‘	PMC5005937	3135	3136	O	-1	-1	0
women	PMC5005937	3136	3141	O	-1	-1	0
at	PMC5005937	3142	3144	O	-1	-1	0
average	PMC5005937	3145	3152	O	-1	-1	0
risk	PMC5005937	3153	3157	O	-1	-1	0
’	PMC5005937	3157	3158	O	-1	-1	0
,	PMC5005937	3158	3159	O	-1	-1	0
but	PMC5005937	3160	3163	O	-1	-1	0
to	PMC5005937	3164	3166	O	-1	-1	0
women	PMC5005937	3167	3172	O	-1	-1	0
at	PMC5005937	3173	3175	O	-1	-1	0

lower	PMC5005937	3176	3181	O	-1	-1	0
than	PMC5005937	3182	3186	O	-1	-1	0
average	PMC5005937	3187	3194	O	-1	-1	0
risk	PMC5005937	3195	3199	O	-1	-1	0
.	PMC5005937	3199	3200	O	-1	-1	0

It	PMC5005937	3201	3203	O	-1	-1	0
is	PMC5005937	3204	3206	O	-1	-1	0
not	PMC5005937	3207	3210	O	-1	-1	0
known	PMC5005937	3211	3216	O	-1	-1	0
if	PMC5005937	3217	3219	O	-1	-1	0
this	PMC5005937	3220	3224	O	-1	-1	0
knowledge	PMC5005937	3225	3234	O	-1	-1	0
applies	PMC5005937	3235	3242	O	-1	-1	0
to	PMC5005937	3243	3245	O	-1	-1	0
women	PMC5005937	3246	3251	O	-1	-1	0
at	PMC5005937	3252	3254	O	-1	-1	0
increased	PMC5005937	3255	3264	O	-1	-1	0
,	PMC5005937	3264	3265	O	-1	-1	0
if	PMC5005937	3266	3268	O	-1	-1	0
not	PMC5005937	3269	3272	O	-1	-1	0
high	PMC5005937	3273	3277	O	-1	-1	0
,	PMC5005937	3277	3278	O	-1	-1	0
risk	PMC5005937	3279	3283	O	-1	-1	0
.	PMC5005937	3283	3284	O	-1	-1	0

To	PMC5005937	3285	3287	O	-1	-1	0
find	PMC5005937	3288	3292	O	-1	-1	0
evidence	PMC5005937	3293	3301	O	-1	-1	0
relevant	PMC5005937	3302	3310	O	-1	-1	0
to	PMC5005937	3311	3313	O	-1	-1	0
women	PMC5005937	3314	3319	O	-1	-1	0
across	PMC5005937	3320	3326	O	-1	-1	0
the	PMC5005937	3327	3330	O	-1	-1	0
full	PMC5005937	3331	3335	O	-1	-1	0
continuum	PMC5005937	3336	3345	O	-1	-1	0
of	PMC5005937	3346	3348	O	-1	-1	0
risk	PMC5005937	3349	3353	O	-1	-1	0
,	PMC5005937	3353	3354	O	-1	-1	0
with	PMC5005937	3355	3359	O	-1	-1	0
the	PMC5005937	3360	3363	O	-1	-1	0
potential	PMC5005937	3364	3373	O	-1	-1	0
for	PMC5005937	3374	3377	O	-1	-1	0
targeted	PMC5005937	3378	3386	O	-1	-1	0
risk	PMC5005937	3387	3391	O	-1	-1	0
modification	PMC5005937	3392	3404	O	-1	-1	0
and	PMC5005937	3405	3408	O	-1	-1	0
prevention	PMC5005937	3409	3419	O	-1	-1	0
,	PMC5005937	3419	3420	O	-1	-1	0
we	PMC5005937	3421	3423	O	-1	-1	0
have	PMC5005937	3424	3428	O	-1	-1	0
established	PMC5005937	3429	3440	O	-1	-1	0
and	PMC5005937	3441	3444	O	-1	-1	0
genetically	PMC5005937	3445	3456	O	-1	-1	0
-	PMC5005937	3456	3457	O	-1	-1	0
characterised	PMC5005937	3457	3470	O	-1	-1	0
a	PMC5005937	3471	3472	O	-1	-1	0
large	PMC5005937	3473	3478	O	-1	-1	0
prospective	PMC5005937	3479	3490	O	-1	-1	0
family	PMC5005937	3491	3497	O	-1	-1	0
-	PMC5005937	3497	3498	O	-1	-1	0
based	PMC5005937	3498	3503	O	-1	-1	0
cohort	PMC5005937	3504	3510	O	-1	-1	0
enriched	PMC5005937	3511	3519	O	-1	-1	0
for	PMC5005937	3520	3523	O	-1	-1	0
familial	PMC5005937	3524	3532	O	-1	-1	0
risk	PMC5005937	3533	3537	O	-1	-1	0
.	PMC5005937	3537	3538	O	-1	-1	0

Over	PMC5005937	3539	3543	O	-1	-1	0
the	PMC5005937	3544	3547	O	-1	-1	0
past	PMC5005937	3548	3552	O	-1	-1	0
two	PMC5005937	3553	3556	O	-1	-1	0
decades	PMC5005937	3557	3564	O	-1	-1	0
,	PMC5005937	3564	3565	O	-1	-1	0
an	PMC5005937	3566	3568	O	-1	-1	0
increasing	PMC5005937	3569	3579	O	-1	-1	0
number	PMC5005937	3580	3586	O	-1	-1	0
of	PMC5005937	3587	3589	O	-1	-1	0
genetic	PMC5005937	3590	3597	O	-1	-1	0
risk	PMC5005937	3598	3602	O	-1	-1	0
factors	PMC5005937	3603	3610	O	-1	-1	0
have	PMC5005937	3611	3615	O	-1	-1	0
been	PMC5005937	3616	3620	O	-1	-1	0
identified.2,3	PMC5005937	3621	3635	O	-1	-1	0

Nevertheless	PMC5005937	3636	3648	O	-1	-1	0
,	PMC5005937	3648	3649	O	-1	-1	0
the	PMC5005937	3650	3653	O	-1	-1	0
majority	PMC5005937	3654	3662	O	-1	-1	0
of	PMC5005937	3663	3665	O	-1	-1	0
women	PMC5005937	3666	3671	O	-1	-1	0
with	PMC5005937	3672	3676	O	-1	-1	0
a	PMC5005937	3677	3678	O	-1	-1	0
family	PMC5005937	3679	3685	O	-1	-1	0
history	PMC5005937	3686	3693	O	-1	-1	0
of	PMC5005937	3694	3696	O	-1	-1	0
breast	PMC5005937	3697	3703	O	-1	-1	0


	PMC5005937	3703	3705	O	-1	-1	0
C	PMC5005937	3705	3706	O	-1	-1	0

The	PMC5005937	3707	3710	O	-1	-1	0
Author	PMC5005937	3711	3717	O	-1	-1	0
2015	PMC5005937	3718	3722	O	-1	-1	0
;	PMC5005937	3722	3723	O	-1	-1	0
all	PMC5005937	3724	3727	O	-1	-1	0
rights	PMC5005937	3728	3734	O	-1	-1	0
reserved	PMC5005937	3735	3743	O	-1	-1	0
.	PMC5005937	3743	3744	O	-1	-1	0

Published	PMC5005937	3745	3754	O	-1	-1	0
by	PMC5005937	3755	3757	O	-1	-1	0
Oxford	PMC5005937	3758	3764	O	-1	-1	0
University	PMC5005937	3765	3775	O	-1	-1	0
Press	PMC5005937	3776	3781	O	-1	-1	0
on	PMC5005937	3782	3784	O	-1	-1	0
behalf	PMC5005937	3785	3791	O	-1	-1	0
of	PMC5005937	3792	3794	O	-1	-1	0
the	PMC5005937	3795	3798	O	-1	-1	0
International	PMC5005937	3799	3812	O	-1	-1	0
Epidemiological	PMC5005937	3813	3828	O	-1	-1	0
Association	PMC5005937	3829	3840	O	-1	-1	0

V	PMC5005937	3841	3842	O	-1	-1	0


	PMC5005937	3842	3844	O	-1	-1	0

683	PMC5005937	3844	3847	O	-1	-1	0


	PMC5005937	3847	3849	O	-1	-1	0

This	PMC5005937	3849	3853	O	-1	-1	0
is	PMC5005937	3854	3856	O	-1	-1	0
an	PMC5005937	3857	3859	O	-1	-1	0
Open	PMC5005937	3860	3864	O	-1	-1	0
Access	PMC5005937	3865	3871	O	-1	-1	0
article	PMC5005937	3872	3879	O	-1	-1	0
distributed	PMC5005937	3880	3891	O	-1	-1	0
under	PMC5005937	3892	3897	O	-1	-1	0
the	PMC5005937	3898	3901	O	-1	-1	0
terms	PMC5005937	3902	3907	O	-1	-1	0
of	PMC5005937	3908	3910	O	-1	-1	0
the	PMC5005937	3911	3914	O	-1	-1	0
Creative	PMC5005937	3915	3923	O	-1	-1	0
Commons	PMC5005937	3924	3931	O	-1	-1	0
Attribution	PMC5005937	3932	3943	O	-1	-1	0
Non	PMC5005937	3944	3947	O	-1	-1	0
-	PMC5005937	3947	3948	O	-1	-1	0
Commercial	PMC5005937	3948	3958	O	-1	-1	0
License	PMC5005937	3959	3966	O	-1	-1	0
(	PMC5005937	3967	3968	O	-1	-1	0
http://creativecommons.org/licenses/by-nc/4.0/	PMC5005937	3968	4014	O	-1	-1	0
)	PMC5005937	4014	4015	O	-1	-1	0
,	PMC5005937	4015	4016	O	-1	-1	0
which	PMC5005937	4017	4022	O	-1	-1	0
permits	PMC5005937	4023	4030	O	-1	-1	0
non	PMC5005937	4031	4034	O	-1	-1	0
-	PMC5005937	4034	4035	O	-1	-1	0
commercial	PMC5005937	4035	4045	O	-1	-1	0
re	PMC5005937	4046	4048	O	-1	-1	0
-	PMC5005937	4048	4049	O	-1	-1	0
use	PMC5005937	4049	4052	O	-1	-1	0
,	PMC5005937	4052	4053	O	-1	-1	0
distribution	PMC5005937	4054	4066	O	-1	-1	0
,	PMC5005937	4066	4067	O	-1	-1	0
and	PMC5005937	4068	4071	O	-1	-1	0
reproduction	PMC5005937	4072	4084	O	-1	-1	0
in	PMC5005937	4085	4087	O	-1	-1	0
any	PMC5005937	4088	4091	O	-1	-1	0
medium	PMC5005937	4092	4098	O	-1	-1	0
,	PMC5005937	4098	4099	O	-1	-1	0
provided	PMC5005937	4100	4108	O	-1	-1	0
the	PMC5005937	4109	4112	O	-1	-1	0
original	PMC5005937	4113	4121	O	-1	-1	0
work	PMC5005937	4122	4126	O	-1	-1	0
is	PMC5005937	4127	4129	O	-1	-1	0
properly	PMC5005937	4130	4138	O	-1	-1	0
cited	PMC5005937	4139	4144	O	-1	-1	0
.	PMC5005937	4144	4145	O	-1	-1	0

For	PMC5005937	4146	4149	O	-1	-1	0
commercial	PMC5005937	4150	4160	O	-1	-1	0
re	PMC5005937	4161	4163	O	-1	-1	0
-	PMC5005937	4163	4164	O	-1	-1	0
use	PMC5005937	4164	4167	O	-1	-1	0
,	PMC5005937	4167	4168	O	-1	-1	0
please	PMC5005937	4169	4175	O	-1	-1	0
contact	PMC5005937	4176	4183	O	-1	-1	0

journals.permissions@oup.com	PMC5005937	4184	4212	O	-1	-1	0


	PMC5005937	4212	4214	O	-1	-1	0
684	PMC5005937	4214	4217	O	-1	-1	0


	PMC5005937	4217	4219	O	-1	-1	0
International	PMC5005937	4219	4232	O	-1	-1	0
Journal	PMC5005937	4233	4240	O	-1	-1	0
of	PMC5005937	4241	4243	O	-1	-1	0
Epidemiology	PMC5005937	4244	4256	O	-1	-1	0
,	PMC5005937	4256	4257	O	-1	-1	0
2016	PMC5005937	4258	4262	O	-1	-1	0
,	PMC5005937	4262	4263	O	-1	-1	0
Vol	PMC5005937	4264	4267	O	-1	-1	0
.	PMC5005937	4267	4268	O	-1	-1	0

45	PMC5005937	4269	4271	O	-1	-1	0
,	PMC5005937	4271	4272	O	-1	-1	0

No	PMC5005937	4273	4275	O	-1	-1	0
.	PMC5005937	4275	4276	O	-1	-1	0
3	PMC5005937	4277	4278	O	-1	-1	0

18	PMC5005937	4279	4281	O	-1	-1	0

16	PMC5005937	4282	4284	O	-1	-1	0


	PMC5005937	4284	4286	O	-1	-1	0

Relative	PMC5005937	4286	4294	O	-1	-1	0
frequency	PMC5005937	4295	4304	O	-1	-1	0


	PMC5005937	4304	4306	O	-1	-1	0

14	PMC5005937	4306	4308	O	-1	-1	0
12	PMC5005937	4309	4311	O	-1	-1	0

10	PMC5005937	4312	4314	O	-1	-1	0

8	PMC5005937	4315	4316	O	-1	-1	0

6	PMC5005937	4317	4318	O	-1	-1	0

4	PMC5005937	4319	4320	O	-1	-1	0

2	PMC5005937	4321	4322	O	-1	-1	0

0	PMC5005937	4323	4324	O	-1	-1	0

0	PMC5005937	4325	4326	O	-1	-1	0


	PMC5005937	4326	4328	O	-1	-1	0

0.2	PMC5005937	4328	4331	O	-1	-1	0


	PMC5005937	4331	4333	O	-1	-1	0

0.4	PMC5005937	4333	4336	O	-1	-1	0


	PMC5005937	4336	4338	O	-1	-1	0
0.6	PMC5005937	4338	4341	O	-1	-1	0


	PMC5005937	4341	4343	O	-1	-1	0

0.8	PMC5005937	4343	4346	O	-1	-1	0


	PMC5005937	4346	4348	O	-1	-1	0

1	PMC5005937	4348	4349	O	-1	-1	0


	PMC5005937	4349	4351	O	-1	-1	0

Life	PMC5005937	4351	4355	O	-1	-1	0
time	PMC5005937	4356	4360	O	-1	-1	0
risk	PMC5005937	4361	4365	O	-1	-1	0


	PMC5005937	4365	4367	O	-1	-1	0

Figure	PMC5005937	4367	4373	O	-1	-1	0
1	PMC5005937	4374	4375	O	-1	-1	0
.	PMC5005937	4375	4376	O	-1	-1	0

Comparison	PMC5005937	4377	4387	O	-1	-1	0
of	PMC5005937	4388	4390	O	-1	-1	0
the	PMC5005937	4391	4394	O	-1	-1	0
theoretical	PMC5005937	4395	4406	O	-1	-1	0
distribution	PMC5005937	4407	4419	O	-1	-1	0
of	PMC5005937	4420	4422	O	-1	-1	0
familial	PMC5005937	4423	4431	O	-1	-1	0
risk	PMC5005937	4432	4436	O	-1	-1	0
profile	PMC5005937	4437	4444	O	-1	-1	0
(	PMC5005937	4445	4446	O	-1	-1	0
FRP	PMC5005937	4446	4449	O	-1	-1	0
)	PMC5005937	4449	4450	O	-1	-1	0
for	PMC5005937	4451	4454	O	-1	-1	0
women	PMC5005937	4455	4460	O	-1	-1	0
from	PMC5005937	4461	4465	O	-1	-1	0
the	PMC5005937	4466	4469	O	-1	-1	0
general	PMC5005937	4470	4477	O	-1	-1	0
population	PMC5005937	4478	4488	O	-1	-1	0
(	PMC5005937	4489	4490	O	-1	-1	0
blue	PMC5005937	4490	4494	O	-1	-1	0
line	PMC5005937	4495	4499	O	-1	-1	0
)	PMC5005937	4499	4500	O	-1	-1	0
and	PMC5005937	4501	4504	O	-1	-1	0
for	PMC5005937	4505	4508	O	-1	-1	0
those	PMC5005937	4509	4514	O	-1	-1	0
affected	PMC5005937	4515	4523	O	-1	-1	0
with	PMC5005937	4524	4528	O	-1	-1	0
either	PMC5005937	4529	4535	O	-1	-1	0
early	PMC5005937	4536	4541	O	-1	-1	0
-	PMC5005937	4541	4542	O	-1	-1	0
onset	PMC5005937	4542	4547	O	-1	-1	0
breast	PMC5005937	4548	4554	O	-1	-1	0
cancer	PMC5005937	4555	4561	O	-1	-1	0
or	PMC5005937	4562	4564	O	-1	-1	0
unaffected	PMC5005937	4565	4575	O	-1	-1	0
but	PMC5005937	4576	4579	O	-1	-1	0
with	PMC5005937	4580	4584	O	-1	-1	0
a	PMC5005937	4585	4586	O	-1	-1	0
strong	PMC5005937	4587	4593	O	-1	-1	0
family	PMC5005937	4594	4600	O	-1	-1	0
history	PMC5005937	4601	4608	O	-1	-1	0
of	PMC5005937	4609	4611	O	-1	-1	0
breast	PMC5005937	4612	4618	O	-1	-1	0
cancer	PMC5005937	4619	4625	O	-1	-1	0
,	PMC5005937	4625	4626	O	-1	-1	0
equivalent	PMC5005937	4627	4637	O	-1	-1	0
to	PMC5005937	4638	4640	O	-1	-1	0
a	PMC5005937	4641	4642	O	-1	-1	0
3-fold	PMC5005937	4643	4649	O	-1	-1	0
increased	PMC5005937	4650	4659	O	-1	-1	0
risk	PMC5005937	4660	4664	O	-1	-1	0
(	PMC5005937	4665	4666	O	-1	-1	0
dotted	PMC5005937	4666	4672	O	-1	-1	0
red	PMC5005937	4673	4676	O	-1	-1	0
line	PMC5005937	4677	4681	O	-1	-1	0
)	PMC5005937	4681	4682	O	-1	-1	0
,	PMC5005937	4682	4683	O	-1	-1	0
under	PMC5005937	4684	4689	O	-1	-1	0
a	PMC5005937	4690	4691	O	-1	-1	0
multiplicative	PMC5005937	4692	4706	O	-1	-1	0
,	PMC5005937	4706	4707	O	-1	-1	0
multifactorial	PMC5005937	4708	4722	O	-1	-1	0
,	PMC5005937	4722	4723	O	-1	-1	0
polygenic	PMC5005937	4724	4733	O	-1	-1	0
model	PMC5005937	4734	4739	O	-1	-1	0
.	PMC5005937	4739	4740	O	-1	-1	0

For	PMC5005937	4741	4744	O	-1	-1	0
details	PMC5005937	4745	4752	O	-1	-1	0
see	PMC5005937	4753	4756	O	-1	-1	0
18,47	PMC5005937	4757	4762	O	-1	-1	0
.	PMC5005937	4762	4763	O	-1	-1	0


	PMC5005937	4763	4765	O	-1	-1	0

cancer	PMC5005937	4765	4771	O	-1	-1	0
,	PMC5005937	4771	4772	O	-1	-1	0
even	PMC5005937	4773	4777	O	-1	-1	0
those	PMC5005937	4778	4783	O	-1	-1	0
with	PMC5005937	4784	4788	O	-1	-1	0
a	PMC5005937	4789	4790	O	-1	-1	0
strong	PMC5005937	4791	4797	O	-1	-1	0
family	PMC5005937	4798	4804	O	-1	-1	0
history	PMC5005937	4805	4812	O	-1	-1	0
,	PMC5005937	4812	4813	O	-1	-1	0
do	PMC5005937	4814	4816	O	-1	-1	0
not	PMC5005937	4817	4820	O	-1	-1	0
have	PMC5005937	4821	4825	O	-1	-1	0
causal	PMC5005937	4826	4832	O	-1	-1	0
mutations	PMC5005937	4833	4842	O	-1	-1	0
in	PMC5005937	4843	4845	O	-1	-1	0
the	PMC5005937	4846	4849	O	-1	-1	0
known	PMC5005937	4850	4855	O	-1	-1	0
genes	PMC5005937	4856	4861	O	-1	-1	0
,	PMC5005937	4861	4862	O	-1	-1	0
and	PMC5005937	4863	4866	O	-1	-1	0
large	PMC5005937	4867	4872	O	-1	-1	0
genome	PMC5005937	4873	4879	O	-1	-1	0
-	PMC5005937	4879	4880	O	-1	-1	0
wide	PMC5005937	4880	4884	O	-1	-1	0
association	PMC5005937	4885	4896	O	-1	-1	0
studies	PMC5005937	4897	4904	O	-1	-1	0
(	PMC5005937	4905	4906	O	-1	-1	0
GWAS	PMC5005937	4906	4910	O	-1	-1	0
)	PMC5005937	4910	4911	O	-1	-1	0
and	PMC5005937	4912	4915	O	-1	-1	0
now	PMC5005937	4916	4919	O	-1	-1	0
next	PMC5005937	4920	4924	O	-1	-1	0
-	PMC5005937	4924	4925	O	-1	-1	0
generation	PMC5005937	4925	4935	O	-1	-1	0
sequencing	PMC5005937	4936	4946	O	-1	-1	0
efforts	PMC5005937	4947	4954	O	-1	-1	0
are	PMC5005937	4955	4958	O	-1	-1	0
identifying	PMC5005937	4959	4970	O	-1	-1	0
additional	PMC5005937	4971	4981	O	-1	-1	0
genetic	PMC5005937	4982	4989	O	-1	-1	0
risk	PMC5005937	4990	4994	O	-1	-1	0
factors.4–10	PMC5005937	4995	5007	O	-1	-1	0

Epidemiological	PMC5005937	5008	5023	O	-1	-1	0
evidence	PMC5005937	5024	5032	O	-1	-1	0
suggests	PMC5005937	5033	5041	O	-1	-1	0
that	PMC5005937	5042	5046	O	-1	-1	0
some	PMC5005937	5047	5051	O	-1	-1	0
environmental	PMC5005937	5052	5065	O	-1	-1	0
factors	PMC5005937	5066	5073	O	-1	-1	0
modify	PMC5005937	5074	5080	O	-1	-1	0
breast	PMC5005937	5081	5087	O	-1	-1	0
cancer	PMC5005937	5088	5094	O	-1	-1	0
risk	PMC5005937	5095	5099	O	-1	-1	0
for	PMC5005937	5100	5103	O	-1	-1	0
women	PMC5005937	5104	5109	O	-1	-1	0
with	PMC5005937	5110	5114	O	-1	-1	0
a	PMC5005937	5115	5116	O	-1	-1	0
family	PMC5005937	5117	5123	O	-1	-1	0
history	PMC5005937	5124	5131	O	-1	-1	0
.	PMC5005937	5131	5132	O	-1	-1	0

Most	PMC5005937	5133	5137	O	-1	-1	0
epidemiology	PMC5005937	5138	5150	O	-1	-1	0
studies	PMC5005937	5151	5158	O	-1	-1	0
,	PMC5005937	5158	5159	O	-1	-1	0
however	PMC5005937	5160	5167	O	-1	-1	0
,	PMC5005937	5167	5168	O	-1	-1	0
record	PMC5005937	5169	5175	O	-1	-1	0
only	PMC5005937	5176	5180	O	-1	-1	0
first	PMC5005937	5181	5186	O	-1	-1	0
-	PMC5005937	5186	5187	O	-1	-1	0
degree	PMC5005937	5187	5193	O	-1	-1	0
family	PMC5005937	5194	5200	O	-1	-1	0
history	PMC5005937	5201	5208	O	-1	-1	0
as	PMC5005937	5209	5211	O	-1	-1	0
a	PMC5005937	5212	5213	O	-1	-1	0
binary	PMC5005937	5214	5220	O	-1	-1	0
factor	PMC5005937	5221	5227	O	-1	-1	0

(	PMC5005937	5228	5229	O	-1	-1	0
e.g.1,11,12	PMC5005937	5229	5240	O	-1	-1	0
)	PMC5005937	5240	5241	O	-1	-1	0
,	PMC5005937	5241	5242	O	-1	-1	0
which	PMC5005937	5243	5248	O	-1	-1	0
does	PMC5005937	5249	5253	O	-1	-1	0
not	PMC5005937	5254	5257	O	-1	-1	0
capture	PMC5005937	5258	5265	O	-1	-1	0
the	PMC5005937	5266	5269	O	-1	-1	0
potential	PMC5005937	5270	5279	O	-1	-1	0
importance	PMC5005937	5280	5290	O	-1	-1	0
of	PMC5005937	5291	5293	O	-1	-1	0
disease	PMC5005937	5294	5301	O	-1	-1	0
in	PMC5005937	5302	5304	O	-1	-1	0
second	PMC5005937	5305	5311	O	-1	-1	0
-	PMC5005937	5311	5312	O	-1	-1	0
degree	PMC5005937	5312	5318	O	-1	-1	0
and	PMC5005937	5319	5322	O	-1	-1	0
more	PMC5005937	5323	5327	O	-1	-1	0
distant	PMC5005937	5328	5335	O	-1	-1	0
relatives,13–15	PMC5005937	5336	5351	O	-1	-1	0
and	PMC5005937	5352	5355	O	-1	-1	0
rarely	PMC5005937	5356	5362	O	-1	-1	0
take	PMC5005937	5363	5367	O	-1	-1	0
into	PMC5005937	5368	5372	O	-1	-1	0
account	PMC5005937	5373	5380	O	-1	-1	0
the	PMC5005937	5381	5384	O	-1	-1	0
importance	PMC5005937	5385	5395	O	-1	-1	0
of	PMC5005937	5396	5398	O	-1	-1	0
age	PMC5005937	5399	5402	O	-1	-1	0
at	PMC5005937	5403	5405	O	-1	-1	0
diagnosis	PMC5005937	5406	5415	O	-1	-1	0
of	PMC5005937	5416	5418	O	-1	-1	0
affected	PMC5005937	5419	5427	O	-1	-1	0
relatives	PMC5005937	5428	5437	O	-1	-1	0
.	PMC5005937	5437	5438	O	-1	-1	0

The	PMC5005937	5439	5442	O	-1	-1	0
few	PMC5005937	5443	5446	O	-1	-1	0
studies	PMC5005937	5447	5454	O	-1	-1	0

that	PMC5005937	5455	5459	O	-1	-1	0
do16,17	PMC5005937	5460	5467	O	-1	-1	0
suggest	PMC5005937	5468	5475	O	-1	-1	0
greater	PMC5005937	5476	5483	O	-1	-1	0
environmental	PMC5005937	5484	5497	O	-1	-1	0
and	PMC5005937	5498	5501	O	-1	-1	0
genetic	PMC5005937	5502	5509	O	-1	-1	0
heterogeneity	PMC5005937	5510	5523	O	-1	-1	0
in	PMC5005937	5524	5526	O	-1	-1	0
risk	PMC5005937	5527	5531	O	-1	-1	0
.	PMC5005937	5531	5532	O	-1	-1	0

One	PMC5005937	5533	5536	O	-1	-1	0
approach	PMC5005937	5537	5545	O	-1	-1	0
to	PMC5005937	5546	5548	O	-1	-1	0
studying	PMC5005937	5549	5557	O	-1	-1	0
gene	PMC5005937	5558	5562	O	-1	-1	0
-	PMC5005937	5562	5563	O	-1	-1	0
environment	PMC5005937	5563	5574	O	-1	-1	0
interactions	PMC5005937	5575	5587	O	-1	-1	0
is	PMC5005937	5588	5590	O	-1	-1	0
to	PMC5005937	5591	5593	O	-1	-1	0
consider	PMC5005937	5594	5602	O	-1	-1	0
a	PMC5005937	5603	5604	O	-1	-1	0
woman	PMC5005937	5605	5610	O	-1	-1	0
’s	PMC5005937	5610	5612	O	-1	-1	0
underlying	PMC5005937	5613	5623	O	-1	-1	0
familial	PMC5005937	5624	5632	O	-1	-1	0
risk	PMC5005937	5633	5637	O	-1	-1	0
profile	PMC5005937	5638	5645	O	-1	-1	0
(	PMC5005937	5646	5647	O	-1	-1	0
FRP	PMC5005937	5647	5650	O	-1	-1	0
)	PMC5005937	5650	5651	O	-1	-1	0
,	PMC5005937	5651	5652	O	-1	-1	0
representing	PMC5005937	5653	5665	O	-1	-1	0
her	PMC5005937	5666	5669	O	-1	-1	0
inherent	PMC5005937	5670	5678	O	-1	-1	0
lifetime	PMC5005937	5679	5687	O	-1	-1	0
risk	PMC5005937	5688	5692	O	-1	-1	0
due	PMC5005937	5693	5696	O	-1	-1	0
to	PMC5005937	5697	5699	O	-1	-1	0
familial	PMC5005937	5700	5708	O	-1	-1	0
determinants	PMC5005937	5709	5721	O	-1	-1	0
.	PMC5005937	5721	5722	O	-1	-1	0

A	PMC5005937	5723	5724	O	-1	-1	0
woman	PMC5005937	5725	5730	O	-1	-1	0
’s	PMC5005937	5730	5732	O	-1	-1	0
FRP	PMC5005937	5733	5736	O	-1	-1	0
can	PMC5005937	5737	5740	O	-1	-1	0
be	PMC5005937	5741	5743	O	-1	-1	0
predicted	PMC5005937	5744	5753	O	-1	-1	0
from	PMC5005937	5754	5758	O	-1	-1	0
her	PMC5005937	5759	5762	O	-1	-1	0
multi	PMC5005937	5763	5768	O	-1	-1	0
-	PMC5005937	5768	5769	O	-1	-1	0
generational	PMC5005937	5769	5781	O	-1	-1	0
family	PMC5005937	5782	5788	O	-1	-1	0
history	PMC5005937	5789	5796	O	-1	-1	0
including	PMC5005937	5797	5806	O	-1	-1	0
the	PMC5005937	5807	5810	O	-1	-1	0
number	PMC5005937	5811	5817	O	-1	-1	0
of	PMC5005937	5818	5820	O	-1	-1	0
affected	PMC5005937	5821	5829	O	-1	-1	0
relatives	PMC5005937	5830	5839	O	-1	-1	0
and	PMC5005937	5840	5843	O	-1	-1	0
her	PMC5005937	5844	5847	O	-1	-1	0
relationship	PMC5005937	5848	5860	O	-1	-1	0
with	PMC5005937	5861	5865	O	-1	-1	0
each	PMC5005937	5866	5870	O	-1	-1	0
affected	PMC5005937	5871	5879	O	-1	-1	0
relative	PMC5005937	5880	5888	O	-1	-1	0
,	PMC5005937	5888	5889	O	-1	-1	0
their	PMC5005937	5890	5895	O	-1	-1	0
age(s	PMC5005937	5896	5901	O	-1	-1	0
)	PMC5005937	5901	5902	O	-1	-1	0
at	PMC5005937	5903	5905	O	-1	-1	0
diagnosis	PMC5005937	5906	5915	O	-1	-1	0
,	PMC5005937	5915	5916	O	-1	-1	0
and	PMC5005937	5917	5920	O	-1	-1	0
if	PMC5005937	5921	5923	O	-1	-1	0
known	PMC5005937	5924	5929	O	-1	-1	0
,	PMC5005937	5929	5930	O	-1	-1	0
her	PMC5005937	5931	5934	O	-1	-1	0
genetic	PMC5005937	5935	5942	O	-1	-1	0
risk	PMC5005937	5943	5947	O	-1	-1	0
status	PMC5005937	5948	5954	O	-1	-1	0
(	PMC5005937	5955	5956	O	-1	-1	0
including	PMC5005937	5956	5965	O	-1	-1	0
causal	PMC5005937	5966	5972	O	-1	-1	0
variants	PMC5005937	5973	5981	O	-1	-1	0
and	PMC5005937	5982	5985	O	-1	-1	0
markers	PMC5005937	5986	5993	O	-1	-1	0
associated	PMC5005937	5994	6004	O	-1	-1	0
with	PMC5005937	6005	6009	O	-1	-1	0
risk	PMC5005937	6010	6014	O	-1	-1	0
)	PMC5005937	6014	6015	O	-1	-1	0
and	PMC5005937	6016	6019	O	-1	-1	0
the	PMC5005937	6020	6023	O	-1	-1	0
genetic	PMC5005937	6024	6031	O	-1	-1	0
risk	PMC5005937	6032	6036	O	-1	-1	0
status	PMC5005937	6037	6043	O	-1	-1	0
of	PMC5005937	6044	6046	O	-1	-1	0
her	PMC5005937	6047	6050	O	-1	-1	0
relatives	PMC5005937	6051	6060	O	-1	-1	0
.	PMC5005937	6060	6061	O	-1	-1	0

It	PMC5005937	6062	6064	O	-1	-1	0
is	PMC5005937	6065	6067	O	-1	-1	0
not	PMC5005937	6068	6071	O	-1	-1	0
well	PMC5005937	6072	6076	O	-1	-1	0
recognised	PMC5005937	6077	6087	O	-1	-1	0
that	PMC5005937	6088	6092	O	-1	-1	0
there	PMC5005937	6093	6098	O	-1	-1	0
must	PMC5005937	6099	6103	O	-1	-1	0
be	PMC5005937	6104	6106	O	-1	-1	0
very	PMC5005937	6107	6111	O	-1	-1	0
large	PMC5005937	6112	6117	O	-1	-1	0
variation	PMC5005937	6118	6127	O	-1	-1	0
in	PMC5005937	6128	6130	O	-1	-1	0
FRP	PMC5005937	6131	6134	O	-1	-1	0
.	PMC5005937	6134	6135	O	-1	-1	0

Given	PMC5005937	6136	6141	O	-1	-1	0
the	PMC5005937	6142	6145	O	-1	-1	0
increased	PMC5005937	6146	6155	O	-1	-1	0
risks	PMC5005937	6156	6161	O	-1	-1	0
associated	PMC5005937	6162	6172	O	-1	-1	0
with	PMC5005937	6173	6177	O	-1	-1	0
having	PMC5005937	6178	6184	O	-1	-1	0
a	PMC5005937	6185	6186	O	-1	-1	0
family	PMC5005937	6187	6193	O	-1	-1	0
history	PMC5005937	6194	6201	O	-1	-1	0
,	PMC5005937	6201	6202	O	-1	-1	0
mathematical	PMC5005937	6203	6215	O	-1	-1	0
models	PMC5005937	6216	6222	O	-1	-1	0
predict	PMC5005937	6223	6230	O	-1	-1	0
that	PMC5005937	6231	6235	O	-1	-1	0
,	PMC5005937	6235	6236	O	-1	-1	0
as	PMC5005937	6237	6239	O	-1	-1	0
a	PMC5005937	6240	6241	O	-1	-1	0
group	PMC5005937	6242	6247	O	-1	-1	0
,	PMC5005937	6247	6248	O	-1	-1	0
women	PMC5005937	6249	6254	O	-1	-1	0
in	PMC5005937	6255	6257	O	-1	-1	0
the	PMC5005937	6258	6261	O	-1	-1	0
top	PMC5005937	6262	6265	O	-1	-1	0
25	PMC5005937	6266	6268	O	-1	-1	0
%	PMC5005937	6268	6269	O	-1	-1	0
of	PMC5005937	6270	6272	O	-1	-1	0
FRP	PMC5005937	6273	6276	O	-1	-1	0
must	PMC5005937	6277	6281	O	-1	-1	0
be	PMC5005937	6282	6284	O	-1	-1	0
at	PMC5005937	6285	6287	O	-1	-1	0
least	PMC5005937	6288	6293	O	-1	-1	0
20	PMC5005937	6294	6296	O	-1	-1	0
times	PMC5005937	6297	6302	O	-1	-1	0
more	PMC5005937	6303	6307	O	-1	-1	0
likely	PMC5005937	6308	6314	O	-1	-1	0
to	PMC5005937	6315	6317	O	-1	-1	0
develop	PMC5005937	6318	6325	O	-1	-1	0
breast	PMC5005937	6326	6332	O	-1	-1	0
cancer	PMC5005937	6333	6339	O	-1	-1	0
than	PMC5005937	6340	6344	O	-1	-1	0
women	PMC5005937	6345	6350	O	-1	-1	0
in	PMC5005937	6351	6353	O	-1	-1	0
the	PMC5005937	6354	6357	O	-1	-1	0
bottom	PMC5005937	6358	6364	O	-1	-1	0
25	PMC5005937	6365	6367	O	-1	-1	0
%	PMC5005937	6367	6368	O	-1	-1	0
of	PMC5005937	6369	6371	O	-1	-1	0
FRP.18,19	PMC5005937	6372	6381	O	-1	-1	0

Nevertheless	PMC5005937	6382	6394	O	-1	-1	0
,	PMC5005937	6394	6395	O	-1	-1	0
unlike	PMC5005937	6396	6402	O	-1	-1	0
matching	PMC5005937	6403	6411	O	-1	-1	0
on	PMC5005937	6412	6414	O	-1	-1	0
age	PMC5005937	6415	6418	O	-1	-1	0
to	PMC5005937	6419	6421	O	-1	-1	0
control	PMC5005937	6422	6429	O	-1	-1	0
for	PMC5005937	6430	6433	O	-1	-1	0
its	PMC5005937	6434	6437	O	-1	-1	0
strong	PMC5005937	6438	6444	O	-1	-1	0
effect	PMC5005937	6445	6451	O	-1	-1	0
on	PMC5005937	6452	6454	O	-1	-1	0
cancer	PMC5005937	6455	6461	O	-1	-1	0
risk	PMC5005937	6462	6466	O	-1	-1	0
,	PMC5005937	6466	6467	O	-1	-1	0
epidemiological	PMC5005937	6468	6483	O	-1	-1	0
studies	PMC5005937	6484	6491	O	-1	-1	0
rarely	PMC5005937	6492	6498	O	-1	-1	0
match	PMC5005937	6499	6504	O	-1	-1	0
well	PMC5005937	6505	6509	O	-1	-1	0
by	PMC5005937	6510	6512	O	-1	-1	0
design	PMC5005937	6513	6519	O	-1	-1	0
or	PMC5005937	6520	6522	O	-1	-1	0


	PMC5005937	6522	6524	O	-1	-1	0
analysis	PMC5005937	6524	6532	O	-1	-1	0
on	PMC5005937	6533	6535	O	-1	-1	0
FRP	PMC5005937	6536	6539	O	-1	-1	0
,	PMC5005937	6539	6540	O	-1	-1	0
even	PMC5005937	6541	6545	O	-1	-1	0
though	PMC5005937	6546	6552	O	-1	-1	0
cases	PMC5005937	6553	6558	O	-1	-1	0
and	PMC5005937	6559	6562	O	-1	-1	0
controls	PMC5005937	6563	6571	O	-1	-1	0
differ	PMC5005937	6572	6578	O	-1	-1	0
greatly	PMC5005937	6579	6586	O	-1	-1	0
by	PMC5005937	6587	6589	O	-1	-1	0
FRP	PMC5005937	6590	6593	O	-1	-1	0
,	PMC5005937	6593	6594	O	-1	-1	0
especially	PMC5005937	6595	6605	O	-1	-1	0
in	PMC5005937	6606	6608	O	-1	-1	0
the	PMC5005937	6609	6612	O	-1	-1	0
upper	PMC5005937	6613	6618	O	-1	-1	0
tail	PMC5005937	6619	6623	O	-1	-1	0
.	PMC5005937	6623	6624	O	-1	-1	0

Environmental	PMC5005937	6625	6638	O	-1	-1	0
and	PMC5005937	6639	6642	O	-1	-1	0
genetic	PMC5005937	6643	6650	O	-1	-1	0
effects	PMC5005937	6651	6658	O	-1	-1	0
may	PMC5005937	6659	6662	O	-1	-1	0
have	PMC5005937	6663	6667	O	-1	-1	0
different	PMC5005937	6668	6677	O	-1	-1	0
effects	PMC5005937	6678	6685	O	-1	-1	0
in	PMC5005937	6686	6688	O	-1	-1	0
women	PMC5005937	6689	6694	O	-1	-1	0
with	PMC5005937	6695	6699	O	-1	-1	0
increased	PMC5005937	6700	6709	O	-1	-1	0
FRP	PMC5005937	6710	6713	O	-1	-1	0
.	PMC5005937	6713	6714	O	-1	-1	0

Studies	PMC5005937	6715	6722	O	-1	-1	0
of	PMC5005937	6723	6725	O	-1	-1	0
such	PMC5005937	6726	6730	O	-1	-1	0
‘	PMC5005937	6731	6732	O	-1	-1	0
geneenvironment	PMC5005937	6732	6747	O	-1	-1	0
interactions	PMC5005937	6748	6760	O	-1	-1	0
’	PMC5005937	6760	6761	O	-1	-1	0
for	PMC5005937	6762	6765	O	-1	-1	0
which	PMC5005937	6766	6771	O	-1	-1	0
controls	PMC5005937	6772	6780	O	-1	-1	0
are	PMC5005937	6781	6784	O	-1	-1	0
better	PMC5005937	6785	6791	O	-1	-1	0
matched	PMC5005937	6792	6799	O	-1	-1	0
to	PMC5005937	6800	6802	O	-1	-1	0
cases	PMC5005937	6803	6808	O	-1	-1	0
for	PMC5005937	6809	6812	O	-1	-1	0
FRP	PMC5005937	6813	6816	O	-1	-1	0
,	PMC5005937	6816	6817	O	-1	-1	0
and	PMC5005937	6818	6821	O	-1	-1	0
even	PMC5005937	6822	6826	O	-1	-1	0
for	PMC5005937	6827	6830	O	-1	-1	0
mutations	PMC5005937	6831	6840	O	-1	-1	0
in	PMC5005937	6841	6843	O	-1	-1	0
specific	PMC5005937	6844	6852	O	-1	-1	0
genes	PMC5005937	6853	6858	O	-1	-1	0
—	PMC5005937	6858	6859	O	-1	-1	0
either	PMC5005937	6859	6865	O	-1	-1	0
by	PMC5005937	6866	6868	O	-1	-1	0
design	PMC5005937	6869	6875	O	-1	-1	0
or	PMC5005937	6876	6878	O	-1	-1	0
by	PMC5005937	6879	6881	O	-1	-1	0
analyses	PMC5005937	6882	6890	O	-1	-1	0
that	PMC5005937	6891	6895	O	-1	-1	0
use	PMC5005937	6896	6899	O	-1	-1	0
good	PMC5005937	6900	6904	O	-1	-1	0
predictors	PMC5005937	6905	6915	O	-1	-1	0
of	PMC5005937	6916	6918	O	-1	-1	0
FRP	PMC5005937	6919	6922	O	-1	-1	0
—	PMC5005937	6922	6923	O	-1	-1	0
might	PMC5005937	6923	6928	O	-1	-1	0
be	PMC5005937	6929	6931	O	-1	-1	0
more	PMC5005937	6932	6936	O	-1	-1	0
informative	PMC5005937	6937	6948	O	-1	-1	0
,	PMC5005937	6948	6949	O	-1	-1	0
especially	PMC5005937	6950	6960	O	-1	-1	0
if	PMC5005937	6961	6963	O	-1	-1	0
both	PMC5005937	6964	6968	O	-1	-1	0
cases	PMC5005937	6969	6974	O	-1	-1	0
and	PMC5005937	6975	6978	O	-1	-1	0
controls	PMC5005937	6979	6987	O	-1	-1	0
are	PMC5005937	6988	6991	O	-1	-1	0
over	PMC5005937	6992	6996	O	-1	-1	0
-	PMC5005937	6996	6997	O	-1	-1	0
sampled	PMC5005937	6997	7004	O	-1	-1	0
for	PMC5005937	7005	7008	O	-1	-1	0
increased	PMC5005937	7009	7018	O	-1	-1	0
familial	PMC5005937	7019	7027	O	-1	-1	0
risk	PMC5005937	7028	7032	O	-1	-1	0
.	PMC5005937	7032	7033	O	-1	-1	0

They	PMC5005937	7034	7038	O	-1	-1	0
also	PMC5005937	7039	7043	O	-1	-1	0
have	PMC5005937	7044	7048	O	-1	-1	0
greater	PMC5005937	7049	7056	O	-1	-1	0
validity	PMC5005937	7057	7065	O	-1	-1	0
if	PMC5005937	7066	7068	O	-1	-1	0
they	PMC5005937	7069	7073	O	-1	-1	0
are	PMC5005937	7074	7077	O	-1	-1	0
prospective.18,19	PMC5005937	7078	7095	O	-1	-1	0

Few	PMC5005937	7096	7099	O	-1	-1	0
prospective	PMC5005937	7100	7111	O	-1	-1	0
studies	PMC5005937	7112	7119	O	-1	-1	0
of	PMC5005937	7120	7122	O	-1	-1	0
families	PMC5005937	7123	7131	O	-1	-1	0
exist	PMC5005937	7132	7137	O	-1	-1	0
.	PMC5005937	7137	7138	O	-1	-1	0

They	PMC5005937	7139	7143	O	-1	-1	0
include	PMC5005937	7144	7151	O	-1	-1	0
the	PMC5005937	7152	7155	O	-1	-1	0
Minnesota	PMC5005937	7156	7165	O	-1	-1	0
Breast	PMC5005937	7166	7172	O	-1	-1	0
Cancer	PMC5005937	7173	7179	O	-1	-1	0
Family	PMC5005937	7180	7186	O	-1	-1	0
Study	PMC5005937	7187	7192	O	-1	-1	0
(	PMC5005937	7193	7194	O	-1	-1	0
544	PMC5005937	7194	7197	O	-1	-1	0
families	PMC5005937	7198	7206	O	-1	-1	0
)	PMC5005937	7206	7207	O	-1	-1	0
,	PMC5005937	7207	7208	O	-1	-1	0
established	PMC5005937	7209	7220	O	-1	-1	0
in	PMC5005937	7221	7223	O	-1	-1	0
the	PMC5005937	7224	7227	O	-1	-1	0
1950s,20–23	PMC5005937	7228	7239	O	-1	-1	0
and	PMC5005937	7240	7243	O	-1	-1	0
the	PMC5005937	7244	7247	O	-1	-1	0
USAbased	PMC5005937	7248	7256	O	-1	-1	0
Sisters	PMC5005937	7257	7264	O	-1	-1	0
Study	PMC5005937	7265	7270	O	-1	-1	0
(	PMC5005937	7271	7272	O	-1	-1	0
50	PMC5005937	7272	7274	O	-1	-1	0
844	PMC5005937	7275	7278	O	-1	-1	0
unaffected	PMC5005937	7279	7289	O	-1	-1	0
sisters	PMC5005937	7290	7297	O	-1	-1	0
of	PMC5005937	7298	7300	O	-1	-1	0
affected	PMC5005937	7301	7309	O	-1	-1	0
women	PMC5005937	7310	7315	O	-1	-1	0
aged	PMC5005937	7316	7320	O	-1	-1	0
35–74	PMC5005937	7321	7326	O	-1	-1	0
years).24	PMC5005937	7327	7336	O	-1	-1	0
Family	PMC5005937	7337	7343	O	-1	-1	0
-	PMC5005937	7343	7344	O	-1	-1	0
based	PMC5005937	7344	7349	O	-1	-1	0
cohorts	PMC5005937	7350	7357	O	-1	-1	0
are	PMC5005937	7358	7361	O	-1	-1	0
also	PMC5005937	7362	7366	O	-1	-1	0
important	PMC5005937	7367	7376	O	-1	-1	0
for	PMC5005937	7377	7380	O	-1	-1	0
novel	PMC5005937	7381	7386	O	-1	-1	0
behavioural	PMC5005937	7387	7398	O	-1	-1	0
,	PMC5005937	7398	7399	O	-1	-1	0
psychosocial	PMC5005937	7400	7412	O	-1	-1	0
and	PMC5005937	7413	7416	O	-1	-1	0
health	PMC5005937	7417	7423	O	-1	-1	0
care	PMC5005937	7424	7428	O	-1	-1	0
utilization	PMC5005937	7429	7440	O	-1	-1	0
research	PMC5005937	7441	7449	O	-1	-1	0
,	PMC5005937	7449	7450	O	-1	-1	0
such	PMC5005937	7451	7455	O	-1	-1	0
as	PMC5005937	7456	7458	O	-1	-1	0
attitudes	PMC5005937	7459	7468	O	-1	-1	0
and	PMC5005937	7469	7472	O	-1	-1	0
practices	PMC5005937	7473	7482	O	-1	-1	0
regarding	PMC5005937	7483	7492	O	-1	-1	0
screening	PMC5005937	7493	7502	O	-1	-1	0
and	PMC5005937	7503	7506	O	-1	-1	0
risk	PMC5005937	7507	7511	O	-1	-1	0
reduction	PMC5005937	7512	7521	O	-1	-1	0
,	PMC5005937	7521	7522	O	-1	-1	0
and	PMC5005937	7523	7526	O	-1	-1	0
for	PMC5005937	7527	7530	O	-1	-1	0
the	PMC5005937	7531	7534	O	-1	-1	0
translation	PMC5005937	7535	7546	O	-1	-1	0
of	PMC5005937	7547	7549	O	-1	-1	0
primary	PMC5005937	7550	7557	O	-1	-1	0
,	PMC5005937	7557	7558	O	-1	-1	0
secondary	PMC5005937	7559	7568	O	-1	-1	0
and	PMC5005937	7569	7572	O	-1	-1	0
tertiary	PMC5005937	7573	7581	O	-1	-1	0
prevention	PMC5005937	7582	7592	O	-1	-1	0
findings	PMC5005937	7593	7601	O	-1	-1	0
into	PMC5005937	7602	7606	O	-1	-1	0
clinical	PMC5005937	7607	7615	O	-1	-1	0
practice.25–28	PMC5005937	7616	7630	O	-1	-1	0

In	PMC5005937	7631	7633	O	-1	-1	0
the	PMC5005937	7634	7637	O	-1	-1	0
mid-1990s	PMC5005937	7638	7647	O	-1	-1	0
,	PMC5005937	7647	7648	O	-1	-1	0
when	PMC5005937	7648	7652	O	-1	-1	0
two	PMC5005937	7653	7656	O	-1	-1	0
major	PMC5005937	7657	7662	O	-1	-1	0
susceptibility	PMC5005937	7663	7677	O	-1	-1	0
genes	PMC5005937	7678	7683	O	-1	-1	0
,	PMC5005937	7683	7684	O	-1	-1	0
BRCA1	PMC5005937	7685	7690	O	-1	-1	0
and	PMC5005937	7691	7694	O	-1	-1	0
BRCA2	PMC5005937	7695	7700	O	-1	-1	0
,	PMC5005937	7700	7701	O	-1	-1	0
were	PMC5005937	7702	7706	O	-1	-1	0
discovered	PMC5005937	7707	7717	O	-1	-1	0
,	PMC5005937	7717	7718	O	-1	-1	0
the	PMC5005937	7719	7722	O	-1	-1	0
Breast	PMC5005937	7723	7729	O	-1	-1	0
Cancer	PMC5005937	7730	7736	O	-1	-1	0
Family	PMC5005937	7737	7743	O	-1	-1	0
Registry	PMC5005937	7744	7752	O	-1	-1	0
(	PMC5005937	7753	7754	O	-1	-1	0
BCFR),29	PMC5005937	7754	7762	O	-1	-1	0
and	PMC5005937	7763	7766	O	-1	-1	0
the	PMC5005937	7767	7770	O	-1	-1	0
Kathleen	PMC5005937	7771	7779	O	-1	-1	0
Cuningham	PMC5005937	7780	7789	O	-1	-1	0
Foundation	PMC5005937	7790	7800	O	-1	-1	0
Consortium	PMC5005937	7801	7811	O	-1	-1	0
for	PMC5005937	7812	7815	O	-1	-1	0
research	PMC5005937	7816	7824	O	-1	-1	0
into	PMC5005937	7825	7829	O	-1	-1	0
Familial	PMC5005937	7830	7838	O	-1	-1	0
Breast	PMC5005937	7839	7845	O	-1	-1	0
cancer	PMC5005937	7846	7852	O	-1	-1	0
(	PMC5005937	7853	7854	O	-1	-1	0
kConFab)30	PMC5005937	7854	7864	O	-1	-1	0
(	PMC5005937	7865	7866	O	-1	-1	0
in	PMC5005937	7866	7868	O	-1	-1	0
2001	PMC5005937	7869	7873	O	-1	-1	0
the	PMC5005937	7874	7877	O	-1	-1	0
kConFab	PMC5005937	7878	7885	O	-1	-1	0
FUP	PMC5005937	7886	7889	O	-1	-1	0
started31	PMC5005937	7890	7899	O	-1	-1	0
)	PMC5005937	7899	7900	O	-1	-1	0
were	PMC5005937	7901	7905	O	-1	-1	0
established	PMC5005937	7906	7917	O	-1	-1	0
.	PMC5005937	7917	7918	O	-1	-1	0

Importantly	PMC5005937	7919	7930	O	-1	-1	0
,	PMC5005937	7930	7931	O	-1	-1	0
both	PMC5005937	7932	7936	O	-1	-1	0
the	PMC5005937	7937	7940	O	-1	-1	0
BCFR	PMC5005937	7941	7945	O	-1	-1	0
and	PMC5005937	7946	7949	O	-1	-1	0
the	PMC5005937	7950	7953	O	-1	-1	0
kConFab	PMC5005937	7954	7961	O	-1	-1	0
were	PMC5005937	7962	7966	O	-1	-1	0
designed	PMC5005937	7967	7975	O	-1	-1	0
from	PMC5005937	7976	7980	O	-1	-1	0
the	PMC5005937	7981	7984	O	-1	-1	0
outset	PMC5005937	7985	7991	O	-1	-1	0
so	PMC5005937	7992	7994	O	-1	-1	0
that	PMC5005937	7995	7999	O	-1	-1	0
they	PMC5005937	8000	8004	O	-1	-1	0
could	PMC5005937	8005	8010	O	-1	-1	0
generate	PMC5005937	8011	8019	O	-1	-1	0
cohorts	PMC5005937	8020	8027	O	-1	-1	0
from	PMC5005937	8028	8032	O	-1	-1	0
which	PMC5005937	8033	8038	O	-1	-1	0
data	PMC5005937	8039	8043	O	-1	-1	0
could	PMC5005937	8044	8049	O	-1	-1	0
be	PMC5005937	8050	8052	O	-1	-1	0
pooled	PMC5005937	8053	8059	O	-1	-1	0
;	PMC5005937	8059	8060	O	-1	-1	0
they	PMC5005937	8061	8065	O	-1	-1	0
used	PMC5005937	8066	8070	O	-1	-1	0
the	PMC5005937	8071	8074	O	-1	-1	0
same	PMC5005937	8075	8079	O	-1	-1	0
baseline	PMC5005937	8080	8088	O	-1	-1	0
questionnaire	PMC5005937	8089	8102	O	-1	-1	0
and	PMC5005937	8103	8106	O	-1	-1	0
have	PMC5005937	8107	8111	O	-1	-1	0
conducted	PMC5005937	8112	8121	O	-1	-1	0
regular	PMC5005937	8122	8129	O	-1	-1	0
active	PMC5005937	8130	8136	O	-1	-1	0
follow	PMC5005937	8137	8143	O	-1	-1	0
-	PMC5005937	8143	8144	O	-1	-1	0
up	PMC5005937	8144	8146	O	-1	-1	0
of	PMC5005937	8147	8149	O	-1	-1	0
families	PMC5005937	8150	8158	O	-1	-1	0
.	PMC5005937	8158	8159	O	-1	-1	0

In	PMC5005937	8160	8162	O	-1	-1	0
mid-2014	PMC5005937	8163	8171	O	-1	-1	0
,	PMC5005937	8171	8172	O	-1	-1	0
a	PMC5005937	8173	8174	O	-1	-1	0
systematic	PMC5005937	8175	8185	O	-1	-1	0
follow	PMC5005937	8186	8192	O	-1	-1	0
-	PMC5005937	8192	8193	O	-1	-1	0
up	PMC5005937	8193	8195	O	-1	-1	0
of	PMC5005937	8196	8198	O	-1	-1	0
both	PMC5005937	8199	8203	O	-1	-1	0
the	PMC5005937	8204	8207	O	-1	-1	0
BCFR	PMC5005937	8208	8212	O	-1	-1	0
and	PMC5005937	8213	8216	O	-1	-1	0
kConFab	PMC5005937	8217	8224	O	-1	-1	0
FUP	PMC5005937	8225	8228	O	-1	-1	0
was	PMC5005937	8229	8232	O	-1	-1	0
completed	PMC5005937	8233	8242	O	-1	-1	0
as	PMC5005937	8243	8245	O	-1	-1	0
part	PMC5005937	8246	8250	O	-1	-1	0
of	PMC5005937	8251	8253	O	-1	-1	0
an	PMC5005937	8254	8256	O	-1	-1	0
NIH	PMC5005937	8257	8260	O	-1	-1	0
-	PMC5005937	8260	8261	O	-1	-1	0
funded	PMC5005937	8261	8267	O	-1	-1	0
grant	PMC5005937	8268	8273	O	-1	-1	0
to	PMC5005937	8274	8276	O	-1	-1	0
study	PMC5005937	8277	8282	O	-1	-1	0
the	PMC5005937	8283	8286	O	-1	-1	0
following	PMC5005937	8287	8296	O	-1	-1	0
aims	PMC5005937	8297	8301	O	-1	-1	0
using	PMC5005937	8302	8307	O	-1	-1	0
a	PMC5005937	8308	8309	O	-1	-1	0
prospective	PMC5005937	8310	8321	O	-1	-1	0
family	PMC5005937	8322	8328	O	-1	-1	0
study	PMC5005937	8329	8334	O	-1	-1	0
cohort	PMC5005937	8335	8341	O	-1	-1	0


	PMC5005937	8341	8343	O	-1	-1	0
International	PMC5005937	8343	8356	O	-1	-1	0
Journal	PMC5005937	8357	8364	O	-1	-1	0
of	PMC5005937	8365	8367	O	-1	-1	0
Epidemiology	PMC5005937	8368	8380	O	-1	-1	0
,	PMC5005937	8380	8381	O	-1	-1	0
2016	PMC5005937	8382	8386	O	-1	-1	0
,	PMC5005937	8386	8387	O	-1	-1	0
Vol	PMC5005937	8388	8391	O	-1	-1	0
.	PMC5005937	8391	8392	O	-1	-1	0

45	PMC5005937	8393	8395	O	-1	-1	0
,	PMC5005937	8395	8396	O	-1	-1	0

No	PMC5005937	8397	8399	O	-1	-1	0
.	PMC5005937	8399	8400	O	-1	-1	0
3	PMC5005937	8401	8402	O	-1	-1	0


	PMC5005937	8402	8404	O	-1	-1	0

(	PMC5005937	8404	8405	O	-1	-1	0
ProF	PMC5005937	8405	8409	O	-1	-1	0
-	PMC5005937	8409	8410	O	-1	-1	0
SC	PMC5005937	8410	8412	O	-1	-1	0
)	PMC5005937	8412	8413	O	-1	-1	0

(	PMC5005937	8414	8415	O	-1	-1	0
CA159868	PMC5005937	8415	8423	O	-1	-1	0
)	PMC5005937	8423	8424	O	-1	-1	0
:	PMC5005937	8424	8425	O	-1	-1	0

(	PMC5005937	8426	8427	O	-1	-1	0
i	PMC5005937	8427	8428	O	-1	-1	0
)	PMC5005937	8428	8429	O	-1	-1	0
estimate	PMC5005937	8430	8438	O	-1	-1	0
age	PMC5005937	8439	8442	O	-1	-1	0
-	PMC5005937	8442	8443	O	-1	-1	0
specific	PMC5005937	8443	8451	O	-1	-1	0
absolute	PMC5005937	8452	8460	O	-1	-1	0
risks	PMC5005937	8461	8466	O	-1	-1	0
of	PMC5005937	8467	8469	O	-1	-1	0
breast	PMC5005937	8470	8476	O	-1	-1	0
cancer	PMC5005937	8477	8483	O	-1	-1	0
;	PMC5005937	8483	8484	O	-1	-1	0
(	PMC5005937	8485	8486	O	-1	-1	0
ii	PMC5005937	8486	8488	O	-1	-1	0
)	PMC5005937	8488	8489	O	-1	-1	0
estimate	PMC5005937	8490	8498	O	-1	-1	0
relative	PMC5005937	8499	8507	O	-1	-1	0
risks	PMC5005937	8508	8513	O	-1	-1	0
associated	PMC5005937	8514	8524	O	-1	-1	0
with	PMC5005937	8525	8529	O	-1	-1	0
modifiable	PMC5005937	8530	8540	O	-1	-1	0
factors	PMC5005937	8541	8548	O	-1	-1	0
and	PMC5005937	8549	8552	O	-1	-1	0
test	PMC5005937	8553	8557	O	-1	-1	0
whether	PMC5005937	8558	8565	O	-1	-1	0
these	PMC5005937	8566	8571	O	-1	-1	0
associations	PMC5005937	8572	8584	O	-1	-1	0
vary	PMC5005937	8585	8589	O	-1	-1	0
by	PMC5005937	8590	8592	O	-1	-1	0
FRP	PMC5005937	8593	8596	O	-1	-1	0
;	PMC5005937	8596	8597	O	-1	-1	0
and	PMC5005937	8598	8601	O	-1	-1	0
(	PMC5005937	8602	8603	O	-1	-1	0
iii	PMC5005937	8603	8606	O	-1	-1	0
)	PMC5005937	8606	8607	O	-1	-1	0
develop	PMC5005937	8608	8615	O	-1	-1	0
and	PMC5005937	8616	8619	O	-1	-1	0
internally	PMC5005937	8620	8630	O	-1	-1	0
validate	PMC5005937	8631	8639	O	-1	-1	0
comprehensive	PMC5005937	8640	8653	O	-1	-1	0
clinical	PMC5005937	8654	8662	O	-1	-1	0
breast	PMC5005937	8663	8669	O	-1	-1	0
cancer	PMC5005937	8670	8676	O	-1	-1	0
risk	PMC5005937	8677	8681	O	-1	-1	0
assessment	PMC5005937	8682	8692	O	-1	-1	0
models	PMC5005937	8693	8699	O	-1	-1	0
for	PMC5005937	8700	8703	O	-1	-1	0
women	PMC5005937	8704	8709	O	-1	-1	0
across	PMC5005937	8710	8716	O	-1	-1	0
the	PMC5005937	8717	8720	O	-1	-1	0
spectrum	PMC5005937	8721	8729	O	-1	-1	0
of	PMC5005937	8730	8732	O	-1	-1	0
breast	PMC5005937	8733	8739	O	-1	-1	0
cancer	PMC5005937	8740	8746	O	-1	-1	0
risk	PMC5005937	8747	8751	O	-1	-1	0
.	PMC5005937	8751	8752	O	-1	-1	0


	PMC5005937	8752	8754	O	-1	-1	0

Who	PMC5005937	8754	8757	O	-1	-1	0
is	PMC5005937	8758	8760	O	-1	-1	0
in	PMC5005937	8761	8763	O	-1	-1	0
the	PMC5005937	8764	8767	O	-1	-1	0
cohort	PMC5005937	8768	8774	O	-1	-1	0
?	PMC5005937	8774	8775	O	-1	-1	0

The	PMC5005937	8776	8779	O	-1	-1	0
ProF	PMC5005937	8780	8784	O	-1	-1	0
-	PMC5005937	8784	8785	O	-1	-1	0
SC	PMC5005937	8785	8787	O	-1	-1	0
includes	PMC5005937	8788	8796	O	-1	-1	0
all	PMC5005937	8797	8800	O	-1	-1	0
female	PMC5005937	8801	8807	O	-1	-1	0
participants	PMC5005937	8808	8820	O	-1	-1	0
in	PMC5005937	8821	8823	O	-1	-1	0
the	PMC5005937	8824	8827	O	-1	-1	0
BCFR	PMC5005937	8828	8832	O	-1	-1	0
or	PMC5005937	8833	8835	O	-1	-1	0
kConFab	PMC5005937	8836	8843	O	-1	-1	0
FUP	PMC5005937	8844	8847	O	-1	-1	0
who	PMC5005937	8848	8851	O	-1	-1	0
were	PMC5005937	8852	8856	O	-1	-1	0
enrolled	PMC5005937	8857	8865	O	-1	-1	0
before	PMC5005937	8866	8872	O	-1	-1	0
30	PMC5005937	8873	8875	O	-1	-1	0
June	PMC5005937	8876	8880	O	-1	-1	0
2011	PMC5005937	8881	8885	O	-1	-1	0
and	PMC5005937	8886	8889	O	-1	-1	0
completed	PMC5005937	8890	8899	O	-1	-1	0
a	PMC5005937	8900	8901	O	-1	-1	0
baseline	PMC5005937	8902	8910	O	-1	-1	0
questionnaire	PMC5005937	8911	8924	O	-1	-1	0
.	PMC5005937	8924	8925	O	-1	-1	0

A	PMC5005937	8926	8927	O	-1	-1	0
total	PMC5005937	8928	8933	O	-1	-1	0
of	PMC5005937	8934	8936	O	-1	-1	0
31	PMC5005937	8937	8939	O	-1	-1	0
640	PMC5005937	8940	8943	O	-1	-1	0
women	PMC5005937	8944	8949	O	-1	-1	0
from	PMC5005937	8950	8954	O	-1	-1	0
11	PMC5005937	8955	8957	O	-1	-1	0
171	PMC5005937	8958	8961	O	-1	-1	0
families	PMC5005937	8962	8970	O	-1	-1	0
,	PMC5005937	8970	8971	O	-1	-1	0
11.4	PMC5005937	8972	8976	O	-1	-1	0
%	PMC5005937	8976	8977	O	-1	-1	0
of	PMC5005937	8978	8980	O	-1	-1	0
whom	PMC5005937	8981	8985	O	-1	-1	0
are	PMC5005937	8986	8989	O	-1	-1	0
Ashkenazi	PMC5005937	8990	8999	O	-1	-1	0
Jewish	PMC5005937	9000	9006	O	-1	-1	0
,	PMC5005937	9006	9007	O	-1	-1	0
completed	PMC5005937	9008	9017	O	-1	-1	0
the	PMC5005937	9018	9021	O	-1	-1	0
same	PMC5005937	9022	9026	O	-1	-1	0
baseline	PMC5005937	9027	9035	O	-1	-1	0
questionnaire	PMC5005937	9036	9049	O	-1	-1	0
.	PMC5005937	9049	9050	O	-1	-1	0

The	PMC5005937	9051	9054	O	-1	-1	0
BCFR	PMC5005937	9055	9059	O	-1	-1	0
recruited	PMC5005937	9060	9069	O	-1	-1	0
families	PMC5005937	9070	9078	O	-1	-1	0
from	PMC5005937	9079	9083	O	-1	-1	0
six	PMC5005937	9084	9087	O	-1	-1	0
sites	PMC5005937	9088	9093	O	-1	-1	0
;	PMC5005937	9093	9094	O	-1	-1	0
one	PMC5005937	9095	9098	O	-1	-1	0
in	PMC5005937	9099	9101	O	-1	-1	0
Australia	PMC5005937	9102	9111	B-Location	-1	-1	0
,	PMC5005937	9111	9112	O	-1	-1	0
one	PMC5005937	9113	9116	O	-1	-1	0
in	PMC5005937	9117	9119	O	-1	-1	0
Canada	PMC5005937	9120	9126	B-Location	-1	-1	0
and	PMC5005937	9127	9130	O	-1	-1	0
four	PMC5005937	9131	9135	O	-1	-1	0
in	PMC5005937	9136	9138	O	-1	-1	0
the	PMC5005937	9139	9142	O	-1	-1	0
USA	PMC5005937	9143	9146	B-Location	-1	-1	0
.	PMC5005937	9146	9147	O	-1	-1	0

The	PMC5005937	9148	9151	O	-1	-1	0
Australian	PMC5005937	9152	9162	O	-1	-1	0
,	PMC5005937	9162	9163	O	-1	-1	0
Canadian	PMC5005937	9164	9172	O	-1	-1	0
and	PMC5005937	9173	9176	O	-1	-1	0
Northern	PMC5005937	9177	9185	O	-1	-1	0
Californian	PMC5005937	9186	9197	O	-1	-1	0
sites	PMC5005937	9198	9203	O	-1	-1	0
recruited	PMC5005937	9204	9213	O	-1	-1	0
population	PMC5005937	9214	9224	O	-1	-1	0
-	PMC5005937	9224	9225	O	-1	-1	0
based	PMC5005937	9225	9230	O	-1	-1	0
case	PMC5005937	9231	9235	O	-1	-1	0
families	PMC5005937	9236	9244	O	-1	-1	0
using	PMC5005937	9245	9250	O	-1	-1	0
cancer	PMC5005937	9251	9257	O	-1	-1	0
registries	PMC5005937	9258	9268	O	-1	-1	0
.	PMC5005937	9268	9269	O	-1	-1	0

kConFab	PMC5005937	9270	9277	O	-1	-1	0
and	PMC5005937	9278	9281	O	-1	-1	0
the	PMC5005937	9282	9285	O	-1	-1	0
Australian	PMC5005937	9286	9296	O	-1	-1	0
BCFR	PMC5005937	9297	9301	O	-1	-1	0
recruited	PMC5005937	9302	9311	O	-1	-1	0
cases	PMC5005937	9312	9317	O	-1	-1	0
unselected	PMC5005937	9318	9328	O	-1	-1	0
for	PMC5005937	9329	9332	O	-1	-1	0
family	PMC5005937	9333	9339	O	-1	-1	0
history	PMC5005937	9340	9347	O	-1	-1	0
,	PMC5005937	9347	9348	O	-1	-1	0
over	PMC5005937	9349	9353	O	-1	-1	0
-	PMC5005937	9353	9354	O	-1	-1	0
sampling	PMC5005937	9354	9362	O	-1	-1	0
for	PMC5005937	9363	9366	O	-1	-1	0
early	PMC5005937	9367	9372	O	-1	-1	0
age	PMC5005937	9373	9376	O	-1	-1	0
at	PMC5005937	9377	9379	O	-1	-1	0
diagnosis	PMC5005937	9380	9389	O	-1	-1	0
,	PMC5005937	9389	9390	O	-1	-1	0
whereas	PMC5005937	9391	9398	O	-1	-1	0
the	PMC5005937	9399	9402	O	-1	-1	0
other	PMC5005937	9403	9408	O	-1	-1	0
two	PMC5005937	9409	9412	O	-1	-1	0
population	PMC5005937	9413	9423	O	-1	-1	0
-	PMC5005937	9423	9424	O	-1	-1	0
based	PMC5005937	9424	9429	O	-1	-1	0
sites	PMC5005937	9430	9435	O	-1	-1	0
used	PMC5005937	9436	9440	O	-1	-1	0
a	PMC5005937	9441	9442	O	-1	-1	0
two	PMC5005937	9443	9446	O	-1	-1	0
-	PMC5005937	9446	9447	O	-1	-1	0
stage	PMC5005937	9447	9452	O	-1	-1	0
sampling	PMC5005937	9453	9461	O	-1	-1	0
scheme	PMC5005937	9462	9468	O	-1	-1	0
,	PMC5005937	9468	9469	O	-1	-1	0
over	PMC5005937	9470	9474	O	-1	-1	0
-	PMC5005937	9474	9475	O	-1	-1	0
sampling	PMC5005937	9475	9483	O	-1	-1	0
for	PMC5005937	9484	9487	O	-1	-1	0
early	PMC5005937	9488	9493	O	-1	-1	0
age	PMC5005937	9494	9497	O	-1	-1	0
at	PMC5005937	9498	9500	O	-1	-1	0
diagnosis	PMC5005937	9501	9510	O	-1	-1	0
and/or	PMC5005937	9511	9517	O	-1	-1	0
having	PMC5005937	9518	9524	O	-1	-1	0
a	PMC5005937	9525	9526	O	-1	-1	0
family	PMC5005937	9527	9533	O	-1	-1	0
history	PMC5005937	9534	9541	O	-1	-1	0
or	PMC5005937	9542	9544	O	-1	-1	0
other	PMC5005937	9545	9550	O	-1	-1	0
predictors	PMC5005937	9551	9561	O	-1	-1	0
of	PMC5005937	9562	9564	O	-1	-1	0
a	PMC5005937	9565	9566	O	-1	-1	0
genetic	PMC5005937	9567	9574	O	-1	-1	0
predisposition	PMC5005937	9575	9589	O	-1	-1	0
.	PMC5005937	9589	9590	O	-1	-1	0

The	PMC5005937	9591	9594	O	-1	-1	0
Northern	PMC5005937	9595	9603	O	-1	-1	0
California	PMC5005937	9604	9614	O	-1	-1	0
site	PMC5005937	9615	9619	O	-1	-1	0
over	PMC5005937	9620	9624	O	-1	-1	0
-	PMC5005937	9624	9625	O	-1	-1	0
sampled	PMC5005937	9625	9632	O	-1	-1	0
racial	PMC5005937	9633	9639	O	-1	-1	0
/	PMC5005937	9639	9640	O	-1	-1	0
ethnic	PMC5005937	9640	9646	O	-1	-1	0
minority	PMC5005937	9647	9655	O	-1	-1	0
families	PMC5005937	9656	9664	O	-1	-1	0
.	PMC5005937	9664	9665	O	-1	-1	0

The	PMC5005937	9666	9669	O	-1	-1	0
New	PMC5005937	9670	9673	O	-1	-1	0
York	PMC5005937	9674	9678	O	-1	-1	0
,	PMC5005937	9678	9679	O	-1	-1	0
Philadelphia	PMC5005937	9680	9692	O	-1	-1	0
,	PMC5005937	9692	9693	O	-1	-1	0
Utah	PMC5005937	9694	9698	O	-1	-1	0
,	PMC5005937	9698	9699	O	-1	-1	0
Canadian	PMC5005937	9700	9708	O	-1	-1	0
and	PMC5005937	9709	9712	O	-1	-1	0

Australian	PMC5005937	9713	9723	O	-1	-1	0
sites	PMC5005937	9724	9729	O	-1	-1	0
recruited	PMC5005937	9730	9739	O	-1	-1	0
multiple	PMC5005937	9740	9748	O	-1	-1	0
-	PMC5005937	9748	9749	O	-1	-1	0
case	PMC5005937	9749	9753	O	-1	-1	0
families	PMC5005937	9754	9762	O	-1	-1	0
through	PMC5005937	9763	9770	O	-1	-1	0
family	PMC5005937	9771	9777	O	-1	-1	0
cancer	PMC5005937	9778	9784	O	-1	-1	0
clinics	PMC5005937	9785	9792	O	-1	-1	0
and	PMC5005937	9793	9796	O	-1	-1	0
community	PMC5005937	9797	9806	O	-1	-1	0
outreach	PMC5005937	9807	9815	O	-1	-1	0
.	PMC5005937	9815	9816	O	-1	-1	0

kConFab	PMC5005937	9817	9824	O	-1	-1	0
recruited	PMC5005937	9825	9834	O	-1	-1	0
multi	PMC5005937	9835	9840	O	-1	-1	0
-	PMC5005937	9840	9841	O	-1	-1	0
generational	PMC5005937	9841	9853	O	-1	-1	0
,	PMC5005937	9853	9854	O	-1	-1	0
multiple	PMC5005937	9855	9863	O	-1	-1	0
-	PMC5005937	9863	9864	O	-1	-1	0
case	PMC5005937	9864	9868	O	-1	-1	0
families	PMC5005937	9869	9877	O	-1	-1	0
through	PMC5005937	9878	9885	O	-1	-1	0
cancer	PMC5005937	9886	9892	O	-1	-1	0
family	PMC5005937	9893	9899	O	-1	-1	0
clinics	PMC5005937	9900	9907	O	-1	-1	0
in	PMC5005937	9908	9910	O	-1	-1	0
Australia	PMC5005937	9911	9920	B-Location	-1	-1	0
and	PMC5005937	9921	9924	O	-1	-1	0
New	PMC5005937	9925	9928	B-Location	-1	-1	0
Zealand.30,31	PMC5005937	9929	9942	O	-1	-1	0

The	PMC5005937	9943	9946	O	-1	-1	0
eligibility	PMC5005937	9947	9958	O	-1	-1	0
criteria	PMC5005937	9959	9967	O	-1	-1	0
for	PMC5005937	9968	9971	O	-1	-1	0
recruitment	PMC5005937	9972	9983	O	-1	-1	0
of	PMC5005937	9984	9986	O	-1	-1	0
families	PMC5005937	9987	9995	O	-1	-1	0
evolved	PMC5005937	9996	10003	O	-1	-1	0
over	PMC5005937	10004	10008	O	-1	-1	0
time	PMC5005937	10009	10013	O	-1	-1	0
and	PMC5005937	10014	10017	O	-1	-1	0
were	PMC5005937	10018	10022	O	-1	-1	0
intended	PMC5005937	10023	10031	O	-1	-1	0
to	PMC5005937	10032	10034	O	-1	-1	0
maximise	PMC5005937	10035	10043	O	-1	-1	0
the	PMC5005937	10044	10047	O	-1	-1	0
number	PMC5005937	10048	10054	O	-1	-1	0
of	PMC5005937	10055	10057	O	-1	-1	0
living	PMC5005937	10058	10064	O	-1	-1	0
potentially	PMC5005937	10065	10076	O	-1	-1	0
high	PMC5005937	10077	10081	O	-1	-1	0
-	PMC5005937	10081	10082	O	-1	-1	0
risk	PMC5005937	10082	10086	O	-1	-1	0
women	PMC5005937	10087	10092	O	-1	-1	0
,	PMC5005937	10092	10093	O	-1	-1	0
including	PMC5005937	10094	10103	O	-1	-1	0
known	PMC5005937	10104	10109	O	-1	-1	0
BRCA1	PMC5005937	10110	10115	O	-1	-1	0
and	PMC5005937	10116	10119	O	-1	-1	0
BRCA2	PMC5005937	10120	10125	O	-1	-1	0

mutation	PMC5005937	10126	10134	O	-1	-1	0
carriers	PMC5005937	10135	10143	O	-1	-1	0
,	PMC5005937	10143	10144	O	-1	-1	0

whether	PMC5005937	10145	10152	O	-1	-1	0
or	PMC5005937	10153	10155	O	-1	-1	0
not	PMC5005937	10156	10159	O	-1	-1	0
they	PMC5005937	10160	10164	O	-1	-1	0
had	PMC5005937	10165	10168	O	-1	-1	0
been	PMC5005937	10169	10173	O	-1	-1	0
diagnosed	PMC5005937	10174	10183	O	-1	-1	0
with	PMC5005937	10184	10188	O	-1	-1	0
breast	PMC5005937	10189	10195	O	-1	-1	0
cancer	PMC5005937	10196	10202	O	-1	-1	0
.	PMC5005937	10202	10203	O	-1	-1	0

Although	PMC5005937	10204	10212	O	-1	-1	0
ascertainment	PMC5005937	10213	10226	O	-1	-1	0
issues	PMC5005937	10227	10233	O	-1	-1	0
sometimes	PMC5005937	10234	10243	O	-1	-1	0
require	PMC5005937	10244	10251	O	-1	-1	0
separate	PMC5005937	10252	10260	O	-1	-1	0
analyses	PMC5005937	10261	10269	O	-1	-1	0
of	PMC5005937	10270	10272	O	-1	-1	0
population	PMC5005937	10273	10283	O	-1	-1	0
-	PMC5005937	10283	10284	O	-1	-1	0
based	PMC5005937	10284	10289	O	-1	-1	0
and	PMC5005937	10290	10293	O	-1	-1	0
clinic	PMC5005937	10294	10300	O	-1	-1	0
-	PMC5005937	10300	10301	O	-1	-1	0
ascertained	PMC5005937	10301	10312	O	-1	-1	0
families	PMC5005937	10313	10321	O	-1	-1	0
for	PMC5005937	10322	10325	O	-1	-1	0
retrospective	PMC5005937	10326	10339	O	-1	-1	0
studies	PMC5005937	10340	10347	O	-1	-1	0
,	PMC5005937	10347	10348	O	-1	-1	0
for	PMC5005937	10349	10352	O	-1	-1	0
prospective	PMC5005937	10353	10364	O	-1	-1	0
studies	PMC5005937	10365	10372	O	-1	-1	0
all	PMC5005937	10373	10376	O	-1	-1	0
unaffected	PMC5005937	10377	10387	O	-1	-1	0
family	PMC5005937	10388	10394	O	-1	-1	0
members	PMC5005937	10395	10402	O	-1	-1	0
can	PMC5005937	10403	10406	O	-1	-1	0
be	PMC5005937	10407	10409	O	-1	-1	0
combined	PMC5005937	10410	10418	O	-1	-1	0
into	PMC5005937	10419	10423	O	-1	-1	0
a	PMC5005937	10424	10425	O	-1	-1	0
single	PMC5005937	10426	10432	O	-1	-1	0
cohort	PMC5005937	10433	10439	O	-1	-1	0
because	PMC5005937	10440	10447	O	-1	-1	0
all	PMC5005937	10448	10451	O	-1	-1	0
families	PMC5005937	10452	10460	O	-1	-1	0
are	PMC5005937	10461	10464	O	-1	-1	0
being	PMC5005937	10465	10470	O	-1	-1	0
followed	PMC5005937	10471	10479	O	-1	-1	0
using	PMC5005937	10480	10485	O	-1	-1	0
the	PMC5005937	10486	10489	O	-1	-1	0
same	PMC5005937	10490	10494	O	-1	-1	0
methods	PMC5005937	10495	10502	O	-1	-1	0
and	PMC5005937	10503	10506	O	-1	-1	0
their	PMC5005937	10507	10512	O	-1	-1	0
members	PMC5005937	10513	10520	O	-1	-1	0
have	PMC5005937	10521	10525	O	-1	-1	0
been	PMC5005937	10526	10530	O	-1	-1	0
studied	PMC5005937	10531	10538	O	-1	-1	0
using	PMC5005937	10539	10544	O	-1	-1	0
the	PMC5005937	10545	10548	O	-1	-1	0
same	PMC5005937	10549	10553	O	-1	-1	0
protocol	PMC5005937	10554	10562	O	-1	-1	0
at	PMC5005937	10563	10565	O	-1	-1	0
baseline	PMC5005937	10566	10574	O	-1	-1	0
.	PMC5005937	10574	10575	O	-1	-1	0

A	PMC5005937	10576	10577	O	-1	-1	0
family	PMC5005937	10578	10584	O	-1	-1	0
cohort	PMC5005937	10585	10591	O	-1	-1	0
is	PMC5005937	10592	10594	O	-1	-1	0
in	PMC5005937	10595	10597	O	-1	-1	0
contrast	PMC5005937	10598	10606	O	-1	-1	0
to	PMC5005937	10607	10609	O	-1	-1	0
conventional	PMC5005937	10610	10622	O	-1	-1	0
cohort	PMC5005937	10623	10629	O	-1	-1	0
studies	PMC5005937	10630	10637	O	-1	-1	0
in	PMC5005937	10638	10640	O	-1	-1	0
which	PMC5005937	10641	10646	O	-1	-1	0
the	PMC5005937	10647	10650	O	-1	-1	0
vast	PMC5005937	10651	10655	O	-1	-1	0
majority	PMC5005937	10656	10664	O	-1	-1	0
of	PMC5005937	10665	10667	O	-1	-1	0
incident	PMC5005937	10668	10676	O	-1	-1	0
cases	PMC5005937	10677	10682	O	-1	-1	0
do	PMC5005937	10683	10685	O	-1	-1	0
not	PMC5005937	10686	10689	O	-1	-1	0
have	PMC5005937	10690	10694	O	-1	-1	0
a	PMC5005937	10695	10696	O	-1	-1	0
family	PMC5005937	10697	10703	O	-1	-1	0
history	PMC5005937	10704	10711	O	-1	-1	0
,	PMC5005937	10711	10712	O	-1	-1	0
at	PMC5005937	10713	10715	O	-1	-1	0
least	PMC5005937	10716	10721	O	-1	-1	0
not	PMC5005937	10722	10725	O	-1	-1	0
for	PMC5005937	10726	10729	O	-1	-1	0
first-	PMC5005937	10730	10736	O	-1	-1	0
or	PMC5005937	10737	10739	O	-1	-1	0
second	PMC5005937	10740	10746	O	-1	-1	0
-	PMC5005937	10746	10747	O	-1	-1	0
degree	PMC5005937	10747	10753	O	-1	-1	0
relatives	PMC5005937	10754	10763	O	-1	-1	0
.	PMC5005937	10763	10764	O	-1	-1	0

A	PMC5005937	10765	10766	O	-1	-1	0
large	PMC5005937	10767	10772	O	-1	-1	0
proportion	PMC5005937	10773	10783	O	-1	-1	0
of	PMC5005937	10784	10786	O	-1	-1	0
the	PMC5005937	10787	10790	O	-1	-1	0
ProF	PMC5005937	10791	10795	O	-1	-1	0
-	PMC5005937	10795	10796	O	-1	-1	0
SC	PMC5005937	10796	10798	O	-1	-1	0
cohort	PMC5005937	10799	10805	O	-1	-1	0
was	PMC5005937	10806	10809	O	-1	-1	0
affected	PMC5005937	10810	10818	O	-1	-1	0
at	PMC5005937	10819	10821	O	-1	-1	0
baseline	PMC5005937	10822	10830	O	-1	-1	0
,	PMC5005937	10830	10831	O	-1	-1	0
which	PMC5005937	10832	10837	O	-1	-1	0
also	PMC5005937	10838	10842	O	-1	-1	0
facilitates	PMC5005937	10843	10854	O	-1	-1	0
studies	PMC5005937	10855	10862	O	-1	-1	0
on	PMC5005937	10863	10865	O	-1	-1	0
risk	PMC5005937	10866	10870	O	-1	-1	0
factors	PMC5005937	10871	10878	O	-1	-1	0
for	PMC5005937	10879	10882	O	-1	-1	0
subsequent	PMC5005937	10883	10893	O	-1	-1	0
primary	PMC5005937	10894	10901	O	-1	-1	0
breast	PMC5005937	10902	10908	O	-1	-1	0
cancer	PMC5005937	10909	10915	O	-1	-1	0
,	PMC5005937	10915	10916	O	-1	-1	0
including	PMC5005937	10917	10926	O	-1	-1	0
contralateral	PMC5005937	10927	10940	O	-1	-1	0
disease	PMC5005937	10941	10948	O	-1	-1	0
.	PMC5005937	10948	10949	O	-1	-1	0

Table	PMC5005937	10950	10955	O	-1	-1	0
1	PMC5005937	10956	10957	O	-1	-1	0
describes	PMC5005937	10958	10967	O	-1	-1	0
the	PMC5005937	10968	10971	O	-1	-1	0
baseline	PMC5005937	10972	10980	O	-1	-1	0
characteristics	PMC5005937	10981	10996	O	-1	-1	0
of	PMC5005937	10997	10999	O	-1	-1	0
ProFSC	PMC5005937	11000	11006	O	-1	-1	0
,	PMC5005937	11006	11007	O	-1	-1	0
illustrating	PMC5005937	11008	11020	O	-1	-1	0
wide	PMC5005937	11021	11025	O	-1	-1	0
variation	PMC5005937	11026	11035	O	-1	-1	0
in	PMC5005937	11036	11038	O	-1	-1	0
demographics	PMC5005937	11039	11051	O	-1	-1	0
,	PMC5005937	11051	11052	O	-1	-1	0
family	PMC5005937	11053	11059	O	-1	-1	0


	PMC5005937	11059	11061	O	-1	-1	0
685	PMC5005937	11061	11064	O	-1	-1	0


	PMC5005937	11064	11066	O	-1	-1	0
history	PMC5005937	11066	11073	O	-1	-1	0
and	PMC5005937	11074	11077	O	-1	-1	0
other	PMC5005937	11078	11083	O	-1	-1	0
risk	PMC5005937	11084	11088	O	-1	-1	0
factors	PMC5005937	11089	11096	O	-1	-1	0
.	PMC5005937	11096	11097	O	-1	-1	0

Table	PMC5005937	11098	11103	O	-1	-1	0
2	PMC5005937	11104	11105	O	-1	-1	0
summarises	PMC5005937	11106	11116	O	-1	-1	0
the	PMC5005937	11117	11120	O	-1	-1	0
distribution	PMC5005937	11121	11133	O	-1	-1	0
of	PMC5005937	11134	11136	O	-1	-1	0
the	PMC5005937	11137	11140	O	-1	-1	0
incident	PMC5005937	11141	11149	O	-1	-1	0
breast	PMC5005937	11150	11156	O	-1	-1	0
cancer	PMC5005937	11157	11163	O	-1	-1	0
cases	PMC5005937	11164	11169	O	-1	-1	0
diagnosed	PMC5005937	11170	11179	O	-1	-1	0
since	PMC5005937	11180	11185	O	-1	-1	0
baseline	PMC5005937	11186	11194	O	-1	-1	0
.	PMC5005937	11194	11195	O	-1	-1	0

There	PMC5005937	11196	11201	O	-1	-1	0
is	PMC5005937	11202	11204	O	-1	-1	0
a	PMC5005937	11205	11206	O	-1	-1	0
wide	PMC5005937	11207	11211	O	-1	-1	0
distribution	PMC5005937	11212	11224	O	-1	-1	0
in	PMC5005937	11225	11227	O	-1	-1	0
age	PMC5005937	11228	11231	O	-1	-1	0
at	PMC5005937	11232	11234	O	-1	-1	0
diagnosis	PMC5005937	11235	11244	O	-1	-1	0
,	PMC5005937	11244	11245	O	-1	-1	0
with	PMC5005937	11246	11250	O	-1	-1	0
cases	PMC5005937	11251	11256	O	-1	-1	0
diagnosed	PMC5005937	11257	11266	O	-1	-1	0
before	PMC5005937	11267	11273	O	-1	-1	0
age	PMC5005937	11274	11277	O	-1	-1	0
50	PMC5005937	11278	11280	O	-1	-1	0
years	PMC5005937	11281	11286	O	-1	-1	0
accounting	PMC5005937	11287	11297	O	-1	-1	0
for	PMC5005937	11298	11301	O	-1	-1	0
34	PMC5005937	11302	11304	O	-1	-1	0
%	PMC5005937	11304	11305	O	-1	-1	0
in	PMC5005937	11306	11308	O	-1	-1	0
the	PMC5005937	11309	11312	O	-1	-1	0
sub	PMC5005937	11313	11316	O	-1	-1	0
-	PMC5005937	11316	11317	O	-1	-1	0
cohort	PMC5005937	11317	11323	O	-1	-1	0
of	PMC5005937	11324	11326	O	-1	-1	0
women	PMC5005937	11327	11332	O	-1	-1	0
unaffected	PMC5005937	11333	11343	O	-1	-1	0
at	PMC5005937	11344	11346	O	-1	-1	0
baseline	PMC5005937	11347	11355	O	-1	-1	0
and	PMC5005937	11356	11359	O	-1	-1	0
28	PMC5005937	11360	11362	O	-1	-1	0
%	PMC5005937	11362	11363	O	-1	-1	0
in	PMC5005937	11364	11366	O	-1	-1	0
the	PMC5005937	11367	11370	O	-1	-1	0
sub	PMC5005937	11371	11374	O	-1	-1	0
-	PMC5005937	11374	11375	O	-1	-1	0
cohort	PMC5005937	11375	11381	O	-1	-1	0
of	PMC5005937	11382	11384	O	-1	-1	0
women	PMC5005937	11385	11390	O	-1	-1	0
affected	PMC5005937	11391	11399	O	-1	-1	0
at	PMC5005937	11400	11402	O	-1	-1	0
baseline	PMC5005937	11403	11411	O	-1	-1	0
,	PMC5005937	11411	11412	O	-1	-1	0
respectively	PMC5005937	11413	11425	O	-1	-1	0
.	PMC5005937	11425	11426	O	-1	-1	0

For	PMC5005937	11427	11430	O	-1	-1	0
both	PMC5005937	11431	11435	O	-1	-1	0
these	PMC5005937	11436	11441	O	-1	-1	0
sub	PMC5005937	11442	11445	O	-1	-1	0
-	PMC5005937	11445	11446	O	-1	-1	0
cohorts	PMC5005937	11446	11453	O	-1	-1	0
,	PMC5005937	11453	11454	O	-1	-1	0
a	PMC5005937	11455	11456	O	-1	-1	0
high	PMC5005937	11457	11461	O	-1	-1	0
proportion	PMC5005937	11462	11472	O	-1	-1	0
of	PMC5005937	11473	11475	O	-1	-1	0
incident	PMC5005937	11476	11484	O	-1	-1	0
cases	PMC5005937	11485	11490	O	-1	-1	0
have	PMC5005937	11491	11495	O	-1	-1	0
been	PMC5005937	11496	11500	O	-1	-1	0
confirmed	PMC5005937	11501	11510	O	-1	-1	0
through	PMC5005937	11511	11518	O	-1	-1	0
pathology	PMC5005937	11519	11528	O	-1	-1	0
records	PMC5005937	11529	11536	O	-1	-1	0
(	PMC5005937	11537	11538	O	-1	-1	0
78	PMC5005937	11538	11540	O	-1	-1	0
%	PMC5005937	11540	11541	O	-1	-1	0
and	PMC5005937	11542	11545	O	-1	-1	0
71	PMC5005937	11546	11548	O	-1	-1	0
%	PMC5005937	11548	11549	O	-1	-1	0
,	PMC5005937	11549	11550	O	-1	-1	0
respectively	PMC5005937	11551	11563	O	-1	-1	0
)	PMC5005937	11563	11564	O	-1	-1	0
and	PMC5005937	11565	11568	O	-1	-1	0
a	PMC5005937	11569	11570	O	-1	-1	0
high	PMC5005937	11571	11575	O	-1	-1	0
proportion	PMC5005937	11576	11586	O	-1	-1	0
have	PMC5005937	11587	11591	O	-1	-1	0
DNA	PMC5005937	11592	11595	O	-1	-1	0
available	PMC5005937	11596	11605	O	-1	-1	0
(	PMC5005937	11606	11607	O	-1	-1	0
88	PMC5005937	11607	11609	O	-1	-1	0
%	PMC5005937	11609	11610	O	-1	-1	0
and	PMC5005937	11611	11614	O	-1	-1	0
95	PMC5005937	11615	11617	O	-1	-1	0
%	PMC5005937	11617	11618	O	-1	-1	0
,	PMC5005937	11618	11619	O	-1	-1	0
respectively	PMC5005937	11620	11632	O	-1	-1	0
)	PMC5005937	11632	11633	O	-1	-1	0
.	PMC5005937	11633	11634	O	-1	-1	0


	PMC5005937	11634	11636	O	-1	-1	0

How	PMC5005937	11636	11639	O	-1	-1	0
often	PMC5005937	11640	11645	O	-1	-1	0
have	PMC5005937	11646	11650	O	-1	-1	0
they	PMC5005937	11651	11655	O	-1	-1	0
been	PMC5005937	11656	11660	O	-1	-1	0
followed	PMC5005937	11661	11669	O	-1	-1	0
up	PMC5005937	11670	11672	O	-1	-1	0
?	PMC5005937	11672	11673	O	-1	-1	0

The	PMC5005937	11674	11677	O	-1	-1	0
family	PMC5005937	11678	11684	O	-1	-1	0
-	PMC5005937	11684	11685	O	-1	-1	0
based	PMC5005937	11685	11690	O	-1	-1	0
design	PMC5005937	11691	11697	O	-1	-1	0
facilitates	PMC5005937	11698	11709	O	-1	-1	0
follow	PMC5005937	11710	11716	O	-1	-1	0
-	PMC5005937	11716	11717	O	-1	-1	0
up	PMC5005937	11717	11719	O	-1	-1	0
primarily	PMC5005937	11720	11729	O	-1	-1	0
through	PMC5005937	11730	11737	O	-1	-1	0
tracing	PMC5005937	11738	11745	O	-1	-1	0
and	PMC5005937	11746	11749	O	-1	-1	0
updates	PMC5005937	11750	11757	O	-1	-1	0
of	PMC5005937	11758	11760	O	-1	-1	0
vital	PMC5005937	11761	11766	O	-1	-1	0
status	PMC5005937	11767	11773	O	-1	-1	0

using	PMC5005937	11774	11779	O	-1	-1	0
multiple	PMC5005937	11780	11788	O	-1	-1	0
informants	PMC5005937	11789	11799	O	-1	-1	0
,	PMC5005937	11799	11800	O	-1	-1	0
thereby	PMC5005937	11801	11808	O	-1	-1	0
increasing	PMC5005937	11809	11819	O	-1	-1	0
the	PMC5005937	11820	11823	O	-1	-1	0
validity	PMC5005937	11824	11832	O	-1	-1	0
of	PMC5005937	11833	11835	O	-1	-1	0
the	PMC5005937	11836	11839	O	-1	-1	0
cohort	PMC5005937	11840	11846	O	-1	-1	0

’s	PMC5005937	11846	11848	O	-1	-1	0

data	PMC5005937	11849	11853	O	-1	-1	0
on	PMC5005937	11854	11856	O	-1	-1	0
outcomes	PMC5005937	11857	11865	O	-1	-1	0
and	PMC5005937	11866	11869	O	-1	-1	0
family	PMC5005937	11870	11876	O	-1	-1	0
cancer	PMC5005937	11877	11883	O	-1	-1	0
history.32	PMC5005937	11884	11894	O	-1	-1	0
Since	PMC5005937	11895	11900	O	-1	-1	0
baseline	PMC5005937	11901	11909	O	-1	-1	0

,	PMC5005937	11909	11910	O	-1	-1	0
there	PMC5005937	11911	11916	O	-1	-1	0
has	PMC5005937	11917	11920	O	-1	-1	0
been	PMC5005937	11921	11925	O	-1	-1	0
regular	PMC5005937	11926	11933	O	-1	-1	0
contact	PMC5005937	11934	11941	O	-1	-1	0
with	PMC5005937	11942	11946	O	-1	-1	0
families	PMC5005937	11947	11955	O	-1	-1	0
through	PMC5005937	11956	11963	O	-1	-1	0
BCFR	PMC5005937	11964	11968	O	-1	-1	0
and	PMC5005937	11969	11972	O	-1	-1	0
kConFab	PMC5005937	11973	11980	O	-1	-1	0
newsletters	PMC5005937	11981	11992	O	-1	-1	0
and	PMC5005937	11993	11996	O	-1	-1	0
websites	PMC5005937	11997	12005	O	-1	-1	0
.	PMC5005937	12005	12006	O	-1	-1	0

Vital	PMC5005937	12007	12012	O	-1	-1	0
and	PMC5005937	12013	12016	O	-1	-1	0
cancer	PMC5005937	12017	12023	O	-1	-1	0
statuses	PMC5005937	12024	12032	O	-1	-1	0
have	PMC5005937	12033	12037	O	-1	-1	0
been	PMC5005937	12038	12042	O	-1	-1	0
updated	PMC5005937	12043	12050	O	-1	-1	0
through	PMC5005937	12051	12058	O	-1	-1	0
phone	PMC5005937	12059	12064	O	-1	-1	0
interviews	PMC5005937	12065	12075	O	-1	-1	0
,	PMC5005937	12075	12076	O	-1	-1	0
mailed	PMC5005937	12077	12083	O	-1	-1	0
questionnaires	PMC5005937	12084	12098	O	-1	-1	0
,	PMC5005937	12098	12099	O	-1	-1	0
clinic	PMC5005937	12100	12106	O	-1	-1	0
visits	PMC5005937	12107	12113	O	-1	-1	0
and	PMC5005937	12114	12117	O	-1	-1	0
linkages	PMC5005937	12118	12126	O	-1	-1	0
to	PMC5005937	12127	12129	O	-1	-1	0
cancer	PMC5005937	12130	12136	O	-1	-1	0
registries	PMC5005937	12137	12147	O	-1	-1	0
.	PMC5005937	12147	12148	O	-1	-1	0

In	PMC5005937	12149	12151	O	-1	-1	0
addition	PMC5005937	12152	12160	O	-1	-1	0
,	PMC5005937	12160	12161	O	-1	-1	0
there	PMC5005937	12162	12167	O	-1	-1	0
have	PMC5005937	12168	12172	O	-1	-1	0
been	PMC5005937	12173	12177	O	-1	-1	0
systematic	PMC5005937	12178	12188	O	-1	-1	0
updates	PMC5005937	12189	12196	O	-1	-1	0
of	PMC5005937	12197	12199	O	-1	-1	0
risk	PMC5005937	12200	12204	O	-1	-1	0
factor	PMC5005937	12205	12211	O	-1	-1	0
and	PMC5005937	12212	12215	O	-1	-1	0
clinical	PMC5005937	12216	12224	O	-1	-1	0
outcomes	PMC5005937	12225	12233	O	-1	-1	0
data	PMC5005937	12234	12238	O	-1	-1	0
(	PMC5005937	12239	12240	O	-1	-1	0
see	PMC5005937	12240	12243	O	-1	-1	0
below	PMC5005937	12244	12249	O	-1	-1	0
for	PMC5005937	12250	12253	O	-1	-1	0
details	PMC5005937	12254	12261	O	-1	-1	0
)	PMC5005937	12261	12262	O	-1	-1	0
.	PMC5005937	12262	12263	O	-1	-1	0

High	PMC5005937	12264	12268	O	-1	-1	0
participation	PMC5005937	12269	12282	O	-1	-1	0
at	PMC5005937	12283	12285	O	-1	-1	0
follow	PMC5005937	12286	12292	O	-1	-1	0
-	PMC5005937	12292	12293	O	-1	-1	0
up	PMC5005937	12293	12295	O	-1	-1	0
is	PMC5005937	12296	12298	O	-1	-1	0
a	PMC5005937	12299	12300	O	-1	-1	0
critical	PMC5005937	12301	12309	O	-1	-1	0
issue	PMC5005937	12310	12315	O	-1	-1	0
for	PMC5005937	12316	12319	O	-1	-1	0
the	PMC5005937	12320	12323	O	-1	-1	0
validity	PMC5005937	12324	12332	O	-1	-1	0
of	PMC5005937	12333	12335	O	-1	-1	0
cohort	PMC5005937	12336	12342	O	-1	-1	0
studies	PMC5005937	12343	12350	O	-1	-1	0
,	PMC5005937	12350	12351	O	-1	-1	0
and	PMC5005937	12352	12355	O	-1	-1	0
we	PMC5005937	12356	12358	O	-1	-1	0
have	PMC5005937	12359	12363	O	-1	-1	0
demonstrated	PMC5005937	12364	12376	O	-1	-1	0
that	PMC5005937	12377	12381	O	-1	-1	0
this	PMC5005937	12382	12386	O	-1	-1	0
can	PMC5005937	12387	12390	O	-1	-1	0
be	PMC5005937	12391	12393	O	-1	-1	0
achieved	PMC5005937	12394	12402	O	-1	-1	0
by	PMC5005937	12403	12405	O	-1	-1	0
using	PMC5005937	12406	12411	O	-1	-1	0
a	PMC5005937	12412	12413	O	-1	-1	0
family	PMC5005937	12414	12420	O	-1	-1	0
-	PMC5005937	12420	12421	O	-1	-1	0
based	PMC5005937	12421	12426	O	-1	-1	0
design	PMC5005937	12427	12433	O	-1	-1	0
with	PMC5005937	12434	12438	O	-1	-1	0
multiple	PMC5005937	12439	12447	O	-1	-1	0
contacts	PMC5005937	12448	12456	O	-1	-1	0
typically	PMC5005937	12457	12466	O	-1	-1	0
available	PMC5005937	12467	12476	O	-1	-1	0
for	PMC5005937	12477	12480	O	-1	-1	0
each	PMC5005937	12481	12485	O	-1	-1	0
cohort	PMC5005937	12486	12492	O	-1	-1	0
member	PMC5005937	12493	12499	O	-1	-1	0
.	PMC5005937	12499	12500	O	-1	-1	0

Of	PMC5005937	12501	12503	O	-1	-1	0
the	PMC5005937	12504	12507	O	-1	-1	0
31	PMC5005937	12508	12510	O	-1	-1	0
640	PMC5005937	12511	12514	O	-1	-1	0
women	PMC5005937	12515	12520	O	-1	-1	0
in	PMC5005937	12521	12523	O	-1	-1	0
the	PMC5005937	12524	12527	O	-1	-1	0
cohort	PMC5005937	12528	12534	O	-1	-1	0
,	PMC5005937	12534	12535	O	-1	-1	0
after	PMC5005937	12536	12541	O	-1	-1	0
an	PMC5005937	12542	12544	O	-1	-1	0
average	PMC5005937	12545	12552	O	-1	-1	0
of	PMC5005937	12553	12555	O	-1	-1	0
9	PMC5005937	12556	12557	O	-1	-1	0
years	PMC5005937	12558	12563	O	-1	-1	0
of	PMC5005937	12564	12566	O	-1	-1	0
follow	PMC5005937	12567	12573	O	-1	-1	0
-	PMC5005937	12573	12574	O	-1	-1	0
up	PMC5005937	12574	12576	O	-1	-1	0
,	PMC5005937	12576	12577	O	-1	-1	0
11	PMC5005937	12578	12580	O	-1	-1	0
%	PMC5005937	12580	12581	O	-1	-1	0
were	PMC5005937	12582	12586	O	-1	-1	0
no	PMC5005937	12587	12589	O	-1	-1	0
longer	PMC5005937	12590	12596	O	-1	-1	0
living	PMC5005937	12597	12603	O	-1	-1	0
,	PMC5005937	12603	12604	O	-1	-1	0
5	PMC5005937	12605	12606	O	-1	-1	0
%	PMC5005937	12606	12607	O	-1	-1	0
no	PMC5005937	12608	12610	O	-1	-1	0
longer	PMC5005937	12611	12617	O	-1	-1	0
wished	PMC5005937	12618	12624	O	-1	-1	0
to	PMC5005937	12625	12627	O	-1	-1	0
participate	PMC5005937	12628	12639	O	-1	-1	0
in	PMC5005937	12640	12642	O	-1	-1	0
follow	PMC5005937	12643	12649	O	-1	-1	0
-	PMC5005937	12649	12650	O	-1	-1	0
up	PMC5005937	12650	12652	O	-1	-1	0
and	PMC5005937	12653	12656	O	-1	-1	0
14	PMC5005937	12657	12659	O	-1	-1	0
%	PMC5005937	12659	12660	O	-1	-1	0
have	PMC5005937	12661	12665	O	-1	-1	0
been	PMC5005937	12666	12670	O	-1	-1	0
lost	PMC5005937	12671	12675	O	-1	-1	0
to	PMC5005937	12676	12678	O	-1	-1	0
follow	PMC5005937	12679	12685	O	-1	-1	0
-	PMC5005937	12685	12686	O	-1	-1	0
up	PMC5005937	12686	12688	O	-1	-1	0
.	PMC5005937	12688	12689	O	-1	-1	0

Table	PMC5005937	12690	12695	O	-1	-1	0
1	PMC5005937	12696	12697	O	-1	-1	0
shows	PMC5005937	12698	12703	O	-1	-1	0
that	PMC5005937	12704	12708	O	-1	-1	0
baseline	PMC5005937	12709	12717	O	-1	-1	0
characteristics	PMC5005937	12718	12733	O	-1	-1	0
are	PMC5005937	12734	12737	O	-1	-1	0
similar	PMC5005937	12738	12745	O	-1	-1	0
for	PMC5005937	12746	12749	O	-1	-1	0
those	PMC5005937	12750	12755	O	-1	-1	0
lost	PMC5005937	12756	12760	O	-1	-1	0
to	PMC5005937	12761	12763	O	-1	-1	0
follow	PMC5005937	12764	12770	O	-1	-1	0
-	PMC5005937	12770	12771	O	-1	-1	0
up	PMC5005937	12771	12773	O	-1	-1	0
or	PMC5005937	12774	12776	O	-1	-1	0
no	PMC5005937	12777	12779	O	-1	-1	0
longer	PMC5005937	12780	12786	O	-1	-1	0
participating	PMC5005937	12787	12800	O	-1	-1	0
in	PMC5005937	12801	12803	O	-1	-1	0
active	PMC5005937	12804	12810	O	-1	-1	0
follow	PMC5005937	12811	12817	O	-1	-1	0
-	PMC5005937	12817	12818	O	-1	-1	0
up	PMC5005937	12818	12820	O	-1	-1	0
and	PMC5005937	12821	12824	O	-1	-1	0
those	PMC5005937	12825	12830	O	-1	-1	0
who	PMC5005937	12831	12834	O	-1	-1	0
have	PMC5005937	12835	12839	O	-1	-1	0
remained	PMC5005937	12840	12848	O	-1	-1	0
active	PMC5005937	12849	12855	O	-1	-1	0
.	PMC5005937	12855	12856	O	-1	-1	0

For	PMC5005937	12857	12860	O	-1	-1	0
those	PMC5005937	12861	12866	O	-1	-1	0
lost	PMC5005937	12867	12871	O	-1	-1	0
to	PMC5005937	12872	12874	O	-1	-1	0
follow	PMC5005937	12875	12881	O	-1	-1	0
-	PMC5005937	12881	12882	O	-1	-1	0
up	PMC5005937	12882	12884	O	-1	-1	0
and/or	PMC5005937	12885	12891	O	-1	-1	0
who	PMC5005937	12892	12895	O	-1	-1	0
dropped	PMC5005937	12896	12903	O	-1	-1	0
out	PMC5005937	12904	12907	O	-1	-1	0
of	PMC5005937	12908	12910	O	-1	-1	0
active	PMC5005937	12911	12917	O	-1	-1	0
follow	PMC5005937	12918	12924	O	-1	-1	0
-	PMC5005937	12924	12925	O	-1	-1	0
up	PMC5005937	12925	12927	O	-1	-1	0
,	PMC5005937	12927	12928	O	-1	-1	0
we	PMC5005937	12929	12931	O	-1	-1	0
have	PMC5005937	12932	12936	O	-1	-1	0
information	PMC5005937	12937	12948	O	-1	-1	0
on	PMC5005937	12949	12951	O	-1	-1	0
vital	PMC5005937	12952	12957	O	-1	-1	0
status	PMC5005937	12958	12964	O	-1	-1	0
,	PMC5005937	12964	12965	O	-1	-1	0
including	PMC5005937	12966	12975	O	-1	-1	0
cancer	PMC5005937	12976	12982	O	-1	-1	0
history	PMC5005937	12983	12990	O	-1	-1	0
,	PMC5005937	12990	12991	O	-1	-1	0
for	PMC5005937	12992	12995	O	-1	-1	0
63	PMC5005937	12996	12998	O	-1	-1	0
%	PMC5005937	12998	12999	O	-1	-1	0
from	PMC5005937	13000	13004	O	-1	-1	0
their	PMC5005937	13005	13010	O	-1	-1	0
participating	PMC5005937	13011	13024	O	-1	-1	0
relatives	PMC5005937	13025	13034	O	-1	-1	0
.	PMC5005937	13034	13035	O	-1	-1	0


	PMC5005937	13035	13037	O	-1	-1	0

What	PMC5005937	13037	13041	O	-1	-1	0
has	PMC5005937	13042	13045	O	-1	-1	0
been	PMC5005937	13046	13050	O	-1	-1	0
measured	PMC5005937	13051	13059	O	-1	-1	0
?	PMC5005937	13059	13060	O	-1	-1	0

For	PMC5005937	13061	13064	O	-1	-1	0
all	PMC5005937	13065	13068	O	-1	-1	0
ProF	PMC5005937	13069	13073	O	-1	-1	0
-	PMC5005937	13073	13074	O	-1	-1	0
SC	PMC5005937	13074	13076	O	-1	-1	0
members	PMC5005937	13077	13084	O	-1	-1	0
,	PMC5005937	13084	13085	O	-1	-1	0
the	PMC5005937	13086	13089	O	-1	-1	0
BCFR	PMC5005937	13090	13094	O	-1	-1	0
and	PMC5005937	13095	13098	O	-1	-1	0
kConFab	PMC5005937	13099	13106	O	-1	-1	0
have	PMC5005937	13107	13111	O	-1	-1	0
collected	PMC5005937	13112	13121	O	-1	-1	0
detailed	PMC5005937	13122	13130	O	-1	-1	0
family	PMC5005937	13131	13137	O	-1	-1	0
history	PMC5005937	13138	13145	O	-1	-1	0
,	PMC5005937	13145	13146	O	-1	-1	0
demographic	PMC5005937	13147	13158	O	-1	-1	0
and	PMC5005937	13159	13162	O	-1	-1	0
risk	PMC5005937	13163	13167	O	-1	-1	0
factor	PMC5005937	13168	13174	O	-1	-1	0
data	PMC5005937	13175	13179	O	-1	-1	0
and	PMC5005937	13180	13183	O	-1	-1	0
biospecimens	PMC5005937	13184	13196	O	-1	-1	0
,	PMC5005937	13196	13197	O	-1	-1	0
regardless	PMC5005937	13198	13208	O	-1	-1	0
of	PMC5005937	13209	13211	O	-1	-1	0
their	PMC5005937	13212	13217	O	-1	-1	0
breast	PMC5005937	13218	13224	O	-1	-1	0
cancer	PMC5005937	13225	13231	O	-1	-1	0
history	PMC5005937	13232	13239	O	-1	-1	0
.	PMC5005937	13239	13240	O	-1	-1	0

For	PMC5005937	13241	13244	O	-1	-1	0
all	PMC5005937	13245	13248	O	-1	-1	0
women	PMC5005937	13249	13254	O	-1	-1	0
with	PMC5005937	13255	13259	O	-1	-1	0
breast	PMC5005937	13260	13266	O	-1	-1	0
cancer	PMC5005937	13267	13273	O	-1	-1	0
,	PMC5005937	13273	13274	O	-1	-1	0
pathology	PMC5005937	13275	13284	O	-1	-1	0
records	PMC5005937	13285	13292	O	-1	-1	0
,	PMC5005937	13292	13293	O	-1	-1	0
archived	PMC5005937	13294	13302	O	-1	-1	0
tumour	PMC5005937	13303	13309	O	-1	-1	0
tissue	PMC5005937	13310	13316	O	-1	-1	0
and	PMC5005937	13317	13320	O	-1	-1	0
self	PMC5005937	13321	13325	O	-1	-1	0
-	PMC5005937	13325	13326	O	-1	-1	0
reported	PMC5005937	13326	13334	O	-1	-1	0
information	PMC5005937	13335	13346	O	-1	-1	0
on	PMC5005937	13347	13349	O	-1	-1	0
cancer	PMC5005937	13350	13356	O	-1	-1	0
treatment	PMC5005937	13357	13366	O	-1	-1	0
have	PMC5005937	13367	13371	O	-1	-1	0
been	PMC5005937	13372	13376	O	-1	-1	0
sought	PMC5005937	13377	13383	O	-1	-1	0
(	PMC5005937	13384	13385	O	-1	-1	0
Table	PMC5005937	13385	13390	O	-1	-1	0
3	PMC5005937	13391	13392	O	-1	-1	0
)	PMC5005937	13392	13393	O	-1	-1	0
.	PMC5005937	13393	13394	O	-1	-1	0

Family	PMC5005937	13395	13401	O	-1	-1	0
history	PMC5005937	13402	13409	O	-1	-1	0
/	PMC5005937	13409	13410	O	-1	-1	0
pedigrees	PMC5005937	13410	13419	O	-1	-1	0
.	PMC5005937	13419	13420	O	-1	-1	0

Pedigree	PMC5005937	13421	13429	O	-1	-1	0
information	PMC5005937	13430	13441	O	-1	-1	0
includes	PMC5005937	13442	13450	O	-1	-1	0
age	PMC5005937	13451	13454	O	-1	-1	0
at	PMC5005937	13455	13457	O	-1	-1	0
diagnosis	PMC5005937	13458	13467	O	-1	-1	0
of	PMC5005937	13468	13470	O	-1	-1	0
all	PMC5005937	13471	13474	O	-1	-1	0
cancers	PMC5005937	13475	13482	O	-1	-1	0
(	PMC5005937	13483	13484	O	-1	-1	0
except	PMC5005937	13484	13490	O	-1	-1	0
non	PMC5005937	13491	13494	O	-1	-1	0
-	PMC5005937	13494	13495	O	-1	-1	0
melanoma	PMC5005937	13495	13503	O	-1	-1	0
skin	PMC5005937	13504	13508	O	-1	-1	0
cancer	PMC5005937	13509	13515	O	-1	-1	0
)	PMC5005937	13515	13516	O	-1	-1	0
and	PMC5005937	13517	13520	O	-1	-1	0
deaths	PMC5005937	13521	13527	O	-1	-1	0
for	PMC5005937	13528	13531	O	-1	-1	0
first-	PMC5005937	13532	13538	O	-1	-1	0
and	PMC5005937	13539	13542	O	-1	-1	0
second	PMC5005937	13543	13549	O	-1	-1	0
-	PMC5005937	13549	13550	O	-1	-1	0
degree	PMC5005937	13550	13556	O	-1	-1	0
relatives	PMC5005937	13557	13566	O	-1	-1	0
of	PMC5005937	13567	13569	O	-1	-1	0
all	PMC5005937	13570	13573	O	-1	-1	0
participants	PMC5005937	13574	13586	O	-1	-1	0
(	PMC5005937	13587	13588	O	-1	-1	0
not	PMC5005937	13588	13591	O	-1	-1	0
just	PMC5005937	13592	13596	O	-1	-1	0
probands	PMC5005937	13597	13605	O	-1	-1	0
)	PMC5005937	13605	13606	O	-1	-1	0
.	PMC5005937	13606	13607	O	-1	-1	0

This	PMC5005937	13608	13612	O	-1	-1	0
provides	PMC5005937	13613	13621	O	-1	-1	0
the	PMC5005937	13622	13625	O	-1	-1	0
most	PMC5005937	13626	13630	O	-1	-1	0


	PMC5005937	13630	13632	O	-1	-1	0
686	PMC5005937	13632	13635	O	-1	-1	0


	PMC5005937	13635	13637	O	-1	-1	0
International	PMC5005937	13637	13650	O	-1	-1	0
Journal	PMC5005937	13651	13658	O	-1	-1	0
of	PMC5005937	13659	13661	O	-1	-1	0
Epidemiology	PMC5005937	13662	13674	O	-1	-1	0
,	PMC5005937	13674	13675	O	-1	-1	0
2016	PMC5005937	13676	13680	O	-1	-1	0
,	PMC5005937	13680	13681	O	-1	-1	0
Vol	PMC5005937	13682	13685	O	-1	-1	0
.	PMC5005937	13685	13686	O	-1	-1	0

45	PMC5005937	13687	13689	O	-1	-1	0
,	PMC5005937	13689	13690	O	-1	-1	0
No	PMC5005937	13691	13693	O	-1	-1	0
.	PMC5005937	13693	13694	O	-1	-1	0
3	PMC5005937	13695	13696	O	-1	-1	0


	PMC5005937	13696	13698	O	-1	-1	0

Table	PMC5005937	13698	13703	O	-1	-1	0
1	PMC5005937	13704	13705	O	-1	-1	0
.	PMC5005937	13705	13706	O	-1	-1	0

Baseline	PMC5005937	13707	13715	O	-1	-1	0
characteristics	PMC5005937	13716	13731	O	-1	-1	0
of	PMC5005937	13732	13734	O	-1	-1	0
ProF	PMC5005937	13735	13739	O	-1	-1	0
-	PMC5005937	13739	13740	O	-1	-1	0
SC	PMC5005937	13740	13742	O	-1	-1	0
participants	PMC5005937	13743	13755	O	-1	-1	0
,	PMC5005937	13755	13756	O	-1	-1	0
by	PMC5005937	13757	13759	O	-1	-1	0
breast	PMC5005937	13760	13766	O	-1	-1	0
cancer	PMC5005937	13767	13773	O	-1	-1	0
status	PMC5005937	13774	13780	O	-1	-1	0
at	PMC5005937	13781	13783	O	-1	-1	0
baseline	PMC5005937	13784	13792	O	-1	-1	0
and	PMC5005937	13793	13796	O	-1	-1	0
by	PMC5005937	13797	13799	O	-1	-1	0
loss	PMC5005937	13800	13804	O	-1	-1	0
to	PMC5005937	13805	13807	O	-1	-1	0
follow	PMC5005937	13808	13814	O	-1	-1	0
-	PMC5005937	13814	13815	O	-1	-1	0
up	PMC5005937	13815	13817	O	-1	-1	0


	PMC5005937	13817	13819	O	-1	-1	0
BRCA1	PMC5005937	13819	13824	O	-1	-1	0
mutation	PMC5005937	13825	13833	O	-1	-1	0
only	PMC5005937	13834	13838	O	-1	-1	0

BRCA2	PMC5005937	13839	13844	O	-1	-1	0
mutation	PMC5005937	13845	13853	O	-1	-1	0

only	PMC5005937	13854	13858	O	-1	-1	0
BRCA1&BRCA2	PMC5005937	13859	13870	O	-1	-1	0

mutation	PMC5005937	13871	13879	O	-1	-1	0

Year	PMC5005937	13880	13884	O	-1	-1	0
at	PMC5005937	13885	13887	O	-1	-1	0
recruitment	PMC5005937	13888	13899	O	-1	-1	0

1992–94	PMC5005937	13900	13907	O	-1	-1	0

1995–99	PMC5005937	13908	13915	O	-1	-1	0

2000_04	PMC5005937	13916	13923	O	-1	-1	0

2005–09	PMC5005937	13924	13931	O	-1	-1	0

2010–30	PMC5005937	13932	13939	O	-1	-1	0
June	PMC5005937	13940	13944	O	-1	-1	0
2011	PMC5005937	13945	13949	O	-1	-1	0

Age	PMC5005937	13950	13953	O	-1	-1	0
at	PMC5005937	13954	13956	O	-1	-1	0
baseline	PMC5005937	13957	13965	O	-1	-1	0
(	PMC5005937	13966	13967	O	-1	-1	0
years	PMC5005937	13967	13972	O	-1	-1	0
)	PMC5005937	13972	13973	O	-1	-1	0

Number	PMC5005937	13974	13980	O	-1	-1	0
of	PMC5005937	13981	13983	O	-1	-1	0
first	PMC5005937	13984	13989	O	-1	-1	0
-	PMC5005937	13989	13990	O	-1	-1	0
degree	PMC5005937	13990	13996	O	-1	-1	0
relatives	PMC5005937	13997	14006	O	-1	-1	0
with	PMC5005937	14007	14011	O	-1	-1	0
breast	PMC5005937	14012	14018	O	-1	-1	0
cancer	PMC5005937	14019	14025	O	-1	-1	0

Number	PMC5005937	14026	14032	O	-1	-1	0
of	PMC5005937	14033	14035	O	-1	-1	0
second	PMC5005937	14036	14042	O	-1	-1	0
-	PMC5005937	14042	14043	O	-1	-1	0
degree	PMC5005937	14043	14049	O	-1	-1	0
relatives	PMC5005937	14050	14059	O	-1	-1	0
with	PMC5005937	14060	14064	O	-1	-1	0
breast	PMC5005937	14065	14071	O	-1	-1	0
cancer	PMC5005937	14072	14078	O	-1	-1	0

Body	PMC5005937	14079	14083	O	-1	-1	0
mass	PMC5005937	14084	14088	O	-1	-1	0
index	PMC5005937	14089	14094	O	-1	-1	0
(	PMC5005937	14095	14096	O	-1	-1	0
BMI	PMC5005937	14096	14099	O	-1	-1	0
)	PMC5005937	14099	14100	O	-1	-1	0
(	PMC5005937	14101	14102	O	-1	-1	0
kg	PMC5005937	14102	14104	O	-1	-1	0
/	PMC5005937	14104	14105	O	-1	-1	0
m2	PMC5005937	14105	14107	O	-1	-1	0
)	PMC5005937	14107	14108	O	-1	-1	0
Age	PMC5005937	14109	14112	O	-1	-1	0
at	PMC5005937	14113	14115	O	-1	-1	0
menarche	PMC5005937	14116	14124	O	-1	-1	0
(	PMC5005937	14125	14126	O	-1	-1	0
years	PMC5005937	14126	14131	O	-1	-1	0
)	PMC5005937	14131	14132	O	-1	-1	0

Smoking	PMC5005937	14133	14140	O	-1	-1	0
status	PMC5005937	14141	14147	O	-1	-1	0

Never	PMC5005937	14148	14153	O	-1	-1	0
Former	PMC5005937	14154	14160	O	-1	-1	0
Current	PMC5005937	14161	14168	O	-1	-1	0

Alcohol	PMC5005937	14169	14176	O	-1	-1	0
intake	PMC5005937	14177	14183	O	-1	-1	0

Never	PMC5005937	14184	14189	O	-1	-1	0
Former	PMC5005937	14190	14196	O	-1	-1	0
Current	PMC5005937	14197	14204	O	-1	-1	0

Menopausal	PMC5005937	14205	14215	O	-1	-1	0
hormone	PMC5005937	14216	14223	O	-1	-1	0
use	PMC5005937	14224	14227	O	-1	-1	0

Never	PMC5005937	14228	14233	O	-1	-1	0
Former	PMC5005937	14234	14240	O	-1	-1	0
Current	PMC5005937	14241	14248	O	-1	-1	0

Hormonal	PMC5005937	14249	14257	O	-1	-1	0
contraceptive	PMC5005937	14258	14271	O	-1	-1	0
use	PMC5005937	14272	14275	O	-1	-1	0

Never	PMC5005937	14276	14281	O	-1	-1	0
Former	PMC5005937	14282	14288	O	-1	-1	0
Current	PMC5005937	14289	14296	O	-1	-1	0
Race	PMC5005937	14297	14301	O	-1	-1	0
/	PMC5005937	14301	14302	O	-1	-1	0
ethnicity	PMC5005937	14302	14311	O	-1	-1	0

Non	PMC5005937	14312	14315	O	-1	-1	0
-	PMC5005937	14315	14316	O	-1	-1	0
Hispanic	PMC5005937	14316	14324	O	-1	-1	0
White	PMC5005937	14325	14330	O	-1	-1	0

Non	PMC5005937	14331	14334	O	-1	-1	0
-	PMC5005937	14334	14335	O	-1	-1	0
Hispanic	PMC5005937	14335	14343	O	-1	-1	0
Black	PMC5005937	14344	14349	O	-1	-1	0

Hispanic	PMC5005937	14350	14358	O	-1	-1	0

Asian	PMC5005937	14359	14364	O	-1	-1	0

Other	PMC5005937	14365	14370	O	-1	-1	0

Education	PMC5005937	14371	14380	O	-1	-1	0

High	PMC5005937	14381	14386	O	-1	-1	0
school	PMC5005937	14387	14393	O	-1	-1	0
graduation	PMC5005937	14394	14404	O	-1	-1	0
/	PMC5005937	14405	14406	O	-1	-1	0
GED	PMC5005937	14407	14410	O	-1	-1	0
Vocational	PMC5005937	14411	14421	O	-1	-1	0
or	PMC5005937	14422	14424	O	-1	-1	0
technical	PMC5005937	14425	14434	O	-1	-1	0

school	PMC5005937	14435	14441	O	-1	-1	0
/	PMC5005937	14442	14443	O	-1	-1	0

some	PMC5005937	14444	14448	O	-1	-1	0
college	PMC5005937	14449	14456	O	-1	-1	0
or	PMC5005937	14457	14459	O	-1	-1	0
university	PMC5005937	14460	14470	O	-1	-1	0
Bachelor	PMC5005937	14471	14479	O	-1	-1	0
’s	PMC5005937	14479	14481	O	-1	-1	0
or	PMC5005937	14482	14484	O	-1	-1	0
graduate	PMC5005937	14485	14493	O	-1	-1	0
degree	PMC5005937	14494	14500	O	-1	-1	0

Benign	PMC5005937	14501	14507	O	-1	-1	0
breast	PMC5005937	14508	14514	O	-1	-1	0
disease	PMC5005937	14515	14522	O	-1	-1	0

Yes	PMC5005937	14523	14526	O	-1	-1	0

No	PMC5005937	14527	14529	O	-1	-1	0


	PMC5005937	14529	14531	O	-1	-1	0

Total	PMC5005937	14531	14536	O	-1	-1	0
cohort	PMC5005937	14537	14543	O	-1	-1	0
(	PMC5005937	14544	14545	O	-1	-1	0

n	PMC5005937	14545	14546	O	-1	-1	0
¼	PMC5005937	14547	14548	O	-1	-1	0
31640	PMC5005937	14549	14554	O	-1	-1	0
)	PMC5005937	14554	14555	O	-1	-1	0


	PMC5005937	14555	14557	O	-1	-1	0

Affected	PMC5005937	14557	14565	O	-1	-1	0
at	PMC5005937	14566	14568	O	-1	-1	0
baseline	PMC5005937	14569	14577	O	-1	-1	0
(	PMC5005937	14578	14579	O	-1	-1	0
n	PMC5005937	14579	14580	O	-1	-1	0
¼	PMC5005937	14581	14582	O	-1	-1	0
12787	PMC5005937	14583	14588	O	-1	-1	0
)	PMC5005937	14588	14589	O	-1	-1	0


	PMC5005937	14589	14591	O	-1	-1	0

Unaffected	PMC5005937	14591	14601	O	-1	-1	0
at	PMC5005937	14602	14604	O	-1	-1	0
baseline	PMC5005937	14605	14613	O	-1	-1	0
(	PMC5005937	14614	14615	O	-1	-1	0
n	PMC5005937	14615	14616	O	-1	-1	0
¼	PMC5005937	14617	14618	O	-1	-1	0
18853	PMC5005937	14619	14624	O	-1	-1	0
)	PMC5005937	14624	14625	O	-1	-1	0


	PMC5005937	14625	14627	O	-1	-1	0

Lost	PMC5005937	14627	14631	O	-1	-1	0
to	PMC5005937	14632	14634	O	-1	-1	0
follow	PMC5005937	14635	14641	O	-1	-1	0
-	PMC5005937	14641	14642	O	-1	-1	0
up	PMC5005937	14642	14644	O	-1	-1	0
(	PMC5005937	14645	14646	O	-1	-1	0
n	PMC5005937	14646	14647	O	-1	-1	0
¼	PMC5005937	14648	14649	O	-1	-1	0
5728)a	PMC5005937	14650	14656	O	-1	-1	0


	PMC5005937	14656	14658	O	-1	-1	0
N	PMC5005937	14658	14659	O	-1	-1	0
or	PMC5005937	14660	14662	O	-1	-1	0
%	PMC5005937	14663	14664	O	-1	-1	0
or	PMC5005937	14665	14667	O	-1	-1	0
mean	PMC5005937	14668	14672	O	-1	-1	0

6	PMC5005937	14673	14674	O	-1	-1	0
SD	PMC5005937	14675	14677	O	-1	-1	0
(	PMC5005937	14678	14679	O	-1	-1	0
min	PMC5005937	14679	14682	O	-1	-1	0
,	PMC5005937	14682	14683	O	-1	-1	0
max	PMC5005937	14684	14687	O	-1	-1	0
)	PMC5005937	14687	14688	O	-1	-1	0


	PMC5005937	14688	14690	O	-1	-1	0
N	PMC5005937	14690	14691	O	-1	-1	0
or	PMC5005937	14692	14694	O	-1	-1	0
%	PMC5005937	14695	14696	O	-1	-1	0
or	PMC5005937	14697	14699	O	-1	-1	0
mean	PMC5005937	14700	14704	O	-1	-1	0

6	PMC5005937	14705	14706	O	-1	-1	0
SD	PMC5005937	14707	14709	O	-1	-1	0
(	PMC5005937	14710	14711	O	-1	-1	0
min	PMC5005937	14711	14714	O	-1	-1	0
,	PMC5005937	14714	14715	O	-1	-1	0
max	PMC5005937	14716	14719	O	-1	-1	0
)	PMC5005937	14719	14720	O	-1	-1	0


	PMC5005937	14720	14722	O	-1	-1	0
N	PMC5005937	14722	14723	O	-1	-1	0
or	PMC5005937	14724	14726	O	-1	-1	0
%	PMC5005937	14727	14728	O	-1	-1	0
or	PMC5005937	14729	14731	O	-1	-1	0
mean	PMC5005937	14732	14736	O	-1	-1	0

6	PMC5005937	14737	14738	O	-1	-1	0
SD	PMC5005937	14739	14741	O	-1	-1	0
(	PMC5005937	14742	14743	O	-1	-1	0
min	PMC5005937	14743	14746	O	-1	-1	0
,	PMC5005937	14746	14747	O	-1	-1	0
max	PMC5005937	14748	14751	O	-1	-1	0
)	PMC5005937	14751	14752	O	-1	-1	0


	PMC5005937	14752	14754	O	-1	-1	0
N	PMC5005937	14754	14755	O	-1	-1	0
or	PMC5005937	14756	14758	O	-1	-1	0
%	PMC5005937	14759	14760	O	-1	-1	0
or	PMC5005937	14761	14763	O	-1	-1	0
mean	PMC5005937	14764	14768	O	-1	-1	0

6	PMC5005937	14769	14770	O	-1	-1	0
SD	PMC5005937	14771	14773	O	-1	-1	0
(	PMC5005937	14774	14775	O	-1	-1	0
min	PMC5005937	14775	14778	O	-1	-1	0
,	PMC5005937	14778	14779	O	-1	-1	0
max	PMC5005937	14780	14783	O	-1	-1	0
)	PMC5005937	14783	14784	O	-1	-1	0


	PMC5005937	14784	14786	O	-1	-1	0
1514	PMC5005937	14786	14790	O	-1	-1	0

1219	PMC5005937	14791	14795	O	-1	-1	0

8	PMC5005937	14796	14797	O	-1	-1	0


	PMC5005937	14797	14799	O	-1	-1	0

782	PMC5005937	14799	14802	O	-1	-1	0

633	PMC5005937	14803	14806	O	-1	-1	0

8	PMC5005937	14807	14808	O	-1	-1	0


	PMC5005937	14808	14810	O	-1	-1	0

732	PMC5005937	14810	14813	O	-1	-1	0

586	PMC5005937	14814	14817	O	-1	-1	0

0	PMC5005937	14818	14819	O	-1	-1	0


	PMC5005937	14819	14821	O	-1	-1	0

174	PMC5005937	14821	14824	O	-1	-1	0

138	PMC5005937	14825	14828	O	-1	-1	0

1	PMC5005937	14829	14830	O	-1	-1	0


	PMC5005937	14830	14832	O	-1	-1	0
1.7	PMC5005937	14832	14835	O	-1	-1	0

47.1	PMC5005937	14836	14840	O	-1	-1	0

30.2	PMC5005937	14841	14845	O	-1	-1	0

18.3	PMC5005937	14846	14850	O	-1	-1	0

2.7	PMC5005937	14851	14854	O	-1	-1	0

49.8	PMC5005937	14855	14859	O	-1	-1	0
6	PMC5005937	14860	14861	O	-1	-1	0
14.8	PMC5005937	14862	14866	O	-1	-1	0
(	PMC5005937	14867	14868	O	-1	-1	0
18	PMC5005937	14868	14870	O	-1	-1	0
,	PMC5005937	14870	14871	O	-1	-1	0
101	PMC5005937	14872	14875	O	-1	-1	0
)	PMC5005937	14875	14876	O	-1	-1	0

0.9	PMC5005937	14877	14880	O	-1	-1	0
6	PMC5005937	14881	14882	O	-1	-1	0
0.8	PMC5005937	14883	14886	O	-1	-1	0
(	PMC5005937	14887	14888	O	-1	-1	0
0	PMC5005937	14888	14889	O	-1	-1	0
,	PMC5005937	14889	14890	O	-1	-1	0
6	PMC5005937	14891	14892	O	-1	-1	0
)	PMC5005937	14892	14893	O	-1	-1	0

0.7	PMC5005937	14894	14897	O	-1	-1	0

6	PMC5005937	14898	14899	O	-1	-1	0
0.9	PMC5005937	14900	14903	O	-1	-1	0
(	PMC5005937	14904	14905	O	-1	-1	0
0	PMC5005937	14905	14906	O	-1	-1	0
,	PMC5005937	14906	14907	O	-1	-1	0
11	PMC5005937	14908	14910	O	-1	-1	0
)	PMC5005937	14910	14911	O	-1	-1	0


	PMC5005937	14911	14913	O	-1	-1	0

1.1	PMC5005937	14913	14916	O	-1	-1	0

47.8	PMC5005937	14917	14921	O	-1	-1	0

29.8	PMC5005937	14922	14926	O	-1	-1	0

17.9	PMC5005937	14927	14931	O	-1	-1	0

3.3	PMC5005937	14932	14935	O	-1	-1	0

52.9	PMC5005937	14936	14940	O	-1	-1	0

6	PMC5005937	14941	14942	O	-1	-1	0
12.1	PMC5005937	14943	14947	O	-1	-1	0
(	PMC5005937	14948	14949	O	-1	-1	0
21	PMC5005937	14949	14951	O	-1	-1	0
,	PMC5005937	14951	14952	O	-1	-1	0
98	PMC5005937	14953	14955	O	-1	-1	0
)	PMC5005937	14955	14956	O	-1	-1	0
0.6	PMC5005937	14957	14960	O	-1	-1	0
6	PMC5005937	14961	14962	O	-1	-1	0
0.8	PMC5005937	14963	14966	O	-1	-1	0
(	PMC5005937	14967	14968	O	-1	-1	0
0	PMC5005937	14968	14969	O	-1	-1	0
,	PMC5005937	14969	14970	O	-1	-1	0
6	PMC5005937	14971	14972	O	-1	-1	0
)	PMC5005937	14972	14973	O	-1	-1	0

0.6	PMC5005937	14974	14977	O	-1	-1	0

6	PMC5005937	14978	14979	O	-1	-1	0
0.9	PMC5005937	14980	14983	O	-1	-1	0
(	PMC5005937	14984	14985	O	-1	-1	0
0	PMC5005937	14985	14986	O	-1	-1	0
,	PMC5005937	14986	14987	O	-1	-1	0
8)	PMC5005937	14988	14990	O	-1	-1	0


	PMC5005937	14990	14992	O	-1	-1	0
2.0	PMC5005937	14992	14995	O	-1	-1	0
46.6	PMC5005937	14996	15000	O	-1	-1	0

30.5	PMC5005937	15001	15005	O	-1	-1	0

18.6	PMC5005937	15006	15010	O	-1	-1	0

2.3	PMC5005937	15011	15014	O	-1	-1	0

47.8	PMC5005937	15015	15019	O	-1	-1	0
6	PMC5005937	15020	15021	O	-1	-1	0
16.1	PMC5005937	15022	15026	O	-1	-1	0
(	PMC5005937	15027	15028	O	-1	-1	0
18	PMC5005937	15028	15030	O	-1	-1	0
,	PMC5005937	15030	15031	O	-1	-1	0
101	PMC5005937	15032	15035	O	-1	-1	0
)	PMC5005937	15035	15036	O	-1	-1	0

1.1	PMC5005937	15037	15040	O	-1	-1	0

6	PMC5005937	15041	15042	O	-1	-1	0
0.7	PMC5005937	15043	15046	O	-1	-1	0
(	PMC5005937	15047	15048	O	-1	-1	0
0	PMC5005937	15048	15049	O	-1	-1	0
,	PMC5005937	15049	15050	O	-1	-1	0
6	PMC5005937	15051	15052	O	-1	-1	0
)	PMC5005937	15052	15053	O	-1	-1	0
0.8	PMC5005937	15054	15057	O	-1	-1	0
6	PMC5005937	15058	15059	O	-1	-1	0
1.0	PMC5005937	15060	15063	O	-1	-1	0
(	PMC5005937	15064	15065	O	-1	-1	0
0	PMC5005937	15065	15066	O	-1	-1	0
,	PMC5005937	15066	15067	O	-1	-1	0
11	PMC5005937	15068	15070	O	-1	-1	0
)	PMC5005937	15070	15071	O	-1	-1	0


	PMC5005937	15071	15073	O	-1	-1	0
0.6	PMC5005937	15073	15076	O	-1	-1	0

38.0	PMC5005937	15077	15081	O	-1	-1	0
35.0	PMC5005937	15082	15086	O	-1	-1	0

23.3	PMC5005937	15087	15091	O	-1	-1	0

3.1	PMC5005937	15092	15095	O	-1	-1	0

48.8	PMC5005937	15096	15100	O	-1	-1	0
6	PMC5005937	15101	15102	O	-1	-1	0
15.5	PMC5005937	15103	15107	O	-1	-1	0
(	PMC5005937	15108	15109	O	-1	-1	0
18	PMC5005937	15109	15111	O	-1	-1	0
,	PMC5005937	15111	15112	O	-1	-1	0
97	PMC5005937	15113	15115	O	-1	-1	0
)	PMC5005937	15115	15116	O	-1	-1	0
0.9	PMC5005937	15117	15120	O	-1	-1	0

6	PMC5005937	15121	15122	O	-1	-1	0
0.8	PMC5005937	15123	15126	O	-1	-1	0
(	PMC5005937	15127	15128	O	-1	-1	0
0	PMC5005937	15128	15129	O	-1	-1	0
,	PMC5005937	15129	15130	O	-1	-1	0
6	PMC5005937	15131	15132	O	-1	-1	0
)	PMC5005937	15132	15133	O	-1	-1	0
0.7	PMC5005937	15134	15137	O	-1	-1	0
6	PMC5005937	15138	15139	O	-1	-1	0
0.9	PMC5005937	15140	15143	O	-1	-1	0

(	PMC5005937	15144	15145	O	-1	-1	0
0	PMC5005937	15145	15146	O	-1	-1	0
,	PMC5005937	15146	15147	O	-1	-1	0
7	PMC5005937	15148	15149	O	-1	-1	0
)	PMC5005937	15149	15150	O	-1	-1	0


	PMC5005937	15150	15152	O	-1	-1	0
25.9	PMC5005937	15152	15156	O	-1	-1	0
6	PMC5005937	15157	15158	O	-1	-1	0
5.6	PMC5005937	15159	15162	O	-1	-1	0


	PMC5005937	15162	15164	O	-1	-1	0

26.2	PMC5005937	15164	15168	O	-1	-1	0
6	PMC5005937	15169	15170	O	-1	-1	0

5.6	PMC5005937	15171	15174	O	-1	-1	0


	PMC5005937	15174	15176	O	-1	-1	0

25.8	PMC5005937	15176	15180	O	-1	-1	0
6	PMC5005937	15181	15182	O	-1	-1	0
5.6	PMC5005937	15183	15186	O	-1	-1	0


	PMC5005937	15186	15188	O	-1	-1	0

26.2	PMC5005937	15188	15192	O	-1	-1	0

6	PMC5005937	15193	15194	O	-1	-1	0
5.8	PMC5005937	15195	15198	O	-1	-1	0


	PMC5005937	15198	15200	O	-1	-1	0

12.8	PMC5005937	15200	15204	O	-1	-1	0
6	PMC5005937	15205	15206	O	-1	-1	0
1.6	PMC5005937	15207	15210	O	-1	-1	0


	PMC5005937	15210	15212	O	-1	-1	0
12.7	PMC5005937	15212	15216	O	-1	-1	0
6	PMC5005937	15217	15218	O	-1	-1	0
1.6	PMC5005937	15219	15222	O	-1	-1	0


	PMC5005937	15222	15224	O	-1	-1	0

12.9	PMC5005937	15224	15228	O	-1	-1	0
6	PMC5005937	15229	15230	O	-1	-1	0

1.6	PMC5005937	15231	15234	O	-1	-1	0


	PMC5005937	15234	15236	O	-1	-1	0

12.8	PMC5005937	15236	15240	O	-1	-1	0
6	PMC5005937	15241	15242	O	-1	-1	0
1.6	PMC5005937	15243	15246	O	-1	-1	0


	PMC5005937	15246	15248	O	-1	-1	0
60.1	PMC5005937	15248	15252	O	-1	-1	0

26.9	PMC5005937	15253	15257	O	-1	-1	0

13.1	PMC5005937	15258	15262	O	-1	-1	0


	PMC5005937	15262	15264	O	-1	-1	0

59.4	PMC5005937	15264	15268	O	-1	-1	0

28.3	PMC5005937	15269	15273	O	-1	-1	0

12.3	PMC5005937	15274	15278	O	-1	-1	0


	PMC5005937	15278	15280	O	-1	-1	0

60.5	PMC5005937	15280	15284	O	-1	-1	0

25.9	PMC5005937	15285	15289	O	-1	-1	0

13.7	PMC5005937	15290	15294	O	-1	-1	0


	PMC5005937	15294	15296	O	-1	-1	0

61.1	PMC5005937	15296	15300	O	-1	-1	0

23.3	PMC5005937	15301	15305	O	-1	-1	0

15.6	PMC5005937	15306	15310	O	-1	-1	0


	PMC5005937	15310	15312	O	-1	-1	0
52.4	PMC5005937	15312	15316	O	-1	-1	0

14.3	PMC5005937	15317	15321	O	-1	-1	0

33.3	PMC5005937	15322	15326	O	-1	-1	0


	PMC5005937	15326	15328	O	-1	-1	0
54.4	PMC5005937	15328	15332	O	-1	-1	0

13.4	PMC5005937	15333	15337	O	-1	-1	0

32.3	PMC5005937	15338	15342	O	-1	-1	0


	PMC5005937	15342	15344	O	-1	-1	0
51.1	PMC5005937	15344	15348	O	-1	-1	0
14.9	PMC5005937	15349	15353	O	-1	-1	0

34.0	PMC5005937	15354	15358	O	-1	-1	0


	PMC5005937	15358	15360	O	-1	-1	0

58.7	PMC5005937	15360	15364	O	-1	-1	0

14.1	PMC5005937	15365	15369	O	-1	-1	0

27.2	PMC5005937	15370	15374	O	-1	-1	0


	PMC5005937	15374	15376	O	-1	-1	0

75.1	PMC5005937	15376	15380	O	-1	-1	0

16.9	PMC5005937	15381	15385	O	-1	-1	0

7.9	PMC5005937	15386	15389	O	-1	-1	0


	PMC5005937	15389	15391	O	-1	-1	0

72.8	PMC5005937	15391	15395	O	-1	-1	0

24.5	PMC5005937	15396	15400	O	-1	-1	0

2.7	PMC5005937	15401	15404	O	-1	-1	0


	PMC5005937	15404	15406	O	-1	-1	0

76.7	PMC5005937	15406	15410	O	-1	-1	0

11.8	PMC5005937	15411	15415	O	-1	-1	0

11.5	PMC5005937	15416	15420	O	-1	-1	0


	PMC5005937	15420	15422	O	-1	-1	0

79.6	PMC5005937	15422	15426	O	-1	-1	0

13.9	PMC5005937	15427	15431	O	-1	-1	0

6.5	PMC5005937	15432	15435	O	-1	-1	0


	PMC5005937	15435	15437	O	-1	-1	0

27.5	PMC5005937	15437	15441	O	-1	-1	0

64.1	PMC5005937	15442	15446	O	-1	-1	0

8.4	PMC5005937	15447	15450	O	-1	-1	0


	PMC5005937	15450	15452	O	-1	-1	0

29.1	PMC5005937	15452	15456	O	-1	-1	0

69.3	PMC5005937	15457	15461	O	-1	-1	0

1.6	PMC5005937	15462	15465	O	-1	-1	0


	PMC5005937	15465	15467	O	-1	-1	0
26.4	PMC5005937	15467	15471	O	-1	-1	0

60.5	PMC5005937	15472	15476	O	-1	-1	0

13.0	PMC5005937	15477	15481	O	-1	-1	0


	PMC5005937	15481	15483	O	-1	-1	0

33.5	PMC5005937	15483	15487	O	-1	-1	0
58.5	PMC5005937	15488	15492	O	-1	-1	0

8.0	PMC5005937	15493	15496	O	-1	-1	0


	PMC5005937	15496	15498	O	-1	-1	0

75.9	PMC5005937	15498	15502	O	-1	-1	0

6.2	PMC5005937	15503	15506	O	-1	-1	0

9.4	PMC5005937	15507	15510	O	-1	-1	0

5.8	PMC5005937	15511	15514	O	-1	-1	0

2.7	PMC5005937	15515	15518	O	-1	-1	0


	PMC5005937	15518	15520	O	-1	-1	0

68.8	PMC5005937	15520	15524	O	-1	-1	0

8.6	PMC5005937	15525	15528	O	-1	-1	0

11.2	PMC5005937	15529	15533	O	-1	-1	0

8.8	PMC5005937	15534	15537	O	-1	-1	0
2.7	PMC5005937	15538	15541	O	-1	-1	0


	PMC5005937	15541	15543	O	-1	-1	0

80.8	PMC5005937	15543	15547	O	-1	-1	0

4.6	PMC5005937	15548	15551	O	-1	-1	0
8.1	PMC5005937	15552	15555	O	-1	-1	0

3.8	PMC5005937	15556	15559	O	-1	-1	0

2.7	PMC5005937	15560	15563	O	-1	-1	0


	PMC5005937	15563	15565	O	-1	-1	0

62.7	PMC5005937	15565	15569	O	-1	-1	0

8.7	PMC5005937	15570	15573	O	-1	-1	0

15.1	PMC5005937	15574	15578	O	-1	-1	0

10.2	PMC5005937	15579	15583	O	-1	-1	0
3.3	PMC5005937	15584	15587	O	-1	-1	0


	PMC5005937	15587	15589	O	-1	-1	0
34.4	PMC5005937	15589	15593	O	-1	-1	0

36.8	PMC5005937	15594	15598	O	-1	-1	0


	PMC5005937	15598	15600	O	-1	-1	0

34.6	PMC5005937	15600	15604	O	-1	-1	0

35.6	PMC5005937	15605	15609	O	-1	-1	0


	PMC5005937	15609	15611	O	-1	-1	0
34.3	PMC5005937	15611	15615	O	-1	-1	0

37.7	PMC5005937	15616	15620	O	-1	-1	0


	PMC5005937	15620	15622	O	-1	-1	0

40.4	PMC5005937	15622	15626	O	-1	-1	0

33.7	PMC5005937	15627	15631	O	-1	-1	0


	PMC5005937	15631	15633	O	-1	-1	0
28.7	PMC5005937	15633	15637	O	-1	-1	0


	PMC5005937	15637	15639	O	-1	-1	0

29.8	PMC5005937	15639	15643	O	-1	-1	0


	PMC5005937	15643	15645	O	-1	-1	0

28.0	PMC5005937	15645	15649	O	-1	-1	0


	PMC5005937	15649	15651	O	-1	-1	0

26.0	PMC5005937	15651	15655	O	-1	-1	0


	PMC5005937	15655	15657	O	-1	-1	0

31.0	PMC5005937	15657	15661	O	-1	-1	0

69.0	PMC5005937	15662	15666	O	-1	-1	0


	PMC5005937	15666	15668	O	-1	-1	0

36.3	PMC5005937	15668	15672	O	-1	-1	0

63.7	PMC5005937	15673	15677	O	-1	-1	0


	PMC5005937	15677	15679	O	-1	-1	0

27.4	PMC5005937	15679	15683	O	-1	-1	0

72.6	PMC5005937	15684	15688	O	-1	-1	0


	PMC5005937	15688	15690	O	-1	-1	0

26.7	PMC5005937	15690	15694	O	-1	-1	0

73.3	PMC5005937	15695	15699	O	-1	-1	0

(	PMC5005937	15700	15701	O	-1	-1	0
Continued	PMC5005937	15701	15710	O	-1	-1	0
)	PMC5005937	15710	15711	O	-1	-1	0


	PMC5005937	15711	15713	O	-1	-1	0
International	PMC5005937	15713	15726	O	-1	-1	0
Journal	PMC5005937	15727	15734	O	-1	-1	0
of	PMC5005937	15735	15737	O	-1	-1	0
Epidemiology	PMC5005937	15738	15750	O	-1	-1	0
,	PMC5005937	15750	15751	O	-1	-1	0
2016	PMC5005937	15752	15756	O	-1	-1	0
,	PMC5005937	15756	15757	O	-1	-1	0
Vol	PMC5005937	15758	15761	O	-1	-1	0
.	PMC5005937	15761	15762	O	-1	-1	0

45	PMC5005937	15763	15765	O	-1	-1	0
,	PMC5005937	15765	15766	O	-1	-1	0
No	PMC5005937	15767	15769	O	-1	-1	0
.	PMC5005937	15769	15770	O	-1	-1	0
3	PMC5005937	15771	15772	O	-1	-1	0


	PMC5005937	15772	15774	O	-1	-1	0
687	PMC5005937	15774	15777	O	-1	-1	0


	PMC5005937	15777	15779	O	-1	-1	0

Table	PMC5005937	15779	15784	O	-1	-1	0
1	PMC5005937	15785	15786	O	-1	-1	0
.	PMC5005937	15786	15787	O	-1	-1	0

Continued	PMC5005937	15788	15797	O	-1	-1	0


	PMC5005937	15797	15799	O	-1	-1	0
Parity	PMC5005937	15799	15805	O	-1	-1	0

0	PMC5005937	15806	15807	O	-1	-1	0

1	PMC5005937	15808	15809	O	-1	-1	0

2	PMC5005937	15810	15811	O	-1	-1	0

3	PMC5005937	15812	15813	O	-1	-1	0

4	PMC5005937	15814	15816	O	-1	-1	0

Menopausal	PMC5005937	15817	15827	O	-1	-1	0
status	PMC5005937	15828	15834	O	-1	-1	0

Premenopausal	PMC5005937	15835	15848	O	-1	-1	0

Postmenopausal	PMC5005937	15849	15863	O	-1	-1	0


	PMC5005937	15863	15865	O	-1	-1	0
Total	PMC5005937	15865	15870	O	-1	-1	0
cohort	PMC5005937	15871	15877	O	-1	-1	0
(	PMC5005937	15878	15879	O	-1	-1	0

n	PMC5005937	15879	15880	O	-1	-1	0
¼	PMC5005937	15881	15882	O	-1	-1	0
31640	PMC5005937	15883	15888	O	-1	-1	0
)	PMC5005937	15888	15889	O	-1	-1	0


	PMC5005937	15889	15891	O	-1	-1	0

Affected	PMC5005937	15891	15899	O	-1	-1	0
at	PMC5005937	15900	15902	O	-1	-1	0
baseline	PMC5005937	15903	15911	O	-1	-1	0
(	PMC5005937	15912	15913	O	-1	-1	0
n	PMC5005937	15913	15914	O	-1	-1	0
¼	PMC5005937	15915	15916	O	-1	-1	0
12787	PMC5005937	15917	15922	O	-1	-1	0
)	PMC5005937	15922	15923	O	-1	-1	0


	PMC5005937	15923	15925	O	-1	-1	0

Unaffected	PMC5005937	15925	15935	O	-1	-1	0
at	PMC5005937	15936	15938	O	-1	-1	0
baseline	PMC5005937	15939	15947	O	-1	-1	0
(	PMC5005937	15948	15949	O	-1	-1	0
n	PMC5005937	15949	15950	O	-1	-1	0
¼	PMC5005937	15951	15952	O	-1	-1	0
18853	PMC5005937	15953	15958	O	-1	-1	0
)	PMC5005937	15958	15959	O	-1	-1	0


	PMC5005937	15959	15961	O	-1	-1	0

Lost	PMC5005937	15961	15965	O	-1	-1	0
to	PMC5005937	15966	15968	O	-1	-1	0
follow	PMC5005937	15969	15975	O	-1	-1	0
-	PMC5005937	15975	15976	O	-1	-1	0
up	PMC5005937	15976	15978	O	-1	-1	0
(	PMC5005937	15979	15980	O	-1	-1	0
n	PMC5005937	15980	15981	O	-1	-1	0
¼	PMC5005937	15982	15983	O	-1	-1	0
5728)a	PMC5005937	15984	15990	O	-1	-1	0


	PMC5005937	15990	15992	O	-1	-1	0
N	PMC5005937	15992	15993	O	-1	-1	0
or	PMC5005937	15994	15996	O	-1	-1	0
%	PMC5005937	15997	15998	O	-1	-1	0
or	PMC5005937	15999	16001	O	-1	-1	0
mean	PMC5005937	16002	16006	O	-1	-1	0

6	PMC5005937	16007	16008	O	-1	-1	0
SD	PMC5005937	16009	16011	O	-1	-1	0
(	PMC5005937	16012	16013	O	-1	-1	0
min	PMC5005937	16013	16016	O	-1	-1	0
,	PMC5005937	16016	16017	O	-1	-1	0
max	PMC5005937	16018	16021	O	-1	-1	0
)	PMC5005937	16021	16022	O	-1	-1	0


	PMC5005937	16022	16024	O	-1	-1	0
N	PMC5005937	16024	16025	O	-1	-1	0
or	PMC5005937	16026	16028	O	-1	-1	0
%	PMC5005937	16029	16030	O	-1	-1	0
or	PMC5005937	16031	16033	O	-1	-1	0
mean	PMC5005937	16034	16038	O	-1	-1	0

6	PMC5005937	16039	16040	O	-1	-1	0
SD	PMC5005937	16041	16043	O	-1	-1	0
(	PMC5005937	16044	16045	O	-1	-1	0
min	PMC5005937	16045	16048	O	-1	-1	0
,	PMC5005937	16048	16049	O	-1	-1	0
max	PMC5005937	16050	16053	O	-1	-1	0
)	PMC5005937	16053	16054	O	-1	-1	0


	PMC5005937	16054	16056	O	-1	-1	0
N	PMC5005937	16056	16057	O	-1	-1	0
or	PMC5005937	16058	16060	O	-1	-1	0
%	PMC5005937	16061	16062	O	-1	-1	0
or	PMC5005937	16063	16065	O	-1	-1	0
mean	PMC5005937	16066	16070	O	-1	-1	0

6	PMC5005937	16071	16072	O	-1	-1	0
SD	PMC5005937	16073	16075	O	-1	-1	0
(	PMC5005937	16076	16077	O	-1	-1	0
min	PMC5005937	16077	16080	O	-1	-1	0
,	PMC5005937	16080	16081	O	-1	-1	0
max	PMC5005937	16082	16085	O	-1	-1	0
)	PMC5005937	16085	16086	O	-1	-1	0


	PMC5005937	16086	16088	O	-1	-1	0
N	PMC5005937	16088	16089	O	-1	-1	0
or	PMC5005937	16090	16092	O	-1	-1	0
%	PMC5005937	16093	16094	O	-1	-1	0
or	PMC5005937	16095	16097	O	-1	-1	0
mean	PMC5005937	16098	16102	O	-1	-1	0

6	PMC5005937	16103	16104	O	-1	-1	0
SD	PMC5005937	16105	16107	O	-1	-1	0
(	PMC5005937	16108	16109	O	-1	-1	0
min	PMC5005937	16109	16112	O	-1	-1	0
,	PMC5005937	16112	16113	O	-1	-1	0
max	PMC5005937	16114	16117	O	-1	-1	0
)	PMC5005937	16117	16118	O	-1	-1	0


	PMC5005937	16118	16120	O	-1	-1	0
21.1	PMC5005937	16120	16124	O	-1	-1	0

11.7	PMC5005937	16125	16129	O	-1	-1	0

30.0	PMC5005937	16130	16134	O	-1	-1	0

20.3	PMC5005937	16135	16139	O	-1	-1	0

16.8	PMC5005937	16140	16144	O	-1	-1	0


	PMC5005937	16144	16146	O	-1	-1	0

17.7	PMC5005937	16146	16150	O	-1	-1	0

13.0	PMC5005937	16151	16155	O	-1	-1	0

33.4	PMC5005937	16156	16160	O	-1	-1	0
20.5	PMC5005937	16161	16165	O	-1	-1	0

15.5	PMC5005937	16166	16170	O	-1	-1	0


	PMC5005937	16170	16172	O	-1	-1	0
23.5	PMC5005937	16172	16176	O	-1	-1	0

10.8	PMC5005937	16177	16181	O	-1	-1	0

27.7	PMC5005937	16182	16186	O	-1	-1	0
20.2	PMC5005937	16187	16191	O	-1	-1	0

17.7	PMC5005937	16192	16196	O	-1	-1	0


	PMC5005937	16196	16198	O	-1	-1	0
23.2	PMC5005937	16198	16202	O	-1	-1	0

13.3	PMC5005937	16203	16207	O	-1	-1	0
27.8	PMC5005937	16208	16212	O	-1	-1	0

17.8	PMC5005937	16213	16217	O	-1	-1	0

17.9	PMC5005937	16218	16222	O	-1	-1	0


	PMC5005937	16222	16224	O	-1	-1	0

45.1	PMC5005937	16224	16228	O	-1	-1	0

54.9	PMC5005937	16229	16233	O	-1	-1	0


	PMC5005937	16233	16235	O	-1	-1	0

30.3	PMC5005937	16235	16239	O	-1	-1	0

69.7	PMC5005937	16240	16244	O	-1	-1	0


	PMC5005937	16244	16246	O	-1	-1	0
55.3	PMC5005937	16246	16250	O	-1	-1	0

44.7	PMC5005937	16251	16255	O	-1	-1	0


	PMC5005937	16255	16257	O	-1	-1	0
49.9	PMC5005937	16257	16261	O	-1	-1	0

50.1	PMC5005937	16262	16266	O	-1	-1	0


	PMC5005937	16266	16268	O	-1	-1	0

a	PMC5005937	16268	16269	O	-1	-1	0


	PMC5005937	16269	16271	O	-1	-1	0

Includes	PMC5005937	16271	16279	O	-1	-1	0
refusals	PMC5005937	16280	16288	O	-1	-1	0
and	PMC5005937	16289	16292	O	-1	-1	0
not	PMC5005937	16293	16296	O	-1	-1	0
located	PMC5005937	16297	16304	O	-1	-1	0
.	PMC5005937	16304	16305	O	-1	-1	0


	PMC5005937	16305	16307	O	-1	-1	0

Table	PMC5005937	16307	16312	O	-1	-1	0
2	PMC5005937	16313	16314	O	-1	-1	0
.	PMC5005937	16314	16315	O	-1	-1	0

Prospectively	PMC5005937	16316	16329	O	-1	-1	0
ascertained	PMC5005937	16330	16341	O	-1	-1	0
breast	PMC5005937	16342	16348	O	-1	-1	0
cancer	PMC5005937	16349	16355	O	-1	-1	0
cases	PMC5005937	16356	16361	O	-1	-1	0
among	PMC5005937	16362	16367	O	-1	-1	0
ProF	PMC5005937	16368	16372	O	-1	-1	0
-	PMC5005937	16372	16373	O	-1	-1	0
SC	PMC5005937	16373	16375	O	-1	-1	0
participants	PMC5005937	16376	16388	O	-1	-1	0

Unaffected	PMC5005937	16389	16399	O	-1	-1	0
at	PMC5005937	16400	16402	O	-1	-1	0
baseline	PMC5005937	16403	16411	O	-1	-1	0

Number	PMC5005937	16412	16418	O	-1	-1	0
of	PMC5005937	16419	16421	O	-1	-1	0
women	PMC5005937	16422	16427	O	-1	-1	0
with	PMC5005937	16428	16432	O	-1	-1	0
self	PMC5005937	16433	16437	O	-1	-1	0
-	PMC5005937	16437	16438	O	-1	-1	0
reported	PMC5005937	16438	16446	O	-1	-1	0
new	PMC5005937	16447	16450	O	-1	-1	0
breast	PMC5005937	16451	16457	O	-1	-1	0
cancers	PMC5005937	16458	16465	O	-1	-1	0

New	PMC5005937	16466	16469	O	-1	-1	0
breast	PMC5005937	16470	16476	O	-1	-1	0
cancers	PMC5005937	16477	16484	O	-1	-1	0
confirmed	PMC5005937	16485	16494	O	-1	-1	0
by	PMC5005937	16495	16497	O	-1	-1	0
pathology	PMC5005937	16498	16507	O	-1	-1	0
,	PMC5005937	16507	16508	O	-1	-1	0
n	PMC5005937	16509	16510	O	-1	-1	0
(	PMC5005937	16511	16512	O	-1	-1	0
%	PMC5005937	16512	16513	O	-1	-1	0
)	PMC5005937	16513	16514	O	-1	-1	0

New	PMC5005937	16515	16518	O	-1	-1	0
breast	PMC5005937	16519	16525	O	-1	-1	0
cancers	PMC5005937	16526	16533	O	-1	-1	0
with	PMC5005937	16534	16538	O	-1	-1	0
blood	PMC5005937	16539	16544	O	-1	-1	0
/	PMC5005937	16544	16545	O	-1	-1	0
buccalsample	PMC5005937	16545	16557	O	-1	-1	0
collected	PMC5005937	16558	16567	O	-1	-1	0
,	PMC5005937	16567	16568	O	-1	-1	0
n	PMC5005937	16569	16570	O	-1	-1	0
(	PMC5005937	16571	16572	O	-1	-1	0
%	PMC5005937	16572	16573	O	-1	-1	0
)	PMC5005937	16573	16574	O	-1	-1	0

Age	PMC5005937	16575	16578	O	-1	-1	0
at	PMC5005937	16579	16581	O	-1	-1	0
diagnosis	PMC5005937	16582	16591	O	-1	-1	0
of	PMC5005937	16592	16594	O	-1	-1	0
new	PMC5005937	16595	16598	O	-1	-1	0
breast	PMC5005937	16599	16605	O	-1	-1	0
cancer	PMC5005937	16606	16612	O	-1	-1	0
(	PMC5005937	16613	16614	O	-1	-1	0
years	PMC5005937	16614	16619	O	-1	-1	0
)	PMC5005937	16619	16620	O	-1	-1	0
,	PMC5005937	16620	16621	O	-1	-1	0

n	PMC5005937	16622	16623	O	-1	-1	0
(	PMC5005937	16624	16625	O	-1	-1	0
%	PMC5005937	16625	16626	O	-1	-1	0
)	PMC5005937	16626	16627	O	-1	-1	0

<	PMC5005937	16628	16629	O	-1	-1	0
40	PMC5005937	16629	16631	O	-1	-1	0
40–44	PMC5005937	16632	16637	O	-1	-1	0

45–49	PMC5005937	16638	16643	O	-1	-1	0

50–54	PMC5005937	16644	16649	O	-1	-1	0

55–59	PMC5005937	16650	16655	O	-1	-1	0

60–64	PMC5005937	16656	16661	O	-1	-1	0

65–69	PMC5005937	16662	16667	O	-1	-1	0

70	PMC5005937	16668	16671	O	-1	-1	0

Unknown	PMC5005937	16672	16679	O	-1	-1	0


	PMC5005937	16679	16681	O	-1	-1	0
1093	PMC5005937	16681	16685	O	-1	-1	0


	PMC5005937	16685	16687	O	-1	-1	0

Affected	PMC5005937	16687	16695	O	-1	-1	0
at	PMC5005937	16696	16698	O	-1	-1	0
baseline	PMC5005937	16699	16707	O	-1	-1	0

1252	PMC5005937	16708	16712	O	-1	-1	0


	PMC5005937	16712	16714	O	-1	-1	0

848	PMC5005937	16714	16717	O	-1	-1	0
(	PMC5005937	16718	16719	O	-1	-1	0
78	PMC5005937	16719	16721	O	-1	-1	0
%	PMC5005937	16721	16722	O	-1	-1	0
)	PMC5005937	16722	16723	O	-1	-1	0


	PMC5005937	16723	16725	O	-1	-1	0
883	PMC5005937	16725	16728	O	-1	-1	0
(	PMC5005937	16729	16730	O	-1	-1	0
71	PMC5005937	16730	16732	O	-1	-1	0
%	PMC5005937	16732	16733	O	-1	-1	0
)	PMC5005937	16733	16734	O	-1	-1	0


	PMC5005937	16734	16736	O	-1	-1	0
961	PMC5005937	16736	16739	O	-1	-1	0
(	PMC5005937	16740	16741	O	-1	-1	0
88	PMC5005937	16741	16743	O	-1	-1	0
%	PMC5005937	16743	16744	O	-1	-1	0
)	PMC5005937	16744	16745	O	-1	-1	0


	PMC5005937	16745	16747	O	-1	-1	0

1184	PMC5005937	16747	16751	O	-1	-1	0
(	PMC5005937	16752	16753	O	-1	-1	0
95	PMC5005937	16753	16755	O	-1	-1	0
%	PMC5005937	16755	16756	O	-1	-1	0
)	PMC5005937	16756	16757	O	-1	-1	0


	PMC5005937	16757	16759	O	-1	-1	0
117	PMC5005937	16759	16762	O	-1	-1	0
(	PMC5005937	16763	16764	O	-1	-1	0
11	PMC5005937	16764	16766	O	-1	-1	0
%	PMC5005937	16766	16767	O	-1	-1	0
)	PMC5005937	16767	16768	O	-1	-1	0
107	PMC5005937	16769	16772	O	-1	-1	0
(	PMC5005937	16773	16774	O	-1	-1	0
10	PMC5005937	16774	16776	O	-1	-1	0
%	PMC5005937	16776	16777	O	-1	-1	0
)	PMC5005937	16777	16778	O	-1	-1	0

147	PMC5005937	16779	16782	O	-1	-1	0
(	PMC5005937	16783	16784	O	-1	-1	0
13	PMC5005937	16784	16786	O	-1	-1	0
%	PMC5005937	16786	16787	O	-1	-1	0
)	PMC5005937	16787	16788	O	-1	-1	0

128	PMC5005937	16789	16792	O	-1	-1	0
(	PMC5005937	16793	16794	O	-1	-1	0
12	PMC5005937	16794	16796	O	-1	-1	0
%	PMC5005937	16796	16797	O	-1	-1	0
)	PMC5005937	16797	16798	O	-1	-1	0
132	PMC5005937	16799	16802	O	-1	-1	0
(	PMC5005937	16803	16804	O	-1	-1	0
12	PMC5005937	16804	16806	O	-1	-1	0
%	PMC5005937	16806	16807	O	-1	-1	0
)	PMC5005937	16807	16808	O	-1	-1	0
135	PMC5005937	16809	16812	O	-1	-1	0
(	PMC5005937	16813	16814	O	-1	-1	0
12	PMC5005937	16814	16816	O	-1	-1	0
%	PMC5005937	16816	16817	O	-1	-1	0
)	PMC5005937	16817	16818	O	-1	-1	0
98	PMC5005937	16819	16821	O	-1	-1	0
(	PMC5005937	16822	16823	O	-1	-1	0
9	PMC5005937	16823	16824	O	-1	-1	0
%	PMC5005937	16824	16825	O	-1	-1	0
)	PMC5005937	16825	16826	O	-1	-1	0
199	PMC5005937	16827	16830	O	-1	-1	0
(	PMC5005937	16831	16832	O	-1	-1	0
18	PMC5005937	16832	16834	O	-1	-1	0
%	PMC5005937	16834	16835	O	-1	-1	0
)	PMC5005937	16835	16836	O	-1	-1	0
30	PMC5005937	16837	16839	O	-1	-1	0
(	PMC5005937	16840	16841	O	-1	-1	0
3	PMC5005937	16841	16842	O	-1	-1	0
%	PMC5005937	16842	16843	O	-1	-1	0
)	PMC5005937	16843	16844	O	-1	-1	0


	PMC5005937	16844	16846	O	-1	-1	0
103	PMC5005937	16846	16849	O	-1	-1	0

(	PMC5005937	16850	16851	O	-1	-1	0
8	PMC5005937	16851	16852	O	-1	-1	0
%	PMC5005937	16852	16853	O	-1	-1	0
)	PMC5005937	16853	16854	O	-1	-1	0

120	PMC5005937	16855	16858	O	-1	-1	0
(	PMC5005937	16859	16860	O	-1	-1	0
10	PMC5005937	16860	16862	O	-1	-1	0
%	PMC5005937	16862	16863	O	-1	-1	0
)	PMC5005937	16863	16864	O	-1	-1	0

131	PMC5005937	16865	16868	O	-1	-1	0
(	PMC5005937	16869	16870	O	-1	-1	0
10	PMC5005937	16870	16872	O	-1	-1	0
%	PMC5005937	16872	16873	O	-1	-1	0
)	PMC5005937	16873	16874	O	-1	-1	0
205	PMC5005937	16875	16878	O	-1	-1	0
(	PMC5005937	16879	16880	O	-1	-1	0
16	PMC5005937	16880	16882	O	-1	-1	0
%	PMC5005937	16882	16883	O	-1	-1	0
)	PMC5005937	16883	16884	O	-1	-1	0
186	PMC5005937	16885	16888	O	-1	-1	0
(	PMC5005937	16889	16890	O	-1	-1	0
15	PMC5005937	16890	16892	O	-1	-1	0
%	PMC5005937	16892	16893	O	-1	-1	0
)	PMC5005937	16893	16894	O	-1	-1	0

181	PMC5005937	16895	16898	O	-1	-1	0
(	PMC5005937	16899	16900	O	-1	-1	0
14	PMC5005937	16900	16902	O	-1	-1	0
%	PMC5005937	16902	16903	O	-1	-1	0
)	PMC5005937	16903	16904	O	-1	-1	0
129	PMC5005937	16905	16908	O	-1	-1	0
(	PMC5005937	16909	16910	O	-1	-1	0
10	PMC5005937	16910	16912	O	-1	-1	0
%	PMC5005937	16912	16913	O	-1	-1	0
)	PMC5005937	16913	16914	O	-1	-1	0

185	PMC5005937	16915	16918	O	-1	-1	0
(	PMC5005937	16919	16920	O	-1	-1	0
15	PMC5005937	16920	16922	O	-1	-1	0
%	PMC5005937	16922	16923	O	-1	-1	0
)	PMC5005937	16923	16924	O	-1	-1	0

12	PMC5005937	16925	16927	O	-1	-1	0
(	PMC5005937	16928	16929	O	-1	-1	0
1	PMC5005937	16929	16930	O	-1	-1	0
%	PMC5005937	16930	16931	O	-1	-1	0
)	PMC5005937	16931	16932	O	-1	-1	0


	PMC5005937	16932	16934	O	-1	-1	0

comprehensive	PMC5005937	16934	16947	O	-1	-1	0
description	PMC5005937	16948	16959	O	-1	-1	0
of	PMC5005937	16960	16962	O	-1	-1	0
family	PMC5005937	16963	16969	O	-1	-1	0
history	PMC5005937	16970	16977	O	-1	-1	0
of	PMC5005937	16978	16980	O	-1	-1	0
any	PMC5005937	16981	16984	O	-1	-1	0
epidemiological	PMC5005937	16985	17000	O	-1	-1	0
breast	PMC5005937	17001	17007	O	-1	-1	0
cancer	PMC5005937	17008	17014	O	-1	-1	0
study	PMC5005937	17015	17020	O	-1	-1	0
.	PMC5005937	17020	17021	O	-1	-1	0

Risk	PMC5005937	17022	17026	O	-1	-1	0
factor	PMC5005937	17027	17033	O	-1	-1	0
questionnaires	PMC5005937	17034	17048	O	-1	-1	0
.	PMC5005937	17048	17049	O	-1	-1	0

The	PMC5005937	17050	17053	O	-1	-1	0
BCFR	PMC5005937	17054	17058	O	-1	-1	0
and	PMC5005937	17059	17062	O	-1	-1	0
kConFab	PMC5005937	17063	17070	O	-1	-1	0
used	PMC5005937	17071	17075	O	-1	-1	0
the	PMC5005937	17076	17079	O	-1	-1	0
same	PMC5005937	17080	17084	O	-1	-1	0
baseline	PMC5005937	17085	17093	O	-1	-1	0
questionnaire	PMC5005937	17094	17107	O	-1	-1	0
to	PMC5005937	17108	17110	O	-1	-1	0
collect	PMC5005937	17111	17118	O	-1	-1	0
data	PMC5005937	17119	17123	O	-1	-1	0
on	PMC5005937	17124	17126	O	-1	-1	0
menstrual	PMC5005937	17127	17136	O	-1	-1	0
and	PMC5005937	17137	17140	O	-1	-1	0
reproductive	PMC5005937	17141	17153	O	-1	-1	0
history	PMC5005937	17154	17161	O	-1	-1	0
,	PMC5005937	17161	17162	O	-1	-1	0
medical	PMC5005937	17163	17170	O	-1	-1	0
history	PMC5005937	17171	17178	O	-1	-1	0
and	PMC5005937	17179	17182	O	-1	-1	0
behavioral	PMC5005937	17183	17193	O	-1	-1	0
factors	PMC5005937	17194	17201	O	-1	-1	0
.	PMC5005937	17201	17202	O	-1	-1	0

The	PMC5005937	17203	17206	O	-1	-1	0
BCFR	PMC5005937	17207	17211	O	-1	-1	0
conducted	PMC5005937	17212	17221	O	-1	-1	0
a	PMC5005937	17222	17223	O	-1	-1	0
systematic	PMC5005937	17224	17234	O	-1	-1	0
follow	PMC5005937	17235	17241	O	-1	-1	0
-	PMC5005937	17241	17242	O	-1	-1	0
up	PMC5005937	17242	17244	O	-1	-1	0
beginning	PMC5005937	17245	17254	O	-1	-1	0
in	PMC5005937	17255	17257	O	-1	-1	0
2007	PMC5005937	17258	17262	O	-1	-1	0
,	PMC5005937	17262	17263	O	-1	-1	0
and	PMC5005937	17264	17267	O	-1	-1	0
collected	PMC5005937	17268	17277	O	-1	-1	0
updated	PMC5005937	17278	17285	O	-1	-1	0
information	PMC5005937	17286	17297	O	-1	-1	0
on	PMC5005937	17298	17300	O	-1	-1	0
personal	PMC5005937	17301	17309	O	-1	-1	0
and	PMC5005937	17310	17313	O	-1	-1	0
family	PMC5005937	17314	17320	O	-1	-1	0
history	PMC5005937	17321	17328	O	-1	-1	0
of	PMC5005937	17329	17331	O	-1	-1	0
cancer	PMC5005937	17332	17338	O	-1	-1	0
,	PMC5005937	17338	17339	O	-1	-1	0
breast	PMC5005937	17340	17346	O	-1	-1	0
and	PMC5005937	17347	17350	O	-1	-1	0
ovarian	PMC5005937	17351	17358	O	-1	-1	0
surgeries	PMC5005937	17359	17368	O	-1	-1	0
and	PMC5005937	17369	17372	O	-1	-1	0
breast	PMC5005937	17373	17379	O	-1	-1	0
cancer	PMC5005937	17380	17386	O	-1	-1	0
risk	PMC5005937	17387	17391	O	-1	-1	0
factors	PMC5005937	17392	17399	O	-1	-1	0
collected	PMC5005937	17400	17409	O	-1	-1	0
at	PMC5005937	17410	17412	O	-1	-1	0
baseline	PMC5005937	17413	17421	O	-1	-1	0
.	PMC5005937	17421	17422	O	-1	-1	0

New	PMC5005937	17423	17426	O	-1	-1	0
items	PMC5005937	17427	17432	O	-1	-1	0
of	PMC5005937	17433	17435	O	-1	-1	0
interest	PMC5005937	17436	17444	O	-1	-1	0
were	PMC5005937	17445	17449	O	-1	-1	0
added	PMC5005937	17450	17455	O	-1	-1	0
,	PMC5005937	17455	17456	O	-1	-1	0
including	PMC5005937	17457	17466	O	-1	-1	0
screening	PMC5005937	17467	17476	O	-1	-1	0
behaviours	PMC5005937	17477	17487	O	-1	-1	0


	PMC5005937	17487	17489	O	-1	-1	0
such	PMC5005937	17489	17493	O	-1	-1	0
as	PMC5005937	17494	17496	O	-1	-1	0
use	PMC5005937	17497	17500	O	-1	-1	0
of	PMC5005937	17501	17503	O	-1	-1	0
magnetic	PMC5005937	17504	17512	O	-1	-1	0
resonance	PMC5005937	17513	17522	O	-1	-1	0
imaging	PMC5005937	17523	17530	O	-1	-1	0
(	PMC5005937	17531	17532	O	-1	-1	0
MRI	PMC5005937	17532	17535	O	-1	-1	0
)	PMC5005937	17535	17536	O	-1	-1	0
,	PMC5005937	17536	17537	O	-1	-1	0
use	PMC5005937	17538	17541	O	-1	-1	0
of	PMC5005937	17542	17544	O	-1	-1	0
non	PMC5005937	17545	17548	O	-1	-1	0
-	PMC5005937	17548	17549	O	-1	-1	0
steroidal	PMC5005937	17549	17558	O	-1	-1	0
anti	PMC5005937	17559	17563	O	-1	-1	0
-	PMC5005937	17563	17564	O	-1	-1	0
inflammatory	PMC5005937	17564	17576	O	-1	-1	0
drugs	PMC5005937	17577	17582	O	-1	-1	0
(	PMC5005937	17583	17584	O	-1	-1	0
NSAIDs	PMC5005937	17584	17590	O	-1	-1	0
)	PMC5005937	17590	17591	O	-1	-1	0
and	PMC5005937	17592	17595	O	-1	-1	0
knowledge	PMC5005937	17596	17605	O	-1	-1	0
and	PMC5005937	17606	17609	O	-1	-1	0
understanding	PMC5005937	17610	17623	O	-1	-1	0
of	PMC5005937	17624	17626	O	-1	-1	0
genetic	PMC5005937	17627	17634	O	-1	-1	0
test	PMC5005937	17635	17639	O	-1	-1	0
results	PMC5005937	17640	17647	O	-1	-1	0
.	PMC5005937	17647	17648	O	-1	-1	0

The	PMC5005937	17649	17652	O	-1	-1	0
most	PMC5005937	17653	17657	O	-1	-1	0
recent	PMC5005937	17658	17664	O	-1	-1	0
systematic	PMC5005937	17665	17675	O	-1	-1	0
follow	PMC5005937	17676	17682	O	-1	-1	0
-	PMC5005937	17682	17683	O	-1	-1	0
up	PMC5005937	17683	17685	O	-1	-1	0
of	PMC5005937	17686	17688	O	-1	-1	0
the	PMC5005937	17689	17692	O	-1	-1	0
BCFR	PMC5005937	17693	17697	O	-1	-1	0
,	PMC5005937	17697	17698	O	-1	-1	0
conducted	PMC5005937	17699	17708	O	-1	-1	0
in	PMC5005937	17709	17711	O	-1	-1	0
2011–14	PMC5005937	17712	17719	O	-1	-1	0
,	PMC5005937	17719	17720	O	-1	-1	0
updated	PMC5005937	17721	17728	O	-1	-1	0
some	PMC5005937	17729	17733	O	-1	-1	0
risk	PMC5005937	17734	17738	O	-1	-1	0
factor	PMC5005937	17739	17745	O	-1	-1	0
data	PMC5005937	17746	17750	O	-1	-1	0
in	PMC5005937	17751	17753	O	-1	-1	0
addition	PMC5005937	17754	17762	O	-1	-1	0
to	PMC5005937	17763	17765	O	-1	-1	0
family	PMC5005937	17766	17772	O	-1	-1	0
history	PMC5005937	17773	17780	O	-1	-1	0
and	PMC5005937	17781	17784	O	-1	-1	0
pedigree	PMC5005937	17785	17793	O	-1	-1	0
information	PMC5005937	17794	17805	O	-1	-1	0
.	PMC5005937	17805	17806	O	-1	-1	0

kConFab	PMC5005937	17807	17814	O	-1	-1	0
FUP	PMC5005937	17815	17818	O	-1	-1	0
surveyed	PMC5005937	17819	17827	O	-1	-1	0
participants	PMC5005937	17828	17840	O	-1	-1	0
every	PMC5005937	17841	17846	O	-1	-1	0
3	PMC5005937	17847	17848	O	-1	-1	0
years	PMC5005937	17849	17854	O	-1	-1	0
,	PMC5005937	17854	17855	O	-1	-1	0
using	PMC5005937	17856	17861	O	-1	-1	0
questionnaires	PMC5005937	17862	17876	O	-1	-1	0
that	PMC5005937	17877	17881	O	-1	-1	0
cover	PMC5005937	17882	17887	O	-1	-1	0
the	PMC5005937	17888	17891	O	-1	-1	0
same	PMC5005937	17892	17896	O	-1	-1	0
content	PMC5005937	17897	17904	O	-1	-1	0
as	PMC5005937	17905	17907	O	-1	-1	0
the	PMC5005937	17908	17911	O	-1	-1	0
BCFR	PMC5005937	17912	17916	O	-1	-1	0
follow	PMC5005937	17917	17923	O	-1	-1	0
-	PMC5005937	17923	17924	O	-1	-1	0
up	PMC5005937	17924	17926	O	-1	-1	0
questionnaires	PMC5005937	17927	17941	O	-1	-1	0
,	PMC5005937	17941	17942	O	-1	-1	0
with	PMC5005937	17943	17947	O	-1	-1	0
the	PMC5005937	17948	17951	O	-1	-1	0
exception	PMC5005937	17952	17961	O	-1	-1	0
of	PMC5005937	17962	17964	O	-1	-1	0
diagnostic	PMC5005937	17965	17975	O	-1	-1	0
radiation	PMC5005937	17976	17985	O	-1	-1	0
.	PMC5005937	17985	17986	O	-1	-1	0

Biospecimen	PMC5005937	17987	17998	O	-1	-1	0
collection	PMC5005937	17999	18009	O	-1	-1	0
.	PMC5005937	18009	18010	O	-1	-1	0

At	PMC5005937	18011	18013	O	-1	-1	0
baseline	PMC5005937	18014	18022	O	-1	-1	0
,	PMC5005937	18022	18023	O	-1	-1	0
depending	PMC5005937	18024	18033	O	-1	-1	0
on	PMC5005937	18034	18036	O	-1	-1	0
relationship	PMC5005937	18037	18049	O	-1	-1	0
to	PMC5005937	18050	18052	O	-1	-1	0
the	PMC5005937	18053	18056	O	-1	-1	0
proband	PMC5005937	18057	18064	O	-1	-1	0
,	PMC5005937	18064	18065	O	-1	-1	0
most	PMC5005937	18066	18070	O	-1	-1	0
women	PMC5005937	18071	18076	O	-1	-1	0
were	PMC5005937	18077	18081	O	-1	-1	0
asked	PMC5005937	18082	18087	O	-1	-1	0
by	PMC5005937	18088	18090	O	-1	-1	0
the	PMC5005937	18091	18094	O	-1	-1	0
BCFR	PMC5005937	18095	18099	O	-1	-1	0
and	PMC5005937	18100	18103	O	-1	-1	0
kConFab	PMC5005937	18104	18111	O	-1	-1	0
to	PMC5005937	18112	18114	O	-1	-1	0
provide	PMC5005937	18115	18122	O	-1	-1	0
either	PMC5005937	18123	18129	O	-1	-1	0
a	PMC5005937	18130	18131	O	-1	-1	0
blood	PMC5005937	18132	18137	O	-1	-1	0
or	PMC5005937	18138	18140	O	-1	-1	0
a	PMC5005937	18141	18142	O	-1	-1	0
buccal	PMC5005937	18143	18149	O	-1	-1	0
sample	PMC5005937	18150	18156	O	-1	-1	0
.	PMC5005937	18156	18157	O	-1	-1	0

As	PMC5005937	18158	18160	O	-1	-1	0
a	PMC5005937	18161	18162	O	-1	-1	0
result	PMC5005937	18163	18169	O	-1	-1	0
,	PMC5005937	18169	18170	O	-1	-1	0
for	PMC5005937	18171	18174	O	-1	-1	0
83	PMC5005937	18175	18177	O	-1	-1	0
%	PMC5005937	18177	18178	O	-1	-1	0
of	PMC5005937	18179	18181	O	-1	-1	0
ProF	PMC5005937	18182	18186	O	-1	-1	0
-	PMC5005937	18186	18187	O	-1	-1	0
SC	PMC5005937	18187	18189	O	-1	-1	0
there	PMC5005937	18190	18195	O	-1	-1	0
are	PMC5005937	18196	18199	O	-1	-1	0
banked	PMC5005937	18200	18206	O	-1	-1	0
DNA	PMC5005937	18207	18210	O	-1	-1	0
and	PMC5005937	18211	18214	O	-1	-1	0
plasma	PMC5005937	18215	18221	O	-1	-1	0
samples	PMC5005937	18222	18229	O	-1	-1	0
,	PMC5005937	18229	18230	O	-1	-1	0
and	PMC5005937	18231	18234	O	-1	-1	0
for	PMC5005937	18235	18238	O	-1	-1	0
an	PMC5005937	18239	18241	O	-1	-1	0
additional	PMC5005937	18242	18252	O	-1	-1	0
2	PMC5005937	18253	18254	O	-1	-1	0
%	PMC5005937	18254	18255	O	-1	-1	0
there	PMC5005937	18256	18261	O	-1	-1	0
is	PMC5005937	18262	18264	O	-1	-1	0
DNA	PMC5005937	18265	18268	O	-1	-1	0
from	PMC5005937	18269	18273	O	-1	-1	0
buccal	PMC5005937	18274	18280	O	-1	-1	0
samples	PMC5005937	18281	18288	O	-1	-1	0
.	PMC5005937	18288	18289	O	-1	-1	0

There	PMC5005937	18290	18295	O	-1	-1	0
are	PMC5005937	18296	18299	O	-1	-1	0
no	PMC5005937	18300	18302	O	-1	-1	0
major	PMC5005937	18303	18308	O	-1	-1	0
differences	PMC5005937	18309	18320	O	-1	-1	0
between	PMC5005937	18321	18328	O	-1	-1	0
women	PMC5005937	18329	18334	O	-1	-1	0
who	PMC5005937	18335	18338	O	-1	-1	0
gave	PMC5005937	18339	18343	O	-1	-1	0
blood	PMC5005937	18344	18349	O	-1	-1	0
and	PMC5005937	18350	18353	O	-1	-1	0
those	PMC5005937	18354	18359	O	-1	-1	0
who	PMC5005937	18360	18363	O	-1	-1	0
did	PMC5005937	18364	18367	O	-1	-1	0
not	PMC5005937	18368	18371	O	-1	-1	0
with	PMC5005937	18372	18376	O	-1	-1	0
regard	PMC5005937	18377	18383	O	-1	-1	0
to	PMC5005937	18384	18386	O	-1	-1	0
the	PMC5005937	18387	18390	O	-1	-1	0
characteristics	PMC5005937	18391	18406	O	-1	-1	0
in	PMC5005937	18407	18409	O	-1	-1	0
Table	PMC5005937	18410	18415	O	-1	-1	0
1	PMC5005937	18416	18417	O	-1	-1	0
(	PMC5005937	18418	18419	O	-1	-1	0
data	PMC5005937	18419	18423	O	-1	-1	0
not	PMC5005937	18424	18427	O	-1	-1	0
shown	PMC5005937	18428	18433	O	-1	-1	0
)	PMC5005937	18433	18434	O	-1	-1	0
.	PMC5005937	18434	18435	O	-1	-1	0

BRCA1	PMC5005937	18436	18441	O	-1	-1	0
and	PMC5005937	18442	18445	O	-1	-1	0
BRCA2	PMC5005937	18446	18451	O	-1	-1	0
genotyping	PMC5005937	18452	18462	O	-1	-1	0
.	PMC5005937	18462	18463	O	-1	-1	0

Screening	PMC5005937	18464	18473	O	-1	-1	0
for	PMC5005937	18474	18477	O	-1	-1	0
germline	PMC5005937	18478	18486	O	-1	-1	0

BRCA1	PMC5005937	18487	18492	O	-1	-1	0
and	PMC5005937	18493	18496	O	-1	-1	0
BRCA2	PMC5005937	18497	18502	O	-1	-1	0
mutations	PMC5005937	18503	18512	O	-1	-1	0
and	PMC5005937	18513	18516	O	-1	-1	0
other	PMC5005937	18517	18522	O	-1	-1	0
known	PMC5005937	18523	18528	O	-1	-1	0
or	PMC5005937	18529	18531	O	-1	-1	0
putative	PMC5005937	18532	18540	O	-1	-1	0
susceptibility	PMC5005937	18541	18555	O	-1	-1	0
variations	PMC5005937	18556	18566	O	-1	-1	0
in	PMC5005937	18567	18569	O	-1	-1	0
other	PMC5005937	18570	18575	O	-1	-1	0
genes	PMC5005937	18576	18581	O	-1	-1	0
has	PMC5005937	18582	18585	O	-1	-1	0
been	PMC5005937	18586	18590	O	-1	-1	0
undertaken	PMC5005937	18591	18601	O	-1	-1	0
by	PMC5005937	18602	18604	O	-1	-1	0
the	PMC5005937	18605	18608	O	-1	-1	0
BCFR	PMC5005937	18609	18613	O	-1	-1	0
and	PMC5005937	18614	18617	O	-1	-1	0
kConFab	PMC5005937	18618	18625	O	-1	-1	0
,	PMC5005937	18625	18626	O	-1	-1	0
as	PMC5005937	18627	18629	O	-1	-1	0
previously	PMC5005937	18630	18640	O	-1	-1	0

described.29,33,34	PMC5005937	18641	18659	O	-1	-1	0

The	PMC5005937	18660	18663	O	-1	-1	0
cohort	PMC5005937	18664	18670	O	-1	-1	0
includes	PMC5005937	18671	18679	O	-1	-1	0
1508	PMC5005937	18680	18684	O	-1	-1	0
(	PMC5005937	18685	18686	O	-1	-1	0
844	PMC5005937	18686	18689	O	-1	-1	0
BRCA1	PMC5005937	18690	18695	O	-1	-1	0
,	PMC5005937	18695	18696	O	-1	-1	0

658	PMC5005937	18697	18700	O	-1	-1	0
BRCA2	PMC5005937	18701	18706	O	-1	-1	0
,	PMC5005937	18706	18707	O	-1	-1	0
6	PMC5005937	18708	18709	O	-1	-1	0
both	PMC5005937	18710	18714	O	-1	-1	0
BRCA1	PMC5005937	18715	18720	O	-1	-1	0
and	PMC5005937	18721	18724	O	-1	-1	0
BRCA2	PMC5005937	18725	18730	O	-1	-1	0

)	PMC5005937	18730	18731	O	-1	-1	0
female	PMC5005937	18732	18738	O	-1	-1	0
carriers	PMC5005937	18739	18747	O	-1	-1	0
from	PMC5005937	18748	18752	O	-1	-1	0
the	PMC5005937	18753	18756	O	-1	-1	0
BCFR	PMC5005937	18757	18761	O	-1	-1	0
,	PMC5005937	18761	18762	O	-1	-1	0
and	PMC5005937	18763	18766	O	-1	-1	0
1233	PMC5005937	18767	18771	O	-1	-1	0

(	PMC5005937	18772	18773	O	-1	-1	0
670	PMC5005937	18773	18776	O	-1	-1	0
BRCA1	PMC5005937	18777	18782	O	-1	-1	0
,	PMC5005937	18782	18783	O	-1	-1	0
561	PMC5005937	18784	18787	O	-1	-1	0

BRCA2	PMC5005937	18788	18793	O	-1	-1	0
,	PMC5005937	18793	18794	O	-1	-1	0
2	PMC5005937	18795	18796	O	-1	-1	0

both	PMC5005937	18797	18801	O	-1	-1	0
BRCA1	PMC5005937	18802	18807	O	-1	-1	0
and	PMC5005937	18808	18811	O	-1	-1	0
BRCA2	PMC5005937	18812	18817	O	-1	-1	0

)	PMC5005937	18817	18818	O	-1	-1	0
female	PMC5005937	18819	18825	O	-1	-1	0
carriers	PMC5005937	18826	18834	O	-1	-1	0
from	PMC5005937	18835	18839	O	-1	-1	0
kConFab	PMC5005937	18840	18847	O	-1	-1	0
.	PMC5005937	18847	18848	O	-1	-1	0

Outcome	PMC5005937	18849	18856	O	-1	-1	0
information	PMC5005937	18857	18868	O	-1	-1	0
.	PMC5005937	18868	18869	O	-1	-1	0

We	PMC5005937	18870	18872	O	-1	-1	0
have	PMC5005937	18873	18877	O	-1	-1	0
collected	PMC5005937	18878	18887	O	-1	-1	0
pathology	PMC5005937	18888	18897	O	-1	-1	0
reports	PMC5005937	18898	18905	O	-1	-1	0
for	PMC5005937	18906	18909	O	-1	-1	0
74	PMC5005937	18910	18912	O	-1	-1	0
%	PMC5005937	18912	18913	O	-1	-1	0
of	PMC5005937	18914	18916	O	-1	-1	0
prospectively	PMC5005937	18917	18930	O	-1	-1	0
ascertained	PMC5005937	18931	18942	O	-1	-1	0
(	PMC5005937	18943	18944	O	-1	-1	0
incident	PMC5005937	18944	18952	O	-1	-1	0
)	PMC5005937	18952	18953	O	-1	-1	0
cases	PMC5005937	18954	18959	O	-1	-1	0
to	PMC5005937	18960	18962	O	-1	-1	0
date	PMC5005937	18963	18967	O	-1	-1	0
.	PMC5005937	18967	18968	O	-1	-1	0

The	PMC5005937	18969	18972	O	-1	-1	0
BCFR	PMC5005937	18973	18977	O	-1	-1	0
collected	PMC5005937	18978	18987	O	-1	-1	0
self	PMC5005937	18988	18992	O	-1	-1	0
-	PMC5005937	18992	18993	O	-1	-1	0
reported	PMC5005937	18993	19001	O	-1	-1	0
treatment	PMC5005937	19002	19011	O	-1	-1	0
data	PMC5005937	19012	19016	O	-1	-1	0
using	PMC5005937	19017	19022	O	-1	-1	0
a	PMC5005937	19023	19024	O	-1	-1	0
validated	PMC5005937	19025	19034	O	-1	-1	0
questionnaire	PMC5005937	19035	19048	O	-1	-1	0
addressing	PMC5005937	19049	19059	O	-1	-1	0
stage	PMC5005937	19060	19065	O	-1	-1	0
and	PMC5005937	19066	19069	O	-1	-1	0
the	PMC5005937	19070	19073	O	-1	-1	0
type	PMC5005937	19074	19078	O	-1	-1	0
of	PMC5005937	19079	19081	O	-1	-1	0
initial	PMC5005937	19082	19089	O	-1	-1	0
breast	PMC5005937	19090	19096	O	-1	-1	0
cancer	PMC5005937	19097	19103	O	-1	-1	0
treatments	PMC5005937	19104	19114	O	-1	-1	0
(	PMC5005937	19115	19116	O	-1	-1	0
surgery	PMC5005937	19116	19123	O	-1	-1	0
,	PMC5005937	19123	19124	O	-1	-1	0
radiation	PMC5005937	19125	19134	O	-1	-1	0
treatment	PMC5005937	19135	19144	O	-1	-1	0
,	PMC5005937	19144	19145	O	-1	-1	0
endocrine	PMC5005937	19146	19155	O	-1	-1	0
treatment	PMC5005937	19156	19165	O	-1	-1	0
and	PMC5005937	19166	19169	O	-1	-1	0
chemotherapy).35,36	PMC5005937	19170	19189	O	-1	-1	0

The	PMC5005937	19190	19193	O	-1	-1	0
Australian	PMC5005937	19194	19204	O	-1	-1	0
,	PMC5005937	19204	19205	O	-1	-1	0
Canadian	PMC5005937	19206	19214	O	-1	-1	0
and	PMC5005937	19215	19218	O	-1	-1	0
Utah	PMC5005937	19219	19223	O	-1	-1	0
sites	PMC5005937	19224	19229	O	-1	-1	0
of	PMC5005937	19230	19232	O	-1	-1	0
the	PMC5005937	19233	19236	O	-1	-1	0
BCFR	PMC5005937	19237	19241	O	-1	-1	0
regularly	PMC5005937	19242	19251	O	-1	-1	0
link	PMC5005937	19252	19256	O	-1	-1	0
to	PMC5005937	19257	19259	O	-1	-1	0


	PMC5005937	19259	19261	O	-1	-1	0
688	PMC5005937	19261	19264	O	-1	-1	0


	PMC5005937	19264	19266	O	-1	-1	0
International	PMC5005937	19266	19279	O	-1	-1	0
Journal	PMC5005937	19280	19287	O	-1	-1	0
of	PMC5005937	19288	19290	O	-1	-1	0
Epidemiology	PMC5005937	19291	19303	O	-1	-1	0
,	PMC5005937	19303	19304	O	-1	-1	0
2016	PMC5005937	19305	19309	O	-1	-1	0
,	PMC5005937	19309	19310	O	-1	-1	0
Vol	PMC5005937	19311	19314	O	-1	-1	0
.	PMC5005937	19314	19315	O	-1	-1	0

45	PMC5005937	19316	19318	O	-1	-1	0
,	PMC5005937	19318	19319	O	-1	-1	0
No	PMC5005937	19320	19322	O	-1	-1	0
.	PMC5005937	19322	19323	O	-1	-1	0
3	PMC5005937	19324	19325	O	-1	-1	0


	PMC5005937	19325	19327	O	-1	-1	0
population	PMC5005937	19327	19337	O	-1	-1	0
-	PMC5005937	19337	19338	O	-1	-1	0
based	PMC5005937	19338	19343	O	-1	-1	0
cancer	PMC5005937	19344	19350	O	-1	-1	0
registries	PMC5005937	19351	19361	O	-1	-1	0
to	PMC5005937	19362	19364	O	-1	-1	0
validate	PMC5005937	19365	19373	O	-1	-1	0
cancers	PMC5005937	19374	19381	O	-1	-1	0
reported	PMC5005937	19382	19390	O	-1	-1	0
during	PMC5005937	19391	19397	O	-1	-1	0
follow	PMC5005937	19398	19404	O	-1	-1	0
-	PMC5005937	19404	19405	O	-1	-1	0
up	PMC5005937	19405	19407	O	-1	-1	0
.	PMC5005937	19407	19408	O	-1	-1	0

Linkage	PMC5005937	19409	19416	O	-1	-1	0
to	PMC5005937	19417	19419	O	-1	-1	0
death	PMC5005937	19420	19425	O	-1	-1	0
registries	PMC5005937	19426	19436	O	-1	-1	0
in	PMC5005937	19437	19439	O	-1	-1	0
Australia	PMC5005937	19440	19449	B-Location	-1	-1	0
and	PMC5005937	19450	19453	O	-1	-1	0
Canada	PMC5005937	19454	19460	B-Location	-1	-1	0
has	PMC5005937	19461	19464	O	-1	-1	0
been	PMC5005937	19465	19469	O	-1	-1	0
used	PMC5005937	19470	19474	O	-1	-1	0
to	PMC5005937	19475	19477	O	-1	-1	0
update	PMC5005937	19478	19484	O	-1	-1	0
vital	PMC5005937	19485	19490	O	-1	-1	0
status	PMC5005937	19491	19497	O	-1	-1	0
and	PMC5005937	19498	19501	O	-1	-1	0
related	PMC5005937	19502	19509	O	-1	-1	0
information	PMC5005937	19510	19521	O	-1	-1	0
(	PMC5005937	19522	19523	O	-1	-1	0
date	PMC5005937	19523	19527	O	-1	-1	0
and	PMC5005937	19528	19531	O	-1	-1	0
cause	PMC5005937	19532	19537	O	-1	-1	0
of	PMC5005937	19538	19540	O	-1	-1	0
death	PMC5005937	19541	19546	O	-1	-1	0
)	PMC5005937	19546	19547	O	-1	-1	0
as	PMC5005937	19548	19550	O	-1	-1	0
well	PMC5005937	19551	19555	O	-1	-1	0
as	PMC5005937	19556	19558	O	-1	-1	0
the	PMC5005937	19559	19562	O	-1	-1	0
National	PMC5005937	19563	19571	O	-1	-1	0
Death	PMC5005937	19572	19577	O	-1	-1	0
Index	PMC5005937	19578	19583	O	-1	-1	0
for	PMC5005937	19584	19587	O	-1	-1	0
the	PMC5005937	19588	19591	O	-1	-1	0
USA	PMC5005937	19592	19595	O	-1	-1	0
-	PMC5005937	19595	19596	O	-1	-1	0
based	PMC5005937	19596	19601	O	-1	-1	0
sites	PMC5005937	19602	19607	O	-1	-1	0
.	PMC5005937	19607	19608	O	-1	-1	0


	PMC5005937	19608	19610	O	-1	-1	0

What	PMC5005937	19610	19614	O	-1	-1	0
has	PMC5005937	19615	19618	O	-1	-1	0
it	PMC5005937	19619	19621	O	-1	-1	0
found	PMC5005937	19622	19627	O	-1	-1	0
?	PMC5005937	19627	19628	O	-1	-1	0

To	PMC5005937	19629	19631	O	-1	-1	0
empirically	PMC5005937	19632	19643	O	-1	-1	0
evaluate	PMC5005937	19644	19652	O	-1	-1	0
the	PMC5005937	19653	19656	O	-1	-1	0
differences	PMC5005937	19657	19668	O	-1	-1	0
in	PMC5005937	19669	19671	O	-1	-1	0
breast	PMC5005937	19672	19678	O	-1	-1	0
cancer	PMC5005937	19679	19685	O	-1	-1	0

risk	PMC5005937	19686	19690	O	-1	-1	0
estimates	PMC5005937	19691	19700	O	-1	-1	0
from	PMC5005937	19701	19705	O	-1	-1	0
different	PMC5005937	19706	19715	O	-1	-1	0
constructs	PMC5005937	19716	19726	O	-1	-1	0
of	PMC5005937	19727	19729	O	-1	-1	0
family	PMC5005937	19730	19736	O	-1	-1	0
history	PMC5005937	19737	19744	O	-1	-1	0
,	PMC5005937	19744	19745	O	-1	-1	0


	PMC5005937	19745	19747	O	-1	-1	0

we	PMC5005937	19747	19749	O	-1	-1	0
compared	PMC5005937	19750	19758	O	-1	-1	0
standard	PMC5005937	19759	19767	O	-1	-1	0
ways	PMC5005937	19768	19772	O	-1	-1	0
of	PMC5005937	19773	19775	O	-1	-1	0
defining	PMC5005937	19776	19784	O	-1	-1	0
family	PMC5005937	19785	19791	O	-1	-1	0
history	PMC5005937	19792	19799	O	-1	-1	0
with	PMC5005937	19800	19804	O	-1	-1	0
estimates	PMC5005937	19805	19814	O	-1	-1	0
using	PMC5005937	19815	19820	O	-1	-1	0
full	PMC5005937	19821	19825	O	-1	-1	0
family	PMC5005937	19826	19832	O	-1	-1	0
history	PMC5005937	19833	19840	O	-1	-1	0
pedigrees	PMC5005937	19841	19850	O	-1	-1	0
(	PMC5005937	19851	19852	O	-1	-1	0
Table	PMC5005937	19852	19857	O	-1	-1	0
4	PMC5005937	19858	19859	O	-1	-1	0
)	PMC5005937	19859	19860	O	-1	-1	0
.	PMC5005937	19860	19861	O	-1	-1	0

For	PMC5005937	19862	19865	O	-1	-1	0
the	PMC5005937	19866	19869	O	-1	-1	0
more	PMC5005937	19870	19874	O	-1	-1	0
than	PMC5005937	19875	19879	O	-1	-1	0
18	PMC5005937	19880	19882	O	-1	-1	0
000	PMC5005937	19883	19886	O	-1	-1	0
women	PMC5005937	19887	19892	O	-1	-1	0
unaffected	PMC5005937	19893	19903	O	-1	-1	0
at	PMC5005937	19904	19906	O	-1	-1	0
baseline	PMC5005937	19907	19915	O	-1	-1	0
,	PMC5005937	19915	19916	O	-1	-1	0
we	PMC5005937	19917	19919	O	-1	-1	0
compared	PMC5005937	19920	19928	O	-1	-1	0
family	PMC5005937	19929	19935	O	-1	-1	0
history	PMC5005937	19936	19943	O	-1	-1	0
as	PMC5005937	19944	19946	O	-1	-1	0
typically	PMC5005937	19947	19956	O	-1	-1	0
defined	PMC5005937	19957	19964	O	-1	-1	0
by	PMC5005937	19965	19967	O	-1	-1	0
cohort	PMC5005937	19968	19974	O	-1	-1	0
studies	PMC5005937	19975	19982	O	-1	-1	0
[	PMC5005937	19983	19984	O	-1	-1	0
any	PMC5005937	19984	19987	O	-1	-1	0
affected	PMC5005937	19988	19996	O	-1	-1	0
first	PMC5005937	19997	20002	O	-1	-1	0
-	PMC5005937	20002	20003	O	-1	-1	0
degree	PMC5005937	20003	20009	O	-1	-1	0
relative(s	PMC5005937	20010	20020	O	-1	-1	0
)	PMC5005937	20020	20021	O	-1	-1	0
;	PMC5005937	20021	20022	O	-1	-1	0
yes	PMC5005937	20023	20026	O	-1	-1	0

/	PMC5005937	20026	20027	O	-1	-1	0
no	PMC5005937	20027	20029	O	-1	-1	0
]	PMC5005937	20029	20030	O	-1	-1	0
with	PMC5005937	20031	20035	O	-1	-1	0
that	PMC5005937	20036	20040	O	-1	-1	0
of	PMC5005937	20041	20043	O	-1	-1	0
the	PMC5005937	20044	20047	O	-1	-1	0
number	PMC5005937	20048	20054	O	-1	-1	0
of	PMC5005937	20055	20057	O	-1	-1	0
affected	PMC5005937	20058	20066	O	-1	-1	0
first	PMC5005937	20067	20072	O	-1	-1	0
-	PMC5005937	20072	20073	O	-1	-1	0
degree	PMC5005937	20073	20079	O	-1	-1	0
relatives	PMC5005937	20080	20089	O	-1	-1	0
,	PMC5005937	20089	20090	O	-1	-1	0
and	PMC5005937	20091	20094	O	-1	-1	0
with	PMC5005937	20095	20099	O	-1	-1	0
the	PMC5005937	20100	20103	O	-1	-1	0
more	PMC5005937	20104	20108	O	-1	-1	0
comprehensive	PMC5005937	20109	20122	O	-1	-1	0
family	PMC5005937	20123	20129	O	-1	-1	0
history	PMC5005937	20130	20137	O	-1	-1	0
measure	PMC5005937	20138	20145	O	-1	-1	0
of	PMC5005937	20146	20148	O	-1	-1	0
FRP	PMC5005937	20149	20152	O	-1	-1	0
based	PMC5005937	20153	20158	O	-1	-1	0
on	PMC5005937	20159	20161	O	-1	-1	0
the	PMC5005937	20162	20165	O	-1	-1	0
Breast	PMC5005937	20166	20172	O	-1	-1	0
and	PMC5005937	20173	20176	O	-1	-1	0
Ovarian	PMC5005937	20177	20184	O	-1	-1	0
Analysis	PMC5005937	20185	20193	O	-1	-1	0
of	PMC5005937	20194	20196	O	-1	-1	0
Disease	PMC5005937	20197	20204	O	-1	-1	0
Incidence	PMC5005937	20205	20214	O	-1	-1	0
and	PMC5005937	20215	20218	O	-1	-1	0
Carrier	PMC5005937	20219	20226	O	-1	-1	0
Estimation	PMC5005937	20227	20237	O	-1	-1	0
Algorithm	PMC5005937	20238	20247	O	-1	-1	0
(	PMC5005937	20248	20249	O	-1	-1	0
BOADICEA)47	PMC5005937	20249	20260	O	-1	-1	0
model	PMC5005937	20261	20266	O	-1	-1	0
(	PMC5005937	20267	20268	O	-1	-1	0
10-year	PMC5005937	20268	20275	O	-1	-1	0
predicted	PMC5005937	20276	20285	O	-1	-1	0
risk	PMC5005937	20286	20290	O	-1	-1	0
)	PMC5005937	20290	20291	O	-1	-1	0
.	PMC5005937	20291	20292	O	-1	-1	0

We	PMC5005937	20293	20295	O	-1	-1	0
fitted	PMC5005937	20296	20302	O	-1	-1	0


	PMC5005937	20302	20304	O	-1	-1	0
Table	PMC5005937	20304	20309	O	-1	-1	0
3	PMC5005937	20310	20311	O	-1	-1	0
.	PMC5005937	20311	20312	O	-1	-1	0

Overview	PMC5005937	20313	20321	O	-1	-1	0
of	PMC5005937	20322	20324	O	-1	-1	0
measurements	PMC5005937	20325	20337	O	-1	-1	0
made	PMC5005937	20338	20342	O	-1	-1	0
for	PMC5005937	20343	20346	O	-1	-1	0
ProF	PMC5005937	20347	20351	O	-1	-1	0
-	PMC5005937	20351	20352	O	-1	-1	0
SC	PMC5005937	20352	20354	O	-1	-1	0
participants	PMC5005937	20355	20367	O	-1	-1	0
Type	PMC5005937	20368	20372	O	-1	-1	0
of	PMC5005937	20373	20375	O	-1	-1	0
construct	PMC5005937	20376	20385	O	-1	-1	0


	PMC5005937	20385	20387	O	-1	-1	0

When	PMC5005937	20387	20391	O	-1	-1	0
collected	PMC5005937	20392	20401	O	-1	-1	0


	PMC5005937	20401	20403	O	-1	-1	0
Details	PMC5005937	20403	20410	O	-1	-1	0


	PMC5005937	20410	20412	O	-1	-1	0

Family	PMC5005937	20412	20418	O	-1	-1	0
history	PMC5005937	20419	20426	O	-1	-1	0
/	PMC5005937	20426	20427	O	-1	-1	0
pedigree	PMC5005937	20427	20435	O	-1	-1	0


	PMC5005937	20435	20437	O	-1	-1	0

Baseline	PMC5005937	20437	20445	O	-1	-1	0

Annual	PMC5005937	20446	20452	O	-1	-1	0
follow	PMC5005937	20453	20459	O	-1	-1	0
-	PMC5005937	20459	20460	O	-1	-1	0
up	PMC5005937	20460	20462	O	-1	-1	0

10-year	PMC5005937	20463	20470	O	-1	-1	0
follow	PMC5005937	20471	20477	O	-1	-1	0
-	PMC5005937	20477	20478	O	-1	-1	0
up	PMC5005937	20478	20480	O	-1	-1	0

ProF	PMC5005937	20481	20485	O	-1	-1	0
-	PMC5005937	20485	20486	O	-1	-1	0
SC	PMC5005937	20486	20488	O	-1	-1	0
follow	PMC5005937	20489	20495	O	-1	-1	0
-	PMC5005937	20495	20496	O	-1	-1	0
up	PMC5005937	20496	20498	O	-1	-1	0

Baseline	PMC5005937	20499	20507	O	-1	-1	0

10-year	PMC5005937	20508	20515	O	-1	-1	0
follow	PMC5005937	20516	20522	O	-1	-1	0
-	PMC5005937	20522	20523	O	-1	-1	0
up	PMC5005937	20523	20525	O	-1	-1	0

ProF	PMC5005937	20526	20530	O	-1	-1	0
-	PMC5005937	20530	20531	O	-1	-1	0
SC	PMC5005937	20531	20533	O	-1	-1	0
follow	PMC5005937	20534	20540	O	-1	-1	0
-	PMC5005937	20540	20541	O	-1	-1	0
up	PMC5005937	20541	20543	O	-1	-1	0

Every	PMC5005937	20544	20549	O	-1	-1	0
3	PMC5005937	20550	20551	O	-1	-1	0
yearsa	PMC5005937	20552	20558	O	-1	-1	0

Baseline	PMC5005937	20559	20567	O	-1	-1	0
Baseline	PMC5005937	20568	20576	O	-1	-1	0
Follow	PMC5005937	20577	20583	O	-1	-1	0
-	PMC5005937	20583	20584	O	-1	-1	0
up	PMC5005937	20584	20586	O	-1	-1	0
as	PMC5005937	20587	20589	O	-1	-1	0
new	PMC5005937	20590	20593	O	-1	-1	0
family	PMC5005937	20594	20600	O	-1	-1	0
mutations	PMC5005937	20601	20610	O	-1	-1	0
are	PMC5005937	20611	20614	O	-1	-1	0
identified	PMC5005937	20615	20625	O	-1	-1	0


	PMC5005937	20625	20627	O	-1	-1	0
Multi	PMC5005937	20627	20632	O	-1	-1	0
-	PMC5005937	20632	20633	O	-1	-1	0
generational	PMC5005937	20633	20645	O	-1	-1	0
pedigree	PMC5005937	20646	20654	O	-1	-1	0
completed	PMC5005937	20655	20664	O	-1	-1	0
at	PMC5005937	20665	20667	O	-1	-1	0
baseline	PMC5005937	20668	20676	O	-1	-1	0
,	PMC5005937	20676	20677	O	-1	-1	0
10-year	PMC5005937	20678	20685	O	-1	-1	0
and	PMC5005937	20686	20689	O	-1	-1	0
ProF	PMC5005937	20690	20694	O	-1	-1	0
-	PMC5005937	20694	20695	O	-1	-1	0
SC	PMC5005937	20695	20697	O	-1	-1	0
interviews	PMC5005937	20698	20708	O	-1	-1	0

;	PMC5005937	20708	20709	O	-1	-1	0
additional	PMC5005937	20710	20720	O	-1	-1	0
updates	PMC5005937	20721	20728	O	-1	-1	0
collected	PMC5005937	20729	20738	O	-1	-1	0
when	PMC5005937	20739	20743	O	-1	-1	0
families	PMC5005937	20744	20752	O	-1	-1	0
contacted	PMC5005937	20753	20762	O	-1	-1	0
annually	PMC5005937	20763	20771	O	-1	-1	0


	PMC5005937	20771	20773	O	-1	-1	0

Epidemiological	PMC5005937	20773	20788	O	-1	-1	0
questionnaires	PMC5005937	20789	20803	O	-1	-1	0


	PMC5005937	20803	20805	O	-1	-1	0

Biospecimen	PMC5005937	20805	20816	O	-1	-1	0
collection	PMC5005937	20817	20827	O	-1	-1	0

BRCA1	PMC5005937	20828	20833	O	-1	-1	0
and	PMC5005937	20834	20837	O	-1	-1	0
BRCA2	PMC5005937	20838	20843	O	-1	-1	0
genotyping	PMC5005937	20844	20854	O	-1	-1	0


	PMC5005937	20854	20856	O	-1	-1	0

Outcome	PMC5005937	20856	20863	O	-1	-1	0
information	PMC5005937	20864	20875	O	-1	-1	0


	PMC5005937	20875	20877	O	-1	-1	0

At	PMC5005937	20877	20879	O	-1	-1	0
diagnosis	PMC5005937	20880	20889	O	-1	-1	0
After	PMC5005937	20890	20895	O	-1	-1	0
identified	PMC5005937	20896	20906	O	-1	-1	0
through	PMC5005937	20907	20914	O	-1	-1	0
personal	PMC5005937	20915	20923	O	-1	-1	0
or	PMC5005937	20924	20926	O	-1	-1	0
family	PMC5005937	20927	20933	O	-1	-1	0
report	PMC5005937	20934	20940	O	-1	-1	0

Linkage	PMC5005937	20941	20948	O	-1	-1	0
with	PMC5005937	20949	20953	O	-1	-1	0
cancer	PMC5005937	20954	20960	O	-1	-1	0
(	PMC5005937	20961	20962	O	-1	-1	0
Australia	PMC5005937	20962	20971	B-Location	-1	-1	0
,	PMC5005937	20971	20972	O	-1	-1	0
California	PMC5005937	20973	20983	B-Location	-1	-1	0
,	PMC5005937	20983	20984	O	-1	-1	0
Canada	PMC5005937	20985	20991	B-Location	-1	-1	0
)	PMC5005937	20991	20992	O	-1	-1	0
and	PMC5005937	20993	20996	O	-1	-1	0
national	PMC5005937	20997	21005	O	-1	-1	0
death	PMC5005937	21006	21011	O	-1	-1	0
registries	PMC5005937	21012	21022	O	-1	-1	0


	PMC5005937	21022	21024	O	-1	-1	0
Reproductive	PMC5005937	21024	21036	O	-1	-1	0
history	PMC5005937	21037	21044	O	-1	-1	0
;	PMC5005937	21044	21045	O	-1	-1	0
personal	PMC5005937	21046	21054	O	-1	-1	0
medical	PMC5005937	21055	21062	O	-1	-1	0
history	PMC5005937	21063	21070	O	-1	-1	0
;	PMC5005937	21070	21071	O	-1	-1	0
behavioural	PMC5005937	21072	21083	O	-1	-1	0
risk	PMC5005937	21084	21088	O	-1	-1	0
factors	PMC5005937	21089	21096	O	-1	-1	0


	PMC5005937	21096	21098	O	-1	-1	0

Blood	PMC5005937	21098	21103	O	-1	-1	0
and/or	PMC5005937	21104	21110	O	-1	-1	0
buccal	PMC5005937	21111	21117	O	-1	-1	0
sample	PMC5005937	21118	21124	O	-1	-1	0

Youngest	PMC5005937	21125	21133	O	-1	-1	0
affected	PMC5005937	21134	21142	O	-1	-1	0
family	PMC5005937	21143	21149	O	-1	-1	0
member	PMC5005937	21150	21156	O	-1	-1	0
tested	PMC5005937	21157	21163	O	-1	-1	0
,	PMC5005937	21163	21164	O	-1	-1	0
other	PMC5005937	21165	21170	O	-1	-1	0
family	PMC5005937	21171	21177	O	-1	-1	0
members	PMC5005937	21178	21185	O	-1	-1	0
tested	PMC5005937	21186	21192	O	-1	-1	0
if	PMC5005937	21193	21195	O	-1	-1	0
youngest	PMC5005937	21196	21204	O	-1	-1	0
affected	PMC5005937	21205	21213	O	-1	-1	0
had	PMC5005937	21214	21217	O	-1	-1	0
mutation	PMC5005937	21218	21226	O	-1	-1	0

Pathology	PMC5005937	21227	21236	O	-1	-1	0
report	PMC5005937	21237	21243	O	-1	-1	0
;	PMC5005937	21243	21244	O	-1	-1	0
pathology	PMC5005937	21245	21254	O	-1	-1	0
material	PMC5005937	21255	21263	O	-1	-1	0
Treatment	PMC5005937	21264	21273	O	-1	-1	0
questionnaire	PMC5005937	21274	21287	O	-1	-1	0

Linkage	PMC5005937	21288	21295	O	-1	-1	0
with	PMC5005937	21296	21300	O	-1	-1	0
cancer	PMC5005937	21301	21307	O	-1	-1	0
registries	PMC5005937	21308	21318	O	-1	-1	0
and	PMC5005937	21319	21322	O	-1	-1	0
linkage	PMC5005937	21323	21330	O	-1	-1	0
with	PMC5005937	21331	21335	O	-1	-1	0
National	PMC5005937	21336	21344	O	-1	-1	0
Death	PMC5005937	21345	21350	O	-1	-1	0
Index	PMC5005937	21351	21356	O	-1	-1	0


	PMC5005937	21356	21358	O	-1	-1	0

a	PMC5005937	21358	21359	O	-1	-1	0


	PMC5005937	21359	21361	O	-1	-1	0

kConFab	PMC5005937	21361	21368	O	-1	-1	0
FUP	PMC5005937	21369	21372	O	-1	-1	0
only	PMC5005937	21373	21377	O	-1	-1	0
.	PMC5005937	21377	21378	O	-1	-1	0


	PMC5005937	21378	21380	O	-1	-1	0

Table	PMC5005937	21380	21385	O	-1	-1	0
4	PMC5005937	21386	21387	O	-1	-1	0
.	PMC5005937	21387	21388	O	-1	-1	0

Associations	PMC5005937	21389	21401	O	-1	-1	0
of	PMC5005937	21402	21404	O	-1	-1	0
family	PMC5005937	21405	21411	O	-1	-1	0
history	PMC5005937	21412	21419	O	-1	-1	0
measures	PMC5005937	21420	21428	O	-1	-1	0
as	PMC5005937	21429	21431	O	-1	-1	0
predictors	PMC5005937	21432	21442	O	-1	-1	0
of	PMC5005937	21443	21445	O	-1	-1	0
age	PMC5005937	21446	21449	O	-1	-1	0
-	PMC5005937	21449	21450	O	-1	-1	0
adjusted	PMC5005937	21450	21458	O	-1	-1	0
breast	PMC5005937	21459	21465	O	-1	-1	0
cancer	PMC5005937	21466	21472	O	-1	-1	0
incidence	PMC5005937	21473	21482	O	-1	-1	0
for	PMC5005937	21483	21486	O	-1	-1	0
the	PMC5005937	21487	21490	O	-1	-1	0
sub	PMC5005937	21491	21494	O	-1	-1	0
-	PMC5005937	21494	21495	O	-1	-1	0
cohort	PMC5005937	21495	21501	O	-1	-1	0
of	PMC5005937	21502	21504	O	-1	-1	0
17	PMC5005937	21505	21507	O	-1	-1	0
403	PMC5005937	21508	21511	O	-1	-1	0
women	PMC5005937	21512	21517	O	-1	-1	0
in	PMC5005937	21518	21520	O	-1	-1	0
ProF	PMC5005937	21521	21525	O	-1	-1	0
-	PMC5005937	21525	21526	O	-1	-1	0
SC	PMC5005937	21526	21528	O	-1	-1	0
who	PMC5005937	21529	21532	O	-1	-1	0
were	PMC5005937	21533	21537	O	-1	-1	0
unaffected	PMC5005937	21538	21548	O	-1	-1	0
at	PMC5005937	21549	21551	O	-1	-1	0
baseline	PMC5005937	21552	21560	O	-1	-1	0

Number	PMC5005937	21561	21567	O	-1	-1	0
of	PMC5005937	21568	21570	O	-1	-1	0
events	PMC5005937	21571	21577	O	-1	-1	0


	PMC5005937	21577	21579	O	-1	-1	0

Person	PMC5005937	21579	21585	O	-1	-1	0
-	PMC5005937	21585	21586	O	-1	-1	0
time	PMC5005937	21586	21590	O	-1	-1	0

(	PMC5005937	21591	21592	O	-1	-1	0
yrs	PMC5005937	21592	21595	O	-1	-1	0
)	PMC5005937	21595	21596	O	-1	-1	0


	PMC5005937	21596	21598	O	-1	-1	0

Hazard	PMC5005937	21598	21604	O	-1	-1	0

ratio	PMC5005937	21605	21610	O	-1	-1	0
estimatea	PMC5005937	21611	21620	O	-1	-1	0


	PMC5005937	21620	21622	O	-1	-1	0

95	PMC5005937	21622	21624	O	-1	-1	0
%	PMC5005937	21624	21625	O	-1	-1	0
confidence	PMC5005937	21626	21636	O	-1	-1	0

interval	PMC5005937	21637	21645	O	-1	-1	0


	PMC5005937	21645	21647	O	-1	-1	0

v12	PMC5005937	21647	21650	O	-1	-1	0


	PMC5005937	21650	21652	O	-1	-1	0

Breast	PMC5005937	21652	21658	O	-1	-1	0
cancer	PMC5005937	21659	21665	O	-1	-1	0
in	PMC5005937	21666	21668	O	-1	-1	0
1st	PMC5005937	21669	21672	O	-1	-1	0
-	PMC5005937	21672	21673	O	-1	-1	0
degree	PMC5005937	21673	21679	O	-1	-1	0
relative(s	PMC5005937	21680	21690	O	-1	-1	0
)	PMC5005937	21690	21691	O	-1	-1	0

(	PMC5005937	21692	21693	O	-1	-1	0
yes	PMC5005937	21693	21696	O	-1	-1	0
/	PMC5005937	21696	21697	O	-1	-1	0
no	PMC5005937	21697	21699	O	-1	-1	0
,	PMC5005937	21699	21700	O	-1	-1	0
binary	PMC5005937	21701	21707	O	-1	-1	0
categorical	PMC5005937	21708	21719	O	-1	-1	0
)	PMC5005937	21719	21720	O	-1	-1	0

Number	PMC5005937	21721	21727	O	-1	-1	0
of	PMC5005937	21728	21730	O	-1	-1	0
1st	PMC5005937	21731	21734	O	-1	-1	0
-	PMC5005937	21734	21735	O	-1	-1	0
degree	PMC5005937	21735	21741	O	-1	-1	0
relatives	PMC5005937	21742	21751	O	-1	-1	0
with	PMC5005937	21752	21756	O	-1	-1	0
breast	PMC5005937	21757	21763	O	-1	-1	0
cancer	PMC5005937	21764	21770	O	-1	-1	0
(	PMC5005937	21771	21772	O	-1	-1	0
ordered	PMC5005937	21772	21779	O	-1	-1	0
categorical	PMC5005937	21780	21791	O	-1	-1	0
)	PMC5005937	21791	21792	O	-1	-1	0
BOADICEA	PMC5005937	21793	21801	O	-1	-1	0
10-year	PMC5005937	21802	21809	O	-1	-1	0
risk	PMC5005937	21810	21814	O	-1	-1	0
(	PMC5005937	21815	21816	O	-1	-1	0
per	PMC5005937	21816	21819	O	-1	-1	0
1	PMC5005937	21820	21821	O	-1	-1	0
%	PMC5005937	21821	21822	O	-1	-1	0
change	PMC5005937	21823	21829	O	-1	-1	0
,	PMC5005937	21829	21830	O	-1	-1	0
continuous	PMC5005937	21831	21841	O	-1	-1	0
)	PMC5005937	21841	21842	O	-1	-1	0


	PMC5005937	21842	21844	O	-1	-1	0
1070	PMC5005937	21844	21848	O	-1	-1	0


	PMC5005937	21848	21850	O	-1	-1	0

175186	PMC5005937	21850	21856	O	-1	-1	0


	PMC5005937	21856	21858	O	-1	-1	0

1.45	PMC5005937	21858	21862	O	-1	-1	0


	PMC5005937	21862	21864	O	-1	-1	0

(	PMC5005937	21864	21865	O	-1	-1	0
1.22	PMC5005937	21865	21869	O	-1	-1	0
,	PMC5005937	21869	21870	O	-1	-1	0
1.73	PMC5005937	21871	21875	O	-1	-1	0
)	PMC5005937	21875	21876	O	-1	-1	0


	PMC5005937	21876	21878	O	-1	-1	0
18	PMC5005937	21878	21880	O	-1	-1	0


	PMC5005937	21880	21882	O	-1	-1	0

1070	PMC5005937	21882	21886	O	-1	-1	0


	PMC5005937	21886	21888	O	-1	-1	0

175186	PMC5005937	21888	21894	O	-1	-1	0


	PMC5005937	21894	21896	O	-1	-1	0

1.39	PMC5005937	21896	21900	O	-1	-1	0


	PMC5005937	21900	21902	O	-1	-1	0

(	PMC5005937	21902	21903	O	-1	-1	0
1.29	PMC5005937	21903	21907	O	-1	-1	0
,	PMC5005937	21907	21908	O	-1	-1	0
1.49	PMC5005937	21909	21913	O	-1	-1	0
)	PMC5005937	21913	21914	O	-1	-1	0


	PMC5005937	21914	21916	O	-1	-1	0
81	PMC5005937	21916	21918	O	-1	-1	0


	PMC5005937	21918	21920	O	-1	-1	0

947	PMC5005937	21920	21923	O	-1	-1	0


	PMC5005937	21923	21925	O	-1	-1	0

154885	PMC5005937	21925	21931	O	-1	-1	0


	PMC5005937	21931	21933	O	-1	-1	0

1.12	PMC5005937	21933	21937	O	-1	-1	0


	PMC5005937	21937	21939	O	-1	-1	0

(	PMC5005937	21939	21940	O	-1	-1	0
1.11	PMC5005937	21940	21944	O	-1	-1	0
,	PMC5005937	21944	21945	O	-1	-1	0
1.14	PMC5005937	21946	21950	O	-1	-1	0
)	PMC5005937	21950	21951	O	-1	-1	0


	PMC5005937	21951	21953	O	-1	-1	0

523	PMC5005937	21953	21956	O	-1	-1	0


	PMC5005937	21956	21958	O	-1	-1	0

Breast	PMC5005937	21958	21964	O	-1	-1	0
cancer	PMC5005937	21965	21971	O	-1	-1	0
in	PMC5005937	21972	21974	O	-1	-1	0
1st	PMC5005937	21975	21978	O	-1	-1	0
-	PMC5005937	21978	21979	O	-1	-1	0
degree	PMC5005937	21979	21985	O	-1	-1	0
relative(s	PMC5005937	21986	21996	O	-1	-1	0
)	PMC5005937	21996	21997	O	-1	-1	0

(	PMC5005937	21998	21999	O	-1	-1	0
yes	PMC5005937	21999	22002	O	-1	-1	0
/	PMC5005937	22002	22003	O	-1	-1	0
no	PMC5005937	22003	22005	O	-1	-1	0
,	PMC5005937	22005	22006	O	-1	-1	0
binary	PMC5005937	22007	22013	O	-1	-1	0
categorical	PMC5005937	22014	22025	O	-1	-1	0
)	PMC5005937	22025	22026	O	-1	-1	0

BOADICEA	PMC5005937	22027	22035	O	-1	-1	0
10-year	PMC5005937	22036	22043	O	-1	-1	0
risk	PMC5005937	22044	22048	O	-1	-1	0
(	PMC5005937	22049	22050	O	-1	-1	0
per	PMC5005937	22050	22053	O	-1	-1	0
1	PMC5005937	22054	22055	O	-1	-1	0
%	PMC5005937	22055	22056	O	-1	-1	0
change	PMC5005937	22057	22063	O	-1	-1	0
,	PMC5005937	22063	22064	O	-1	-1	0
continuous	PMC5005937	22065	22075	O	-1	-1	0
)	PMC5005937	22075	22076	O	-1	-1	0

Number	PMC5005937	22077	22083	O	-1	-1	0
of	PMC5005937	22084	22086	O	-1	-1	0
1st	PMC5005937	22087	22090	O	-1	-1	0
-	PMC5005937	22090	22091	O	-1	-1	0
degree	PMC5005937	22091	22097	O	-1	-1	0
relatives	PMC5005937	22098	22107	O	-1	-1	0
with	PMC5005937	22108	22112	O	-1	-1	0
breast	PMC5005937	22113	22119	O	-1	-1	0
cancer	PMC5005937	22120	22126	O	-1	-1	0
(	PMC5005937	22127	22128	O	-1	-1	0
ordered	PMC5005937	22128	22135	O	-1	-1	0
categorical	PMC5005937	22136	22147	O	-1	-1	0
)	PMC5005937	22147	22148	O	-1	-1	0
BOADICEA	PMC5005937	22149	22157	O	-1	-1	0
10-year	PMC5005937	22158	22165	O	-1	-1	0
risk	PMC5005937	22166	22170	O	-1	-1	0

(	PMC5005937	22171	22172	O	-1	-1	0
per	PMC5005937	22172	22175	O	-1	-1	0
1	PMC5005937	22176	22177	O	-1	-1	0
%	PMC5005937	22177	22178	O	-1	-1	0
change	PMC5005937	22179	22185	O	-1	-1	0
,	PMC5005937	22185	22186	O	-1	-1	0
continuous	PMC5005937	22187	22197	O	-1	-1	0
)	PMC5005937	22197	22198	O	-1	-1	0


	PMC5005937	22198	22200	O	-1	-1	0
947	PMC5005937	22200	22203	O	-1	-1	0


	PMC5005937	22203	22205	O	-1	-1	0
154885	PMC5005937	22205	22211	O	-1	-1	0


	PMC5005937	22211	22213	O	-1	-1	0
1.22	PMC5005937	22213	22217	O	-1	-1	0


	PMC5005937	22217	22219	O	-1	-1	0

(	PMC5005937	22219	22220	O	-1	-1	0
1.01	PMC5005937	22220	22224	O	-1	-1	0
,	PMC5005937	22224	22225	O	-1	-1	0
1.47	PMC5005937	22226	22230	O	-1	-1	0
)	PMC5005937	22230	22231	O	-1	-1	0


	PMC5005937	22231	22233	O	-1	-1	0
4	PMC5005937	22233	22234	O	-1	-1	0


	PMC5005937	22234	22236	O	-1	-1	0

1.12	PMC5005937	22236	22240	O	-1	-1	0


	PMC5005937	22240	22242	O	-1	-1	0

(	PMC5005937	22242	22243	O	-1	-1	0
1.11	PMC5005937	22243	22247	O	-1	-1	0
,	PMC5005937	22247	22248	O	-1	-1	0
1.13	PMC5005937	22249	22253	O	-1	-1	0
)	PMC5005937	22253	22254	O	-1	-1	0


	PMC5005937	22254	22256	O	-1	-1	0
503	PMC5005937	22256	22259	O	-1	-1	0


	PMC5005937	22259	22261	O	-1	-1	0

1.17	PMC5005937	22261	22265	O	-1	-1	0


	PMC5005937	22265	22267	O	-1	-1	0

(	PMC5005937	22267	22268	O	-1	-1	0
1.08	PMC5005937	22268	22272	O	-1	-1	0
,	PMC5005937	22272	22273	O	-1	-1	0
1.27	PMC5005937	22274	22278	O	-1	-1	0
)	PMC5005937	22278	22279	O	-1	-1	0


	PMC5005937	22279	22281	O	-1	-1	0

14	PMC5005937	22281	22283	O	-1	-1	0


	PMC5005937	22283	22285	O	-1	-1	0

1.12	PMC5005937	22285	22289	O	-1	-1	0


	PMC5005937	22289	22291	O	-1	-1	0

(	PMC5005937	22291	22292	O	-1	-1	0
1.11	PMC5005937	22292	22296	O	-1	-1	0
,	PMC5005937	22296	22297	O	-1	-1	0
1.13	PMC5005937	22298	22302	O	-1	-1	0
)	PMC5005937	22302	22303	O	-1	-1	0


	PMC5005937	22303	22305	O	-1	-1	0
428	PMC5005937	22305	22308	O	-1	-1	0


	PMC5005937	22308	22310	O	-1	-1	0
Family	PMC5005937	22310	22316	O	-1	-1	0
history	PMC5005937	22317	22324	O	-1	-1	0
measure	PMC5005937	22325	22332	O	-1	-1	0


	PMC5005937	22332	22334	O	-1	-1	0
a	PMC5005937	22334	22335	O	-1	-1	0


	PMC5005937	22335	22337	O	-1	-1	0
947	PMC5005937	22337	22340	O	-1	-1	0


	PMC5005937	22340	22342	O	-1	-1	0
154885	PMC5005937	22342	22348	O	-1	-1	0


	PMC5005937	22348	22350	O	-1	-1	0

Each	PMC5005937	22350	22354	O	-1	-1	0
row	PMC5005937	22355	22358	O	-1	-1	0
represents	PMC5005937	22359	22369	O	-1	-1	0
a	PMC5005937	22370	22371	O	-1	-1	0
separate	PMC5005937	22372	22380	O	-1	-1	0
age	PMC5005937	22381	22384	O	-1	-1	0
-	PMC5005937	22384	22385	O	-1	-1	0
adjusted	PMC5005937	22385	22393	O	-1	-1	0
model	PMC5005937	22394	22399	O	-1	-1	0
;	PMC5005937	22399	22400	O	-1	-1	0
rows	PMC5005937	22401	22405	O	-1	-1	0
4	PMC5005937	22406	22407	O	-1	-1	0
and	PMC5005937	22408	22411	O	-1	-1	0
5	PMC5005937	22412	22413	O	-1	-1	0
report	PMC5005937	22414	22420	O	-1	-1	0
models	PMC5005937	22421	22427	O	-1	-1	0
in	PMC5005937	22428	22430	O	-1	-1	0
which	PMC5005937	22431	22436	O	-1	-1	0
two	PMC5005937	22437	22440	O	-1	-1	0
constructs	PMC5005937	22441	22451	O	-1	-1	0
of	PMC5005937	22452	22454	O	-1	-1	0
family	PMC5005937	22455	22461	O	-1	-1	0
history	PMC5005937	22462	22469	O	-1	-1	0
are	PMC5005937	22470	22473	O	-1	-1	0
simultaneously	PMC5005937	22474	22488	O	-1	-1	0
fitted	PMC5005937	22489	22495	O	-1	-1	0
.	PMC5005937	22495	22496	O	-1	-1	0


	PMC5005937	22496	22498	O	-1	-1	0

International	PMC5005937	22498	22511	O	-1	-1	0
Journal	PMC5005937	22512	22519	O	-1	-1	0
of	PMC5005937	22520	22522	O	-1	-1	0
Epidemiology	PMC5005937	22523	22535	O	-1	-1	0
,	PMC5005937	22535	22536	O	-1	-1	0
2016	PMC5005937	22537	22541	O	-1	-1	0
,	PMC5005937	22541	22542	O	-1	-1	0
Vol	PMC5005937	22543	22546	O	-1	-1	0
.	PMC5005937	22546	22547	O	-1	-1	0

45	PMC5005937	22548	22550	O	-1	-1	0
,	PMC5005937	22550	22551	O	-1	-1	0
No	PMC5005937	22552	22554	O	-1	-1	0
.	PMC5005937	22554	22555	O	-1	-1	0
3	PMC5005937	22556	22557	O	-1	-1	0


	PMC5005937	22557	22559	O	-1	-1	0
689	PMC5005937	22559	22562	O	-1	-1	0


	PMC5005937	22562	22564	O	-1	-1	0
Figure	PMC5005937	22564	22570	O	-1	-1	0
2	PMC5005937	22571	22572	O	-1	-1	0
.	PMC5005937	22572	22573	O	-1	-1	0

Remaining	PMC5005937	22574	22583	O	-1	-1	0
lifetime	PMC5005937	22584	22592	O	-1	-1	0
risks	PMC5005937	22593	22598	O	-1	-1	0
according	PMC5005937	22599	22608	O	-1	-1	0
to	PMC5005937	22609	22611	O	-1	-1	0
BOADICEA	PMC5005937	22612	22620	O	-1	-1	0
based	PMC5005937	22621	22626	O	-1	-1	0
on	PMC5005937	22627	22629	O	-1	-1	0
baseline	PMC5005937	22630	22638	O	-1	-1	0
characteristics	PMC5005937	22639	22654	O	-1	-1	0
,	PMC5005937	22654	22655	O	-1	-1	0
including	PMC5005937	22656	22665	O	-1	-1	0
family	PMC5005937	22666	22672	O	-1	-1	0
history	PMC5005937	22673	22680	O	-1	-1	0
,	PMC5005937	22680	22681	O	-1	-1	0
for	PMC5005937	22682	22685	O	-1	-1	0
the	PMC5005937	22686	22689	O	-1	-1	0
sub	PMC5005937	22690	22693	O	-1	-1	0
-	PMC5005937	22693	22694	O	-1	-1	0
cohort	PMC5005937	22694	22700	O	-1	-1	0
of	PMC5005937	22701	22703	O	-1	-1	0
17	PMC5005937	22704	22706	O	-1	-1	0
403	PMC5005937	22707	22710	O	-1	-1	0

women	PMC5005937	22711	22716	O	-1	-1	0
in	PMC5005937	22717	22719	O	-1	-1	0
ProF	PMC5005937	22720	22724	O	-1	-1	0
-	PMC5005937	22724	22725	O	-1	-1	0
SC	PMC5005937	22725	22727	O	-1	-1	0
who	PMC5005937	22728	22731	O	-1	-1	0
were	PMC5005937	22732	22736	O	-1	-1	0
unaffected	PMC5005937	22737	22747	O	-1	-1	0
at	PMC5005937	22748	22750	O	-1	-1	0
baseline	PMC5005937	22751	22759	O	-1	-1	0
.	PMC5005937	22759	22760	O	-1	-1	0


	PMC5005937	22760	22762	O	-1	-1	0

an	PMC5005937	22762	22764	O	-1	-1	0
age	PMC5005937	22765	22768	O	-1	-1	0
-	PMC5005937	22768	22769	O	-1	-1	0
adjusted	PMC5005937	22769	22777	O	-1	-1	0
proportional	PMC5005937	22778	22790	O	-1	-1	0
hazards	PMC5005937	22791	22798	O	-1	-1	0
model	PMC5005937	22799	22804	O	-1	-1	0
and	PMC5005937	22805	22808	O	-1	-1	0
found	PMC5005937	22809	22814	O	-1	-1	0
that	PMC5005937	22815	22819	O	-1	-1	0
all	PMC5005937	22820	22823	O	-1	-1	0
measures	PMC5005937	22824	22832	O	-1	-1	0
predicted	PMC5005937	22833	22842	O	-1	-1	0
risk	PMC5005937	22843	22847	O	-1	-1	0
.	PMC5005937	22847	22848	O	-1	-1	0

As	PMC5005937	22849	22851	O	-1	-1	0
we	PMC5005937	22852	22854	O	-1	-1	0
compare	PMC5005937	22855	22862	O	-1	-1	0
binary	PMC5005937	22863	22869	O	-1	-1	0
categorical	PMC5005937	22870	22881	O	-1	-1	0
,	PMC5005937	22881	22882	O	-1	-1	0
ordered	PMC5005937	22883	22890	O	-1	-1	0
categorical	PMC5005937	22891	22902	O	-1	-1	0
and	PMC5005937	22903	22906	O	-1	-1	0
continuous	PMC5005937	22907	22917	O	-1	-1	0
constructs	PMC5005937	22918	22928	O	-1	-1	0
of	PMC5005937	22929	22931	O	-1	-1	0
family	PMC5005937	22932	22938	O	-1	-1	0
history	PMC5005937	22939	22946	O	-1	-1	0
,	PMC5005937	22946	22947	O	-1	-1	0
the	PMC5005937	22948	22951	O	-1	-1	0
v2	PMC5005937	22952	22954	O	-1	-1	0
statistics	PMC5005937	22955	22965	O	-1	-1	0
(	PMC5005937	22966	22967	O	-1	-1	0
based	PMC5005937	22967	22972	O	-1	-1	0
on	PMC5005937	22973	22975	O	-1	-1	0
the	PMC5005937	22976	22979	O	-1	-1	0
change	PMC5005937	22980	22986	O	-1	-1	0
in	PMC5005937	22987	22989	O	-1	-1	0
log	PMC5005937	22990	22993	O	-1	-1	0
likelihood	PMC5005937	22994	23004	O	-1	-1	0
which	PMC5005937	23005	23010	O	-1	-1	0
allows	PMC5005937	23011	23017	O	-1	-1	0
comparisons	PMC5005937	23018	23029	O	-1	-1	0
across	PMC5005937	23030	23036	O	-1	-1	0
constructs	PMC5005937	23037	23047	O	-1	-1	0
)	PMC5005937	23047	23048	O	-1	-1	0

showed	PMC5005937	23049	23055	O	-1	-1	0
that	PMC5005937	23056	23060	O	-1	-1	0
the	PMC5005937	23061	23064	O	-1	-1	0
BOADICEA	PMC5005937	23065	23073	O	-1	-1	0
score	PMC5005937	23074	23079	O	-1	-1	0
was	PMC5005937	23080	23083	O	-1	-1	0
clearly	PMC5005937	23084	23091	O	-1	-1	0
the	PMC5005937	23092	23095	O	-1	-1	0
best	PMC5005937	23096	23100	O	-1	-1	0
predictor	PMC5005937	23101	23110	O	-1	-1	0
of	PMC5005937	23111	23113	O	-1	-1	0
risk	PMC5005937	23114	23118	O	-1	-1	0
(	PMC5005937	23119	23120	O	-1	-1	0
v2	PMC5005937	23120	23122	O	-1	-1	0
¼	PMC5005937	23123	23124	O	-1	-1	0
523	PMC5005937	23125	23128	O	-1	-1	0
for	PMC5005937	23129	23132	O	-1	-1	0
BOADICEA	PMC5005937	23133	23141	O	-1	-1	0
vs	PMC5005937	23142	23144	O	-1	-1	0
v2	PMC5005937	23145	23147	O	-1	-1	0
¼	PMC5005937	23148	23149	O	-1	-1	0
18	PMC5005937	23150	23152	O	-1	-1	0
for	PMC5005937	23153	23156	O	-1	-1	0

ever	PMC5005937	23157	23161	O	-1	-1	0
/	PMC5005937	23161	23162	O	-1	-1	0
never	PMC5005937	23162	23167	O	-1	-1	0
family	PMC5005937	23168	23174	O	-1	-1	0
history	PMC5005937	23175	23182	O	-1	-1	0
)	PMC5005937	23182	23183	O	-1	-1	0
in	PMC5005937	23184	23186	O	-1	-1	0
that	PMC5005937	23187	23191	O	-1	-1	0
it	PMC5005937	23192	23194	O	-1	-1	0
captures	PMC5005937	23195	23203	O	-1	-1	0
more	PMC5005937	23204	23208	O	-1	-1	0
information	PMC5005937	23209	23220	O	-1	-1	0
on	PMC5005937	23221	23223	O	-1	-1	0
risk	PMC5005937	23224	23228	O	-1	-1	0
.	PMC5005937	23228	23229	O	-1	-1	0

After	PMC5005937	23230	23235	O	-1	-1	0
fitting	PMC5005937	23236	23243	O	-1	-1	0
the	PMC5005937	23244	23247	O	-1	-1	0
BOADICEA	PMC5005937	23248	23256	O	-1	-1	0
score	PMC5005937	23257	23262	O	-1	-1	0
,	PMC5005937	23262	23263	O	-1	-1	0
the	PMC5005937	23264	23267	O	-1	-1	0
strengths	PMC5005937	23268	23277	O	-1	-1	0
of	PMC5005937	23278	23280	O	-1	-1	0
the	PMC5005937	23281	23284	O	-1	-1	0
associations	PMC5005937	23285	23297	O	-1	-1	0
with	PMC5005937	23298	23302	O	-1	-1	0
the	PMC5005937	23303	23306	O	-1	-1	0
other	PMC5005937	23307	23312	O	-1	-1	0
two	PMC5005937	23313	23316	O	-1	-1	0
predictors	PMC5005937	23317	23327	O	-1	-1	0
were	PMC5005937	23328	23332	O	-1	-1	0
approximately	PMC5005937	23333	23346	O	-1	-1	0
halved	PMC5005937	23347	23353	O	-1	-1	0
,	PMC5005937	23353	23354	O	-1	-1	0
whereas	PMC5005937	23355	23362	O	-1	-1	0
the	PMC5005937	23363	23366	O	-1	-1	0
association	PMC5005937	23367	23378	O	-1	-1	0
with	PMC5005937	23379	23383	O	-1	-1	0
the	PMC5005937	23384	23387	O	-1	-1	0
BOADICEA	PMC5005937	23388	23396	O	-1	-1	0
score	PMC5005937	23397	23402	O	-1	-1	0
was	PMC5005937	23403	23406	O	-1	-1	0
virtually	PMC5005937	23407	23416	O	-1	-1	0
unchanged	PMC5005937	23417	23426	O	-1	-1	0
.	PMC5005937	23426	23427	O	-1	-1	0

Therefore	PMC5005937	23428	23437	O	-1	-1	0
,	PMC5005937	23437	23438	O	-1	-1	0
there	PMC5005937	23439	23444	O	-1	-1	0
is	PMC5005937	23445	23447	O	-1	-1	0
also	PMC5005937	23448	23452	O	-1	-1	0
scope	PMC5005937	23453	23458	O	-1	-1	0
for	PMC5005937	23459	23462	O	-1	-1	0
the	PMC5005937	23463	23466	O	-1	-1	0
BOADICEA	PMC5005937	23467	23475	O	-1	-1	0
model	PMC5005937	23476	23481	O	-1	-1	0
to	PMC5005937	23482	23484	O	-1	-1	0
be	PMC5005937	23485	23487	O	-1	-1	0
improved	PMC5005937	23488	23496	O	-1	-1	0
as	PMC5005937	23497	23499	O	-1	-1	0
a	PMC5005937	23500	23501	O	-1	-1	0
measure	PMC5005937	23502	23509	O	-1	-1	0
of	PMC5005937	23510	23512	O	-1	-1	0
FRP	PMC5005937	23513	23516	O	-1	-1	0
.	PMC5005937	23516	23517	O	-1	-1	0

Figure	PMC5005937	23518	23524	O	-1	-1	0
2	PMC5005937	23525	23526	O	-1	-1	0
shows	PMC5005937	23527	23532	O	-1	-1	0
the	PMC5005937	23533	23536	O	-1	-1	0
predicted	PMC5005937	23537	23546	O	-1	-1	0
remaining	PMC5005937	23547	23556	O	-1	-1	0
lifetime	PMC5005937	23557	23565	O	-1	-1	0
risk	PMC5005937	23566	23570	O	-1	-1	0
based	PMC5005937	23571	23576	O	-1	-1	0
on	PMC5005937	23577	23579	O	-1	-1	0
BOADICEA	PMC5005937	23580	23588	O	-1	-1	0
for	PMC5005937	23589	23592	O	-1	-1	0
the	PMC5005937	23593	23596	O	-1	-1	0
sub	PMC5005937	23597	23600	O	-1	-1	0
-	PMC5005937	23600	23601	O	-1	-1	0
cohort	PMC5005937	23601	23607	O	-1	-1	0
of	PMC5005937	23608	23610	O	-1	-1	0
women	PMC5005937	23611	23616	O	-1	-1	0
unaffected	PMC5005937	23617	23627	O	-1	-1	0
at	PMC5005937	23628	23630	O	-1	-1	0
baseline	PMC5005937	23631	23639	O	-1	-1	0
.	PMC5005937	23639	23640	O	-1	-1	0

This	PMC5005937	23641	23645	O	-1	-1	0
illustrates	PMC5005937	23646	23657	O	-1	-1	0
the	PMC5005937	23658	23661	O	-1	-1	0
large	PMC5005937	23662	23667	O	-1	-1	0
range	PMC5005937	23668	23673	O	-1	-1	0
in	PMC5005937	23674	23676	O	-1	-1	0
risk	PMC5005937	23677	23681	O	-1	-1	0
and	PMC5005937	23682	23685	O	-1	-1	0
therefore	PMC5005937	23686	23695	O	-1	-1	0
why	PMC5005937	23696	23699	O	-1	-1	0
ProF	PMC5005937	23700	23704	O	-1	-1	0
-	PMC5005937	23704	23705	O	-1	-1	0
SC	PMC5005937	23705	23707	O	-1	-1	0
can	PMC5005937	23708	23711	O	-1	-1	0
be	PMC5005937	23712	23714	O	-1	-1	0
used	PMC5005937	23715	23719	O	-1	-1	0
to	PMC5005937	23720	23722	O	-1	-1	0
develop	PMC5005937	23723	23730	O	-1	-1	0
risk	PMC5005937	23731	23735	O	-1	-1	0
models	PMC5005937	23736	23742	O	-1	-1	0
which	PMC5005937	23743	23748	O	-1	-1	0
consider	PMC5005937	23749	23757	O	-1	-1	0
modification	PMC5005937	23758	23770	O	-1	-1	0
of	PMC5005937	23771	23773	O	-1	-1	0
risk	PMC5005937	23774	23778	O	-1	-1	0
by	PMC5005937	23779	23781	O	-1	-1	0
underlying	PMC5005937	23782	23792	O	-1	-1	0
FRP	PMC5005937	23793	23796	O	-1	-1	0
for	PMC5005937	23797	23800	O	-1	-1	0
women	PMC5005937	23801	23806	O	-1	-1	0
across	PMC5005937	23807	23813	O	-1	-1	0
the	PMC5005937	23814	23817	O	-1	-1	0
risk	PMC5005937	23818	23822	O	-1	-1	0
continuum	PMC5005937	23823	23832	O	-1	-1	0
.	PMC5005937	23832	23833	O	-1	-1	0

These	PMC5005937	23834	23839	O	-1	-1	0
results	PMC5005937	23840	23847	O	-1	-1	0
suggest	PMC5005937	23848	23855	O	-1	-1	0
that	PMC5005937	23856	23860	O	-1	-1	0
the	PMC5005937	23861	23864	O	-1	-1	0
range	PMC5005937	23865	23870	O	-1	-1	0
of	PMC5005937	23871	23873	O	-1	-1	0
risk	PMC5005937	23874	23878	O	-1	-1	0
across	PMC5005937	23879	23885	O	-1	-1	0
ProfSC	PMC5005937	23886	23892	O	-1	-1	0
participants	PMC5005937	23893	23905	O	-1	-1	0
is	PMC5005937	23906	23908	O	-1	-1	0
large	PMC5005937	23909	23914	O	-1	-1	0
,	PMC5005937	23914	23915	O	-1	-1	0
which	PMC5005937	23916	23921	O	-1	-1	0
will	PMC5005937	23922	23926	O	-1	-1	0
be	PMC5005937	23927	23929	O	-1	-1	0
essential	PMC5005937	23930	23939	O	-1	-1	0
for	PMC5005937	23940	23943	O	-1	-1	0
prospectively	PMC5005937	23944	23957	O	-1	-1	0
validating	PMC5005937	23958	23968	O	-1	-1	0
many	PMC5005937	23969	23973	O	-1	-1	0
of	PMC5005937	23974	23976	O	-1	-1	0
the	PMC5005937	23977	23980	O	-1	-1	0
retrospective	PMC5005937	23981	23994	O	-1	-1	0
findings	PMC5005937	23995	24003	O	-1	-1	0
from	PMC5005937	24004	24008	O	-1	-1	0
our	PMC5005937	24009	24012	O	-1	-1	0
families	PMC5005937	24013	24021	O	-1	-1	0
,	PMC5005937	24021	24022	O	-1	-1	0
including	PMC5005937	24023	24032	O	-1	-1	0
the	PMC5005937	24033	24036	O	-1	-1	0
importance	PMC5005937	24037	24047	O	-1	-1	0
of	PMC5005937	24048	24050	O	-1	-1	0
biomarkers	PMC5005937	24051	24061	O	-1	-1	0
that	PMC5005937	24062	24066	O	-1	-1	0
change	PMC5005937	24067	24073	O	-1	-1	0
over	PMC5005937	24074	24078	O	-1	-1	0
the	PMC5005937	24079	24082	O	-1	-1	0
life	PMC5005937	24083	24087	O	-1	-1	0
course	PMC5005937	24088	24094	O	-1	-1	0
(	PMC5005937	24095	24096	O	-1	-1	0
such	PMC5005937	24096	24100	O	-1	-1	0
as	PMC5005937	24101	24103	O	-1	-1	0
DNA	PMC5005937	24104	24107	O	-1	-1	0
repair	PMC5005937	24108	24114	O	-1	-1	0
phenotype	PMC5005937	24115	24124	O	-1	-1	0
,	PMC5005937	24124	24125	O	-1	-1	0
telomere	PMC5005937	24126	24134	O	-1	-1	0
length	PMC5005937	24135	24141	O	-1	-1	0
,	PMC5005937	24141	24142	O	-1	-1	0
oxidative	PMC5005937	24143	24152	O	-1	-1	0
stress	PMC5005937	24153	24159	O	-1	-1	0
and	PMC5005937	24160	24163	O	-1	-1	0
DNA	PMC5005937	24164	24167	O	-1	-1	0
methylation	PMC5005937	24168	24179	O	-1	-1	0
markers	PMC5005937	24180	24187	O	-1	-1	0
)	PMC5005937	24187	24188	O	-1	-1	0
in	PMC5005937	24189	24191	O	-1	-1	0
high	PMC5005937	24192	24196	O	-1	-1	0
-	PMC5005937	24196	24197	O	-1	-1	0
risk	PMC5005937	24197	24201	O	-1	-1	0
women.37,38	PMC5005937	24202	24213	O	-1	-1	0

We	PMC5005937	24214	24216	O	-1	-1	0
have	PMC5005937	24217	24221	O	-1	-1	0
also	PMC5005937	24222	24226	O	-1	-1	0
investigated	PMC5005937	24227	24239	O	-1	-1	0
environmental	PMC5005937	24240	24253	O	-1	-1	0
modifiers	PMC5005937	24254	24263	O	-1	-1	0
of	PMC5005937	24264	24266	O	-1	-1	0
risk	PMC5005937	24267	24271	O	-1	-1	0
for	PMC5005937	24272	24275	O	-1	-1	0
carriers	PMC5005937	24276	24284	O	-1	-1	0
of	PMC5005937	24285	24287	O	-1	-1	0
BRCA1	PMC5005937	24288	24293	O	-1	-1	0
and	PMC5005937	24294	24297	O	-1	-1	0

BRCA2	PMC5005937	24298	24303	O	-1	-1	0
mutations	PMC5005937	24304	24313	O	-1	-1	0
using	PMC5005937	24314	24319	O	-1	-1	0
retrospective	PMC5005937	24320	24333	O	-1	-1	0
data	PMC5005937	24334	24338	O	-1	-1	0
,	PMC5005937	24338	24339	O	-1	-1	0
and	PMC5005937	24340	24343	O	-1	-1	0
found	PMC5005937	24344	24349	O	-1	-1	0
a	PMC5005937	24350	24351	O	-1	-1	0


	PMC5005937	24351	24353	O	-1	-1	0
positive	PMC5005937	24353	24361	O	-1	-1	0
association	PMC5005937	24362	24373	O	-1	-1	0
with	PMC5005937	24374	24378	O	-1	-1	0
smoking39	PMC5005937	24379	24388	O	-1	-1	0

but	PMC5005937	24389	24392	O	-1	-1	0
no	PMC5005937	24393	24395	O	-1	-1	0
association	PMC5005937	24396	24407	O	-1	-1	0
with	PMC5005937	24408	24412	O	-1	-1	0
alcohol	PMC5005937	24413	24420	O	-1	-1	0

intake,40	PMC5005937	24421	24430	O	-1	-1	0

oral	PMC5005937	24431	24435	O	-1	-1	0
contraceptive	PMC5005937	24436	24449	O	-1	-1	0
use41,42	PMC5005937	24450	24458	O	-1	-1	0
or	PMC5005937	24459	24461	O	-1	-1	0
medical	PMC5005937	24462	24469	O	-1	-1	0
diagnostic	PMC5005937	24470	24480	O	-1	-1	0
radiation.43	PMC5005937	24481	24493	O	-1	-1	0

These	PMC5005937	24494	24499	O	-1	-1	0
studies	PMC5005937	24500	24507	O	-1	-1	0
suggest	PMC5005937	24508	24515	O	-1	-1	0
that	PMC5005937	24516	24520	O	-1	-1	0
it	PMC5005937	24521	24523	O	-1	-1	0
might	PMC5005937	24524	24529	O	-1	-1	0
be	PMC5005937	24530	24532	O	-1	-1	0
misleading	PMC5005937	24533	24543	O	-1	-1	0
to	PMC5005937	24544	24546	O	-1	-1	0
extrapolate	PMC5005937	24547	24558	O	-1	-1	0
findings	PMC5005937	24559	24567	O	-1	-1	0
about	PMC5005937	24568	24573	O	-1	-1	0
cancer	PMC5005937	24574	24580	O	-1	-1	0
risk	PMC5005937	24581	24585	O	-1	-1	0
factors	PMC5005937	24586	24593	O	-1	-1	0
from	PMC5005937	24594	24598	O	-1	-1	0
studying	PMC5005937	24599	24607	O	-1	-1	0
the	PMC5005937	24608	24611	O	-1	-1	0
general	PMC5005937	24612	24619	O	-1	-1	0
population	PMC5005937	24620	24630	O	-1	-1	0
to	PMC5005937	24631	24633	O	-1	-1	0
BRCA1	PMC5005937	24634	24639	O	-1	-1	0
and	PMC5005937	24640	24643	O	-1	-1	0

BRCA2	PMC5005937	24644	24649	O	-1	-1	0
mutation	PMC5005937	24650	24658	O	-1	-1	0
carriers	PMC5005937	24659	24667	O	-1	-1	0
or	PMC5005937	24668	24670	O	-1	-1	0
other	PMC5005937	24671	24676	O	-1	-1	0
sub	PMC5005937	24677	24680	O	-1	-1	0
-	PMC5005937	24680	24681	O	-1	-1	0
populations	PMC5005937	24681	24692	O	-1	-1	0
of	PMC5005937	24693	24695	O	-1	-1	0
women	PMC5005937	24696	24701	O	-1	-1	0
at	PMC5005937	24702	24704	O	-1	-1	0
increased	PMC5005937	24705	24714	O	-1	-1	0
familial	PMC5005937	24715	24723	O	-1	-1	0
/	PMC5005937	24723	24724	O	-1	-1	0
genetic	PMC5005937	24724	24731	O	-1	-1	0
risk	PMC5005937	24732	24736	O	-1	-1	0
.	PMC5005937	24736	24737	O	-1	-1	0

We	PMC5005937	24738	24740	O	-1	-1	0
are	PMC5005937	24741	24744	O	-1	-1	0
currently	PMC5005937	24745	24754	O	-1	-1	0
working	PMC5005937	24755	24762	O	-1	-1	0
to	PMC5005937	24763	24765	O	-1	-1	0
prospectively	PMC5005937	24766	24779	O	-1	-1	0
validate	PMC5005937	24780	24788	O	-1	-1	0
these	PMC5005937	24789	24794	O	-1	-1	0
finding	PMC5005937	24795	24802	O	-1	-1	0
using	PMC5005937	24803	24808	O	-1	-1	0
ProFSC	PMC5005937	24809	24815	O	-1	-1	0
,	PMC5005937	24815	24816	O	-1	-1	0
with	PMC5005937	24817	24821	O	-1	-1	0
the	PMC5005937	24822	24825	O	-1	-1	0
aim	PMC5005937	24826	24829	O	-1	-1	0
of	PMC5005937	24830	24832	O	-1	-1	0
identifying	PMC5005937	24833	24844	O	-1	-1	0
modifiable	PMC5005937	24845	24855	O	-1	-1	0
risk	PMC5005937	24856	24860	O	-1	-1	0
factors	PMC5005937	24861	24868	O	-1	-1	0
for	PMC5005937	24869	24872	O	-1	-1	0
women	PMC5005937	24873	24878	O	-1	-1	0
across	PMC5005937	24879	24885	O	-1	-1	0
the	PMC5005937	24886	24889	O	-1	-1	0
full	PMC5005937	24890	24894	O	-1	-1	0
spectrum	PMC5005937	24895	24903	O	-1	-1	0
of	PMC5005937	24904	24906	O	-1	-1	0
risk.44	PMC5005937	24907	24914	O	-1	-1	0

A	PMC5005937	24915	24916	O	-1	-1	0
key	PMC5005937	24917	24920	O	-1	-1	0
goal	PMC5005937	24921	24925	O	-1	-1	0
of	PMC5005937	24926	24928	O	-1	-1	0
ProF	PMC5005937	24929	24933	O	-1	-1	0
-	PMC5005937	24933	24934	O	-1	-1	0
SC	PMC5005937	24934	24936	O	-1	-1	0
is	PMC5005937	24937	24939	O	-1	-1	0
to	PMC5005937	24940	24942	O	-1	-1	0
validate	PMC5005937	24943	24951	O	-1	-1	0
and	PMC5005937	24952	24955	O	-1	-1	0
extend	PMC5005937	24956	24962	O	-1	-1	0
risk	PMC5005937	24963	24967	O	-1	-1	0
assessment	PMC5005937	24968	24978	O	-1	-1	0
models	PMC5005937	24979	24985	O	-1	-1	0
that	PMC5005937	24986	24990	O	-1	-1	0
predict	PMC5005937	24991	24998	O	-1	-1	0
breast	PMC5005937	24999	25005	O	-1	-1	0
cancer	PMC5005937	25006	25012	O	-1	-1	0
risk	PMC5005937	25013	25017	O	-1	-1	0
and	PMC5005937	25018	25021	O	-1	-1	0
are	PMC5005937	25022	25025	O	-1	-1	0
used	PMC5005937	25026	25030	O	-1	-1	0
in	PMC5005937	25031	25033	O	-1	-1	0
clinics	PMC5005937	25034	25041	O	-1	-1	0
and	PMC5005937	25042	25045	O	-1	-1	0
elsewhere	PMC5005937	25046	25055	O	-1	-1	0
.	PMC5005937	25055	25056	O	-1	-1	0

Most	PMC5005937	25057	25061	O	-1	-1	0
models	PMC5005937	25062	25068	O	-1	-1	0
,	PMC5005937	25068	25069	O	-1	-1	0
such	PMC5005937	25070	25074	O	-1	-1	0
as	PMC5005937	25075	25077	O	-1	-1	0
the	PMC5005937	25078	25081	O	-1	-1	0
BCRAT	PMC5005937	25082	25087	O	-1	-1	0
or	PMC5005937	25088	25090	O	-1	-1	0
Gail	PMC5005937	25091	25095	O	-1	-1	0
model,45	PMC5005937	25096	25104	O	-1	-1	0
have	PMC5005937	25105	25109	O	-1	-1	0
been	PMC5005937	25110	25114	O	-1	-1	0
developed	PMC5005937	25115	25124	O	-1	-1	0
for	PMC5005937	25125	25128	O	-1	-1	0
average	PMC5005937	25129	25136	O	-1	-1	0
risk	PMC5005937	25137	25141	O	-1	-1	0
populations	PMC5005937	25142	25153	O	-1	-1	0
and	PMC5005937	25154	25157	O	-1	-1	0
do	PMC5005937	25158	25160	O	-1	-1	0
not	PMC5005937	25161	25164	O	-1	-1	0
incorporate	PMC5005937	25165	25176	O	-1	-1	0
extensive	PMC5005937	25177	25186	O	-1	-1	0
data	PMC5005937	25187	25191	O	-1	-1	0
on	PMC5005937	25192	25194	O	-1	-1	0
family	PMC5005937	25195	25201	O	-1	-1	0
history	PMC5005937	25202	25209	O	-1	-1	0
of	PMC5005937	25210	25212	O	-1	-1	0
breast	PMC5005937	25213	25219	O	-1	-1	0
cancer	PMC5005937	25220	25226	O	-1	-1	0
or	PMC5005937	25227	25229	O	-1	-1	0
BRCA1	PMC5005937	25230	25235	O	-1	-1	0
and	PMC5005937	25236	25239	O	-1	-1	0
BRCA2	PMC5005937	25240	25245	O	-1	-1	0
mutation	PMC5005937	25246	25254	O	-1	-1	0
status	PMC5005937	25255	25261	O	-1	-1	0
.	PMC5005937	25261	25262	O	-1	-1	0

Exceptions	PMC5005937	25263	25273	O	-1	-1	0
are	PMC5005937	25274	25277	O	-1	-1	0
the	PMC5005937	25278	25281	O	-1	-1	0
International	PMC5005937	25282	25295	O	-1	-1	0
Breast	PMC5005937	25296	25302	O	-1	-1	0
Cancer	PMC5005937	25303	25309	O	-1	-1	0
Intervention	PMC5005937	25310	25322	O	-1	-1	0
Study	PMC5005937	25323	25328	O	-1	-1	0
(	PMC5005937	25329	25330	O	-1	-1	0
IBIS	PMC5005937	25330	25334	O	-1	-1	0
,	PMC5005937	25334	25335	O	-1	-1	0
or	PMC5005937	25336	25338	O	-1	-1	0
the	PMC5005937	25339	25342	O	-1	-1	0
Tyrer	PMC5005937	25343	25348	O	-1	-1	0
-	PMC5005937	25348	25349	O	-1	-1	0
Cuzick	PMC5005937	25349	25355	O	-1	-1	0
model)46	PMC5005937	25356	25364	O	-1	-1	0
and	PMC5005937	25365	25368	O	-1	-1	0
the	PMC5005937	25369	25372	O	-1	-1	0
BOADICEA.47	PMC5005937	25373	25384	O	-1	-1	0

Using	PMC5005937	25385	25390	O	-1	-1	0
data	PMC5005937	25391	25395	O	-1	-1	0
from	PMC5005937	25396	25400	O	-1	-1	0
the	PMC5005937	25401	25404	O	-1	-1	0
New	PMC5005937	25405	25408	O	-1	-1	0
York	PMC5005937	25409	25413	O	-1	-1	0
site	PMC5005937	25414	25418	O	-1	-1	0
of	PMC5005937	25419	25421	O	-1	-1	0
the	PMC5005937	25422	25425	O	-1	-1	0
BCFR	PMC5005937	25426	25430	O	-1	-1	0
,	PMC5005937	25430	25431	O	-1	-1	0
we	PMC5005937	25432	25434	O	-1	-1	0
have	PMC5005937	25435	25439	O	-1	-1	0
observed	PMC5005937	25440	25448	O	-1	-1	0
large	PMC5005937	25449	25454	O	-1	-1	0
discordances	PMC5005937	25455	25467	O	-1	-1	0
across	PMC5005937	25468	25474	O	-1	-1	0
models,48,50	PMC5005937	25475	25487	O	-1	-1	0
for	PMC5005937	25488	25491	O	-1	-1	0
example	PMC5005937	25492	25499	O	-1	-1	0
predictions	PMC5005937	25500	25511	O	-1	-1	0
from	PMC5005937	25512	25516	O	-1	-1	0
the	PMC5005937	25517	25520	O	-1	-1	0
IBIS	PMC5005937	25521	25525	O	-1	-1	0
model	PMC5005937	25526	25531	O	-1	-1	0
were	PMC5005937	25532	25536	O	-1	-1	0
generally	PMC5005937	25537	25546	O	-1	-1	0
closer	PMC5005937	25547	25553	O	-1	-1	0
to	PMC5005937	25554	25556	O	-1	-1	0
the	PMC5005937	25557	25560	O	-1	-1	0
observed	PMC5005937	25561	25569	O	-1	-1	0
number	PMC5005937	25570	25576	O	-1	-1	0
of	PMC5005937	25577	25579	O	-1	-1	0
events	PMC5005937	25580	25586	O	-1	-1	0
than	PMC5005937	25587	25591	O	-1	-1	0
predictions	PMC5005937	25592	25603	O	-1	-1	0
using	PMC5005937	25604	25609	O	-1	-1	0
BCRAT	PMC5005937	25610	25615	O	-1	-1	0
even	PMC5005937	25616	25620	O	-1	-1	0
for	PMC5005937	25621	25624	O	-1	-1	0
the	PMC5005937	25625	25628	O	-1	-1	0
women	PMC5005937	25629	25634	O	-1	-1	0
considered	PMC5005937	25635	25645	O	-1	-1	0
to	PMC5005937	25646	25648	O	-1	-1	0
be	PMC5005937	25649	25651	O	-1	-1	0
at	PMC5005937	25652	25654	O	-1	-1	0
average	PMC5005937	25655	25662	O	-1	-1	0
risk	PMC5005937	25663	25667	O	-1	-1	0

(	PMC5005937	25668	25669	O	-1	-1	0
e.g.	PMC5005937	25669	25673	O	-1	-1	0
those	PMC5005937	25674	25679	O	-1	-1	0
with	PMC5005937	25680	25684	O	-1	-1	0
no	PMC5005937	25685	25687	O	-1	-1	0
family	PMC5005937	25688	25694	O	-1	-1	0
history	PMC5005937	25695	25702	O	-1	-1	0
and	PMC5005937	25703	25706	O	-1	-1	0
no	PMC5005937	25707	25709	O	-1	-1	0
BRCA1	PMC5005937	25710	25715	O	-1	-1	0
or	PMC5005937	25716	25718	O	-1	-1	0
BRCA2	PMC5005937	25719	25724	O	-1	-1	0
mutation).48	PMC5005937	25725	25737	O	-1	-1	0

Using	PMC5005937	25738	25743	O	-1	-1	0
data	PMC5005937	25744	25748	O	-1	-1	0
from	PMC5005937	25749	25753	O	-1	-1	0
the	PMC5005937	25754	25757	O	-1	-1	0
Australian	PMC5005937	25758	25768	O	-1	-1	0
site	PMC5005937	25769	25773	O	-1	-1	0
of	PMC5005937	25774	25776	O	-1	-1	0
the	PMC5005937	25777	25780	O	-1	-1	0
BCFR	PMC5005937	25781	25785	O	-1	-1	0
,	PMC5005937	25785	25786	O	-1	-1	0
we	PMC5005937	25787	25789	O	-1	-1	0
have	PMC5005937	25790	25794	O	-1	-1	0
shown	PMC5005937	25795	25800	O	-1	-1	0
that	PMC5005937	25801	25805	O	-1	-1	0
BOADICEA	PMC5005937	25806	25814	O	-1	-1	0
is	PMC5005937	25815	25817	O	-1	-1	0
well	PMC5005937	25818	25822	O	-1	-1	0
calibrated	PMC5005937	25823	25833	O	-1	-1	0
and	PMC5005937	25834	25837	O	-1	-1	0
has	PMC5005937	25838	25841	O	-1	-1	0
good	PMC5005937	25842	25846	O	-1	-1	0
discrimination	PMC5005937	25847	25861	O	-1	-1	0
and	PMC5005937	25862	25865	O	-1	-1	0
accuracy	PMC5005937	25866	25874	O	-1	-1	0
at	PMC5005937	25875	25877	O	-1	-1	0
the	PMC5005937	25878	25881	O	-1	-1	0
individual	PMC5005937	25882	25892	O	-1	-1	0

level.49	PMC5005937	25893	25901	O	-1	-1	0


	PMC5005937	25901	25903	O	-1	-1	0
690	PMC5005937	25903	25906	O	-1	-1	0


	PMC5005937	25906	25908	O	-1	-1	0

International	PMC5005937	25908	25921	O	-1	-1	0
Journal	PMC5005937	25922	25929	O	-1	-1	0
of	PMC5005937	25930	25932	O	-1	-1	0
Epidemiology	PMC5005937	25933	25945	O	-1	-1	0
,	PMC5005937	25945	25946	O	-1	-1	0
2016	PMC5005937	25947	25951	O	-1	-1	0
,	PMC5005937	25951	25952	O	-1	-1	0
Vol	PMC5005937	25953	25956	O	-1	-1	0
.	PMC5005937	25956	25957	O	-1	-1	0

45	PMC5005937	25958	25960	O	-1	-1	0
,	PMC5005937	25960	25961	O	-1	-1	0

No	PMC5005937	25962	25964	O	-1	-1	0
.	PMC5005937	25964	25965	O	-1	-1	0
3	PMC5005937	25966	25967	O	-1	-1	0


	PMC5005937	25967	25969	O	-1	-1	0

What	PMC5005937	25969	25973	O	-1	-1	0
are	PMC5005937	25974	25977	O	-1	-1	0
the	PMC5005937	25978	25981	O	-1	-1	0
main	PMC5005937	25982	25986	O	-1	-1	0
strengths	PMC5005937	25987	25996	O	-1	-1	0
and	PMC5005937	25997	26000	O	-1	-1	0
weaknesses	PMC5005937	26001	26011	O	-1	-1	0
?	PMC5005937	26011	26012	O	-1	-1	0


	PMC5005937	26012	26014	O	-1	-1	0

identified	PMC5005937	26014	26024	O	-1	-1	0
1093	PMC5005937	26025	26029	O	-1	-1	0
and	PMC5005937	26030	26033	O	-1	-1	0
1252	PMC5005937	26034	26038	O	-1	-1	0
women	PMC5005937	26039	26044	O	-1	-1	0
with	PMC5005937	26045	26049	O	-1	-1	0
incident	PMC5005937	26050	26058	O	-1	-1	0
breast	PMC5005937	26059	26065	O	-1	-1	0


	PMC5005937	26065	26067	O	-1	-1	0

As	PMC5005937	26067	26069	O	-1	-1	0
shown	PMC5005937	26070	26075	O	-1	-1	0
above	PMC5005937	26076	26081	O	-1	-1	0
,	PMC5005937	26081	26082	O	-1	-1	0
a	PMC5005937	26083	26084	O	-1	-1	0
family	PMC5005937	26085	26091	O	-1	-1	0
-	PMC5005937	26091	26092	O	-1	-1	0
based	PMC5005937	26092	26097	O	-1	-1	0
cohort	PMC5005937	26098	26104	O	-1	-1	0
over	PMC5005937	26105	26109	O	-1	-1	0
-	PMC5005937	26109	26110	O	-1	-1	0
sampled	PMC5005937	26110	26117	O	-1	-1	0
for	PMC5005937	26118	26121	O	-1	-1	0
increased	PMC5005937	26122	26131	O	-1	-1	0
familial	PMC5005937	26132	26140	O	-1	-1	0
risk	PMC5005937	26141	26145	O	-1	-1	0
has	PMC5005937	26146	26149	O	-1	-1	0
many	PMC5005937	26150	26154	O	-1	-1	0
strengths	PMC5005937	26155	26164	O	-1	-1	0
including	PMC5005937	26165	26174	O	-1	-1	0
:	PMC5005937	26174	26175	O	-1	-1	0
(	PMC5005937	26176	26177	O	-1	-1	0
i	PMC5005937	26177	26178	O	-1	-1	0
)	PMC5005937	26178	26179	O	-1	-1	0
enrichment	PMC5005937	26180	26190	O	-1	-1	0
on	PMC5005937	26191	26193	O	-1	-1	0
outcome	PMC5005937	26194	26201	O	-1	-1	0
so	PMC5005937	26202	26204	O	-1	-1	0
that	PMC5005937	26205	26209	O	-1	-1	0
fewer	PMC5005937	26210	26215	O	-1	-1	0
individuals	PMC5005937	26216	26227	O	-1	-1	0
need	PMC5005937	26228	26232	O	-1	-1	0
be	PMC5005937	26233	26235	O	-1	-1	0
followed	PMC5005937	26236	26244	O	-1	-1	0
,	PMC5005937	26244	26245	O	-1	-1	0
and/or	PMC5005937	26246	26252	O	-1	-1	0
for	PMC5005937	26253	26256	O	-1	-1	0
a	PMC5005937	26257	26258	O	-1	-1	0
shorter	PMC5005937	26259	26266	O	-1	-1	0
time	PMC5005937	26267	26271	O	-1	-1	0
,	PMC5005937	26271	26272	O	-1	-1	0
in	PMC5005937	26273	26275	O	-1	-1	0
order	PMC5005937	26276	26281	O	-1	-1	0
to	PMC5005937	26282	26284	O	-1	-1	0
have	PMC5005937	26285	26289	O	-1	-1	0
the	PMC5005937	26290	26293	O	-1	-1	0
same	PMC5005937	26294	26298	O	-1	-1	0
statistical	PMC5005937	26299	26310	O	-1	-1	0
power	PMC5005937	26311	26316	O	-1	-1	0
as	PMC5005937	26317	26319	O	-1	-1	0
a	PMC5005937	26320	26321	O	-1	-1	0
cohort	PMC5005937	26322	26328	O	-1	-1	0
unselected	PMC5005937	26329	26339	O	-1	-1	0
for	PMC5005937	26340	26343	O	-1	-1	0
risk	PMC5005937	26344	26348	O	-1	-1	0
;	PMC5005937	26348	26349	O	-1	-1	0
(	PMC5005937	26350	26351	O	-1	-1	0
ii	PMC5005937	26351	26353	O	-1	-1	0
)	PMC5005937	26353	26354	O	-1	-1	0

ensuring	PMC5005937	26355	26363	O	-1	-1	0
the	PMC5005937	26364	26367	O	-1	-1	0
cohort	PMC5005937	26368	26374	O	-1	-1	0
covers	PMC5005937	26375	26381	O	-1	-1	0
a	PMC5005937	26382	26383	O	-1	-1	0
large	PMC5005937	26384	26389	O	-1	-1	0
range	PMC5005937	26390	26395	O	-1	-1	0
of	PMC5005937	26396	26398	O	-1	-1	0
risk	PMC5005937	26399	26403	O	-1	-1	0
;	PMC5005937	26403	26404	O	-1	-1	0

(	PMC5005937	26405	26406	O	-1	-1	0
iii	PMC5005937	26406	26409	O	-1	-1	0
)	PMC5005937	26409	26410	O	-1	-1	0
ability	PMC5005937	26411	26418	O	-1	-1	0
to	PMC5005937	26419	26421	O	-1	-1	0
identify	PMC5005937	26422	26430	O	-1	-1	0
environmental	PMC5005937	26431	26444	O	-1	-1	0
and	PMC5005937	26445	26448	O	-1	-1	0
genetic	PMC5005937	26449	26456	O	-1	-1	0
modifiers	PMC5005937	26457	26466	O	-1	-1	0
of	PMC5005937	26467	26469	O	-1	-1	0
risk	PMC5005937	26470	26474	O	-1	-1	0
for	PMC5005937	26475	26478	O	-1	-1	0
women	PMC5005937	26479	26484	O	-1	-1	0
at	PMC5005937	26485	26487	O	-1	-1	0
higher	PMC5005937	26488	26494	O	-1	-1	0
than	PMC5005937	26495	26499	O	-1	-1	0
average	PMC5005937	26500	26507	O	-1	-1	0
risk	PMC5005937	26508	26512	O	-1	-1	0
;	PMC5005937	26512	26513	O	-1	-1	0
and	PMC5005937	26514	26517	O	-1	-1	0
(	PMC5005937	26518	26519	O	-1	-1	0
iv	PMC5005937	26519	26521	O	-1	-1	0
)	PMC5005937	26521	26522	O	-1	-1	0
better	PMC5005937	26523	26529	O	-1	-1	0
retention	PMC5005937	26530	26539	O	-1	-1	0
through	PMC5005937	26540	26547	O	-1	-1	0
having	PMC5005937	26548	26554	O	-1	-1	0
multiple	PMC5005937	26555	26563	O	-1	-1	0
family	PMC5005937	26564	26570	O	-1	-1	0
contacts	PMC5005937	26571	26579	O	-1	-1	0
.	PMC5005937	26579	26580	O	-1	-1	0

From	PMC5005937	26581	26585	O	-1	-1	0
a	PMC5005937	26586	26587	O	-1	-1	0
practical	PMC5005937	26588	26597	O	-1	-1	0
perspective	PMC5005937	26598	26609	O	-1	-1	0
,	PMC5005937	26609	26610	O	-1	-1	0
however	PMC5005937	26611	26618	O	-1	-1	0
,	PMC5005937	26618	26619	O	-1	-1	0
family	PMC5005937	26620	26626	O	-1	-1	0
studies	PMC5005937	26627	26634	O	-1	-1	0
can	PMC5005937	26635	26638	O	-1	-1	0
be	PMC5005937	26639	26641	O	-1	-1	0
challenging	PMC5005937	26642	26653	O	-1	-1	0
because	PMC5005937	26654	26661	O	-1	-1	0
additional	PMC5005937	26662	26672	O	-1	-1	0
layers	PMC5005937	26673	26679	O	-1	-1	0
of	PMC5005937	26680	26682	O	-1	-1	0
protocol	PMC5005937	26683	26691	O	-1	-1	0
and	PMC5005937	26692	26695	O	-1	-1	0
privacy	PMC5005937	26696	26703	O	-1	-1	0
need	PMC5005937	26704	26708	O	-1	-1	0
to	PMC5005937	26709	26711	O	-1	-1	0
be	PMC5005937	26712	26714	O	-1	-1	0
considered	PMC5005937	26715	26725	O	-1	-1	0
.	PMC5005937	26725	26726	O	-1	-1	0

Care	PMC5005937	26727	26731	O	-1	-1	0
also	PMC5005937	26732	26736	O	-1	-1	0
has	PMC5005937	26737	26740	O	-1	-1	0
to	PMC5005937	26741	26743	O	-1	-1	0
be	PMC5005937	26744	26746	O	-1	-1	0
taken	PMC5005937	26747	26752	O	-1	-1	0
to	PMC5005937	26753	26755	O	-1	-1	0
ensure	PMC5005937	26756	26762	O	-1	-1	0
that	PMC5005937	26763	26767	O	-1	-1	0
information	PMC5005937	26768	26779	O	-1	-1	0
is	PMC5005937	26780	26782	O	-1	-1	0
not	PMC5005937	26783	26786	O	-1	-1	0
inadvertently	PMC5005937	26787	26800	O	-1	-1	0
passed	PMC5005937	26801	26807	O	-1	-1	0
to	PMC5005937	26808	26810	O	-1	-1	0
other	PMC5005937	26811	26816	O	-1	-1	0
family	PMC5005937	26817	26823	O	-1	-1	0
members	PMC5005937	26824	26831	O	-1	-1	0
.	PMC5005937	26831	26832	O	-1	-1	0

These	PMC5005937	26833	26838	O	-1	-1	0
issues	PMC5005937	26839	26845	O	-1	-1	0
,	PMC5005937	26845	26846	O	-1	-1	0
however	PMC5005937	26847	26854	O	-1	-1	0
,	PMC5005937	26854	26855	O	-1	-1	0
can	PMC5005937	26856	26859	O	-1	-1	0
be	PMC5005937	26860	26862	O	-1	-1	0
handled	PMC5005937	26863	26870	O	-1	-1	0
through	PMC5005937	26871	26878	O	-1	-1	0
study	PMC5005937	26879	26884	O	-1	-1	0
protocols	PMC5005937	26885	26894	O	-1	-1	0
and	PMC5005937	26895	26898	O	-1	-1	0
training	PMC5005937	26899	26907	O	-1	-1	0
,	PMC5005937	26907	26908	O	-1	-1	0
and	PMC5005937	26909	26912	O	-1	-1	0
we	PMC5005937	26913	26915	O	-1	-1	0
strongly	PMC5005937	26916	26924	O	-1	-1	0
believe	PMC5005937	26925	26932	O	-1	-1	0
that	PMC5005937	26933	26937	O	-1	-1	0
the	PMC5005937	26938	26941	O	-1	-1	0
benefits	PMC5005937	26942	26950	O	-1	-1	0
of	PMC5005937	26951	26953	O	-1	-1	0
a	PMC5005937	26954	26955	O	-1	-1	0
family	PMC5005937	26956	26962	O	-1	-1	0
cohort	PMC5005937	26963	26969	O	-1	-1	0
far	PMC5005937	26970	26973	O	-1	-1	0
outweigh	PMC5005937	26974	26982	O	-1	-1	0
its	PMC5005937	26983	26986	O	-1	-1	0
limitations	PMC5005937	26987	26998	O	-1	-1	0
and	PMC5005937	26999	27002	O	-1	-1	0
that	PMC5005937	27003	27007	O	-1	-1	0
this	PMC5005937	27008	27012	O	-1	-1	0
design	PMC5005937	27013	27019	O	-1	-1	0
should	PMC5005937	27020	27026	O	-1	-1	0
be	PMC5005937	27027	27029	O	-1	-1	0
considered	PMC5005937	27030	27040	O	-1	-1	0
when	PMC5005937	27041	27045	O	-1	-1	0
conducting	PMC5005937	27046	27056	O	-1	-1	0
aetiological	PMC5005937	27057	27069	O	-1	-1	0
research	PMC5005937	27070	27078	O	-1	-1	0
focused	PMC5005937	27079	27086	O	-1	-1	0
on	PMC5005937	27087	27089	O	-1	-1	0
environmental	PMC5005937	27090	27103	O	-1	-1	0
modifiers	PMC5005937	27104	27113	O	-1	-1	0
across	PMC5005937	27114	27120	O	-1	-1	0
the	PMC5005937	27121	27124	O	-1	-1	0
risk	PMC5005937	27125	27129	O	-1	-1	0
spectrum	PMC5005937	27130	27138	O	-1	-1	0
.	PMC5005937	27138	27139	O	-1	-1	0


	PMC5005937	27139	27141	O	-1	-1	0

Can	PMC5005937	27141	27144	O	-1	-1	0
I	PMC5005937	27145	27146	O	-1	-1	0
use	PMC5005937	27147	27150	O	-1	-1	0
the	PMC5005937	27151	27154	O	-1	-1	0
data	PMC5005937	27155	27159	O	-1	-1	0
?	PMC5005937	27159	27160	O	-1	-1	0

Where	PMC5005937	27161	27166	O	-1	-1	0
can	PMC5005937	27167	27170	O	-1	-1	0
I	PMC5005937	27171	27172	O	-1	-1	0
find	PMC5005937	27173	27177	O	-1	-1	0
out	PMC5005937	27178	27181	O	-1	-1	0
more	PMC5005937	27182	27186	O	-1	-1	0
?	PMC5005937	27186	27187	O	-1	-1	0

For	PMC5005937	27188	27191	O	-1	-1	0
information	PMC5005937	27192	27203	O	-1	-1	0
on	PMC5005937	27204	27206	O	-1	-1	0
how	PMC5005937	27207	27210	O	-1	-1	0
to	PMC5005937	27211	27213	O	-1	-1	0
collaborate	PMC5005937	27214	27225	O	-1	-1	0
with	PMC5005937	27226	27230	O	-1	-1	0
the	PMC5005937	27231	27234	O	-1	-1	0
ProF	PMC5005937	27235	27239	O	-1	-1	0
-	PMC5005937	27239	27240	O	-1	-1	0
SC	PMC5005937	27240	27242	O	-1	-1	0
cohort	PMC5005937	27243	27249	O	-1	-1	0
in	PMC5005937	27250	27252	O	-1	-1	0
making	PMC5005937	27253	27259	O	-1	-1	0
further	PMC5005937	27260	27267	O	-1	-1	0
use	PMC5005937	27268	27271	O	-1	-1	0
of	PMC5005937	27272	27274	O	-1	-1	0
the	PMC5005937	27275	27278	O	-1	-1	0
data	PMC5005937	27279	27283	O	-1	-1	0
and	PMC5005937	27284	27287	O	-1	-1	0
resources	PMC5005937	27288	27297	O	-1	-1	0
,	PMC5005937	27297	27298	O	-1	-1	0
and	PMC5005937	27299	27302	O	-1	-1	0
also	PMC5005937	27303	27307	O	-1	-1	0
with	PMC5005937	27308	27312	O	-1	-1	0
the	PMC5005937	27313	27316	O	-1	-1	0
BCFR	PMC5005937	27317	27321	O	-1	-1	0
,	PMC5005937	27321	27322	O	-1	-1	0
please	PMC5005937	27323	27329	O	-1	-1	0
see	PMC5005937	27330	27333	O	-1	-1	0
[	PMC5005937	27334	27335	O	-1	-1	0
http://www.bcfamilyregistry.org/	PMC5005937	27335	27367	O	-1	-1	0
]	PMC5005937	27367	27368	O	-1	-1	0
.	PMC5005937	27368	27369	O	-1	-1	0

For	PMC5005937	27370	27373	O	-1	-1	0
access	PMC5005937	27374	27380	O	-1	-1	0
to	PMC5005937	27381	27383	O	-1	-1	0
kConFab	PMC5005937	27384	27391	O	-1	-1	0
resources	PMC5005937	27392	27401	O	-1	-1	0
,	PMC5005937	27401	27402	O	-1	-1	0
see	PMC5005937	27403	27406	O	-1	-1	0
[	PMC5005937	27407	27408	O	-1	-1	0
www	PMC5005937	27408	27411	O	-1	-1	0
.	PMC5005937	27411	27412	O	-1	-1	0
kconfab.org	PMC5005937	27413	27424	O	-1	-1	0
]	PMC5005937	27424	27425	O	-1	-1	0
.	PMC5005937	27425	27426	O	-1	-1	0

Profile	PMC5005937	27427	27434	O	-1	-1	0
in	PMC5005937	27435	27437	O	-1	-1	0
a	PMC5005937	27438	27439	O	-1	-1	0
nutshell	PMC5005937	27440	27448	O	-1	-1	0

•	PMC5005937	27449	27450	O	-1	-1	0
ProF	PMC5005937	27451	27455	O	-1	-1	0
-	PMC5005937	27455	27456	O	-1	-1	0
SC	PMC5005937	27456	27458	O	-1	-1	0
is	PMC5005937	27459	27461	O	-1	-1	0
a	PMC5005937	27462	27463	O	-1	-1	0
prospective	PMC5005937	27464	27475	O	-1	-1	0
cohort	PMC5005937	27476	27482	O	-1	-1	0
study	PMC5005937	27483	27488	O	-1	-1	0
of	PMC5005937	27489	27491	O	-1	-1	0
31	PMC5005937	27492	27494	O	-1	-1	0
640	PMC5005937	27495	27498	O	-1	-1	0


	PMC5005937	27498	27500	O	-1	-1	0
women	PMC5005937	27500	27505	O	-1	-1	0
from	PMC5005937	27506	27510	O	-1	-1	0
11	PMC5005937	27511	27513	O	-1	-1	0
171	PMC5005937	27514	27517	O	-1	-1	0
families	PMC5005937	27518	27526	O	-1	-1	0
ascertained	PMC5005937	27527	27538	O	-1	-1	0
through	PMC5005937	27539	27546	O	-1	-1	0
population	PMC5005937	27547	27557	O	-1	-1	0
-	PMC5005937	27557	27558	O	-1	-1	0
based	PMC5005937	27558	27563	O	-1	-1	0
and	PMC5005937	27564	27567	O	-1	-1	0
clinic	PMC5005937	27568	27574	O	-1	-1	0
-	PMC5005937	27574	27575	O	-1	-1	0
based	PMC5005937	27575	27580	O	-1	-1	0
sampling	PMC5005937	27581	27589	O	-1	-1	0
and	PMC5005937	27590	27593	O	-1	-1	0
who	PMC5005937	27594	27597	O	-1	-1	0
cover	PMC5005937	27598	27603	O	-1	-1	0
the	PMC5005937	27604	27607	O	-1	-1	0
full	PMC5005937	27608	27612	O	-1	-1	0
spectrum	PMC5005937	27613	27621	O	-1	-1	0
of	PMC5005937	27622	27624	O	-1	-1	0
familial	PMC5005937	27625	27633	O	-1	-1	0
risk	PMC5005937	27634	27638	O	-1	-1	0
.	PMC5005937	27638	27639	O	-1	-1	0

The	PMC5005937	27640	27643	O	-1	-1	0
study	PMC5005937	27644	27649	O	-1	-1	0
is	PMC5005937	27650	27652	O	-1	-1	0
designed	PMC5005937	27653	27661	O	-1	-1	0
to	PMC5005937	27662	27664	O	-1	-1	0
use	PMC5005937	27665	27668	O	-1	-1	0
pedigree	PMC5005937	27669	27677	O	-1	-1	0
and	PMC5005937	27678	27681	O	-1	-1	0
genetic	PMC5005937	27682	27689	O	-1	-1	0
data	PMC5005937	27690	27694	O	-1	-1	0
to	PMC5005937	27695	27697	O	-1	-1	0
predict	PMC5005937	27698	27705	O	-1	-1	0
the	PMC5005937	27706	27709	O	-1	-1	0
underlying	PMC5005937	27710	27720	O	-1	-1	0
familial	PMC5005937	27721	27729	O	-1	-1	0
risk	PMC5005937	27730	27734	O	-1	-1	0
profile	PMC5005937	27735	27742	O	-1	-1	0
(	PMC5005937	27743	27744	O	-1	-1	0
FRP	PMC5005937	27744	27747	O	-1	-1	0
)	PMC5005937	27747	27748	O	-1	-1	0
of	PMC5005937	27749	27751	O	-1	-1	0
each	PMC5005937	27752	27756	O	-1	-1	0
participant	PMC5005937	27757	27768	O	-1	-1	0
and	PMC5005937	27769	27772	O	-1	-1	0
determine	PMC5005937	27773	27782	O	-1	-1	0
if	PMC5005937	27783	27785	O	-1	-1	0
risk	PMC5005937	27786	27790	O	-1	-1	0
associations	PMC5005937	27791	27803	O	-1	-1	0
differ	PMC5005937	27804	27810	O	-1	-1	0
according	PMC5005937	27811	27820	O	-1	-1	0
to	PMC5005937	27821	27823	O	-1	-1	0
FRP	PMC5005937	27824	27827	O	-1	-1	0
,	PMC5005937	27827	27828	O	-1	-1	0
thereby	PMC5005937	27829	27836	O	-1	-1	0
informing	PMC5005937	27837	27846	O	-1	-1	0
targeted	PMC5005937	27847	27855	O	-1	-1	0
risk	PMC5005937	27856	27860	O	-1	-1	0
modification	PMC5005937	27861	27873	O	-1	-1	0
and	PMC5005937	27874	27877	O	-1	-1	0
prevention	PMC5005937	27878	27888	O	-1	-1	0
.	PMC5005937	27888	27889	O	-1	-1	0

•	PMC5005937	27890	27891	O	-1	-1	0
Recruitment	PMC5005937	27892	27903	O	-1	-1	0
commenced	PMC5005937	27904	27913	O	-1	-1	0
in	PMC5005937	27914	27916	O	-1	-1	0
1992	PMC5005937	27917	27921	O	-1	-1	0
and	PMC5005937	27922	27925	O	-1	-1	0
families	PMC5005937	27926	27934	O	-1	-1	0
were	PMC5005937	27935	27939	O	-1	-1	0


	PMC5005937	27939	27941	O	-1	-1	0
from	PMC5005937	27941	27945	O	-1	-1	0
the	PMC5005937	27946	27949	O	-1	-1	0
USA	PMC5005937	27950	27953	B-Location	-1	-1	0
,	PMC5005937	27953	27954	O	-1	-1	0
Canada	PMC5005937	27955	27961	B-Location	-1	-1	0
and	PMC5005937	27962	27965	O	-1	-1	0
Australia	PMC5005937	27966	27975	B-Location	-1	-1	0
.	PMC5005937	27975	27976	O	-1	-1	0

At	PMC5005937	27977	27979	O	-1	-1	0
baseline	PMC5005937	27980	27988	O	-1	-1	0
this	PMC5005937	27989	27993	O	-1	-1	0
cohort	PMC5005937	27994	28000	O	-1	-1	0
of	PMC5005937	28001	28003	O	-1	-1	0
women	PMC5005937	28004	28009	O	-1	-1	0
over	PMC5005937	28010	28014	O	-1	-1	0
the	PMC5005937	28015	28018	O	-1	-1	0
age	PMC5005937	28019	28022	O	-1	-1	0
of	PMC5005937	28023	28025	O	-1	-1	0
18	PMC5005937	28026	28028	O	-1	-1	0
years	PMC5005937	28029	28034	O	-1	-1	0
included	PMC5005937	28035	28043	O	-1	-1	0
18	PMC5005937	28044	28046	O	-1	-1	0
853	PMC5005937	28047	28050	O	-1	-1	0
unaffected	PMC5005937	28051	28061	O	-1	-1	0
and	PMC5005937	28062	28065	O	-1	-1	0
12	PMC5005937	28066	28068	O	-1	-1	0
787	PMC5005937	28069	28072	O	-1	-1	0
affected	PMC5005937	28073	28081	O	-1	-1	0
with	PMC5005937	28082	28086	O	-1	-1	0
breast	PMC5005937	28087	28093	O	-1	-1	0
cancer	PMC5005937	28094	28100	O	-1	-1	0
,	PMC5005937	28100	28101	O	-1	-1	0
of	PMC5005937	28102	28104	O	-1	-1	0
whom	PMC5005937	28105	28109	O	-1	-1	0
2741	PMC5005937	28110	28114	O	-1	-1	0
are	PMC5005937	28115	28118	O	-1	-1	0
BRCA1	PMC5005937	28119	28124	O	-1	-1	0
or	PMC5005937	28125	28127	O	-1	-1	0
BRCA2	PMC5005937	28128	28133	O	-1	-1	0
mutation	PMC5005937	28134	28142	O	-1	-1	0
carriers	PMC5005937	28143	28151	O	-1	-1	0
.	PMC5005937	28151	28152	O	-1	-1	0

•	PMC5005937	28153	28154	O	-1	-1	0

The	PMC5005937	28155	28158	O	-1	-1	0
most	PMC5005937	28159	28163	O	-1	-1	0
recent	PMC5005937	28164	28170	O	-1	-1	0
follow	PMC5005937	28171	28177	O	-1	-1	0
-	PMC5005937	28177	28178	O	-1	-1	0
up	PMC5005937	28178	28180	O	-1	-1	0
was	PMC5005937	28181	28184	O	-1	-1	0
completed	PMC5005937	28185	28194	O	-1	-1	0
in	PMC5005937	28195	28197	O	-1	-1	0
2014	PMC5005937	28198	28202	O	-1	-1	0


	PMC5005937	28202	28204	O	-1	-1	0
and	PMC5005937	28204	28207	O	-1	-1	0
included	PMC5005937	28208	28216	O	-1	-1	0
updating	PMC5005937	28217	28225	O	-1	-1	0
family	PMC5005937	28226	28232	O	-1	-1	0
cancer	PMC5005937	28233	28239	O	-1	-1	0
histories	PMC5005937	28240	28249	O	-1	-1	0
from	PMC5005937	28250	28254	O	-1	-1	0
multiple	PMC5005937	28255	28263	O	-1	-1	0
sources	PMC5005937	28264	28271	O	-1	-1	0
;	PMC5005937	28271	28272	O	-1	-1	0
5	PMC5005937	28273	28274	O	-1	-1	0
%	PMC5005937	28274	28275	O	-1	-1	0
have	PMC5005937	28276	28280	O	-1	-1	0
withdrawn	PMC5005937	28281	28290	O	-1	-1	0
and	PMC5005937	28291	28294	O	-1	-1	0
14	PMC5005937	28295	28297	O	-1	-1	0
%	PMC5005937	28297	28298	O	-1	-1	0
were	PMC5005937	28299	28303	O	-1	-1	0

lost	PMC5005937	28304	28308	O	-1	-1	0
to	PMC5005937	28309	28311	O	-1	-1	0
follow	PMC5005937	28312	28318	O	-1	-1	0
-	PMC5005937	28318	28319	O	-1	-1	0
up	PMC5005937	28319	28321	O	-1	-1	0
.	PMC5005937	28321	28322	O	-1	-1	0

Over	PMC5005937	28323	28327	O	-1	-1	0
on	PMC5005937	28328	28330	O	-1	-1	0
average	PMC5005937	28331	28338	O	-1	-1	0
9	PMC5005937	28339	28340	O	-1	-1	0
years	PMC5005937	28341	28346	O	-1	-1	0
,	PMC5005937	28346	28347	O	-1	-1	0
we	PMC5005937	28348	28350	O	-1	-1	0
have	PMC5005937	28351	28355	O	-1	-1	0


	PMC5005937	28355	28357	O	-1	-1	0

cancers	PMC5005937	28357	28364	O	-1	-1	0
among	PMC5005937	28365	28370	O	-1	-1	0
those	PMC5005937	28371	28376	O	-1	-1	0
at	PMC5005937	28377	28379	O	-1	-1	0
baseline	PMC5005937	28380	28388	O	-1	-1	0
who	PMC5005937	28389	28392	O	-1	-1	0
were	PMC5005937	28393	28397	O	-1	-1	0
unaffected	PMC5005937	28398	28408	O	-1	-1	0
and	PMC5005937	28409	28412	O	-1	-1	0
affected	PMC5005937	28413	28421	O	-1	-1	0
,	PMC5005937	28421	28422	O	-1	-1	0
respectively	PMC5005937	28423	28435	O	-1	-1	0
.	PMC5005937	28435	28436	O	-1	-1	0

•	PMC5005937	28437	28438	O	-1	-1	0

Multi	PMC5005937	28439	28444	O	-1	-1	0
-	PMC5005937	28444	28445	O	-1	-1	0
generational	PMC5005937	28445	28457	O	-1	-1	0


	PMC5005937	28457	28459	O	-1	-1	0
cancer	PMC5005937	28459	28465	O	-1	-1	0


	PMC5005937	28465	28467	O	-1	-1	0

family	PMC5005937	28467	28473	O	-1	-1	0


	PMC5005937	28473	28475	O	-1	-1	0

histories	PMC5005937	28475	28484	O	-1	-1	0


	PMC5005937	28484	28486	O	-1	-1	0

were	PMC5005937	28486	28490	O	-1	-1	0


	PMC5005937	28490	28492	O	-1	-1	0
sought	PMC5005937	28492	28498	O	-1	-1	0
from	PMC5005937	28499	28503	O	-1	-1	0
all	PMC5005937	28504	28507	O	-1	-1	0
participants	PMC5005937	28508	28520	O	-1	-1	0
who	PMC5005937	28521	28524	O	-1	-1	0
were	PMC5005937	28525	28529	O	-1	-1	0
administered	PMC5005937	28530	28542	O	-1	-1	0

the	PMC5005937	28543	28546	O	-1	-1	0


	PMC5005937	28546	28548	O	-1	-1	0
same	PMC5005937	28548	28552	O	-1	-1	0


	PMC5005937	28552	28554	O	-1	-1	0
baseline	PMC5005937	28554	28562	O	-1	-1	0


	PMC5005937	28562	28564	O	-1	-1	0
epidemiology	PMC5005937	28564	28576	O	-1	-1	0


	PMC5005937	28576	28578	O	-1	-1	0
questionnaire	PMC5005937	28578	28591	O	-1	-1	0
.	PMC5005937	28591	28592	O	-1	-1	0


	PMC5005937	28592	28594	O	-1	-1	0

Blood	PMC5005937	28594	28599	O	-1	-1	0
samples	PMC5005937	28600	28607	O	-1	-1	0
have	PMC5005937	28608	28612	O	-1	-1	0
been	PMC5005937	28613	28617	O	-1	-1	0
collected	PMC5005937	28618	28627	O	-1	-1	0
from	PMC5005937	28628	28632	O	-1	-1	0
83	PMC5005937	28633	28635	O	-1	-1	0
%	PMC5005937	28635	28636	O	-1	-1	0
,	PMC5005937	28636	28637	O	-1	-1	0
and	PMC5005937	28638	28641	O	-1	-1	0
another	PMC5005937	28642	28649	O	-1	-1	0
2	PMC5005937	28650	28651	O	-1	-1	0
%	PMC5005937	28651	28652	O	-1	-1	0
have	PMC5005937	28653	28657	O	-1	-1	0
DNA	PMC5005937	28658	28661	O	-1	-1	0
available	PMC5005937	28662	28671	O	-1	-1	0
through	PMC5005937	28672	28679	O	-1	-1	0
buccal	PMC5005937	28680	28686	O	-1	-1	0
samples	PMC5005937	28687	28694	O	-1	-1	0
,	PMC5005937	28694	28695	O	-1	-1	0
of	PMC5005937	28696	28698	O	-1	-1	0
participants	PMC5005937	28699	28711	O	-1	-1	0
and	PMC5005937	28712	28715	O	-1	-1	0
used	PMC5005937	28716	28720	O	-1	-1	0
for	PMC5005937	28721	28724	O	-1	-1	0
extensive	PMC5005937	28725	28734	O	-1	-1	0
genetic	PMC5005937	28735	28742	O	-1	-1	0
characterisation	PMC5005937	28743	28759	O	-1	-1	0
.	PMC5005937	28759	28760	O	-1	-1	0

•	PMC5005937	28761	28762	O	-1	-1	0

For	PMC5005937	28763	28766	O	-1	-1	0


	PMC5005937	28766	28768	O	-1	-1	0
collaboration	PMC5005937	28768	28781	O	-1	-1	0
with	PMC5005937	28782	28786	O	-1	-1	0
the	PMC5005937	28787	28790	O	-1	-1	0
ProF	PMC5005937	28791	28795	O	-1	-1	0
-	PMC5005937	28795	28796	O	-1	-1	0
SC	PMC5005937	28796	28798	O	-1	-1	0
cohort	PMC5005937	28799	28805	O	-1	-1	0
,	PMC5005937	28805	28806	O	-1	-1	0
see	PMC5005937	28807	28810	O	-1	-1	0


	PMC5005937	28810	28812	O	-1	-1	0

[	PMC5005937	28812	28813	O	-1	-1	0
http://www.bcfamilyregistry.org/	PMC5005937	28813	28845	O	-1	-1	0
]	PMC5005937	28845	28846	O	-1	-1	0


	PMC5005937	28846	28848	O	-1	-1	0

and	PMC5005937	28848	28851	O	-1	-1	0


	PMC5005937	28851	28853	O	-1	-1	0
[	PMC5005937	28853	28854	O	-1	-1	0
www.kcon-	PMC5005937	28854	28863	O	-1	-1	0


	PMC5005937	28863	28865	O	-1	-1	0
fab.org	PMC5005937	28865	28872	O	-1	-1	0
]	PMC5005937	28872	28873	O	-1	-1	0
.	PMC5005937	28873	28874	O	-1	-1	0


	PMC5005937	28874	28876	O	-1	-1	0

Funding	PMC5005937	28876	28883	O	-1	-1	0

This	PMC5005937	28884	28888	O	-1	-1	0
work	PMC5005937	28889	28893	O	-1	-1	0
was	PMC5005937	28894	28897	O	-1	-1	0
supported	PMC5005937	28898	28907	O	-1	-1	0
by	PMC5005937	28908	28910	O	-1	-1	0
an	PMC5005937	28911	28913	O	-1	-1	0
award	PMC5005937	28914	28919	O	-1	-1	0
from	PMC5005937	28920	28924	O	-1	-1	0
NIH	PMC5005937	28925	28928	O	-1	-1	0
grants	PMC5005937	28929	28935	O	-1	-1	0
R01	PMC5005937	28936	28939	O	-1	-1	0

CA159868	PMC5005937	28940	28948	O	-1	-1	0
and	PMC5005937	28949	28952	O	-1	-1	0
UM1	PMC5005937	28953	28956	O	-1	-1	0
CA164920	PMC5005937	28957	28965	O	-1	-1	0
from	PMC5005937	28966	28970	O	-1	-1	0
the	PMC5005937	28971	28974	O	-1	-1	0
USA	PMC5005937	28975	28978	O	-1	-1	0
National	PMC5005937	28979	28987	O	-1	-1	0
Cancer	PMC5005937	28988	28994	O	-1	-1	0
Institute	PMC5005937	28995	29004	O	-1	-1	0
.	PMC5005937	29004	29005	O	-1	-1	0

The	PMC5005937	29006	29009	O	-1	-1	0
content	PMC5005937	29010	29017	O	-1	-1	0
of	PMC5005937	29018	29020	O	-1	-1	0
this	PMC5005937	29021	29025	O	-1	-1	0
manuscript	PMC5005937	29026	29036	O	-1	-1	0
does	PMC5005937	29037	29041	O	-1	-1	0
not	PMC5005937	29042	29045	O	-1	-1	0
necessarily	PMC5005937	29046	29057	O	-1	-1	0
reflect	PMC5005937	29058	29065	O	-1	-1	0
the	PMC5005937	29066	29069	O	-1	-1	0
views	PMC5005937	29070	29075	O	-1	-1	0
or	PMC5005937	29076	29078	O	-1	-1	0
policies	PMC5005937	29079	29087	O	-1	-1	0
of	PMC5005937	29088	29090	O	-1	-1	0
the	PMC5005937	29091	29094	O	-1	-1	0
National	PMC5005937	29095	29103	O	-1	-1	0
Cancer	PMC5005937	29104	29110	O	-1	-1	0
Institute	PMC5005937	29111	29120	O	-1	-1	0
or	PMC5005937	29121	29123	O	-1	-1	0
any	PMC5005937	29124	29127	O	-1	-1	0
of	PMC5005937	29128	29130	O	-1	-1	0
the	PMC5005937	29131	29134	O	-1	-1	0
collaborating	PMC5005937	29135	29148	O	-1	-1	0
centres	PMC5005937	29149	29156	O	-1	-1	0
in	PMC5005937	29157	29159	O	-1	-1	0
the	PMC5005937	29160	29163	O	-1	-1	0
BCFR	PMC5005937	29164	29168	O	-1	-1	0
,	PMC5005937	29168	29169	O	-1	-1	0
nor	PMC5005937	29170	29173	O	-1	-1	0
does	PMC5005937	29174	29178	O	-1	-1	0
mention	PMC5005937	29179	29186	O	-1	-1	0
of	PMC5005937	29187	29189	O	-1	-1	0
trade	PMC5005937	29190	29195	O	-1	-1	0
names	PMC5005937	29196	29201	O	-1	-1	0
,	PMC5005937	29201	29202	O	-1	-1	0
commercial	PMC5005937	29203	29213	O	-1	-1	0
products	PMC5005937	29214	29222	O	-1	-1	0
or	PMC5005937	29223	29225	O	-1	-1	0
organisations	PMC5005937	29226	29239	O	-1	-1	0
imply	PMC5005937	29240	29245	O	-1	-1	0
endorsement	PMC5005937	29246	29257	O	-1	-1	0
by	PMC5005937	29258	29260	O	-1	-1	0
the	PMC5005937	29261	29264	O	-1	-1	0
USA	PMC5005937	29265	29268	O	-1	-1	0
Government	PMC5005937	29269	29279	O	-1	-1	0
or	PMC5005937	29280	29282	O	-1	-1	0
the	PMC5005937	29283	29286	O	-1	-1	0
BCFR	PMC5005937	29287	29291	O	-1	-1	0
.	PMC5005937	29291	29292	O	-1	-1	0

K.A.P.	PMC5005937	29293	29299	O	-1	-1	0
is	PMC5005937	29300	29302	O	-1	-1	0
an	PMC5005937	29303	29305	O	-1	-1	0
Australian	PMC5005937	29306	29316	O	-1	-1	0
National	PMC5005937	29317	29325	O	-1	-1	0
Breast	PMC5005937	29326	29332	O	-1	-1	0
Cancer	PMC5005937	29333	29339	O	-1	-1	0
Foundation	PMC5005937	29340	29350	O	-1	-1	0
Fellow	PMC5005937	29351	29357	O	-1	-1	0
.	PMC5005937	29357	29358	O	-1	-1	0

kConFab	PMC5005937	29359	29366	O	-1	-1	0
is	PMC5005937	29367	29369	O	-1	-1	0
supported	PMC5005937	29370	29379	O	-1	-1	0
by	PMC5005937	29380	29382	O	-1	-1	0
grants	PMC5005937	29383	29389	O	-1	-1	0
from	PMC5005937	29390	29394	O	-1	-1	0
the	PMC5005937	29395	29398	O	-1	-1	0
National	PMC5005937	29399	29407	O	-1	-1	0
Breast	PMC5005937	29408	29414	O	-1	-1	0
Cancer	PMC5005937	29415	29421	O	-1	-1	0
Foundation	PMC5005937	29422	29432	O	-1	-1	0
,	PMC5005937	29432	29433	O	-1	-1	0
the	PMC5005937	29434	29437	O	-1	-1	0
National	PMC5005937	29438	29446	O	-1	-1	0
Health	PMC5005937	29447	29453	O	-1	-1	0
and	PMC5005937	29454	29457	O	-1	-1	0
Medical	PMC5005937	29458	29465	O	-1	-1	0
Research	PMC5005937	29466	29474	O	-1	-1	0
Council	PMC5005937	29475	29482	O	-1	-1	0
(	PMC5005937	29483	29484	O	-1	-1	0
NHMRC	PMC5005937	29484	29489	O	-1	-1	0
)	PMC5005937	29489	29490	O	-1	-1	0
and	PMC5005937	29491	29494	O	-1	-1	0
the	PMC5005937	29495	29498	O	-1	-1	0
Queensland	PMC5005937	29499	29509	O	-1	-1	0
Cancer	PMC5005937	29510	29516	O	-1	-1	0
Fund	PMC5005937	29517	29521	O	-1	-1	0
,	PMC5005937	29521	29522	O	-1	-1	0
the	PMC5005937	29523	29526	O	-1	-1	0
Cancer	PMC5005937	29527	29533	O	-1	-1	0
Councils	PMC5005937	29534	29542	O	-1	-1	0
of	PMC5005937	29543	29545	O	-1	-1	0
New	PMC5005937	29546	29549	O	-1	-1	0
South	PMC5005937	29550	29555	O	-1	-1	0
Wales	PMC5005937	29556	29561	O	-1	-1	0
,	PMC5005937	29561	29562	O	-1	-1	0
Victoria	PMC5005937	29563	29571	O	-1	-1	0
,	PMC5005937	29571	29572	O	-1	-1	0
Tasmania	PMC5005937	29573	29581	O	-1	-1	0
and	PMC5005937	29582	29585	O	-1	-1	0
South	PMC5005937	29586	29591	O	-1	-1	0
Australia	PMC5005937	29592	29601	O	-1	-1	0
,	PMC5005937	29601	29602	O	-1	-1	0
and	PMC5005937	29603	29606	O	-1	-1	0
the	PMC5005937	29607	29610	O	-1	-1	0
Cancer	PMC5005937	29611	29617	O	-1	-1	0
Foundation	PMC5005937	29618	29628	O	-1	-1	0
of	PMC5005937	29629	29631	O	-1	-1	0
Western	PMC5005937	29632	29639	O	-1	-1	0
Australia	PMC5005937	29640	29649	O	-1	-1	0
.	PMC5005937	29649	29650	O	-1	-1	0

J.L.H.	PMC5005937	29651	29657	O	-1	-1	0
is	PMC5005937	29658	29660	O	-1	-1	0
an	PMC5005937	29661	29663	O	-1	-1	0
NHMRC	PMC5005937	29664	29669	O	-1	-1	0
Senior	PMC5005937	29670	29676	O	-1	-1	0
Principal	PMC5005937	29677	29686	O	-1	-1	0
Research	PMC5005937	29687	29695	O	-1	-1	0
Fellow	PMC5005937	29696	29702	O	-1	-1	0
.	PMC5005937	29702	29703	O	-1	-1	0

I.L.A.	PMC5005937	29704	29710	O	-1	-1	0
holds	PMC5005937	29711	29716	O	-1	-1	0
the	PMC5005937	29717	29720	O	-1	-1	0
Anne	PMC5005937	29721	29725	O	-1	-1	0
and	PMC5005937	29726	29729	O	-1	-1	0
Max	PMC5005937	29730	29733	O	-1	-1	0
Tanenbaum	PMC5005937	29734	29743	O	-1	-1	0
Chair	PMC5005937	29744	29749	O	-1	-1	0
in	PMC5005937	29750	29752	O	-1	-1	0
Molecular	PMC5005937	29753	29762	O	-1	-1	0
Medicine	PMC5005937	29763	29771	O	-1	-1	0
at	PMC5005937	29772	29774	O	-1	-1	0
Mount	PMC5005937	29775	29780	O	-1	-1	0
Sinai	PMC5005937	29781	29786	O	-1	-1	0
Hospital	PMC5005937	29787	29795	O	-1	-1	0
and	PMC5005937	29796	29799	O	-1	-1	0
the	PMC5005937	29800	29803	O	-1	-1	0
University	PMC5005937	29804	29814	O	-1	-1	0
of	PMC5005937	29815	29817	O	-1	-1	0
Toronto	PMC5005937	29818	29825	O	-1	-1	0
.	PMC5005937	29825	29826	O	-1	-1	0


	PMC5005937	29826	29828	O	-1	-1	0

Acknowledgements	PMC5005937	29828	29844	O	-1	-1	0

We	PMC5005937	29845	29847	O	-1	-1	0
would	PMC5005937	29848	29853	O	-1	-1	0
like	PMC5005937	29854	29858	O	-1	-1	0
to	PMC5005937	29859	29861	O	-1	-1	0
gratefully	PMC5005937	29862	29872	O	-1	-1	0
acknowledge	PMC5005937	29873	29884	O	-1	-1	0
the	PMC5005937	29885	29888	O	-1	-1	0
team	PMC5005937	29889	29893	O	-1	-1	0
of	PMC5005937	29894	29896	O	-1	-1	0
the	PMC5005937	29897	29900	O	-1	-1	0
ProF	PMC5005937	29901	29905	O	-1	-1	0
-	PMC5005937	29905	29906	O	-1	-1	0
SC	PMC5005937	29906	29908	O	-1	-1	0
project	PMC5005937	29909	29916	O	-1	-1	0
coordinators	PMC5005937	29917	29929	O	-1	-1	0
,	PMC5005937	29929	29930	O	-1	-1	0
data	PMC5005937	29931	29935	O	-1	-1	0
managers	PMC5005937	29936	29944	O	-1	-1	0
and	PMC5005937	29945	29948	O	-1	-1	0
analysts	PMC5005937	29949	29957	O	-1	-1	0
and	PMC5005937	29958	29961	O	-1	-1	0
interviewers	PMC5005937	29962	29974	O	-1	-1	0
including	PMC5005937	29975	29984	O	-1	-1	0
:	PMC5005937	29984	29985	O	-1	-1	0
Yuyan	PMC5005937	29986	29991	O	-1	-1	0
Liao	PMC5005937	29992	29996	O	-1	-1	0
,	PMC5005937	29996	29997	O	-1	-1	0
Ann	PMC5005937	29998	30001	O	-1	-1	0
Johnston	PMC5005937	30002	30010	O	-1	-1	0
Cloud	PMC5005937	30011	30016	O	-1	-1	0
,	PMC5005937	30016	30017	O	-1	-1	0
Richard	PMC5005937	30018	30025	O	-1	-1	0
Buschbaum	PMC5005937	30026	30035	O	-1	-1	0
,	PMC5005937	30035	30036	O	-1	-1	0
Diane	PMC5005937	30037	30042	O	-1	-1	0
Levy	PMC5005937	30043	30047	O	-1	-1	0
,	PMC5005937	30047	30048	O	-1	-1	0
Ashley	PMC5005937	30049	30055	O	-1	-1	0
Thai	PMC5005937	30056	30060	O	-1	-1	0
,	PMC5005937	30060	30061	O	-1	-1	0
Melissa	PMC5005937	30062	30069	O	-1	-1	0
White	PMC5005937	30070	30075	O	-1	-1	0
,	PMC5005937	30075	30076	O	-1	-1	0
Gord	PMC5005937	30077	30081	O	-1	-1	0
Glendon	PMC5005937	30082	30089	O	-1	-1	0
,	PMC5005937	30089	30090	O	-1	-1	0
Nayana	PMC5005937	30091	30097	O	-1	-1	0
Weerasooriya	PMC5005937	30098	30110	O	-1	-1	0
,	PMC5005937	30110	30111	O	-1	-1	0
Tom	PMC5005937	30112	30115	O	-1	-1	0
Conner	PMC5005937	30116	30122	O	-1	-1	0
,	PMC5005937	30122	30123	O	-1	-1	0
Enid	PMC5005937	30124	30128	O	-1	-1	0
Satariano	PMC5005937	30129	30138	O	-1	-1	0
,	PMC5005937	30138	30139	O	-1	-1	0
Daisy	PMC5005937	30140	30145	O	-1	-1	0
Lubag	PMC5005937	30146	30151	O	-1	-1	0
,	PMC5005937	30151	30152	O	-1	-1	0
Connie	PMC5005937	30153	30159	O	-1	-1	0

Cady	PMC5005937	30160	30164	O	-1	-1	0
,	PMC5005937	30164	30165	O	-1	-1	0
Jocelyn	PMC5005937	30166	30173	O	-1	-1	0
Koo	PMC5005937	30174	30177	O	-1	-1	0
,	PMC5005937	30177	30178	O	-1	-1	0
Lisa	PMC5005937	30179	30183	O	-1	-1	0
Bealin	PMC5005937	30184	30190	O	-1	-1	0
,	PMC5005937	30190	30191	O	-1	-1	0
Nina	PMC5005937	30192	30196	O	-1	-1	0
Galpern	PMC5005937	30197	30204	O	-1	-1	0
,	PMC5005937	30204	30205	O	-1	-1	0
Prue	PMC5005937	30206	30210	O	-1	-1	0
Weideman	PMC5005937	30211	30219	O	-1	-1	0
,	PMC5005937	30219	30220	O	-1	-1	0

Charmaine	PMC5005937	30221	30230	O	-1	-1	0
Smith	PMC5005937	30231	30236	O	-1	-1	0
,	PMC5005937	30236	30237	O	-1	-1	0
Sandra	PMC5005937	30238	30244	O	-1	-1	0
Picken	PMC5005937	30245	30251	O	-1	-1	0
,	PMC5005937	30251	30252	O	-1	-1	0
Lucy	PMC5005937	30253	30257	O	-1	-1	0
Stanhope	PMC5005937	30258	30266	O	-1	-1	0
,	PMC5005937	30266	30267	O	-1	-1	0
Kelly	PMC5005937	30268	30273	O	-1	-1	0
Aujard	PMC5005937	30274	30280	O	-1	-1	0
,	PMC5005937	30280	30281	O	-1	-1	0
Gillian	PMC5005937	30282	30289	O	-1	-1	0
Dite	PMC5005937	30290	30294	O	-1	-1	0
and	PMC5005937	30295	30298	O	-1	-1	0
Amanda	PMC5005937	30299	30305	O	-1	-1	0
Torosidis	PMC5005937	30306	30315	O	-1	-1	0
.	PMC5005937	30315	30316	O	-1	-1	0

We	PMC5005937	30317	30319	O	-1	-1	0
would	PMC5005937	30320	30325	O	-1	-1	0
also	PMC5005937	30326	30330	O	-1	-1	0
like	PMC5005937	30331	30335	O	-1	-1	0
to	PMC5005937	30336	30338	O	-1	-1	0
acknowledge	PMC5005937	30339	30350	O	-1	-1	0
other	PMC5005937	30351	30356	O	-1	-1	0
co	PMC5005937	30357	30359	O	-1	-1	0
-	PMC5005937	30359	30360	O	-1	-1	0
investigators	PMC5005937	30360	30373	O	-1	-1	0
who	PMC5005937	30374	30377	O	-1	-1	0
have	PMC5005937	30378	30382	O	-1	-1	0
been	PMC5005937	30383	30387	O	-1	-1	0
instrumental	PMC5005937	30388	30400	O	-1	-1	0
in	PMC5005937	30401	30403	O	-1	-1	0
leading	PMC5005937	30404	30411	O	-1	-1	0

the	PMC5005937	30412	30415	O	-1	-1	0
laboratory	PMC5005937	30416	30426	O	-1	-1	0
analyses	PMC5005937	30427	30435	O	-1	-1	0
and/or	PMC5005937	30436	30442	O	-1	-1	0
setting	PMC5005937	30443	30450	O	-1	-1	0
up	PMC5005937	30451	30453	O	-1	-1	0
the	PMC5005937	30454	30457	O	-1	-1	0
original	PMC5005937	30458	30466	O	-1	-1	0
cohorts	PMC5005937	30467	30474	O	-1	-1	0
including	PMC5005937	30475	30484	O	-1	-1	0
:	PMC5005937	30484	30485	O	-1	-1	0
Regina	PMC5005937	30486	30492	O	-1	-1	0
Santella	PMC5005937	30493	30501	O	-1	-1	0
,	PMC5005937	30501	30502	O	-1	-1	0
Dee	PMC5005937	30503	30506	O	-1	-1	0
West	PMC5005937	30507	30511	O	-1	-1	0
,	PMC5005937	30511	30512	O	-1	-1	0
Ruby	PMC5005937	30513	30517	O	-1	-1	0
Senie	PMC5005937	30518	30523	O	-1	-1	0
,	PMC5005937	30523	30524	O	-1	-1	0
Norman	PMC5005937	30525	30531	O	-1	-1	0
Boyd	PMC5005937	30532	30536	O	-1	-1	0
,	PMC5005937	30536	30537	O	-1	-1	0
Melissa	PMC5005937	30538	30545	O	-1	-1	0
Southey	PMC5005937	30546	30553	O	-1	-1	0
and	PMC5005937	30554	30557	O	-1	-1	0
Graham	PMC5005937	30558	30564	O	-1	-1	0
Giles	PMC5005937	30565	30570	O	-1	-1	0
.	PMC5005937	30570	30571	O	-1	-1	0

We	PMC5005937	30572	30574	O	-1	-1	0
thank	PMC5005937	30575	30580	O	-1	-1	0
the	PMC5005937	30581	30584	O	-1	-1	0
kConFab	PMC5005937	30585	30592	O	-1	-1	0
research	PMC5005937	30593	30601	O	-1	-1	0
nurses	PMC5005937	30602	30608	O	-1	-1	0
and	PMC5005937	30609	30612	O	-1	-1	0
staff	PMC5005937	30613	30618	O	-1	-1	0
,	PMC5005937	30618	30619	O	-1	-1	0
the	PMC5005937	30620	30623	O	-1	-1	0
heads	PMC5005937	30624	30629	O	-1	-1	0
and	PMC5005937	30630	30633	O	-1	-1	0
staff	PMC5005937	30634	30639	O	-1	-1	0
of	PMC5005937	30640	30642	O	-1	-1	0
the	PMC5005937	30643	30646	O	-1	-1	0
Australian	PMC5005937	30647	30657	O	-1	-1	0
and	PMC5005937	30658	30661	O	-1	-1	0
New	PMC5005937	30662	30665	O	-1	-1	0
Zealand	PMC5005937	30666	30673	O	-1	-1	0
Family	PMC5005937	30674	30680	O	-1	-1	0
Cancer	PMC5005937	30681	30687	O	-1	-1	0
Clinics	PMC5005937	30688	30695	O	-1	-1	0
and	PMC5005937	30696	30699	O	-1	-1	0
the	PMC5005937	30700	30703	O	-1	-1	0
kConFab	PMC5005937	30704	30711	O	-1	-1	0
investigators	PMC5005937	30712	30725	O	-1	-1	0
responsible	PMC5005937	30726	30737	O	-1	-1	0
for	PMC5005937	30738	30741	O	-1	-1	0
establishing	PMC5005937	30742	30754	O	-1	-1	0
the	PMC5005937	30755	30758	O	-1	-1	0
resource	PMC5005937	30759	30767	O	-1	-1	0
and	PMC5005937	30768	30771	O	-1	-1	0
the	PMC5005937	30772	30775	O	-1	-1	0
follow	PMC5005937	30776	30782	O	-1	-1	0
-	PMC5005937	30782	30783	O	-1	-1	0
up	PMC5005937	30783	30785	O	-1	-1	0
study	PMC5005937	30786	30791	O	-1	-1	0
,	PMC5005937	30791	30792	O	-1	-1	0
including	PMC5005937	30793	30802	O	-1	-1	0
:	PMC5005937	30802	30803	O	-1	-1	0
Michael	PMC5005937	30804	30811	O	-1	-1	0
Friedlander	PMC5005937	30812	30823	O	-1	-1	0
,	PMC5005937	30823	30824	O	-1	-1	0
Sue	PMC5005937	30825	30828	O	-1	-1	0
-	PMC5005937	30828	30829	O	-1	-1	0
Anne	PMC5005937	30829	30833	O	-1	-1	0
MacLachlan	PMC5005937	30834	30844	O	-1	-1	0
,	PMC5005937	30844	30845	O	-1	-1	0
Roger	PMC5005937	30846	30851	O	-1	-1	0
Milne	PMC5005937	30852	30857	O	-1	-1	0
and	PMC5005937	30858	30861	O	-1	-1	0
Heather	PMC5005937	30862	30869	O	-1	-1	0
Thorne	PMC5005937	30870	30876	O	-1	-1	0
,	PMC5005937	30876	30877	O	-1	-1	0
and	PMC5005937	30878	30881	O	-1	-1	0
especially	PMC5005937	30882	30892	O	-1	-1	0
the	PMC5005937	30893	30896	O	-1	-1	0
many	PMC5005937	30897	30901	O	-1	-1	0
families	PMC5005937	30902	30910	O	-1	-1	0
enrolled	PMC5005937	30911	30919	O	-1	-1	0
in	PMC5005937	30920	30922	O	-1	-1	0
the	PMC5005937	30923	30926	O	-1	-1	0
BCFR	PMC5005937	30927	30931	O	-1	-1	0
and	PMC5005937	30932	30935	O	-1	-1	0
kConFab	PMC5005937	30936	30943	O	-1	-1	0
.	PMC5005937	30943	30944	O	-1	-1	0

Conflict	PMC5005937	30945	30953	O	-1	-1	0
of	PMC5005937	30954	30956	O	-1	-1	0
interest	PMC5005937	30957	30965	O	-1	-1	0
:	PMC5005937	30965	30966	O	-1	-1	0
None	PMC5005937	30967	30971	O	-1	-1	0
declared	PMC5005937	30972	30980	O	-1	-1	0
.	PMC5005937	30980	30981	O	-1	-1	0


	PMC5005937	30981	30983	O	-1	-1	0

References	PMC5005937	30983	30993	O	-1	-1	0
1	PMC5005937	30994	30995	O	-1	-1	0
.	PMC5005937	30995	30996	O	-1	-1	0

Familial	PMC5005937	30997	31005	O	-1	-1	0
breast	PMC5005937	31006	31012	O	-1	-1	0
cancer	PMC5005937	31013	31019	O	-1	-1	0
:	PMC5005937	31019	31020	O	-1	-1	0
collaborative	PMC5005937	31021	31034	O	-1	-1	0
reanalysis	PMC5005937	31035	31045	O	-1	-1	0
of	PMC5005937	31046	31048	O	-1	-1	0
individual	PMC5005937	31049	31059	O	-1	-1	0
data	PMC5005937	31060	31064	O	-1	-1	0
from	PMC5005937	31065	31069	O	-1	-1	0
52	PMC5005937	31070	31072	O	-1	-1	0
epidemiological	PMC5005937	31073	31088	O	-1	-1	0
studies	PMC5005937	31089	31096	O	-1	-1	0
including	PMC5005937	31097	31106	O	-1	-1	0
58	PMC5005937	31107	31109	O	-1	-1	0
209	PMC5005937	31110	31113	O	-1	-1	0
women	PMC5005937	31114	31119	O	-1	-1	0


	PMC5005937	31119	31121	O	-1	-1	0
International	PMC5005937	31121	31134	O	-1	-1	0
Journal	PMC5005937	31135	31142	O	-1	-1	0
of	PMC5005937	31143	31145	O	-1	-1	0
Epidemiology	PMC5005937	31146	31158	O	-1	-1	0
,	PMC5005937	31158	31159	O	-1	-1	0
2016	PMC5005937	31160	31164	O	-1	-1	0
,	PMC5005937	31164	31165	O	-1	-1	0
Vol	PMC5005937	31166	31169	O	-1	-1	0
.	PMC5005937	31169	31170	O	-1	-1	0

45	PMC5005937	31171	31173	O	-1	-1	0
,	PMC5005937	31173	31174	O	-1	-1	0

No	PMC5005937	31175	31177	O	-1	-1	0
.	PMC5005937	31177	31178	O	-1	-1	0
3	PMC5005937	31179	31180	O	-1	-1	0


	PMC5005937	31180	31182	O	-1	-1	0
2	PMC5005937	31182	31183	O	-1	-1	0
.	PMC5005937	31183	31184	O	-1	-1	0
3	PMC5005937	31185	31186	O	-1	-1	0
.	PMC5005937	31186	31187	O	-1	-1	0


	PMC5005937	31187	31189	O	-1	-1	0
4	PMC5005937	31189	31190	O	-1	-1	0
.	PMC5005937	31190	31191	O	-1	-1	0


	PMC5005937	31191	31193	O	-1	-1	0
5	PMC5005937	31193	31194	O	-1	-1	0
.	PMC5005937	31194	31195	O	-1	-1	0


	PMC5005937	31195	31197	O	-1	-1	0
6	PMC5005937	31197	31198	O	-1	-1	0
.	PMC5005937	31198	31199	O	-1	-1	0


	PMC5005937	31199	31201	O	-1	-1	0

7	PMC5005937	31201	31202	O	-1	-1	0
.	PMC5005937	31202	31203	O	-1	-1	0


	PMC5005937	31203	31205	O	-1	-1	0

8	PMC5005937	31205	31206	O	-1	-1	0
.	PMC5005937	31206	31207	O	-1	-1	0


	PMC5005937	31207	31209	O	-1	-1	0

9	PMC5005937	31209	31210	O	-1	-1	0
.	PMC5005937	31210	31211	O	-1	-1	0


	PMC5005937	31211	31213	O	-1	-1	0
10	PMC5005937	31213	31215	O	-1	-1	0
.	PMC5005937	31215	31216	O	-1	-1	0


	PMC5005937	31216	31218	O	-1	-1	0

11	PMC5005937	31218	31220	O	-1	-1	0
.	PMC5005937	31220	31221	O	-1	-1	0


	PMC5005937	31221	31223	O	-1	-1	0

12	PMC5005937	31223	31225	O	-1	-1	0
.	PMC5005937	31225	31226	O	-1	-1	0


	PMC5005937	31226	31228	O	-1	-1	0

13	PMC5005937	31228	31230	O	-1	-1	0
.	PMC5005937	31230	31231	O	-1	-1	0


	PMC5005937	31231	31233	O	-1	-1	0

14	PMC5005937	31233	31235	O	-1	-1	0
.	PMC5005937	31235	31236	O	-1	-1	0


	PMC5005937	31236	31238	O	-1	-1	0

15	PMC5005937	31238	31240	O	-1	-1	0
.	PMC5005937	31240	31241	O	-1	-1	0
16	PMC5005937	31242	31244	O	-1	-1	0
.	PMC5005937	31244	31245	O	-1	-1	0


	PMC5005937	31245	31247	O	-1	-1	0

17	PMC5005937	31247	31249	O	-1	-1	0
.	PMC5005937	31249	31250	O	-1	-1	0


	PMC5005937	31250	31252	O	-1	-1	0

with	PMC5005937	31252	31256	O	-1	-1	0
breast	PMC5005937	31257	31263	O	-1	-1	0
cancer	PMC5005937	31264	31270	O	-1	-1	0
and	PMC5005937	31271	31274	O	-1	-1	0
101	PMC5005937	31275	31278	O	-1	-1	0
986	PMC5005937	31279	31282	O	-1	-1	0
women	PMC5005937	31283	31288	O	-1	-1	0
without	PMC5005937	31289	31296	O	-1	-1	0
the	PMC5005937	31297	31300	O	-1	-1	0
disease	PMC5005937	31301	31308	O	-1	-1	0
.	PMC5005937	31308	31309	O	-1	-1	0

Lancet	PMC5005937	31310	31316	O	-1	-1	0
2001;358:1389–99	PMC5005937	31317	31333	O	-1	-1	0
.	PMC5005937	31333	31334	O	-1	-1	0

Stratton	PMC5005937	31335	31343	O	-1	-1	0
MR	PMC5005937	31344	31346	O	-1	-1	0
,	PMC5005937	31346	31347	O	-1	-1	0
Rahman	PMC5005937	31348	31354	O	-1	-1	0
N.	PMC5005937	31355	31357	O	-1	-1	0

The	PMC5005937	31358	31361	O	-1	-1	0
emerging	PMC5005937	31362	31370	O	-1	-1	0
landscape	PMC5005937	31371	31380	O	-1	-1	0
of	PMC5005937	31381	31383	O	-1	-1	0
breast	PMC5005937	31384	31390	O	-1	-1	0
cancer	PMC5005937	31391	31397	O	-1	-1	0
susceptibility	PMC5005937	31398	31412	O	-1	-1	0
.	PMC5005937	31412	31413	O	-1	-1	0

Nat	PMC5005937	31414	31417	O	-1	-1	0
Genet	PMC5005937	31418	31423	O	-1	-1	0
2008;40:17–22	PMC5005937	31424	31437	O	-1	-1	0
.	PMC5005937	31437	31438	O	-1	-1	0

Mavaddat	PMC5005937	31439	31447	O	-1	-1	0
N	PMC5005937	31448	31449	O	-1	-1	0
,	PMC5005937	31449	31450	O	-1	-1	0
Antoniou	PMC5005937	31451	31459	O	-1	-1	0
AC	PMC5005937	31460	31462	O	-1	-1	0
,	PMC5005937	31462	31463	O	-1	-1	0
Easton	PMC5005937	31464	31470	O	-1	-1	0
DF	PMC5005937	31471	31473	O	-1	-1	0
,	PMC5005937	31473	31474	O	-1	-1	0
Garcia	PMC5005937	31475	31481	O	-1	-1	0
-	PMC5005937	31481	31482	O	-1	-1	0
Closas	PMC5005937	31482	31488	O	-1	-1	0
M.	PMC5005937	31489	31491	O	-1	-1	0

Genetic	PMC5005937	31492	31499	O	-1	-1	0
susceptibility	PMC5005937	31500	31514	O	-1	-1	0
to	PMC5005937	31515	31517	O	-1	-1	0
breast	PMC5005937	31518	31524	O	-1	-1	0
cancer	PMC5005937	31525	31531	O	-1	-1	0
.	PMC5005937	31531	31532	O	-1	-1	0

Mol	PMC5005937	31533	31536	O	-1	-1	0
Oncol	PMC5005937	31537	31542	O	-1	-1	0
2010;4	PMC5005937	31543	31549	O	-1	-1	0
:	PMC5005937	31549	31550	O	-1	-1	0
174–91	PMC5005937	31551	31557	O	-1	-1	0
.	PMC5005937	31557	31558	O	-1	-1	0

Campa	PMC5005937	31559	31564	O	-1	-1	0
D	PMC5005937	31565	31566	O	-1	-1	0
,	PMC5005937	31566	31567	O	-1	-1	0
Barrdahl	PMC5005937	31568	31576	O	-1	-1	0
M	PMC5005937	31577	31578	O	-1	-1	0
,	PMC5005937	31578	31579	O	-1	-1	0
Tsilidis	PMC5005937	31580	31588	O	-1	-1	0
KK	PMC5005937	31589	31591	O	-1	-1	0
et	PMC5005937	31592	31594	O	-1	-1	0
al	PMC5005937	31595	31597	O	-1	-1	0
.	PMC5005937	31597	31598	O	-1	-1	0

A	PMC5005937	31599	31600	O	-1	-1	0
genome	PMC5005937	31601	31607	O	-1	-1	0
-	PMC5005937	31607	31608	O	-1	-1	0
wide	PMC5005937	31608	31612	O	-1	-1	0
“	PMC5005937	31613	31614	O	-1	-1	0
pleiotropy	PMC5005937	31614	31624	O	-1	-1	0
scan	PMC5005937	31625	31629	O	-1	-1	0
”	PMC5005937	31629	31630	O	-1	-1	0
does	PMC5005937	31631	31635	O	-1	-1	0
not	PMC5005937	31636	31639	O	-1	-1	0
identify	PMC5005937	31640	31648	O	-1	-1	0
new	PMC5005937	31649	31652	O	-1	-1	0
susceptibility	PMC5005937	31653	31667	O	-1	-1	0
loci	PMC5005937	31668	31672	O	-1	-1	0
for	PMC5005937	31673	31676	O	-1	-1	0
estrogen	PMC5005937	31677	31685	O	-1	-1	0
receptor	PMC5005937	31686	31694	O	-1	-1	0
negative	PMC5005937	31695	31703	O	-1	-1	0
breast	PMC5005937	31704	31710	O	-1	-1	0
cancer	PMC5005937	31711	31717	O	-1	-1	0
.	PMC5005937	31717	31718	O	-1	-1	0

PloS	PMC5005937	31719	31723	O	-1	-1	0
One	PMC5005937	31724	31727	O	-1	-1	0
2014;9	PMC5005937	31728	31734	O	-1	-1	0
:	PMC5005937	31734	31735	O	-1	-1	0
e85955	PMC5005937	31735	31741	O	-1	-1	0
.	PMC5005937	31741	31742	O	-1	-1	0
Garcia	PMC5005937	31743	31749	O	-1	-1	0
-	PMC5005937	31749	31750	O	-1	-1	0
Closas	PMC5005937	31750	31756	O	-1	-1	0
M	PMC5005937	31757	31758	O	-1	-1	0
,	PMC5005937	31758	31759	O	-1	-1	0
Couch	PMC5005937	31760	31765	O	-1	-1	0
FJ	PMC5005937	31766	31768	O	-1	-1	0
,	PMC5005937	31768	31769	O	-1	-1	0
Lindstrom	PMC5005937	31770	31779	O	-1	-1	0
S	PMC5005937	31780	31781	O	-1	-1	0

et	PMC5005937	31782	31784	O	-1	-1	0
al	PMC5005937	31785	31787	O	-1	-1	0
.	PMC5005937	31787	31788	O	-1	-1	0

Genome	PMC5005937	31789	31795	O	-1	-1	0
-	PMC5005937	31795	31796	O	-1	-1	0
wide	PMC5005937	31796	31800	O	-1	-1	0
association	PMC5005937	31801	31812	O	-1	-1	0
studies	PMC5005937	31813	31820	O	-1	-1	0
identify	PMC5005937	31821	31829	O	-1	-1	0
four	PMC5005937	31830	31834	O	-1	-1	0
ER	PMC5005937	31835	31837	O	-1	-1	0
negative	PMC5005937	31838	31846	O	-1	-1	0
-	PMC5005937	31846	31847	O	-1	-1	0
specific	PMC5005937	31847	31855	O	-1	-1	0
breast	PMC5005937	31856	31862	O	-1	-1	0
cancer	PMC5005937	31863	31869	O	-1	-1	0
risk	PMC5005937	31870	31874	O	-1	-1	0
loci	PMC5005937	31875	31879	O	-1	-1	0
.	PMC5005937	31879	31880	O	-1	-1	0

Nat	PMC5005937	31881	31884	O	-1	-1	0
Genet	PMC5005937	31885	31890	O	-1	-1	0
2013;45:39298	PMC5005937	31891	31904	O	-1	-1	0
.	PMC5005937	31904	31905	O	-1	-1	0

Milne	PMC5005937	31906	31911	O	-1	-1	0
RL	PMC5005937	31912	31914	O	-1	-1	0
,	PMC5005937	31914	31915	O	-1	-1	0
Benitez	PMC5005937	31916	31923	O	-1	-1	0
J	PMC5005937	31924	31925	O	-1	-1	0
,	PMC5005937	31925	31926	O	-1	-1	0
Nevanlinna	PMC5005937	31927	31937	O	-1	-1	0
H	PMC5005937	31938	31939	O	-1	-1	0
et	PMC5005937	31940	31942	O	-1	-1	0
al	PMC5005937	31943	31945	O	-1	-1	0
.	PMC5005937	31945	31946	O	-1	-1	0

Risk	PMC5005937	31947	31951	O	-1	-1	0
of	PMC5005937	31952	31954	O	-1	-1	0
estrogen	PMC5005937	31955	31963	O	-1	-1	0
receptor	PMC5005937	31964	31972	O	-1	-1	0
-	PMC5005937	31972	31973	O	-1	-1	0
positive	PMC5005937	31973	31981	O	-1	-1	0
and	PMC5005937	31982	31985	O	-1	-1	0
-negative	PMC5005937	31986	31995	O	-1	-1	0
breast	PMC5005937	31996	32002	O	-1	-1	0
cancer	PMC5005937	32003	32009	O	-1	-1	0
and	PMC5005937	32010	32013	O	-1	-1	0
single	PMC5005937	32014	32020	O	-1	-1	0
-	PMC5005937	32020	32021	O	-1	-1	0
nucleotide	PMC5005937	32021	32031	O	-1	-1	0
polymorphism	PMC5005937	32032	32044	O	-1	-1	0
2q35-rs13387042	PMC5005937	32045	32060	O	-1	-1	0
.	PMC5005937	32060	32061	O	-1	-1	0

J	PMC5005937	32062	32063	O	-1	-1	0
Natl	PMC5005937	32064	32068	O	-1	-1	0
Cancer	PMC5005937	32069	32075	O	-1	-1	0
Inst	PMC5005937	32076	32080	O	-1	-1	0
2009;101	PMC5005937	32081	32089	O	-1	-1	0
:	PMC5005937	32089	32090	O	-1	-1	0
1012–18	PMC5005937	32091	32098	O	-1	-1	0
.	PMC5005937	32098	32099	O	-1	-1	0

Warren	PMC5005937	32100	32106	O	-1	-1	0
H	PMC5005937	32107	32108	O	-1	-1	0
,	PMC5005937	32108	32109	O	-1	-1	0
Dudbridge	PMC5005937	32110	32119	O	-1	-1	0
F	PMC5005937	32120	32121	O	-1	-1	0
,	PMC5005937	32121	32122	O	-1	-1	0
Fletcher	PMC5005937	32123	32131	O	-1	-1	0

O	PMC5005937	32132	32133	O	-1	-1	0

et	PMC5005937	32134	32136	O	-1	-1	0
al	PMC5005937	32137	32139	O	-1	-1	0
.	PMC5005937	32139	32140	O	-1	-1	0
9q31.2-rs865686	PMC5005937	32141	32156	O	-1	-1	0
as	PMC5005937	32157	32159	O	-1	-1	0
a	PMC5005937	32160	32161	O	-1	-1	0
susceptibility	PMC5005937	32162	32176	O	-1	-1	0
locus	PMC5005937	32177	32182	O	-1	-1	0
for	PMC5005937	32183	32186	O	-1	-1	0
estrogen	PMC5005937	32187	32195	O	-1	-1	0
receptor	PMC5005937	32196	32204	O	-1	-1	0
-	PMC5005937	32204	32205	O	-1	-1	0
positive	PMC5005937	32205	32213	O	-1	-1	0
breast	PMC5005937	32214	32220	O	-1	-1	0
cancer	PMC5005937	32221	32227	O	-1	-1	0
:	PMC5005937	32227	32228	O	-1	-1	0

evidence	PMC5005937	32229	32237	O	-1	-1	0
from	PMC5005937	32238	32242	O	-1	-1	0
the	PMC5005937	32243	32246	O	-1	-1	0
Breast	PMC5005937	32247	32253	O	-1	-1	0
Cancer	PMC5005937	32254	32260	O	-1	-1	0
Association	PMC5005937	32261	32272	O	-1	-1	0
Consortium	PMC5005937	32273	32283	O	-1	-1	0
.	PMC5005937	32283	32284	O	-1	-1	0

Cancer	PMC5005937	32285	32291	O	-1	-1	0
Epidemiol	PMC5005937	32292	32301	O	-1	-1	0
Biomarkers	PMC5005937	32302	32312	O	-1	-1	0

Prev	PMC5005937	32313	32317	O	-1	-1	0
2012;21):1783–91	PMC5005937	32318	32334	O	-1	-1	0
.	PMC5005937	32334	32335	O	-1	-1	0

Antoniou	PMC5005937	32336	32344	O	-1	-1	0
AC	PMC5005937	32345	32347	O	-1	-1	0
,	PMC5005937	32347	32348	O	-1	-1	0
Kuchenbaecker	PMC5005937	32349	32362	O	-1	-1	0
KB	PMC5005937	32363	32365	O	-1	-1	0
,	PMC5005937	32365	32366	O	-1	-1	0
Soucy	PMC5005937	32367	32372	O	-1	-1	0
P	PMC5005937	32373	32374	O	-1	-1	0

et	PMC5005937	32375	32377	O	-1	-1	0
al	PMC5005937	32378	32380	O	-1	-1	0
.	PMC5005937	32380	32381	O	-1	-1	0

Common	PMC5005937	32382	32388	O	-1	-1	0
variants	PMC5005937	32389	32397	O	-1	-1	0
at	PMC5005937	32398	32400	O	-1	-1	0
12p11	PMC5005937	32401	32406	O	-1	-1	0
,	PMC5005937	32406	32407	O	-1	-1	0
12q24	PMC5005937	32408	32413	O	-1	-1	0
,	PMC5005937	32413	32414	O	-1	-1	0
9p21	PMC5005937	32415	32419	O	-1	-1	0
,	PMC5005937	32419	32420	O	-1	-1	0
9q31.2	PMC5005937	32421	32427	O	-1	-1	0
and	PMC5005937	32428	32431	O	-1	-1	0
in	PMC5005937	32432	32434	O	-1	-1	0
ZNF365	PMC5005937	32435	32441	O	-1	-1	0
are	PMC5005937	32442	32445	O	-1	-1	0
associated	PMC5005937	32446	32456	O	-1	-1	0
with	PMC5005937	32457	32461	O	-1	-1	0
breast	PMC5005937	32462	32468	O	-1	-1	0
cancer	PMC5005937	32469	32475	O	-1	-1	0
risk	PMC5005937	32476	32480	O	-1	-1	0
for	PMC5005937	32481	32484	O	-1	-1	0
BRCA1	PMC5005937	32485	32490	O	-1	-1	0

and/or	PMC5005937	32491	32497	O	-1	-1	0
BRCA2	PMC5005937	32498	32503	O	-1	-1	0
mutation	PMC5005937	32504	32512	O	-1	-1	0
carriers	PMC5005937	32513	32521	O	-1	-1	0
.	PMC5005937	32521	32522	O	-1	-1	0

Breast	PMC5005937	32523	32529	O	-1	-1	0
Cancer	PMC5005937	32530	32536	O	-1	-1	0
Res	PMC5005937	32537	32540	O	-1	-1	0
2012;14	PMC5005937	32541	32548	O	-1	-1	0
:	PMC5005937	32548	32549	O	-1	-1	0
R33	PMC5005937	32549	32552	O	-1	-1	0
.	PMC5005937	32552	32553	O	-1	-1	0

Couch	PMC5005937	32554	32559	O	-1	-1	0
FJ	PMC5005937	32560	32562	O	-1	-1	0
,	PMC5005937	32562	32563	O	-1	-1	0
Gaudet	PMC5005937	32564	32570	O	-1	-1	0
MM	PMC5005937	32571	32573	O	-1	-1	0
,	PMC5005937	32573	32574	O	-1	-1	0
Antoniou	PMC5005937	32575	32583	O	-1	-1	0
AC	PMC5005937	32584	32586	O	-1	-1	0

et	PMC5005937	32587	32589	O	-1	-1	0
al	PMC5005937	32590	32592	O	-1	-1	0
.	PMC5005937	32592	32593	O	-1	-1	0

Common	PMC5005937	32594	32600	O	-1	-1	0
variants	PMC5005937	32601	32609	O	-1	-1	0
at	PMC5005937	32610	32612	O	-1	-1	0

the	PMC5005937	32613	32616	O	-1	-1	0
19p13.1	PMC5005937	32617	32624	O	-1	-1	0
and	PMC5005937	32625	32628	O	-1	-1	0
ZNF365	PMC5005937	32629	32635	O	-1	-1	0
loci	PMC5005937	32636	32640	O	-1	-1	0
are	PMC5005937	32641	32644	O	-1	-1	0
associated	PMC5005937	32645	32655	O	-1	-1	0
with	PMC5005937	32656	32660	O	-1	-1	0
ER	PMC5005937	32661	32663	O	-1	-1	0
subtypes	PMC5005937	32664	32672	O	-1	-1	0
of	PMC5005937	32673	32675	O	-1	-1	0
breast	PMC5005937	32676	32682	O	-1	-1	0
cancer	PMC5005937	32683	32689	O	-1	-1	0
and	PMC5005937	32690	32693	O	-1	-1	0
ovarian	PMC5005937	32694	32701	O	-1	-1	0
cancer	PMC5005937	32702	32708	O	-1	-1	0
risk	PMC5005937	32709	32713	O	-1	-1	0
in	PMC5005937	32714	32716	O	-1	-1	0
BRCA1	PMC5005937	32717	32722	O	-1	-1	0
and	PMC5005937	32723	32726	O	-1	-1	0
BRCA2	PMC5005937	32727	32732	O	-1	-1	0
mutation	PMC5005937	32733	32741	O	-1	-1	0
carriers	PMC5005937	32742	32750	O	-1	-1	0
.	PMC5005937	32750	32751	O	-1	-1	0

Cancer	PMC5005937	32752	32758	O	-1	-1	0
Epidemiol	PMC5005937	32759	32768	O	-1	-1	0
Biomarkers	PMC5005937	32769	32779	O	-1	-1	0
Prev	PMC5005937	32780	32784	O	-1	-1	0
2012;21	PMC5005937	32785	32792	O	-1	-1	0
:	PMC5005937	32792	32793	O	-1	-1	0

645–57	PMC5005937	32794	32800	O	-1	-1	0
.	PMC5005937	32800	32801	O	-1	-1	0

Michailidou	PMC5005937	32802	32813	O	-1	-1	0
K	PMC5005937	32814	32815	O	-1	-1	0
,	PMC5005937	32815	32816	O	-1	-1	0
Hall	PMC5005937	32817	32821	O	-1	-1	0
P	PMC5005937	32822	32823	O	-1	-1	0
,	PMC5005937	32823	32824	O	-1	-1	0
Gonzalez	PMC5005937	32825	32833	O	-1	-1	0
-	PMC5005937	32833	32834	O	-1	-1	0
Neira	PMC5005937	32834	32839	O	-1	-1	0

A	PMC5005937	32840	32841	O	-1	-1	0

et	PMC5005937	32842	32844	O	-1	-1	0
al	PMC5005937	32845	32847	O	-1	-1	0
.	PMC5005937	32847	32848	O	-1	-1	0

Large	PMC5005937	32849	32854	O	-1	-1	0
-	PMC5005937	32854	32855	O	-1	-1	0
scale	PMC5005937	32855	32860	O	-1	-1	0
genotyping	PMC5005937	32861	32871	O	-1	-1	0
identifies	PMC5005937	32872	32882	O	-1	-1	0
41	PMC5005937	32883	32885	O	-1	-1	0
new	PMC5005937	32886	32889	O	-1	-1	0
loci	PMC5005937	32890	32894	O	-1	-1	0
associated	PMC5005937	32895	32905	O	-1	-1	0
with	PMC5005937	32906	32910	O	-1	-1	0
breast	PMC5005937	32911	32917	O	-1	-1	0
cancer	PMC5005937	32918	32924	O	-1	-1	0
risk	PMC5005937	32925	32929	O	-1	-1	0
.	PMC5005937	32929	32930	O	-1	-1	0

Nat	PMC5005937	32931	32934	O	-1	-1	0
Genet	PMC5005937	32935	32940	O	-1	-1	0
2013;45:353–61	PMC5005937	32941	32955	O	-1	-1	0
.	PMC5005937	32955	32956	O	-1	-1	0

Collaborative	PMC5005937	32957	32970	O	-1	-1	0
Group	PMC5005937	32971	32976	O	-1	-1	0
on	PMC5005937	32977	32979	O	-1	-1	0
Hormonal	PMC5005937	32980	32988	O	-1	-1	0
Factors	PMC5005937	32989	32996	O	-1	-1	0
in	PMC5005937	32997	32999	O	-1	-1	0
Breast	PMC5005937	33000	33006	O	-1	-1	0
Cancer	PMC5005937	33007	33013	O	-1	-1	0
.	PMC5005937	33013	33014	O	-1	-1	0

Breast	PMC5005937	33015	33021	O	-1	-1	0
cancer	PMC5005937	33022	33028	O	-1	-1	0
and	PMC5005937	33029	33032	O	-1	-1	0
hormone	PMC5005937	33033	33040	O	-1	-1	0
replacement	PMC5005937	33041	33052	O	-1	-1	0
therapy	PMC5005937	33053	33060	O	-1	-1	0
:	PMC5005937	33060	33061	O	-1	-1	0
collaborative	PMC5005937	33062	33075	O	-1	-1	0
reanalysis	PMC5005937	33076	33086	O	-1	-1	0
of	PMC5005937	33087	33089	O	-1	-1	0
data	PMC5005937	33090	33094	O	-1	-1	0
from	PMC5005937	33095	33099	O	-1	-1	0
51	PMC5005937	33100	33102	O	-1	-1	0
epidemiological	PMC5005937	33103	33118	O	-1	-1	0
studies	PMC5005937	33119	33126	O	-1	-1	0
of	PMC5005937	33127	33129	O	-1	-1	0
52	PMC5005937	33130	33132	O	-1	-1	0
705	PMC5005937	33133	33136	O	-1	-1	0
women	PMC5005937	33137	33142	O	-1	-1	0
with	PMC5005937	33143	33147	O	-1	-1	0
breast	PMC5005937	33148	33154	O	-1	-1	0
cancer	PMC5005937	33155	33161	O	-1	-1	0
and	PMC5005937	33162	33165	O	-1	-1	0
108	PMC5005937	33166	33169	O	-1	-1	0
411	PMC5005937	33170	33173	O	-1	-1	0
women	PMC5005937	33174	33179	O	-1	-1	0
without	PMC5005937	33180	33187	O	-1	-1	0
breast	PMC5005937	33188	33194	O	-1	-1	0
cancer	PMC5005937	33195	33201	O	-1	-1	0
.	PMC5005937	33201	33202	O	-1	-1	0

Lancet	PMC5005937	33203	33209	O	-1	-1	0
1997;350:1047–59	PMC5005937	33210	33226	O	-1	-1	0
.	PMC5005937	33226	33227	O	-1	-1	0
Hamajima	PMC5005937	33228	33236	O	-1	-1	0
N	PMC5005937	33237	33238	O	-1	-1	0
,	PMC5005937	33238	33239	O	-1	-1	0
Hirose	PMC5005937	33240	33246	O	-1	-1	0
K	PMC5005937	33247	33248	O	-1	-1	0
,	PMC5005937	33248	33249	O	-1	-1	0
Tajima	PMC5005937	33250	33256	O	-1	-1	0
K	PMC5005937	33257	33258	O	-1	-1	0
et	PMC5005937	33259	33261	O	-1	-1	0
al	PMC5005937	33262	33264	O	-1	-1	0
.	PMC5005937	33264	33265	O	-1	-1	0

Alcohol	PMC5005937	33266	33273	O	-1	-1	0
,	PMC5005937	33273	33274	O	-1	-1	0
tobacco	PMC5005937	33275	33282	O	-1	-1	0
and	PMC5005937	33283	33286	O	-1	-1	0
breast	PMC5005937	33287	33293	O	-1	-1	0
cancer	PMC5005937	33294	33300	O	-1	-1	0
–	PMC5005937	33301	33302	O	-1	-1	0
collaborative	PMC5005937	33303	33316	O	-1	-1	0
reanalysis	PMC5005937	33317	33327	O	-1	-1	0
of	PMC5005937	33328	33330	O	-1	-1	0
individual	PMC5005937	33331	33341	O	-1	-1	0
data	PMC5005937	33342	33346	O	-1	-1	0
from	PMC5005937	33347	33351	O	-1	-1	0
53	PMC5005937	33352	33354	O	-1	-1	0
epidemiological	PMC5005937	33355	33370	O	-1	-1	0
studies	PMC5005937	33371	33378	O	-1	-1	0
,	PMC5005937	33378	33379	O	-1	-1	0
including	PMC5005937	33380	33389	O	-1	-1	0
58	PMC5005937	33390	33392	O	-1	-1	0
515	PMC5005937	33393	33396	O	-1	-1	0
women	PMC5005937	33397	33402	O	-1	-1	0
with	PMC5005937	33403	33407	O	-1	-1	0
breast	PMC5005937	33408	33414	O	-1	-1	0
cancer	PMC5005937	33415	33421	O	-1	-1	0
and	PMC5005937	33422	33425	O	-1	-1	0
95	PMC5005937	33426	33428	O	-1	-1	0
067	PMC5005937	33429	33432	O	-1	-1	0
women	PMC5005937	33433	33438	O	-1	-1	0
without	PMC5005937	33439	33446	O	-1	-1	0
the	PMC5005937	33447	33450	O	-1	-1	0
disease	PMC5005937	33451	33458	O	-1	-1	0
.	PMC5005937	33458	33459	O	-1	-1	0

Br	PMC5005937	33460	33462	O	-1	-1	0
J	PMC5005937	33463	33464	O	-1	-1	0
Cancer	PMC5005937	33465	33471	O	-1	-1	0
2002;87:1234–45	PMC5005937	33472	33487	O	-1	-1	0
.	PMC5005937	33487	33488	O	-1	-1	0

Colditz	PMC5005937	33489	33496	O	-1	-1	0
GA	PMC5005937	33497	33499	O	-1	-1	0
,	PMC5005937	33499	33500	O	-1	-1	0
Willett	PMC5005937	33501	33508	O	-1	-1	0
WC	PMC5005937	33509	33511	O	-1	-1	0
,	PMC5005937	33511	33512	O	-1	-1	0
Hunter	PMC5005937	33513	33519	O	-1	-1	0
DJ	PMC5005937	33520	33522	O	-1	-1	0

et	PMC5005937	33523	33525	O	-1	-1	0
al	PMC5005937	33526	33528	O	-1	-1	0
.	PMC5005937	33528	33529	O	-1	-1	0

Family	PMC5005937	33530	33536	O	-1	-1	0
history	PMC5005937	33537	33544	O	-1	-1	0
,	PMC5005937	33544	33545	O	-1	-1	0
age	PMC5005937	33546	33549	O	-1	-1	0
,	PMC5005937	33549	33550	O	-1	-1	0
and	PMC5005937	33551	33554	O	-1	-1	0
risk	PMC5005937	33555	33559	O	-1	-1	0
of	PMC5005937	33560	33562	O	-1	-1	0
breast	PMC5005937	33563	33569	O	-1	-1	0
cancer	PMC5005937	33570	33576	O	-1	-1	0
.	PMC5005937	33576	33577	O	-1	-1	0

Prospective	PMC5005937	33578	33589	O	-1	-1	0
data	PMC5005937	33590	33594	O	-1	-1	0
from	PMC5005937	33595	33599	O	-1	-1	0
the	PMC5005937	33600	33603	O	-1	-1	0
Nurses	PMC5005937	33604	33610	O	-1	-1	0
’	PMC5005937	33610	33611	O	-1	-1	0

Health	PMC5005937	33612	33618	O	-1	-1	0
Study	PMC5005937	33619	33624	O	-1	-1	0
.	PMC5005937	33624	33625	O	-1	-1	0

JAMA	PMC5005937	33626	33630	O	-1	-1	0
1993;270:338–43	PMC5005937	33631	33646	O	-1	-1	0
.	PMC5005937	33646	33647	O	-1	-1	0

Pharoah	PMC5005937	33648	33655	O	-1	-1	0
PD	PMC5005937	33656	33658	O	-1	-1	0
,	PMC5005937	33658	33659	O	-1	-1	0
Day	PMC5005937	33660	33663	O	-1	-1	0
NE	PMC5005937	33664	33666	O	-1	-1	0
,	PMC5005937	33666	33667	O	-1	-1	0
Duffy	PMC5005937	33668	33673	O	-1	-1	0
S	PMC5005937	33674	33675	O	-1	-1	0
,	PMC5005937	33675	33676	O	-1	-1	0
Easton	PMC5005937	33677	33683	O	-1	-1	0
DF	PMC5005937	33684	33686	O	-1	-1	0
,	PMC5005937	33686	33687	O	-1	-1	0
Ponder	PMC5005937	33688	33694	O	-1	-1	0
BA	PMC5005937	33695	33697	O	-1	-1	0
.	PMC5005937	33697	33698	O	-1	-1	0

Family	PMC5005937	33699	33705	O	-1	-1	0
history	PMC5005937	33706	33713	O	-1	-1	0
and	PMC5005937	33714	33717	O	-1	-1	0
the	PMC5005937	33718	33721	O	-1	-1	0
risk	PMC5005937	33722	33726	O	-1	-1	0
of	PMC5005937	33727	33729	O	-1	-1	0
breast	PMC5005937	33730	33736	O	-1	-1	0
cancer	PMC5005937	33737	33743	O	-1	-1	0
:	PMC5005937	33743	33744	O	-1	-1	0
a	PMC5005937	33745	33746	O	-1	-1	0
systematic	PMC5005937	33747	33757	O	-1	-1	0
review	PMC5005937	33758	33764	O	-1	-1	0
and	PMC5005937	33765	33768	O	-1	-1	0
meta	PMC5005937	33769	33773	O	-1	-1	0
-	PMC5005937	33773	33774	O	-1	-1	0
analysis	PMC5005937	33774	33782	O	-1	-1	0
.	PMC5005937	33782	33783	O	-1	-1	0

Int	PMC5005937	33784	33787	O	-1	-1	0
J	PMC5005937	33788	33789	O	-1	-1	0
Cancer	PMC5005937	33790	33796	O	-1	-1	0
1997;71:800–09	PMC5005937	33797	33811	O	-1	-1	0
.	PMC5005937	33811	33812	O	-1	-1	0

Houlston	PMC5005937	33813	33821	O	-1	-1	0
RS	PMC5005937	33822	33824	O	-1	-1	0
,	PMC5005937	33824	33825	O	-1	-1	0
McCarter	PMC5005937	33826	33834	O	-1	-1	0
E	PMC5005937	33835	33836	O	-1	-1	0
,	PMC5005937	33836	33837	O	-1	-1	0
Parbhoo	PMC5005937	33838	33845	O	-1	-1	0
S	PMC5005937	33846	33847	O	-1	-1	0
,	PMC5005937	33847	33848	O	-1	-1	0
Scurr	PMC5005937	33849	33854	O	-1	-1	0
JH	PMC5005937	33855	33857	O	-1	-1	0
,	PMC5005937	33857	33858	O	-1	-1	0
Slack	PMC5005937	33859	33864	O	-1	-1	0
J.	PMC5005937	33865	33867	O	-1	-1	0
Family	PMC5005937	33868	33874	O	-1	-1	0
history	PMC5005937	33875	33882	O	-1	-1	0
and	PMC5005937	33883	33886	O	-1	-1	0
risk	PMC5005937	33887	33891	O	-1	-1	0
of	PMC5005937	33892	33894	O	-1	-1	0
breast	PMC5005937	33895	33901	O	-1	-1	0
cancer	PMC5005937	33902	33908	O	-1	-1	0
.	PMC5005937	33908	33909	O	-1	-1	0

J	PMC5005937	33910	33911	O	-1	-1	0
Med	PMC5005937	33912	33915	O	-1	-1	0
Genet	PMC5005937	33916	33921	O	-1	-1	0
1992;29:154–57	PMC5005937	33922	33936	O	-1	-1	0
.	PMC5005937	33936	33937	O	-1	-1	0

Becher	PMC5005937	33938	33944	O	-1	-1	0
H	PMC5005937	33945	33946	O	-1	-1	0
,	PMC5005937	33946	33947	O	-1	-1	0
Schmidt	PMC5005937	33948	33955	O	-1	-1	0
S	PMC5005937	33956	33957	O	-1	-1	0
,	PMC5005937	33957	33958	O	-1	-1	0
Chang	PMC5005937	33959	33964	O	-1	-1	0
-	PMC5005937	33964	33965	O	-1	-1	0
Claude	PMC5005937	33965	33971	O	-1	-1	0
J.	PMC5005937	33972	33974	O	-1	-1	0
Reproductive	PMC5005937	33975	33987	O	-1	-1	0
factors	PMC5005937	33988	33995	O	-1	-1	0
and	PMC5005937	33996	33999	O	-1	-1	0
familial	PMC5005937	34000	34008	O	-1	-1	0
predisposition	PMC5005937	34009	34023	O	-1	-1	0
for	PMC5005937	34024	34027	O	-1	-1	0
breast	PMC5005937	34028	34034	O	-1	-1	0
cancer	PMC5005937	34035	34041	O	-1	-1	0
by	PMC5005937	34042	34044	O	-1	-1	0
age	PMC5005937	34045	34048	O	-1	-1	0
50	PMC5005937	34049	34051	O	-1	-1	0
years	PMC5005937	34052	34057	O	-1	-1	0
.	PMC5005937	34057	34058	O	-1	-1	0

A	PMC5005937	34059	34060	O	-1	-1	0
casecontrol	PMC5005937	34061	34072	O	-1	-1	0
-	PMC5005937	34072	34073	O	-1	-1	0
family	PMC5005937	34073	34079	O	-1	-1	0
study	PMC5005937	34080	34085	O	-1	-1	0
for	PMC5005937	34086	34089	O	-1	-1	0
assessing	PMC5005937	34090	34099	O	-1	-1	0
main	PMC5005937	34100	34104	O	-1	-1	0
effects	PMC5005937	34105	34112	O	-1	-1	0
and	PMC5005937	34113	34116	O	-1	-1	0
possible	PMC5005937	34117	34125	O	-1	-1	0
geneenvironment	PMC5005937	34126	34141	O	-1	-1	0
interaction	PMC5005937	34142	34153	O	-1	-1	0
.	PMC5005937	34153	34154	O	-1	-1	0

Int	PMC5005937	34155	34158	O	-1	-1	0
J	PMC5005937	34159	34160	O	-1	-1	0
Epidemiol	PMC5005937	34161	34170	O	-1	-1	0
2003;32:38–48	PMC5005937	34171	34184	O	-1	-1	0
.	PMC5005937	34184	34185	O	-1	-1	0

Delgado	PMC5005937	34186	34193	O	-1	-1	0
-	PMC5005937	34193	34194	O	-1	-1	0
Cruzata	PMC5005937	34194	34201	O	-1	-1	0
L	PMC5005937	34202	34203	O	-1	-1	0
,	PMC5005937	34203	34204	O	-1	-1	0
Wu	PMC5005937	34205	34207	O	-1	-1	0
HC	PMC5005937	34208	34210	O	-1	-1	0
,	PMC5005937	34210	34211	O	-1	-1	0
Liao	PMC5005937	34212	34216	O	-1	-1	0
Y	PMC5005937	34217	34218	O	-1	-1	0
,	PMC5005937	34218	34219	O	-1	-1	0
Santella	PMC5005937	34220	34228	O	-1	-1	0
RM	PMC5005937	34229	34231	O	-1	-1	0
,	PMC5005937	34231	34232	O	-1	-1	0
Terry	PMC5005937	34233	34238	O	-1	-1	0
MB	PMC5005937	34239	34241	O	-1	-1	0
.	PMC5005937	34241	34242	O	-1	-1	0

Differences	PMC5005937	34243	34254	O	-1	-1	0
in	PMC5005937	34255	34257	O	-1	-1	0
DNA	PMC5005937	34258	34261	O	-1	-1	0
methylation	PMC5005937	34262	34273	O	-1	-1	0
by	PMC5005937	34274	34276	O	-1	-1	0
extent	PMC5005937	34277	34283	O	-1	-1	0
of	PMC5005937	34284	34286	O	-1	-1	0
breast	PMC5005937	34287	34293	O	-1	-1	0
cancer	PMC5005937	34294	34300	O	-1	-1	0
family	PMC5005937	34301	34307	O	-1	-1	0
history	PMC5005937	34308	34315	O	-1	-1	0
in	PMC5005937	34316	34318	O	-1	-1	0
unaffected	PMC5005937	34319	34329	O	-1	-1	0
women	PMC5005937	34330	34335	O	-1	-1	0
.	PMC5005937	34335	34336	O	-1	-1	0

Epigenetics	PMC5005937	34337	34348	O	-1	-1	0
2014;9:243–48	PMC5005937	34349	34362	O	-1	-1	0
.	PMC5005937	34362	34363	O	-1	-1	0


	PMC5005937	34363	34365	O	-1	-1	0

691	PMC5005937	34365	34368	O	-1	-1	0

18	PMC5005937	34369	34371	O	-1	-1	0
.	PMC5005937	34371	34372	O	-1	-1	0

Hopper	PMC5005937	34373	34379	O	-1	-1	0
JL	PMC5005937	34380	34382	O	-1	-1	0
,	PMC5005937	34382	34383	O	-1	-1	0
Carlin	PMC5005937	34384	34390	O	-1	-1	0
JB	PMC5005937	34391	34393	O	-1	-1	0
.	PMC5005937	34393	34394	O	-1	-1	0

Familial	PMC5005937	34395	34403	O	-1	-1	0
aggregation	PMC5005937	34404	34415	O	-1	-1	0
of	PMC5005937	34416	34418	O	-1	-1	0
a	PMC5005937	34419	34420	O	-1	-1	0
disease	PMC5005937	34421	34428	O	-1	-1	0
consequent	PMC5005937	34429	34439	O	-1	-1	0
upon	PMC5005937	34440	34444	O	-1	-1	0
correlation	PMC5005937	34445	34456	O	-1	-1	0
between	PMC5005937	34457	34464	O	-1	-1	0
relatives	PMC5005937	34465	34474	O	-1	-1	0
in	PMC5005937	34475	34477	O	-1	-1	0
a	PMC5005937	34478	34479	O	-1	-1	0
risk	PMC5005937	34480	34484	O	-1	-1	0
factor	PMC5005937	34485	34491	O	-1	-1	0
measured	PMC5005937	34492	34500	O	-1	-1	0
on	PMC5005937	34501	34503	O	-1	-1	0
a	PMC5005937	34504	34505	O	-1	-1	0
continuous	PMC5005937	34506	34516	O	-1	-1	0
scale	PMC5005937	34517	34522	O	-1	-1	0
.	PMC5005937	34522	34523	O	-1	-1	0

Am	PMC5005937	34524	34526	O	-1	-1	0
J	PMC5005937	34527	34528	O	-1	-1	0
Epidemiol	PMC5005937	34529	34538	O	-1	-1	0
1992;136	PMC5005937	34539	34547	O	-1	-1	0
:	PMC5005937	34547	34548	O	-1	-1	0

1138–47	PMC5005937	34549	34556	O	-1	-1	0
.	PMC5005937	34556	34557	O	-1	-1	0

19	PMC5005937	34558	34560	O	-1	-1	0
.	PMC5005937	34560	34561	O	-1	-1	0

Hopper	PMC5005937	34562	34568	O	-1	-1	0
JL	PMC5005937	34569	34571	O	-1	-1	0
.	PMC5005937	34571	34572	O	-1	-1	0

Disease	PMC5005937	34573	34580	O	-1	-1	0
-	PMC5005937	34580	34581	O	-1	-1	0
specific	PMC5005937	34581	34589	O	-1	-1	0
prospective	PMC5005937	34590	34601	O	-1	-1	0
family	PMC5005937	34602	34608	O	-1	-1	0
study	PMC5005937	34609	34614	O	-1	-1	0
cohorts	PMC5005937	34615	34622	O	-1	-1	0
enriched	PMC5005937	34623	34631	O	-1	-1	0
for	PMC5005937	34632	34635	O	-1	-1	0
familial	PMC5005937	34636	34644	O	-1	-1	0
risk	PMC5005937	34645	34649	O	-1	-1	0
.	PMC5005937	34649	34650	O	-1	-1	0

Epidemiol	PMC5005937	34651	34660	O	-1	-1	0
Perspct	PMC5005937	34661	34668	O	-1	-1	0
Innov	PMC5005937	34669	34674	O	-1	-1	0
2011;8:2	PMC5005937	34675	34683	O	-1	-1	0
.	PMC5005937	34683	34684	O	-1	-1	0

20	PMC5005937	34685	34687	O	-1	-1	0
.	PMC5005937	34687	34688	O	-1	-1	0

Sellers	PMC5005937	34689	34696	O	-1	-1	0
TA	PMC5005937	34697	34699	O	-1	-1	0
,	PMC5005937	34699	34700	O	-1	-1	0
Anderson	PMC5005937	34701	34709	O	-1	-1	0
VE	PMC5005937	34710	34712	O	-1	-1	0
,	PMC5005937	34712	34713	O	-1	-1	0
Potter	PMC5005937	34714	34720	O	-1	-1	0
JD	PMC5005937	34721	34723	O	-1	-1	0

et	PMC5005937	34724	34726	O	-1	-1	0
al	PMC5005937	34727	34729	O	-1	-1	0
.	PMC5005937	34729	34730	O	-1	-1	0

Epidemiologic	PMC5005937	34731	34744	O	-1	-1	0
and	PMC5005937	34745	34748	O	-1	-1	0
genetic	PMC5005937	34749	34756	O	-1	-1	0
follow	PMC5005937	34757	34763	O	-1	-1	0
-	PMC5005937	34763	34764	O	-1	-1	0
up	PMC5005937	34764	34766	O	-1	-1	0
study	PMC5005937	34767	34772	O	-1	-1	0
of	PMC5005937	34773	34775	O	-1	-1	0
544	PMC5005937	34776	34779	O	-1	-1	0
Minnesota	PMC5005937	34780	34789	O	-1	-1	0
breast	PMC5005937	34790	34796	O	-1	-1	0
cancer	PMC5005937	34797	34803	O	-1	-1	0
families	PMC5005937	34804	34812	O	-1	-1	0
:	PMC5005937	34812	34813	O	-1	-1	0
design	PMC5005937	34814	34820	O	-1	-1	0
and	PMC5005937	34821	34824	O	-1	-1	0
methods	PMC5005937	34825	34832	O	-1	-1	0
.	PMC5005937	34832	34833	O	-1	-1	0

Genet	PMC5005937	34834	34839	O	-1	-1	0
Epidemiol	PMC5005937	34840	34849	O	-1	-1	0
1995;12:417–29	PMC5005937	34850	34864	O	-1	-1	0
.	PMC5005937	34864	34865	O	-1	-1	0

21	PMC5005937	34866	34868	O	-1	-1	0
.	PMC5005937	34868	34869	O	-1	-1	0

Sellers	PMC5005937	34870	34877	O	-1	-1	0
TA	PMC5005937	34878	34880	O	-1	-1	0
,	PMC5005937	34880	34881	O	-1	-1	0
King	PMC5005937	34882	34886	O	-1	-1	0
RA	PMC5005937	34887	34889	O	-1	-1	0
,	PMC5005937	34889	34890	O	-1	-1	0
Cerhan	PMC5005937	34891	34897	O	-1	-1	0
JR	PMC5005937	34898	34900	O	-1	-1	0

et	PMC5005937	34901	34903	O	-1	-1	0
al	PMC5005937	34904	34906	O	-1	-1	0
.	PMC5005937	34906	34907	O	-1	-1	0

Fifty	PMC5005937	34908	34913	O	-1	-1	0
-	PMC5005937	34913	34914	O	-1	-1	0
year	PMC5005937	34914	34918	O	-1	-1	0
follow	PMC5005937	34919	34925	O	-1	-1	0
-	PMC5005937	34925	34926	O	-1	-1	0
up	PMC5005937	34926	34928	O	-1	-1	0
of	PMC5005937	34929	34931	O	-1	-1	0
cancer	PMC5005937	34932	34938	O	-1	-1	0
incidence	PMC5005937	34939	34948	O	-1	-1	0
in	PMC5005937	34949	34951	O	-1	-1	0
a	PMC5005937	34952	34953	O	-1	-1	0
historical	PMC5005937	34954	34964	O	-1	-1	0
cohort	PMC5005937	34965	34971	O	-1	-1	0
of	PMC5005937	34972	34974	O	-1	-1	0
Minnesota	PMC5005937	34975	34984	O	-1	-1	0
breast	PMC5005937	34985	34991	O	-1	-1	0
cancer	PMC5005937	34992	34998	O	-1	-1	0
families	PMC5005937	34999	35007	O	-1	-1	0
.	PMC5005937	35007	35008	O	-1	-1	0

Cancer	PMC5005937	35009	35015	O	-1	-1	0
Epidemiol	PMC5005937	35016	35025	O	-1	-1	0
Biomarkers	PMC5005937	35026	35036	O	-1	-1	0
Prev	PMC5005937	35037	35041	O	-1	-1	0
1999;8:1051–57	PMC5005937	35042	35056	O	-1	-1	0
.	PMC5005937	35056	35057	O	-1	-1	0

22	PMC5005937	35058	35060	O	-1	-1	0
.	PMC5005937	35060	35061	O	-1	-1	0

Cerhan	PMC5005937	35062	35068	O	-1	-1	0
JR	PMC5005937	35069	35071	O	-1	-1	0
,	PMC5005937	35071	35072	O	-1	-1	0
Grabrick	PMC5005937	35073	35081	O	-1	-1	0
DM	PMC5005937	35082	35084	O	-1	-1	0
,	PMC5005937	35084	35085	O	-1	-1	0
Vierkant	PMC5005937	35086	35094	O	-1	-1	0
RA	PMC5005937	35095	35097	O	-1	-1	0

et	PMC5005937	35098	35100	O	-1	-1	0
al	PMC5005937	35101	35103	O	-1	-1	0
.	PMC5005937	35103	35104	O	-1	-1	0

Interaction	PMC5005937	35105	35116	O	-1	-1	0
of	PMC5005937	35117	35119	O	-1	-1	0
adolescent	PMC5005937	35120	35130	O	-1	-1	0
anthropometric	PMC5005937	35131	35145	O	-1	-1	0
characteristics	PMC5005937	35146	35161	O	-1	-1	0
and	PMC5005937	35162	35165	O	-1	-1	0
family	PMC5005937	35166	35172	O	-1	-1	0
history	PMC5005937	35173	35180	O	-1	-1	0
on	PMC5005937	35181	35183	O	-1	-1	0
breast	PMC5005937	35184	35190	O	-1	-1	0
cancer	PMC5005937	35191	35197	O	-1	-1	0
risk	PMC5005937	35198	35202	O	-1	-1	0
in	PMC5005937	35203	35205	O	-1	-1	0
a	PMC5005937	35206	35207	O	-1	-1	0
Historical	PMC5005937	35208	35218	O	-1	-1	0
Cohort	PMC5005937	35219	35225	O	-1	-1	0
Study	PMC5005937	35226	35231	O	-1	-1	0
of	PMC5005937	35232	35234	O	-1	-1	0
426	PMC5005937	35235	35238	O	-1	-1	0
families	PMC5005937	35239	35247	O	-1	-1	0

(	PMC5005937	35248	35249	O	-1	-1	0
USA	PMC5005937	35249	35252	O	-1	-1	0
)	PMC5005937	35252	35253	O	-1	-1	0
.	PMC5005937	35253	35254	O	-1	-1	0

Cancer	PMC5005937	35255	35261	O	-1	-1	0
Causes	PMC5005937	35262	35268	O	-1	-1	0

Control	PMC5005937	35269	35276	O	-1	-1	0
2004;15:1–9	PMC5005937	35277	35288	O	-1	-1	0
.	PMC5005937	35288	35289	O	-1	-1	0

23	PMC5005937	35290	35292	O	-1	-1	0
.	PMC5005937	35292	35293	O	-1	-1	0

Vachon	PMC5005937	35294	35300	O	-1	-1	0
CM	PMC5005937	35301	35303	O	-1	-1	0
,	PMC5005937	35303	35304	O	-1	-1	0
Cerhan	PMC5005937	35305	35311	O	-1	-1	0
JR	PMC5005937	35312	35314	O	-1	-1	0
,	PMC5005937	35314	35315	O	-1	-1	0
Vierkant	PMC5005937	35316	35324	O	-1	-1	0
RA	PMC5005937	35325	35327	O	-1	-1	0
,	PMC5005937	35327	35328	O	-1	-1	0
Sellers	PMC5005937	35329	35336	O	-1	-1	0
TA	PMC5005937	35337	35339	O	-1	-1	0
.	PMC5005937	35339	35340	O	-1	-1	0

Investigation	PMC5005937	35341	35354	O	-1	-1	0
of	PMC5005937	35355	35357	O	-1	-1	0
an	PMC5005937	35358	35360	O	-1	-1	0
interaction	PMC5005937	35361	35372	O	-1	-1	0
of	PMC5005937	35373	35375	O	-1	-1	0
alcohol	PMC5005937	35376	35383	O	-1	-1	0
intake	PMC5005937	35384	35390	O	-1	-1	0
and	PMC5005937	35391	35394	O	-1	-1	0
family	PMC5005937	35395	35401	O	-1	-1	0
history	PMC5005937	35402	35409	O	-1	-1	0
on	PMC5005937	35410	35412	O	-1	-1	0
breast	PMC5005937	35413	35419	O	-1	-1	0
cancer	PMC5005937	35420	35426	O	-1	-1	0
risk	PMC5005937	35427	35431	O	-1	-1	0
in	PMC5005937	35432	35434	O	-1	-1	0
the	PMC5005937	35435	35438	O	-1	-1	0
Minnesota	PMC5005937	35439	35448	O	-1	-1	0
Breast	PMC5005937	35449	35455	O	-1	-1	0
Cancer	PMC5005937	35456	35462	O	-1	-1	0
Family	PMC5005937	35463	35469	O	-1	-1	0
Study	PMC5005937	35470	35475	O	-1	-1	0
.	PMC5005937	35475	35476	O	-1	-1	0

Cancer	PMC5005937	35477	35483	O	-1	-1	0
2001;92:240–48	PMC5005937	35484	35498	O	-1	-1	0
.	PMC5005937	35498	35499	O	-1	-1	0

24	PMC5005937	35500	35502	O	-1	-1	0
.	PMC5005937	35502	35503	O	-1	-1	0

Xu	PMC5005937	35504	35506	O	-1	-1	0
Z	PMC5005937	35507	35508	O	-1	-1	0
,	PMC5005937	35508	35509	O	-1	-1	0
Bolick	PMC5005937	35510	35516	O	-1	-1	0
SC	PMC5005937	35517	35519	O	-1	-1	0
,	PMC5005937	35519	35520	O	-1	-1	0
DeRoo	PMC5005937	35521	35526	O	-1	-1	0
LA	PMC5005937	35527	35529	O	-1	-1	0
,	PMC5005937	35529	35530	O	-1	-1	0
Weinberg	PMC5005937	35531	35539	O	-1	-1	0
CR	PMC5005937	35540	35542	O	-1	-1	0
,	PMC5005937	35542	35543	O	-1	-1	0
Sandler	PMC5005937	35544	35551	O	-1	-1	0
DP	PMC5005937	35552	35554	O	-1	-1	0
,	PMC5005937	35554	35555	O	-1	-1	0
Taylor	PMC5005937	35556	35562	O	-1	-1	0

JA	PMC5005937	35563	35565	O	-1	-1	0
.	PMC5005937	35565	35566	O	-1	-1	0

Epigenome	PMC5005937	35567	35576	O	-1	-1	0
-	PMC5005937	35576	35577	O	-1	-1	0
wide	PMC5005937	35577	35581	O	-1	-1	0
association	PMC5005937	35582	35593	O	-1	-1	0
study	PMC5005937	35594	35599	O	-1	-1	0
of	PMC5005937	35600	35602	O	-1	-1	0
breast	PMC5005937	35603	35609	O	-1	-1	0
cancer	PMC5005937	35610	35616	O	-1	-1	0
using	PMC5005937	35617	35622	O	-1	-1	0
prospectively	PMC5005937	35623	35636	O	-1	-1	0
collected	PMC5005937	35637	35646	O	-1	-1	0
sister	PMC5005937	35647	35653	O	-1	-1	0
study	PMC5005937	35654	35659	O	-1	-1	0
samples	PMC5005937	35660	35667	O	-1	-1	0
.	PMC5005937	35667	35668	O	-1	-1	0

J	PMC5005937	35669	35670	O	-1	-1	0
Natl	PMC5005937	35671	35675	O	-1	-1	0
Cancer	PMC5005937	35676	35682	O	-1	-1	0
Inst	PMC5005937	35683	35687	O	-1	-1	0
2013;105:694–700	PMC5005937	35688	35704	O	-1	-1	0
.	PMC5005937	35704	35705	O	-1	-1	0

25	PMC5005937	35706	35708	O	-1	-1	0
.	PMC5005937	35708	35709	O	-1	-1	0

Price	PMC5005937	35710	35715	O	-1	-1	0
MA	PMC5005937	35716	35718	O	-1	-1	0
,	PMC5005937	35718	35719	O	-1	-1	0
Butow	PMC5005937	35720	35725	O	-1	-1	0
PN	PMC5005937	35726	35728	O	-1	-1	0
,	PMC5005937	35728	35729	O	-1	-1	0
Charles	PMC5005937	35730	35737	O	-1	-1	0
M	PMC5005937	35738	35739	O	-1	-1	0

et	PMC5005937	35740	35742	O	-1	-1	0
al	PMC5005937	35743	35745	O	-1	-1	0
.	PMC5005937	35745	35746	O	-1	-1	0

Predictors	PMC5005937	35747	35757	O	-1	-1	0
of	PMC5005937	35758	35760	O	-1	-1	0
breast	PMC5005937	35761	35767	O	-1	-1	0
cancer	PMC5005937	35768	35774	O	-1	-1	0
screening	PMC5005937	35775	35784	O	-1	-1	0
behavior	PMC5005937	35785	35793	O	-1	-1	0
in	PMC5005937	35794	35796	O	-1	-1	0
women	PMC5005937	35797	35802	O	-1	-1	0
with	PMC5005937	35803	35807	O	-1	-1	0
a	PMC5005937	35808	35809	O	-1	-1	0
strong	PMC5005937	35810	35816	O	-1	-1	0
family	PMC5005937	35817	35823	O	-1	-1	0
history	PMC5005937	35824	35831	O	-1	-1	0
of	PMC5005937	35832	35834	O	-1	-1	0
the	PMC5005937	35835	35838	O	-1	-1	0
disease	PMC5005937	35839	35846	O	-1	-1	0
.	PMC5005937	35846	35847	O	-1	-1	0

BreastCancer	PMC5005937	35848	35860	O	-1	-1	0
Res	PMC5005937	35861	35864	O	-1	-1	0
Treat	PMC5005937	35865	35870	O	-1	-1	0
2010;124:509–19	PMC5005937	35871	35886	O	-1	-1	0
.	PMC5005937	35886	35887	O	-1	-1	0

26	PMC5005937	35888	35890	O	-1	-1	0
.	PMC5005937	35890	35891	O	-1	-1	0

Antill	PMC5005937	35892	35898	O	-1	-1	0
YC	PMC5005937	35899	35901	O	-1	-1	0
,	PMC5005937	35901	35902	O	-1	-1	0
Reynolds	PMC5005937	35903	35911	O	-1	-1	0
J	PMC5005937	35912	35913	O	-1	-1	0
,	PMC5005937	35913	35914	O	-1	-1	0
Young	PMC5005937	35915	35920	O	-1	-1	0
MA	PMC5005937	35921	35923	O	-1	-1	0

et	PMC5005937	35924	35926	O	-1	-1	0
al	PMC5005937	35927	35929	O	-1	-1	0
.	PMC5005937	35929	35930	O	-1	-1	0

Screening	PMC5005937	35931	35940	O	-1	-1	0
behavior	PMC5005937	35941	35949	O	-1	-1	0
in	PMC5005937	35950	35952	O	-1	-1	0
women	PMC5005937	35953	35958	O	-1	-1	0
at	PMC5005937	35959	35961	O	-1	-1	0
increased	PMC5005937	35962	35971	O	-1	-1	0
familial	PMC5005937	35972	35980	O	-1	-1	0
risk	PMC5005937	35981	35985	O	-1	-1	0
for	PMC5005937	35986	35989	O	-1	-1	0
breast	PMC5005937	35990	35996	O	-1	-1	0
cancer	PMC5005937	35997	36003	O	-1	-1	0
.	PMC5005937	36003	36004	O	-1	-1	0

Fam	PMC5005937	36005	36008	O	-1	-1	0
Cancer	PMC5005937	36009	36015	O	-1	-1	0

2006;5:359–68	PMC5005937	36016	36029	O	-1	-1	0
.	PMC5005937	36029	36030	O	-1	-1	0

27	PMC5005937	36031	36033	O	-1	-1	0
.	PMC5005937	36033	36034	O	-1	-1	0

Collins	PMC5005937	36035	36042	O	-1	-1	0
IM	PMC5005937	36043	36045	O	-1	-1	0
,	PMC5005937	36045	36046	O	-1	-1	0
Milne	PMC5005937	36047	36052	O	-1	-1	0
RL	PMC5005937	36053	36055	O	-1	-1	0
,	PMC5005937	36055	36056	O	-1	-1	0
Weideman	PMC5005937	36057	36065	O	-1	-1	0
PC	PMC5005937	36066	36068	O	-1	-1	0

et	PMC5005937	36069	36071	O	-1	-1	0
al	PMC5005937	36072	36074	O	-1	-1	0
.	PMC5005937	36074	36075	O	-1	-1	0

Preventing	PMC5005937	36076	36086	O	-1	-1	0
breast	PMC5005937	36087	36093	O	-1	-1	0
and	PMC5005937	36094	36097	O	-1	-1	0

ovarian	PMC5005937	36098	36105	O	-1	-1	0
cancers	PMC5005937	36106	36113	O	-1	-1	0
in	PMC5005937	36114	36116	O	-1	-1	0
high	PMC5005937	36117	36121	O	-1	-1	0
-	PMC5005937	36121	36122	O	-1	-1	0
risk	PMC5005937	36122	36126	O	-1	-1	0
BRCA1	PMC5005937	36127	36132	O	-1	-1	0
and	PMC5005937	36133	36136	O	-1	-1	0
BRCA2	PMC5005937	36137	36142	O	-1	-1	0
mutation	PMC5005937	36143	36151	O	-1	-1	0
carriers	PMC5005937	36152	36160	O	-1	-1	0
.	PMC5005937	36160	36161	O	-1	-1	0

Med	PMC5005937	36162	36165	O	-1	-1	0
J	PMC5005937	36166	36167	O	-1	-1	0
Aust	PMC5005937	36168	36172	O	-1	-1	0
2013;199:680–83	PMC5005937	36173	36188	O	-1	-1	0
.	PMC5005937	36188	36189	O	-1	-1	0

28	PMC5005937	36190	36192	O	-1	-1	0
.	PMC5005937	36192	36193	O	-1	-1	0

Kiely	PMC5005937	36194	36199	O	-1	-1	0
BE	PMC5005937	36200	36202	O	-1	-1	0
,	PMC5005937	36202	36203	O	-1	-1	0
Jenkins	PMC5005937	36204	36211	O	-1	-1	0
MA	PMC5005937	36212	36214	O	-1	-1	0
,	PMC5005937	36214	36215	O	-1	-1	0
McKinley	PMC5005937	36216	36224	O	-1	-1	0
JM	PMC5005937	36225	36227	O	-1	-1	0

et	PMC5005937	36228	36230	O	-1	-1	0
al	PMC5005937	36231	36233	O	-1	-1	0
.	PMC5005937	36233	36234	O	-1	-1	0

Contralateral	PMC5005937	36235	36248	O	-1	-1	0
riskreducing	PMC5005937	36249	36261	O	-1	-1	0
mastectomy	PMC5005937	36262	36272	O	-1	-1	0
in	PMC5005937	36273	36275	O	-1	-1	0
BRCA1	PMC5005937	36276	36281	O	-1	-1	0
and	PMC5005937	36282	36285	O	-1	-1	0
BRCA2	PMC5005937	36286	36291	O	-1	-1	0
mutation	PMC5005937	36292	36300	O	-1	-1	0
carriers	PMC5005937	36301	36309	O	-1	-1	0
and	PMC5005937	36310	36313	O	-1	-1	0
other	PMC5005937	36314	36319	O	-1	-1	0
high	PMC5005937	36320	36324	O	-1	-1	0
-	PMC5005937	36324	36325	O	-1	-1	0
risk	PMC5005937	36325	36329	O	-1	-1	0
women	PMC5005937	36330	36335	O	-1	-1	0
in	PMC5005937	36336	36338	O	-1	-1	0
the	PMC5005937	36339	36342	O	-1	-1	0
Kathleen	PMC5005937	36343	36351	O	-1	-1	0
Cuningham	PMC5005937	36352	36361	O	-1	-1	0
Foundation	PMC5005937	36362	36372	O	-1	-1	0
Consortium	PMC5005937	36373	36383	O	-1	-1	0
for	PMC5005937	36384	36387	O	-1	-1	0
Research	PMC5005937	36388	36396	O	-1	-1	0
into	PMC5005937	36397	36401	O	-1	-1	0
Familial	PMC5005937	36402	36410	O	-1	-1	0
Breast	PMC5005937	36411	36417	O	-1	-1	0
Cancer	PMC5005937	36418	36424	O	-1	-1	0
(	PMC5005937	36425	36426	O	-1	-1	0
kConFab	PMC5005937	36426	36433	O	-1	-1	0
)	PMC5005937	36433	36434	O	-1	-1	0
.	PMC5005937	36434	36435	O	-1	-1	0

Breast	PMC5005937	36436	36442	O	-1	-1	0
Cancer	PMC5005937	36443	36449	O	-1	-1	0
Res	PMC5005937	36450	36453	O	-1	-1	0
Treat	PMC5005937	36454	36459	O	-1	-1	0
2010;120:715–23	PMC5005937	36460	36475	O	-1	-1	0
.	PMC5005937	36475	36476	O	-1	-1	0

29	PMC5005937	36477	36479	O	-1	-1	0
.	PMC5005937	36479	36480	O	-1	-1	0

John	PMC5005937	36481	36485	O	-1	-1	0
EM	PMC5005937	36486	36488	O	-1	-1	0
,	PMC5005937	36488	36489	O	-1	-1	0
Hopper	PMC5005937	36490	36496	O	-1	-1	0
JL	PMC5005937	36497	36499	O	-1	-1	0
,	PMC5005937	36499	36500	O	-1	-1	0
Beck	PMC5005937	36501	36505	O	-1	-1	0
JC	PMC5005937	36506	36508	O	-1	-1	0
et	PMC5005937	36509	36511	O	-1	-1	0
al	PMC5005937	36512	36514	O	-1	-1	0
.	PMC5005937	36514	36515	O	-1	-1	0

The	PMC5005937	36516	36519	O	-1	-1	0
Breast	PMC5005937	36520	36526	O	-1	-1	0
Cancer	PMC5005937	36527	36533	O	-1	-1	0
Family	PMC5005937	36534	36540	O	-1	-1	0
Registry	PMC5005937	36541	36549	O	-1	-1	0
:	PMC5005937	36549	36550	O	-1	-1	0
an	PMC5005937	36551	36553	O	-1	-1	0
infrastructure	PMC5005937	36554	36568	O	-1	-1	0
for	PMC5005937	36569	36572	O	-1	-1	0
cooperative	PMC5005937	36573	36584	O	-1	-1	0
multinational	PMC5005937	36585	36598	O	-1	-1	0
,	PMC5005937	36598	36599	O	-1	-1	0
interdisciplinary	PMC5005937	36600	36617	O	-1	-1	0
and	PMC5005937	36618	36621	O	-1	-1	0
translational	PMC5005937	36622	36635	O	-1	-1	0
studies	PMC5005937	36636	36643	O	-1	-1	0
of	PMC5005937	36644	36646	O	-1	-1	0
the	PMC5005937	36647	36650	O	-1	-1	0
genetic	PMC5005937	36651	36658	O	-1	-1	0
epidemiology	PMC5005937	36659	36671	O	-1	-1	0
of	PMC5005937	36672	36674	O	-1	-1	0
breast	PMC5005937	36675	36681	O	-1	-1	0
cancer	PMC5005937	36682	36688	O	-1	-1	0
.	PMC5005937	36688	36689	O	-1	-1	0

Breast	PMC5005937	36690	36696	O	-1	-1	0
Cancer	PMC5005937	36697	36703	O	-1	-1	0
Res	PMC5005937	36704	36707	O	-1	-1	0

2004;6	PMC5005937	36708	36714	O	-1	-1	0
:	PMC5005937	36714	36715	O	-1	-1	0
R375–89	PMC5005937	36715	36722	O	-1	-1	0
.	PMC5005937	36722	36723	O	-1	-1	0

30	PMC5005937	36724	36726	O	-1	-1	0
.	PMC5005937	36726	36727	O	-1	-1	0

Osborne	PMC5005937	36728	36735	O	-1	-1	0
RH	PMC5005937	36736	36738	O	-1	-1	0
,	PMC5005937	36738	36739	O	-1	-1	0
Hopper	PMC5005937	36740	36746	O	-1	-1	0
JL	PMC5005937	36747	36749	O	-1	-1	0
,	PMC5005937	36749	36750	O	-1	-1	0
Kirk	PMC5005937	36751	36755	O	-1	-1	0
JA	PMC5005937	36756	36758	O	-1	-1	0
,	PMC5005937	36758	36759	O	-1	-1	0
Chenevix	PMC5005937	36760	36768	O	-1	-1	0
-	PMC5005937	36768	36769	O	-1	-1	0
Trench	PMC5005937	36769	36775	O	-1	-1	0
G	PMC5005937	36776	36777	O	-1	-1	0
,	PMC5005937	36777	36778	O	-1	-1	0
Thorne	PMC5005937	36779	36785	O	-1	-1	0
HJ	PMC5005937	36786	36788	O	-1	-1	0
,	PMC5005937	36788	36789	O	-1	-1	0
Sambrook	PMC5005937	36790	36798	O	-1	-1	0
JF	PMC5005937	36799	36801	O	-1	-1	0
.	PMC5005937	36801	36802	O	-1	-1	0

kConFab	PMC5005937	36803	36810	O	-1	-1	0
:	PMC5005937	36810	36811	O	-1	-1	0
a	PMC5005937	36812	36813	O	-1	-1	0
research	PMC5005937	36814	36822	O	-1	-1	0
resource	PMC5005937	36823	36831	O	-1	-1	0
of	PMC5005937	36832	36834	O	-1	-1	0
Australasian	PMC5005937	36835	36847	O	-1	-1	0
breast	PMC5005937	36848	36854	O	-1	-1	0
cancer	PMC5005937	36855	36861	O	-1	-1	0
families	PMC5005937	36862	36870	O	-1	-1	0
.	PMC5005937	36870	36871	O	-1	-1	0

Kathleen	PMC5005937	36872	36880	O	-1	-1	0
Cuningham	PMC5005937	36881	36890	O	-1	-1	0
Foundation	PMC5005937	36891	36901	O	-1	-1	0
Consortium	PMC5005937	36902	36912	O	-1	-1	0
for	PMC5005937	36913	36916	O	-1	-1	0
Research	PMC5005937	36917	36925	O	-1	-1	0
into	PMC5005937	36926	36930	O	-1	-1	0
Familial	PMC5005937	36931	36939	O	-1	-1	0
Breast	PMC5005937	36940	36946	O	-1	-1	0
Cancer	PMC5005937	36947	36953	O	-1	-1	0
.	PMC5005937	36953	36954	O	-1	-1	0

Med	PMC5005937	36955	36958	O	-1	-1	0
J	PMC5005937	36959	36960	O	-1	-1	0
Aust	PMC5005937	36961	36965	O	-1	-1	0
2000;172:463–64	PMC5005937	36966	36981	O	-1	-1	0
.	PMC5005937	36981	36982	O	-1	-1	0

31	PMC5005937	36983	36985	O	-1	-1	0
.	PMC5005937	36985	36986	O	-1	-1	0

Phillips	PMC5005937	36987	36995	O	-1	-1	0
KA	PMC5005937	36996	36998	O	-1	-1	0
,	PMC5005937	36998	36999	O	-1	-1	0
Butow	PMC5005937	37000	37005	O	-1	-1	0
PN	PMC5005937	37006	37008	O	-1	-1	0
,	PMC5005937	37008	37009	O	-1	-1	0
Stewart	PMC5005937	37010	37017	O	-1	-1	0
AE	PMC5005937	37018	37020	O	-1	-1	0
et	PMC5005937	37021	37023	O	-1	-1	0
al	PMC5005937	37024	37026	O	-1	-1	0
.	PMC5005937	37026	37027	O	-1	-1	0

Predictors	PMC5005937	37028	37038	O	-1	-1	0
of	PMC5005937	37039	37041	O	-1	-1	0
participation	PMC5005937	37042	37055	O	-1	-1	0
in	PMC5005937	37056	37058	O	-1	-1	0
clinical	PMC5005937	37059	37067	O	-1	-1	0
and	PMC5005937	37068	37071	O	-1	-1	0
psychosocial	PMC5005937	37072	37084	O	-1	-1	0
follow	PMC5005937	37085	37091	O	-1	-1	0
-	PMC5005937	37091	37092	O	-1	-1	0
up	PMC5005937	37092	37094	O	-1	-1	0
of	PMC5005937	37095	37097	O	-1	-1	0
the	PMC5005937	37098	37101	O	-1	-1	0
kConFab	PMC5005937	37102	37109	O	-1	-1	0
breast	PMC5005937	37110	37116	O	-1	-1	0
cancer	PMC5005937	37117	37123	O	-1	-1	0
family	PMC5005937	37124	37130	O	-1	-1	0
cohort	PMC5005937	37131	37137	O	-1	-1	0
.	PMC5005937	37137	37138	O	-1	-1	0

Fam	PMC5005937	37139	37142	O	-1	-1	0
Cancer	PMC5005937	37143	37149	O	-1	-1	0
2005;4:105–13	PMC5005937	37150	37163	O	-1	-1	0
.	PMC5005937	37163	37164	O	-1	-1	0

32	PMC5005937	37165	37167	O	-1	-1	0
.	PMC5005937	37167	37168	O	-1	-1	0

Tehranifar	PMC5005937	37169	37179	O	-1	-1	0
P	PMC5005937	37180	37181	O	-1	-1	0
,	PMC5005937	37181	37182	O	-1	-1	0
Wu	PMC5005937	37183	37185	O	-1	-1	0
HC	PMC5005937	37186	37188	O	-1	-1	0
,	PMC5005937	37188	37189	O	-1	-1	0
Shriver	PMC5005937	37190	37197	O	-1	-1	0
T	PMC5005937	37198	37199	O	-1	-1	0
,	PMC5005937	37199	37200	O	-1	-1	0
Cloud	PMC5005937	37201	37206	O	-1	-1	0
AJ	PMC5005937	37207	37209	O	-1	-1	0
,	PMC5005937	37209	37210	O	-1	-1	0
Terry	PMC5005937	37211	37216	O	-1	-1	0
MB	PMC5005937	37217	37219	O	-1	-1	0
.	PMC5005937	37219	37220	O	-1	-1	0
Validation	PMC5005937	37221	37231	O	-1	-1	0
of	PMC5005937	37232	37234	O	-1	-1	0
Family	PMC5005937	37235	37241	O	-1	-1	0
Cancer	PMC5005937	37242	37248	O	-1	-1	0
History	PMC5005937	37249	37256	O	-1	-1	0
Data	PMC5005937	37257	37261	O	-1	-1	0
in	PMC5005937	37262	37264	O	-1	-1	0
High	PMC5005937	37265	37269	O	-1	-1	0
-	PMC5005937	37269	37270	O	-1	-1	0
Risk	PMC5005937	37270	37274	O	-1	-1	0
Families	PMC5005937	37275	37283	O	-1	-1	0
:	PMC5005937	37283	37284	O	-1	-1	0
The	PMC5005937	37285	37288	O	-1	-1	0
Influence	PMC5005937	37289	37298	O	-1	-1	0
of	PMC5005937	37299	37301	O	-1	-1	0
Cancer	PMC5005937	37302	37308	O	-1	-1	0
Site	PMC5005937	37309	37313	O	-1	-1	0
,	PMC5005937	37313	37314	O	-1	-1	0
Ethnicity	PMC5005937	37315	37324	O	-1	-1	0
,	PMC5005937	37324	37325	O	-1	-1	0
Kinship	PMC5005937	37326	37333	O	-1	-1	0
Degree	PMC5005937	37334	37340	O	-1	-1	0
,	PMC5005937	37340	37341	O	-1	-1	0
and	PMC5005937	37342	37345	O	-1	-1	0
Multiple	PMC5005937	37346	37354	O	-1	-1	0
Family	PMC5005937	37355	37361	O	-1	-1	0
Reporters	PMC5005937	37362	37371	O	-1	-1	0
.	PMC5005937	37371	37372	O	-1	-1	0

Am	PMC5005937	37373	37375	O	-1	-1	0
J	PMC5005937	37376	37377	O	-1	-1	0
Epidemiol	PMC5005937	37378	37387	O	-1	-1	0
2015	PMC5005937	37388	37392	O	-1	-1	0
;	PMC5005937	37392	37393	O	-1	-1	0
181:204–12	PMC5005937	37394	37404	O	-1	-1	0

33	PMC5005937	37405	37407	O	-1	-1	0
.	PMC5005937	37407	37408	O	-1	-1	0

Andrulis	PMC5005937	37409	37417	O	-1	-1	0
IL	PMC5005937	37418	37420	O	-1	-1	0
,	PMC5005937	37420	37421	O	-1	-1	0
Anton	PMC5005937	37422	37427	O	-1	-1	0
-	PMC5005937	37427	37428	O	-1	-1	0
Culver	PMC5005937	37428	37434	O	-1	-1	0
H	PMC5005937	37435	37436	O	-1	-1	0
,	PMC5005937	37436	37437	O	-1	-1	0
Beck	PMC5005937	37438	37442	O	-1	-1	0
J	PMC5005937	37443	37444	O	-1	-1	0

et	PMC5005937	37445	37447	O	-1	-1	0
al	PMC5005937	37448	37450	O	-1	-1	0
.	PMC5005937	37450	37451	O	-1	-1	0

Comparison	PMC5005937	37452	37462	O	-1	-1	0
of	PMC5005937	37463	37465	O	-1	-1	0
DNAand	PMC5005937	37466	37472	O	-1	-1	0
RNA	PMC5005937	37473	37476	O	-1	-1	0
-	PMC5005937	37476	37477	O	-1	-1	0
based	PMC5005937	37477	37482	O	-1	-1	0
methods	PMC5005937	37483	37490	O	-1	-1	0
for	PMC5005937	37491	37494	O	-1	-1	0
detection	PMC5005937	37495	37504	O	-1	-1	0
of	PMC5005937	37505	37507	O	-1	-1	0
truncating	PMC5005937	37508	37518	O	-1	-1	0
BRCA1	PMC5005937	37519	37524	O	-1	-1	0
mutations	PMC5005937	37525	37534	O	-1	-1	0
.	PMC5005937	37534	37535	O	-1	-1	0

Hum	PMC5005937	37536	37539	O	-1	-1	0
Mutat	PMC5005937	37540	37545	O	-1	-1	0
2002;20:65–73	PMC5005937	37546	37559	O	-1	-1	0
.	PMC5005937	37559	37560	O	-1	-1	0


	PMC5005937	37560	37562	O	-1	-1	0

692	PMC5005937	37562	37565	O	-1	-1	0

34	PMC5005937	37566	37568	O	-1	-1	0
.	PMC5005937	37568	37569	O	-1	-1	0

Neuhausen	PMC5005937	37570	37579	O	-1	-1	0
SL	PMC5005937	37580	37582	O	-1	-1	0
,	PMC5005937	37582	37583	O	-1	-1	0
Ozcelik	PMC5005937	37584	37591	O	-1	-1	0
H	PMC5005937	37592	37593	O	-1	-1	0
,	PMC5005937	37593	37594	O	-1	-1	0
Southey	PMC5005937	37595	37602	O	-1	-1	0
MC	PMC5005937	37603	37605	O	-1	-1	0

et	PMC5005937	37606	37608	O	-1	-1	0
al	PMC5005937	37609	37611	O	-1	-1	0
.	PMC5005937	37611	37612	O	-1	-1	0

BRCA1	PMC5005937	37613	37618	O	-1	-1	0
and	PMC5005937	37619	37622	O	-1	-1	0

BRCA2	PMC5005937	37623	37628	O	-1	-1	0
mutation	PMC5005937	37629	37637	O	-1	-1	0
carriers	PMC5005937	37638	37646	O	-1	-1	0
in	PMC5005937	37647	37649	O	-1	-1	0
the	PMC5005937	37650	37653	O	-1	-1	0
Breast	PMC5005937	37654	37660	O	-1	-1	0
Cancer	PMC5005937	37661	37667	O	-1	-1	0
Family	PMC5005937	37668	37674	O	-1	-1	0
Registry	PMC5005937	37675	37683	O	-1	-1	0
:	PMC5005937	37683	37684	O	-1	-1	0
an	PMC5005937	37685	37687	O	-1	-1	0
open	PMC5005937	37688	37692	O	-1	-1	0
resource	PMC5005937	37693	37701	O	-1	-1	0
for	PMC5005937	37702	37705	O	-1	-1	0
collaborative	PMC5005937	37706	37719	O	-1	-1	0
research	PMC5005937	37720	37728	O	-1	-1	0
.	PMC5005937	37728	37729	O	-1	-1	0

Breast	PMC5005937	37730	37736	O	-1	-1	0
Cancer	PMC5005937	37737	37743	O	-1	-1	0
Res	PMC5005937	37744	37747	O	-1	-1	0
Treat	PMC5005937	37748	37753	O	-1	-1	0
2009;116:379–86	PMC5005937	37754	37769	O	-1	-1	0
.	PMC5005937	37769	37770	O	-1	-1	0

35	PMC5005937	37771	37773	O	-1	-1	0
.	PMC5005937	37773	37774	O	-1	-1	0

Barisic	PMC5005937	37775	37782	O	-1	-1	0
AG	PMC5005937	37783	37785	O	-1	-1	0
,	PMC5005937	37785	37786	O	-1	-1	0
Weerasooriya	PMC5005937	37787	37799	O	-1	-1	0
N	PMC5005937	37800	37801	O	-1	-1	0
,	PMC5005937	37801	37802	O	-1	-1	0
Andrulis	PMC5005937	37803	37811	O	-1	-1	0
IL	PMC5005937	37812	37814	O	-1	-1	0
,	PMC5005937	37814	37815	O	-1	-1	0
Knight	PMC5005937	37816	37822	O	-1	-1	0
JA	PMC5005937	37823	37825	O	-1	-1	0
.	PMC5005937	37825	37826	O	-1	-1	0

Agreement	PMC5005937	37827	37836	O	-1	-1	0
between	PMC5005937	37837	37844	O	-1	-1	0
self	PMC5005937	37845	37849	O	-1	-1	0
-	PMC5005937	37849	37850	O	-1	-1	0
reported	PMC5005937	37850	37858	O	-1	-1	0
breast	PMC5005937	37859	37865	O	-1	-1	0
cancer	PMC5005937	37866	37872	O	-1	-1	0
information	PMC5005937	37873	37884	O	-1	-1	0
and	PMC5005937	37885	37888	O	-1	-1	0
medical	PMC5005937	37889	37896	O	-1	-1	0
records	PMC5005937	37897	37904	O	-1	-1	0
among	PMC5005937	37905	37910	O	-1	-1	0
women	PMC5005937	37911	37916	O	-1	-1	0
in	PMC5005937	37917	37919	O	-1	-1	0
the	PMC5005937	37920	37923	O	-1	-1	0
Ontario	PMC5005937	37924	37931	O	-1	-1	0
Familial	PMC5005937	37932	37940	O	-1	-1	0
Breast	PMC5005937	37941	37947	O	-1	-1	0
Cancer	PMC5005937	37948	37954	O	-1	-1	0
Registry	PMC5005937	37955	37963	O	-1	-1	0
.	PMC5005937	37963	37964	O	-1	-1	0

J	PMC5005937	37965	37966	O	-1	-1	0
Cancer	PMC5005937	37967	37973	O	-1	-1	0
Epidemio	PMC5005937	37974	37982	O	-1	-1	0
2012;3:10804	PMC5005937	37983	37995	O	-1	-1	0
.	PMC5005937	37995	37996	O	-1	-1	0

36	PMC5005937	37997	37999	O	-1	-1	0
.	PMC5005937	37999	38000	O	-1	-1	0

Phillips	PMC5005937	38001	38009	O	-1	-1	0
KA	PMC5005937	38010	38012	O	-1	-1	0
,	PMC5005937	38012	38013	O	-1	-1	0
Milne	PMC5005937	38014	38019	O	-1	-1	0
RL	PMC5005937	38020	38022	O	-1	-1	0
,	PMC5005937	38022	38023	O	-1	-1	0
Buys	PMC5005937	38024	38028	O	-1	-1	0
S	PMC5005937	38029	38030	O	-1	-1	0
et	PMC5005937	38031	38033	O	-1	-1	0
al	PMC5005937	38034	38036	O	-1	-1	0
.	PMC5005937	38036	38037	O	-1	-1	0

Agreement	PMC5005937	38038	38047	O	-1	-1	0
between	PMC5005937	38048	38055	O	-1	-1	0
self	PMC5005937	38056	38060	O	-1	-1	0
-	PMC5005937	38060	38061	O	-1	-1	0
reported	PMC5005937	38061	38069	O	-1	-1	0
breast	PMC5005937	38070	38076	O	-1	-1	0
cancer	PMC5005937	38077	38083	O	-1	-1	0
treatment	PMC5005937	38084	38093	O	-1	-1	0
and	PMC5005937	38094	38097	O	-1	-1	0
medical	PMC5005937	38098	38105	O	-1	-1	0
records	PMC5005937	38106	38113	O	-1	-1	0
in	PMC5005937	38114	38116	O	-1	-1	0
a	PMC5005937	38117	38118	O	-1	-1	0
population	PMC5005937	38119	38129	O	-1	-1	0
-	PMC5005937	38129	38130	O	-1	-1	0
based	PMC5005937	38130	38135	O	-1	-1	0
Breast	PMC5005937	38136	38142	O	-1	-1	0
Cancer	PMC5005937	38143	38149	O	-1	-1	0
Family	PMC5005937	38150	38156	O	-1	-1	0
Registry	PMC5005937	38157	38165	O	-1	-1	0
.	PMC5005937	38165	38166	O	-1	-1	0

J	PMC5005937	38167	38168	O	-1	-1	0
Clin	PMC5005937	38169	38173	O	-1	-1	0
Oncol	PMC5005937	38174	38179	O	-1	-1	0
2005;23	PMC5005937	38180	38187	O	-1	-1	0
:	PMC5005937	38187	38188	O	-1	-1	0

4679–86	PMC5005937	38189	38196	O	-1	-1	0
.	PMC5005937	38196	38197	O	-1	-1	0

37	PMC5005937	38198	38200	O	-1	-1	0
.	PMC5005937	38200	38201	O	-1	-1	0

Delgado	PMC5005937	38202	38209	O	-1	-1	0
-	PMC5005937	38209	38210	O	-1	-1	0
Cruzata	PMC5005937	38210	38217	O	-1	-1	0
L	PMC5005937	38218	38219	O	-1	-1	0
,	PMC5005937	38219	38220	O	-1	-1	0
Wu	PMC5005937	38221	38223	O	-1	-1	0
HC	PMC5005937	38224	38226	O	-1	-1	0
,	PMC5005937	38226	38227	O	-1	-1	0
Perrin	PMC5005937	38228	38234	O	-1	-1	0
M	PMC5005937	38235	38236	O	-1	-1	0

et	PMC5005937	38237	38239	O	-1	-1	0
al	PMC5005937	38240	38242	O	-1	-1	0
.	PMC5005937	38242	38243	O	-1	-1	0

Global	PMC5005937	38244	38250	O	-1	-1	0
DNA	PMC5005937	38251	38254	O	-1	-1	0
methylation	PMC5005937	38255	38266	O	-1	-1	0
levels	PMC5005937	38267	38273	O	-1	-1	0
in	PMC5005937	38274	38276	O	-1	-1	0
white	PMC5005937	38277	38282	O	-1	-1	0
blood	PMC5005937	38283	38288	O	-1	-1	0
cell	PMC5005937	38289	38293	O	-1	-1	0
DNA	PMC5005937	38294	38297	O	-1	-1	0
from	PMC5005937	38298	38302	O	-1	-1	0
sisters	PMC5005937	38303	38310	O	-1	-1	0
discordant	PMC5005937	38311	38321	O	-1	-1	0
for	PMC5005937	38322	38325	O	-1	-1	0
breast	PMC5005937	38326	38332	O	-1	-1	0
cancer	PMC5005937	38333	38339	O	-1	-1	0
from	PMC5005937	38340	38344	O	-1	-1	0
the	PMC5005937	38345	38348	O	-1	-1	0
New	PMC5005937	38349	38352	O	-1	-1	0
York	PMC5005937	38353	38357	O	-1	-1	0
site	PMC5005937	38358	38362	O	-1	-1	0
of	PMC5005937	38363	38365	O	-1	-1	0
the	PMC5005937	38366	38369	O	-1	-1	0
Breast	PMC5005937	38370	38376	O	-1	-1	0
Cancer	PMC5005937	38377	38383	O	-1	-1	0
Family	PMC5005937	38384	38390	O	-1	-1	0
Registry	PMC5005937	38391	38399	O	-1	-1	0
.	PMC5005937	38399	38400	O	-1	-1	0

Epigenetics	PMC5005937	38401	38412	O	-1	-1	0
2012;7:868–74	PMC5005937	38413	38426	O	-1	-1	0
.	PMC5005937	38426	38427	O	-1	-1	0

38	PMC5005937	38428	38430	O	-1	-1	0
.	PMC5005937	38430	38431	O	-1	-1	0

Wu	PMC5005937	38432	38434	O	-1	-1	0
HC	PMC5005937	38435	38437	O	-1	-1	0
,	PMC5005937	38437	38438	O	-1	-1	0
Wang	PMC5005937	38439	38443	O	-1	-1	0
Q	PMC5005937	38444	38445	O	-1	-1	0
,	PMC5005937	38445	38446	O	-1	-1	0
Yang	PMC5005937	38447	38451	O	-1	-1	0
HI	PMC5005937	38452	38454	O	-1	-1	0
,	PMC5005937	38454	38455	O	-1	-1	0
Tsai	PMC5005937	38456	38460	O	-1	-1	0
WY	PMC5005937	38461	38463	O	-1	-1	0
,	PMC5005937	38463	38464	O	-1	-1	0
Chen	PMC5005937	38465	38469	O	-1	-1	0
CJ	PMC5005937	38470	38472	O	-1	-1	0
,	PMC5005937	38472	38473	O	-1	-1	0
Santella	PMC5005937	38474	38482	O	-1	-1	0
RM	PMC5005937	38483	38485	O	-1	-1	0
.	PMC5005937	38485	38486	O	-1	-1	0

Global	PMC5005937	38487	38493	O	-1	-1	0
DNA	PMC5005937	38494	38497	O	-1	-1	0
methylation	PMC5005937	38498	38509	O	-1	-1	0
levels	PMC5005937	38510	38516	O	-1	-1	0
in	PMC5005937	38517	38519	O	-1	-1	0
white	PMC5005937	38520	38525	O	-1	-1	0
blood	PMC5005937	38526	38531	O	-1	-1	0
cells	PMC5005937	38532	38537	O	-1	-1	0
as	PMC5005937	38538	38540	O	-1	-1	0
a	PMC5005937	38541	38542	O	-1	-1	0
biomarker	PMC5005937	38543	38552	O	-1	-1	0
for	PMC5005937	38553	38556	O	-1	-1	0
hepatocellular	PMC5005937	38557	38571	O	-1	-1	0
carcinoma	PMC5005937	38572	38581	O	-1	-1	0
risk	PMC5005937	38582	38586	O	-1	-1	0
:	PMC5005937	38586	38587	O	-1	-1	0
a	PMC5005937	38588	38589	O	-1	-1	0
nested	PMC5005937	38590	38596	O	-1	-1	0
case	PMC5005937	38597	38601	O	-1	-1	0
-	PMC5005937	38601	38602	O	-1	-1	0
control	PMC5005937	38602	38609	O	-1	-1	0
study	PMC5005937	38610	38615	O	-1	-1	0
.	PMC5005937	38615	38616	O	-1	-1	0

Carcinogenesis	PMC5005937	38617	38631	O	-1	-1	0
2012;33:1340–45	PMC5005937	38632	38647	O	-1	-1	0
.	PMC5005937	38647	38648	O	-1	-1	0

39	PMC5005937	38649	38651	O	-1	-1	0
.	PMC5005937	38651	38652	O	-1	-1	0

Smoking	PMC5005937	38653	38660	O	-1	-1	0
and	PMC5005937	38661	38664	O	-1	-1	0
risk	PMC5005937	38665	38669	O	-1	-1	0
of	PMC5005937	38670	38672	O	-1	-1	0
breast	PMC5005937	38673	38679	O	-1	-1	0
cancer	PMC5005937	38680	38686	O	-1	-1	0
in	PMC5005937	38687	38689	O	-1	-1	0
carriers	PMC5005937	38690	38698	O	-1	-1	0
of	PMC5005937	38699	38701	O	-1	-1	0
mutations	PMC5005937	38702	38711	O	-1	-1	0
in	PMC5005937	38712	38714	O	-1	-1	0
BRCA1	PMC5005937	38715	38720	O	-1	-1	0
or	PMC5005937	38721	38723	O	-1	-1	0
BRCA2	PMC5005937	38724	38729	O	-1	-1	0
aged	PMC5005937	38730	38734	O	-1	-1	0
less	PMC5005937	38735	38739	O	-1	-1	0
than	PMC5005937	38740	38744	O	-1	-1	0
50	PMC5005937	38745	38747	O	-1	-1	0
years	PMC5005937	38748	38753	O	-1	-1	0
.	PMC5005937	38753	38754	O	-1	-1	0

Breast	PMC5005937	38755	38761	O	-1	-1	0
Cancer	PMC5005937	38762	38768	O	-1	-1	0
Res	PMC5005937	38769	38772	O	-1	-1	0
Treat	PMC5005937	38773	38778	O	-1	-1	0
2008;109:67–75	PMC5005937	38779	38793	O	-1	-1	0
.	PMC5005937	38793	38794	O	-1	-1	0

40	PMC5005937	38795	38797	O	-1	-1	0
.	PMC5005937	38797	38798	O	-1	-1	0

McGuire	PMC5005937	38799	38806	O	-1	-1	0
V	PMC5005937	38807	38808	O	-1	-1	0
,	PMC5005937	38808	38809	O	-1	-1	0
John	PMC5005937	38810	38814	O	-1	-1	0
EM	PMC5005937	38815	38817	O	-1	-1	0
,	PMC5005937	38817	38818	O	-1	-1	0
Felberg	PMC5005937	38819	38826	O	-1	-1	0
A	PMC5005937	38827	38828	O	-1	-1	0

et	PMC5005937	38829	38831	O	-1	-1	0
al	PMC5005937	38832	38834	O	-1	-1	0
.	PMC5005937	38834	38835	O	-1	-1	0

No	PMC5005937	38836	38838	O	-1	-1	0
increased	PMC5005937	38839	38848	O	-1	-1	0
risk	PMC5005937	38849	38853	O	-1	-1	0
of	PMC5005937	38854	38856	O	-1	-1	0
breast	PMC5005937	38857	38863	O	-1	-1	0
cancer	PMC5005937	38864	38870	O	-1	-1	0
associated	PMC5005937	38871	38881	O	-1	-1	0
with	PMC5005937	38882	38886	O	-1	-1	0
alcohol	PMC5005937	38887	38894	O	-1	-1	0
consumption	PMC5005937	38895	38906	O	-1	-1	0
among	PMC5005937	38907	38912	O	-1	-1	0
carriers	PMC5005937	38913	38921	O	-1	-1	0
of	PMC5005937	38922	38924	O	-1	-1	0
BRCA1	PMC5005937	38925	38930	O	-1	-1	0
and	PMC5005937	38931	38934	O	-1	-1	0
BRCA2	PMC5005937	38935	38940	O	-1	-1	0
mutations	PMC5005937	38941	38950	O	-1	-1	0
ages	PMC5005937	38951	38955	O	-1	-1	0
<	PMC5005937	38956	38957	O	-1	-1	0
50	PMC5005937	38957	38959	O	-1	-1	0
years	PMC5005937	38960	38965	O	-1	-1	0
.	PMC5005937	38965	38966	O	-1	-1	0

Cancer	PMC5005937	38967	38973	O	-1	-1	0
Epodemiol	PMC5005937	38974	38983	O	-1	-1	0
Biomarkers	PMC5005937	38984	38994	O	-1	-1	0
Prev	PMC5005937	38995	38999	O	-1	-1	0
2006;15:1565–67	PMC5005937	39000	39015	O	-1	-1	0
.	PMC5005937	39015	39016	O	-1	-1	0

41	PMC5005937	39017	39019	O	-1	-1	0
.	PMC5005937	39019	39020	O	-1	-1	0

Milne	PMC5005937	39021	39026	O	-1	-1	0
RL	PMC5005937	39027	39029	O	-1	-1	0
,	PMC5005937	39029	39030	O	-1	-1	0
Knight	PMC5005937	39031	39037	O	-1	-1	0
JA	PMC5005937	39038	39040	O	-1	-1	0
,	PMC5005937	39040	39041	O	-1	-1	0
John	PMC5005937	39042	39046	O	-1	-1	0
EM	PMC5005937	39047	39049	O	-1	-1	0

et	PMC5005937	39050	39052	O	-1	-1	0
al	PMC5005937	39053	39055	O	-1	-1	0
.	PMC5005937	39055	39056	O	-1	-1	0

Oral	PMC5005937	39057	39061	O	-1	-1	0
contraceptive	PMC5005937	39062	39075	O	-1	-1	0
use	PMC5005937	39076	39079	O	-1	-1	0
and	PMC5005937	39080	39083	O	-1	-1	0
risk	PMC5005937	39084	39088	O	-1	-1	0
of	PMC5005937	39089	39091	O	-1	-1	0
early	PMC5005937	39092	39097	O	-1	-1	0
-	PMC5005937	39097	39098	O	-1	-1	0
onset	PMC5005937	39098	39103	O	-1	-1	0
breast	PMC5005937	39104	39110	O	-1	-1	0
cancer	PMC5005937	39111	39117	O	-1	-1	0
in	PMC5005937	39118	39120	O	-1	-1	0
carriers	PMC5005937	39121	39129	O	-1	-1	0
and	PMC5005937	39130	39133	O	-1	-1	0
noncarriers	PMC5005937	39134	39145	O	-1	-1	0
of	PMC5005937	39146	39148	O	-1	-1	0
BRCA1	PMC5005937	39149	39154	O	-1	-1	0
and	PMC5005937	39155	39158	O	-1	-1	0
BRCA2	PMC5005937	39159	39164	O	-1	-1	0
mutations	PMC5005937	39165	39174	O	-1	-1	0
.	PMC5005937	39174	39175	O	-1	-1	0

Cancer	PMC5005937	39176	39182	O	-1	-1	0
Epodemiol	PMC5005937	39183	39192	O	-1	-1	0
Biomarkers	PMC5005937	39193	39203	O	-1	-1	0

Prev	PMC5005937	39204	39208	O	-1	-1	0
2005;14:350–56	PMC5005937	39209	39223	O	-1	-1	0
.	PMC5005937	39223	39224	O	-1	-1	0


	PMC5005937	39224	39226	O	-1	-1	0

International	PMC5005937	39226	39239	O	-1	-1	0
Journal	PMC5005937	39240	39247	O	-1	-1	0
of	PMC5005937	39248	39250	O	-1	-1	0
Epidemiology	PMC5005937	39251	39263	O	-1	-1	0
,	PMC5005937	39263	39264	O	-1	-1	0
2016	PMC5005937	39265	39269	O	-1	-1	0
,	PMC5005937	39269	39270	O	-1	-1	0
Vol	PMC5005937	39271	39274	O	-1	-1	0
.	PMC5005937	39274	39275	O	-1	-1	0

45	PMC5005937	39276	39278	O	-1	-1	0
,	PMC5005937	39278	39279	O	-1	-1	0

No	PMC5005937	39280	39282	O	-1	-1	0
.	PMC5005937	39282	39283	O	-1	-1	0
3	PMC5005937	39284	39285	O	-1	-1	0

42	PMC5005937	39286	39288	O	-1	-1	0
.	PMC5005937	39288	39289	O	-1	-1	0

Haile	PMC5005937	39290	39295	O	-1	-1	0
RW	PMC5005937	39296	39298	O	-1	-1	0
,	PMC5005937	39298	39299	O	-1	-1	0
Thomas	PMC5005937	39300	39306	O	-1	-1	0
DC	PMC5005937	39307	39309	O	-1	-1	0
,	PMC5005937	39309	39310	O	-1	-1	0
McGuire	PMC5005937	39311	39318	O	-1	-1	0
V	PMC5005937	39319	39320	O	-1	-1	0
et	PMC5005937	39321	39323	O	-1	-1	0
al	PMC5005937	39324	39326	O	-1	-1	0
.	PMC5005937	39326	39327	O	-1	-1	0

BRCA1	PMC5005937	39328	39333	O	-1	-1	0
and	PMC5005937	39334	39337	O	-1	-1	0
BRCA2	PMC5005937	39338	39343	O	-1	-1	0

mutation	PMC5005937	39344	39352	O	-1	-1	0
carriers	PMC5005937	39353	39361	O	-1	-1	0
,	PMC5005937	39361	39362	O	-1	-1	0
oral	PMC5005937	39363	39367	O	-1	-1	0
contraceptive	PMC5005937	39368	39381	O	-1	-1	0
use	PMC5005937	39382	39385	O	-1	-1	0
,	PMC5005937	39385	39386	O	-1	-1	0
and	PMC5005937	39387	39390	O	-1	-1	0
breast	PMC5005937	39391	39397	O	-1	-1	0
cancer	PMC5005937	39398	39404	O	-1	-1	0
before	PMC5005937	39405	39411	O	-1	-1	0
age	PMC5005937	39412	39415	O	-1	-1	0
50	PMC5005937	39416	39418	O	-1	-1	0
.	PMC5005937	39418	39419	O	-1	-1	0

Cancer	PMC5005937	39420	39426	O	-1	-1	0
Epodemiol	PMC5005937	39427	39436	O	-1	-1	0
Biomarkers	PMC5005937	39437	39447	O	-1	-1	0
Prev	PMC5005937	39448	39452	O	-1	-1	0
2006;15	PMC5005937	39453	39460	O	-1	-1	0
:	PMC5005937	39460	39461	O	-1	-1	0

1863–70	PMC5005937	39462	39469	O	-1	-1	0
.	PMC5005937	39469	39470	O	-1	-1	0

43	PMC5005937	39471	39473	O	-1	-1	0
.	PMC5005937	39473	39474	O	-1	-1	0

John	PMC5005937	39475	39479	O	-1	-1	0
EM	PMC5005937	39480	39482	O	-1	-1	0
,	PMC5005937	39482	39483	O	-1	-1	0
Phipps	PMC5005937	39484	39490	O	-1	-1	0
AI	PMC5005937	39491	39493	O	-1	-1	0
,	PMC5005937	39493	39494	O	-1	-1	0
Knight	PMC5005937	39495	39501	O	-1	-1	0
JA	PMC5005937	39502	39504	O	-1	-1	0
et	PMC5005937	39505	39507	O	-1	-1	0
al	PMC5005937	39508	39510	O	-1	-1	0
.	PMC5005937	39510	39511	O	-1	-1	0

Medical	PMC5005937	39512	39519	O	-1	-1	0
radiation	PMC5005937	39520	39529	O	-1	-1	0
exposure	PMC5005937	39530	39538	O	-1	-1	0
and	PMC5005937	39539	39542	O	-1	-1	0
breast	PMC5005937	39543	39549	O	-1	-1	0
cancer	PMC5005937	39550	39556	O	-1	-1	0
risk	PMC5005937	39557	39561	O	-1	-1	0
:	PMC5005937	39561	39562	O	-1	-1	0
findings	PMC5005937	39563	39571	O	-1	-1	0
from	PMC5005937	39572	39576	O	-1	-1	0
the	PMC5005937	39577	39580	O	-1	-1	0
Breast	PMC5005937	39581	39587	O	-1	-1	0
Cancer	PMC5005937	39588	39594	O	-1	-1	0
Family	PMC5005937	39595	39601	O	-1	-1	0
Registry	PMC5005937	39602	39610	O	-1	-1	0
.	PMC5005937	39610	39611	O	-1	-1	0

Int	PMC5005937	39612	39615	O	-1	-1	0
J	PMC5005937	39616	39617	O	-1	-1	0
Cancer	PMC5005937	39618	39624	O	-1	-1	0
2007;121:386–94	PMC5005937	39625	39640	O	-1	-1	0
.	PMC5005937	39640	39641	O	-1	-1	0

44	PMC5005937	39642	39644	O	-1	-1	0
.	PMC5005937	39644	39645	O	-1	-1	0

Cloud	PMC5005937	39646	39651	O	-1	-1	0
AJ	PMC5005937	39652	39654	O	-1	-1	0
,	PMC5005937	39654	39655	O	-1	-1	0
Thai	PMC5005937	39656	39660	O	-1	-1	0
A	PMC5005937	39661	39662	O	-1	-1	0
,	PMC5005937	39662	39663	O	-1	-1	0
Liao	PMC5005937	39664	39668	O	-1	-1	0
Y	PMC5005937	39669	39670	O	-1	-1	0
,	PMC5005937	39670	39671	O	-1	-1	0
Terry	PMC5005937	39672	39677	O	-1	-1	0
MB	PMC5005937	39678	39680	O	-1	-1	0
.	PMC5005937	39680	39681	O	-1	-1	0

The	PMC5005937	39682	39685	O	-1	-1	0
impact	PMC5005937	39686	39692	O	-1	-1	0
of	PMC5005937	39693	39695	O	-1	-1	0
cancer	PMC5005937	39696	39702	O	-1	-1	0
prevention	PMC5005937	39703	39713	O	-1	-1	0
guideline	PMC5005937	39714	39723	O	-1	-1	0
adherence	PMC5005937	39724	39733	O	-1	-1	0
on	PMC5005937	39734	39736	O	-1	-1	0
overall	PMC5005937	39737	39744	O	-1	-1	0
mortality	PMC5005937	39745	39754	O	-1	-1	0
in	PMC5005937	39755	39757	O	-1	-1	0
a	PMC5005937	39758	39759	O	-1	-1	0
high	PMC5005937	39760	39764	O	-1	-1	0
-	PMC5005937	39764	39765	O	-1	-1	0
risk	PMC5005937	39765	39769	O	-1	-1	0
cohort	PMC5005937	39770	39776	O	-1	-1	0
of	PMC5005937	39777	39779	O	-1	-1	0
women	PMC5005937	39780	39785	O	-1	-1	0
from	PMC5005937	39786	39790	O	-1	-1	0
the	PMC5005937	39791	39794	O	-1	-1	0
New	PMC5005937	39795	39798	O	-1	-1	0
York	PMC5005937	39799	39803	O	-1	-1	0
site	PMC5005937	39804	39808	O	-1	-1	0
of	PMC5005937	39809	39811	O	-1	-1	0
the	PMC5005937	39812	39815	O	-1	-1	0
Breast	PMC5005937	39816	39822	O	-1	-1	0
Cancer	PMC5005937	39823	39829	O	-1	-1	0
Family	PMC5005937	39830	39836	O	-1	-1	0
Registry	PMC5005937	39837	39845	O	-1	-1	0
.	PMC5005937	39845	39846	O	-1	-1	0

Breast	PMC5005937	39847	39853	O	-1	-1	0
Cancer	PMC5005937	39854	39860	O	-1	-1	0
Res	PMC5005937	39861	39864	O	-1	-1	0
Treat	PMC5005937	39865	39870	O	-1	-1	0
2015;149:537–46	PMC5005937	39871	39886	O	-1	-1	0
.	PMC5005937	39886	39887	O	-1	-1	0

45	PMC5005937	39888	39890	O	-1	-1	0
.	PMC5005937	39890	39891	O	-1	-1	0

Gail	PMC5005937	39892	39896	O	-1	-1	0
MH	PMC5005937	39897	39899	O	-1	-1	0
,	PMC5005937	39899	39900	O	-1	-1	0
Greene	PMC5005937	39901	39907	O	-1	-1	0
MH	PMC5005937	39908	39910	O	-1	-1	0
.	PMC5005937	39910	39911	O	-1	-1	0

Gail	PMC5005937	39912	39916	O	-1	-1	0
model	PMC5005937	39917	39922	O	-1	-1	0
and	PMC5005937	39923	39926	O	-1	-1	0
breast	PMC5005937	39927	39933	O	-1	-1	0
cancer	PMC5005937	39934	39940	O	-1	-1	0
.	PMC5005937	39940	39941	O	-1	-1	0

Lancet	PMC5005937	39942	39948	O	-1	-1	0
2000;355:1017	PMC5005937	39949	39962	O	-1	-1	0
.	PMC5005937	39962	39963	O	-1	-1	0

46	PMC5005937	39964	39966	O	-1	-1	0
.	PMC5005937	39966	39967	O	-1	-1	0

Tyrer	PMC5005937	39968	39973	O	-1	-1	0
J	PMC5005937	39974	39975	O	-1	-1	0
,	PMC5005937	39975	39976	O	-1	-1	0
Duffy	PMC5005937	39977	39982	O	-1	-1	0
SW	PMC5005937	39983	39985	O	-1	-1	0
,	PMC5005937	39985	39986	O	-1	-1	0
Cuzick	PMC5005937	39987	39993	O	-1	-1	0
J.	PMC5005937	39994	39996	O	-1	-1	0
A	PMC5005937	39997	39998	O	-1	-1	0

breast	PMC5005937	39999	40005	O	-1	-1	0
cancer	PMC5005937	40006	40012	O	-1	-1	0
prediction	PMC5005937	40013	40023	O	-1	-1	0
model	PMC5005937	40024	40029	O	-1	-1	0
incorporating	PMC5005937	40030	40043	O	-1	-1	0
familial	PMC5005937	40044	40052	O	-1	-1	0
and	PMC5005937	40053	40056	O	-1	-1	0
personal	PMC5005937	40057	40065	O	-1	-1	0
risk	PMC5005937	40066	40070	O	-1	-1	0
factors	PMC5005937	40071	40078	O	-1	-1	0
.	PMC5005937	40078	40079	O	-1	-1	0

Stat	PMC5005937	40080	40084	O	-1	-1	0
Med	PMC5005937	40085	40088	O	-1	-1	0
2004	PMC5005937	40089	40093	O	-1	-1	0
;	PMC5005937	40093	40094	O	-1	-1	0
23:1111–30	PMC5005937	40095	40105	O	-1	-1	0
.	PMC5005937	40105	40106	O	-1	-1	0

47	PMC5005937	40107	40109	O	-1	-1	0
.	PMC5005937	40109	40110	O	-1	-1	0

Antoniou	PMC5005937	40111	40119	O	-1	-1	0
AC	PMC5005937	40120	40122	O	-1	-1	0
,	PMC5005937	40122	40123	O	-1	-1	0
Pharoah	PMC5005937	40124	40131	O	-1	-1	0
PP	PMC5005937	40132	40134	O	-1	-1	0
,	PMC5005937	40134	40135	O	-1	-1	0
Smith	PMC5005937	40136	40141	O	-1	-1	0
P	PMC5005937	40142	40143	O	-1	-1	0
,	PMC5005937	40143	40144	O	-1	-1	0
Easton	PMC5005937	40145	40151	O	-1	-1	0
DF	PMC5005937	40152	40154	O	-1	-1	0
.	PMC5005937	40154	40155	O	-1	-1	0

The	PMC5005937	40156	40159	O	-1	-1	0
BOADICEA	PMC5005937	40160	40168	O	-1	-1	0
model	PMC5005937	40169	40174	O	-1	-1	0
of	PMC5005937	40175	40177	O	-1	-1	0
genetic	PMC5005937	40178	40185	O	-1	-1	0
susceptibility	PMC5005937	40186	40200	O	-1	-1	0
to	PMC5005937	40201	40203	O	-1	-1	0
breast	PMC5005937	40204	40210	O	-1	-1	0
and	PMC5005937	40211	40214	O	-1	-1	0
ovarian	PMC5005937	40215	40222	O	-1	-1	0
cancer	PMC5005937	40223	40229	O	-1	-1	0
.	PMC5005937	40229	40230	O	-1	-1	0

Br	PMC5005937	40231	40233	O	-1	-1	0
J	PMC5005937	40234	40235	O	-1	-1	0
Cancer	PMC5005937	40236	40242	O	-1	-1	0
2004;91:1580–90	PMC5005937	40243	40258	O	-1	-1	0
.	PMC5005937	40258	40259	O	-1	-1	0

48	PMC5005937	40260	40262	O	-1	-1	0
.	PMC5005937	40262	40263	O	-1	-1	0

Quante	PMC5005937	40264	40270	O	-1	-1	0
AS	PMC5005937	40271	40273	O	-1	-1	0
,	PMC5005937	40273	40274	O	-1	-1	0
Whittemore	PMC5005937	40275	40285	O	-1	-1	0
AS	PMC5005937	40286	40288	O	-1	-1	0
,	PMC5005937	40288	40289	O	-1	-1	0
Shriver	PMC5005937	40290	40297	O	-1	-1	0
T	PMC5005937	40298	40299	O	-1	-1	0
,	PMC5005937	40299	40300	O	-1	-1	0
Strauch	PMC5005937	40301	40308	O	-1	-1	0
K	PMC5005937	40309	40310	O	-1	-1	0
,	PMC5005937	40310	40311	O	-1	-1	0
Terry	PMC5005937	40312	40317	O	-1	-1	0
MB	PMC5005937	40318	40320	O	-1	-1	0
.	PMC5005937	40320	40321	O	-1	-1	0

Breast	PMC5005937	40322	40328	O	-1	-1	0
cancer	PMC5005937	40329	40335	O	-1	-1	0
risk	PMC5005937	40336	40340	O	-1	-1	0
assessment	PMC5005937	40341	40351	O	-1	-1	0
across	PMC5005937	40352	40358	O	-1	-1	0
the	PMC5005937	40359	40362	O	-1	-1	0
risk	PMC5005937	40363	40367	O	-1	-1	0
continuum	PMC5005937	40368	40377	O	-1	-1	0
:	PMC5005937	40377	40378	O	-1	-1	0
genetic	PMC5005937	40379	40386	O	-1	-1	0
and	PMC5005937	40387	40390	O	-1	-1	0
nongenetic	PMC5005937	40391	40401	O	-1	-1	0
risk	PMC5005937	40402	40406	O	-1	-1	0
factors	PMC5005937	40407	40414	O	-1	-1	0
contributing	PMC5005937	40415	40427	O	-1	-1	0
to	PMC5005937	40428	40430	O	-1	-1	0
differential	PMC5005937	40431	40443	O	-1	-1	0
model	PMC5005937	40444	40449	O	-1	-1	0
performance	PMC5005937	40450	40461	O	-1	-1	0
.	PMC5005937	40461	40462	O	-1	-1	0

Breast	PMC5005937	40463	40469	O	-1	-1	0
Cancer	PMC5005937	40470	40476	O	-1	-1	0
Res	PMC5005937	40477	40480	O	-1	-1	0
2012;14	PMC5005937	40481	40488	O	-1	-1	0
:	PMC5005937	40488	40489	O	-1	-1	0
R144	PMC5005937	40489	40493	O	-1	-1	0
.	PMC5005937	40493	40494	O	-1	-1	0

49	PMC5005937	40495	40497	O	-1	-1	0
.	PMC5005937	40497	40498	O	-1	-1	0

MacInnis	PMC5005937	40499	40507	O	-1	-1	0
RJ	PMC5005937	40508	40510	O	-1	-1	0
,	PMC5005937	40510	40511	O	-1	-1	0
Bickerstaffe	PMC5005937	40512	40524	O	-1	-1	0
A	PMC5005937	40525	40526	O	-1	-1	0
,	PMC5005937	40526	40527	O	-1	-1	0
Apicella	PMC5005937	40528	40536	O	-1	-1	0
C	PMC5005937	40537	40538	O	-1	-1	0
et	PMC5005937	40539	40541	O	-1	-1	0
al	PMC5005937	40542	40544	O	-1	-1	0
.	PMC5005937	40544	40545	O	-1	-1	0

Prospective	PMC5005937	40546	40557	O	-1	-1	0
validation	PMC5005937	40558	40568	O	-1	-1	0
of	PMC5005937	40569	40571	O	-1	-1	0
the	PMC5005937	40572	40575	O	-1	-1	0
breast	PMC5005937	40576	40582	O	-1	-1	0
cancer	PMC5005937	40583	40589	O	-1	-1	0
risk	PMC5005937	40590	40594	O	-1	-1	0
prediction	PMC5005937	40595	40605	O	-1	-1	0
model	PMC5005937	40606	40611	O	-1	-1	0
BOADICEA	PMC5005937	40612	40620	O	-1	-1	0
and	PMC5005937	40621	40624	O	-1	-1	0
a	PMC5005937	40625	40626	O	-1	-1	0
batch	PMC5005937	40627	40632	O	-1	-1	0
-	PMC5005937	40632	40633	O	-1	-1	0
mode	PMC5005937	40633	40637	O	-1	-1	0
version	PMC5005937	40638	40645	O	-1	-1	0
BOADICEACentre	PMC5005937	40646	40660	O	-1	-1	0
.	PMC5005937	40660	40661	O	-1	-1	0

Br	PMC5005937	40662	40664	O	-1	-1	0
J	PMC5005937	40665	40666	O	-1	-1	0
Cancer	PMC5005937	40667	40673	O	-1	-1	0
2013	PMC5005937	40674	40678	O	-1	-1	0
;	PMC5005937	40678	40679	O	-1	-1	0
109:1296–301	PMC5005937	40680	40692	O	-1	-1	0
.	PMC5005937	40692	40693	O	-1	-1	0

50	PMC5005937	40694	40696	O	-1	-1	0
.	PMC5005937	40696	40697	O	-1	-1	0

Quante	PMC5005937	40698	40704	O	-1	-1	0
AS	PMC5005937	40705	40707	O	-1	-1	0
,	PMC5005937	40707	40708	O	-1	-1	0
Whittemore	PMC5005937	40709	40719	O	-1	-1	0
AS	PMC5005937	40720	40722	O	-1	-1	0
,	PMC5005937	40722	40723	O	-1	-1	0
Shriver	PMC5005937	40724	40731	O	-1	-1	0
T	PMC5005937	40732	40733	O	-1	-1	0
,	PMC5005937	40733	40734	O	-1	-1	0
Hopper	PMC5005937	40735	40741	O	-1	-1	0
JL	PMC5005937	40742	40744	O	-1	-1	0
,	PMC5005937	40744	40745	O	-1	-1	0
Strauch	PMC5005937	40746	40753	O	-1	-1	0
K	PMC5005937	40754	40755	O	-1	-1	0
,	PMC5005937	40755	40756	O	-1	-1	0
Terry	PMC5005937	40757	40762	O	-1	-1	0
MB	PMC5005937	40763	40765	O	-1	-1	0
.	PMC5005937	40765	40766	O	-1	-1	0

Practical	PMC5005937	40767	40776	O	-1	-1	0
problems	PMC5005937	40777	40785	O	-1	-1	0
with	PMC5005937	40786	40790	O	-1	-1	0
clinical	PMC5005937	40791	40799	O	-1	-1	0
guidelines	PMC5005937	40800	40810	O	-1	-1	0
for	PMC5005937	40811	40814	O	-1	-1	0
breast	PMC5005937	40815	40821	O	-1	-1	0
cancer	PMC5005937	40822	40828	O	-1	-1	0
prevention	PMC5005937	40829	40839	O	-1	-1	0
based	PMC5005937	40840	40845	O	-1	-1	0
on	PMC5005937	40846	40848	O	-1	-1	0
remaining	PMC5005937	40849	40858	O	-1	-1	0
lifetime	PMC5005937	40859	40867	O	-1	-1	0
risk	PMC5005937	40868	40872	O	-1	-1	0
.	PMC5005937	40872	40873	O	-1	-1	0

J	PMC5005937	40874	40875	O	-1	-1	0
Natl	PMC5005937	40876	40880	O	-1	-1	0

Cancer	PMC5005937	40881	40887	O	-1	-1	0
Inst	PMC5005937	40888	40892	O	-1	-1	0
2015;doi	PMC5005937	40893	40901	O	-1	-1	0
:	PMC5005937	40901	40902	O	-1	-1	0
10.1093	PMC5005937	40903	40910	O	-1	-1	0
/	PMC5005937	40910	40911	O	-1	-1	0
jnci	PMC5005937	40911	40915	O	-1	-1	0
/	PMC5005937	40915	40916	O	-1	-1	0
djv124	PMC5005937	40916	40922	O	-1	-1	0
.	PMC5005937	40922	40923	O	-1	-1	0


	PMC5005937	40923	40925	O	-1	-1	0

